data_2m8d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8d _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -175.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.64 1.176 . . . . 0.0 112.586 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.49 ' HB3' ' CG ' ' B' ' 161' ' ' GLU . 0.0 OUTLIER -162.44 179.6 7.68 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . 0.473 ' HB2' HD21 ' B' ' 121' ' ' ASN . 26.5 mt-10 -149.35 -31.21 0.23 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.45 -1.704 . . . . 0.0 113.406 -172.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' B' ' 120' ' ' GLU . 1.6 p30 -140.49 78.74 1.67 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.325 1.85 . . . . 0.0 107.42 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -87.29 158.0 19.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.44 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.65 142.17 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 127.987 2.515 . . . . 0.0 107.279 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.91 159.48 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.07 102.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -117.79 150.65 38.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.193 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.95 -2.71 55.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 14.4 tp -53.42 145.18 28.57 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 128.14 2.576 . . . . 0.0 110.151 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.36 162.45 38.34 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.053 2.502 . . . . 0.0 109.448 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.33 -12.64 35.53 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.881 2.387 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -72.75 -23.0 60.77 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.091 0.957 . . . . 0.0 111.779 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.59 46.25 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.4 0.444 . . . . 0.0 112.645 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 43.8 t -158.12 168.66 26.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -64.49 -30.13 71.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.446 0.566 . . . . 0.0 110.727 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -66.61 -37.07 84.1 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.938 0.335 . . . . 0.0 111.568 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -84.67 -17.88 37.13 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.856 0.298 . . . . 0.0 111.441 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -32.17 66.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -77.73 -38.57 46.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.97 1.57 0.9 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.531 1.132 . . . . 0.0 113.658 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.63 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.6 t60 -136.68 -40.37 0.62 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.413 0.551 . . . . 0.0 111.568 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' B' ' 171' ' ' ALA . 86.4 mmm -68.55 -11.6 60.16 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.413 0.551 . . . . 0.0 110.051 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -47.39 -21.38 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.885 0.874 . . . . 0.0 112.504 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.23 -42.74 88.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.824 -0.548 . . . . 0.0 111.164 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.45 -27.72 66.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.65 0.78 . . . . 0.0 111.666 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.5 -167.54 37.06 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -87.22 77.9 8.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.915 0.864 . . . . 0.0 110.157 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -62.96 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 43.5 t -128.06 -23.77 3.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.743 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -139.59 155.79 47.26 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 119.162 0.892 . . . . 0.0 110.331 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.86 165.12 35.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -147.62 153.61 39.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.48 HG21 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -132.35 147.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.113 0.482 . . . . 0.0 110.305 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.78 10.98 17.93 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.999 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.48 ' H ' HG21 ' B' ' 152' ' ' VAL . 28.0 mtt180 59.24 17.39 5.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.681 0.792 . . . . 0.0 113.053 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.11 15.16 3.28 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.0 52.35 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 11.8 p -140.69 159.19 42.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.352 0.661 . . . . 0.0 110.395 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.78 -170.27 38.39 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.5 161.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.804 0.442 . . . . 0.0 111.131 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -153.49 156.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 123.459 0.704 . . . . 0.0 109.885 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.49 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 1.2 tm-20 -152.39 155.39 37.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.944 0.498 . . . . 0.0 111.728 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -124.17 163.62 21.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.883 1.273 . . . . 0.0 111.73 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.7 -8.37 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.507 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -147.8 133.8 19.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -63.57 -20.66 65.82 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -76.02 -29.37 58.1 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.649 -0.657 . . . . 0.0 110.744 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.8 -19.01 60.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.426 ' HA ' ' CE1' ' B' ' 162' ' ' PHE . 31.7 ttp -77.97 -52.97 7.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.345 1.058 . . . . 0.0 110.674 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -63.46 -21.45 66.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.279 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.559 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 46.0 t80 -74.53 -31.72 62.23 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.413 ' HB3' ' CE ' ' B' ' 141' ' ' MET . . . -74.73 -17.56 60.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.288 0.635 . . . . 0.0 111.628 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.21 34.23 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.714 0.769 . . . . 0.0 111.702 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -143.28 -17.5 0.64 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.559 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -123.54 -25.82 4.3 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.39 0.676 . . . . 0.0 112.611 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.38 -2.64 21.96 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.357 0.263 . . . . 0.0 110.533 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.22 145.9 32.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.008 0.923 . . . . 0.0 109.013 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 29.67 17.85 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.435 0.694 . . . . 0.0 112.532 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 47.4 p -133.44 169.49 16.88 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.965 0.506 . . . . 0.0 110.701 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -57.85 149.47 22.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.63 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.0 t80 -141.71 161.1 38.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.982 1.713 . . . . 0.0 108.937 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 . . . . . 0 C--N 1.338 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 110.178 -170.05 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.69 160.48 19.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.326 1.051 . . . . 0.0 108.849 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.98 157.23 38.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 110.346 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 26.9 pt -123.59 151.7 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.746 0.784 . . . . 0.0 109.64 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -118.41 78.76 1.29 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.78 144.54 10.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 5.3 tttp -126.68 168.78 13.89 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.432 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.0 p -60.22 -29.55 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.526 1.531 . . . . 0.0 114.603 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 127.71 2.404 . . . . 0.0 109.058 -173.316 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -53.9 159.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.167 0.894 . . . . 0.0 112.192 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' B' ' 120' ' ' GLU . 6.8 t -140.1 -94.37 0.16 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' B' ' 119' ' ' SER . 29.5 mt-10 -153.89 -30.51 0.12 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -165.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.94 -37.24 2.12 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -165.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . 0.484 ' H ' ' HG3' ' B' ' 161' ' ' GLU . 86.8 mtt180 46.3 165.33 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' B' ' 168' ' ' MET . 0.0 OUTLIER -159.17 134.65 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 129.59 3.156 . . . . 0.0 107.717 170.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.16 165.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.2 136.41 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 54.6 p -135.32 147.45 49.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.907 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.07 -2.34 31.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.72 140.44 38.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 127.133 2.173 . . . . 0.0 110.076 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.3 162.35 19.92 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.638 2.892 . . . . 0.0 110.11 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -14.77 32.71 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.865 2.377 . . . . 0.0 109.761 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -83.1 6.24 19.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.689 1.196 . . . . 0.0 111.738 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.45 165.09 12.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -159.49 170.67 21.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -61.68 -28.45 69.41 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -69.31 -35.05 75.57 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.45 -19.59 22.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.25 0.477 . . . . 0.0 111.416 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.19 -26.48 59.04 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -75.22 -39.86 59.67 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.98 1.66 1.36 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.163 1.385 . . . . 0.0 113.179 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 8.4 t60 -135.38 -38.92 0.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.125 0.42 . . . . 0.0 111.37 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.0 mmm -68.14 -18.27 64.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.873 -0.517 . . . . 0.0 110.26 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -51.15 -19.88 1.32 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -56.57 -36.93 69.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.946 0.499 . . . . 0.0 111.169 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.424 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.2 -21.9 65.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.966 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.27 -93.82 0.11 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.902 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.8 121.1 6.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -121.84 150.54 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.02 -21.54 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.97 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -131.34 154.17 48.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.356 0.98 . . . . 0.0 111.801 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -158.28 161.48 37.71 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . 0.413 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 18.0 t0 -145.56 148.46 33.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.55 HG21 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -128.45 141.97 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.208 0.528 . . . . 0.0 110.48 -172.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -103.3 5.82 37.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.497 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.55 ' H ' HG21 ' B' ' 152' ' ' VAL . 23.5 mtp85 62.55 17.21 9.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.461 0.705 . . . . 0.0 112.388 170.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -137.38 -11.96 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.06 -2.84 2.15 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 118.872 0.76 . . . . 0.0 113.181 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.2 165.85 26.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.51 -165.72 34.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 4.2 p -142.0 161.25 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 122.971 0.509 . . . . 0.0 110.02 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.5 p -147.62 159.63 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' B' ' 122' ' ' ARG . 42.9 tt0 -154.83 146.96 23.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.912 -0.492 . . . . 0.0 111.968 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 60.6 m-85 -117.94 156.93 27.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.595 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.1 m -61.71 -12.55 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.399 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -152.5 151.16 30.39 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.748 0.819 . . . . 0.0 109.07 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.67 -22.97 65.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.4 -32.83 48.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.597 0.635 . . . . 0.0 111.387 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.11 -17.66 61.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.123 0.487 . . . . 0.0 110.089 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.497 ' SD ' ' CG1' ' B' ' 123' ' ' VAL . 15.2 tmm? -82.95 -51.25 7.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.149 0.98 . . . . 0.0 111.202 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -61.75 -21.81 64.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.53 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 28.5 t80 -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.13 -12.47 60.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.204 0.602 . . . . 0.0 111.459 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . 0.258 13.3 p -118.57 33.22 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 111.514 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.11 -16.5 0.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.506 169.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.9 mppt? -123.58 -25.85 4.29 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.571 0.748 . . . . 0.0 112.428 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.24 -3.36 19.85 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.808 0.276 . . . . 0.0 110.461 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.95 143.64 43.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.716 0.806 . . . . 0.0 110.174 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.16 36.59 27.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 43.0 p -135.55 172.84 12.43 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.278 0.631 . . . . 0.0 110.301 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -58.75 146.31 37.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.937 0.895 . . . . 0.0 112.274 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.58 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 19.0 t80 -136.73 156.5 48.43 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.905 1.282 . . . . 0.0 109.36 169.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 . . . . . 0 N--CA 1.457 -0.082 0 C-N-CA 124.788 1.235 . . . . 0.0 108.173 -173.519 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.086 0.469 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.8 -162.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.435 0.694 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.93 147.53 49.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 102.65 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.595 0.712 . . . . 0.0 112.449 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -80.16 89.11 5.42 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.88 138.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.86 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -117.47 162.43 17.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.74 -29.96 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.333 1.853 . . . . 0.0 114.913 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 127.087 2.155 . . . . 0.0 108.826 -173.062 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.458 ' HB3' ' HG ' ' B' ' 148' ' ' CYS . 51.0 mtt180 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -61.64 166.32 4.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.375 1.443 . . . . 0.0 112.417 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t -146.29 -126.2 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.434 0.694 . . . . 0.0 112.513 -172.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -133.97 -25.79 1.58 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 114.397 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . 0.428 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.9 p30 -130.31 79.97 1.93 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 110.052 -171.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -78.67 158.57 28.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.008 1.723 . . . . 0.0 112.895 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.405 HG12 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -149.92 142.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 127.733 2.413 . . . . 0.0 108.657 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.89 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.55 136.41 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.8 p -141.37 157.39 45.24 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.364 -0.21 . . . . 0.0 111.102 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 4.41 56.17 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.94 146.68 36.87 Favored Pre-proline 0 N--CA 1.452 -0.356 0 C-N-CA 125.287 1.435 . . . . 0.0 110.844 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.1 164.91 33.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.246 3.297 . . . . 0.0 110.948 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -54.17 -6.52 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 125.165 3.91 . . . . 0.0 116.257 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 13.03 1.16 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.604 1.093 . . . . 0.0 113.423 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -53.2 158.28 4.28 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -146.28 168.24 21.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.425 0.613 . . . . 0.0 110.44 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -65.54 -27.46 68.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.604 -0.236 . . . . 0.0 111.364 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -68.68 -40.11 80.27 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 117.928 0.331 . . . . 0.0 111.322 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -80.07 -21.22 43.62 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.132 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -32.51 70.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -79.86 -37.26 35.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.78 3.04 2.12 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.363 1.065 . . . . 0.0 112.916 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.7 t60 -132.51 -41.17 0.97 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.386 0.539 . . . . 0.0 111.159 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' MET . . . . . 0.404 ' CE ' ' HB3' ' B' ' 171' ' ' ALA . 82.3 mmm -69.66 -12.48 61.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.196 0.453 . . . . 0.0 110.315 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -45.2 -24.96 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 112.196 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.91 -42.2 94.93 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.97 67.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.679 0.791 . . . . 0.0 111.505 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.9 -171.04 40.92 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -82.31 64.58 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.445 0.64 . . . . 0.0 111.254 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.3 OUTLIER -55.72 141.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . 0.458 ' HG ' ' HB3' ' B' ' 117' ' ' ARG . 37.5 t -123.52 -30.55 3.62 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -133.1 158.77 41.94 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.658 0.742 . . . . 0.0 111.59 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -154.11 168.95 24.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.493 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . 0.409 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 41.3 t0 -150.04 154.51 38.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.489 HG23 ' H ' ' B' ' 154' ' ' ARG . 9.4 p -131.83 142.29 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.555 0.693 . . . . 0.0 110.473 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -105.07 5.69 32.67 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.11 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.489 ' H ' HG23 ' B' ' 152' ' ' VAL . 14.3 mtt-85 61.56 17.66 8.76 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.867 0.867 . . . . 0.0 112.421 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -137.06 0.67 2.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.01 2.89 7.7 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 118.504 0.593 . . . . 0.0 112.401 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.64 165.9 26.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.458 0.647 . . . . 0.0 110.316 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.89 -166.79 36.01 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 3.6 p -138.86 162.02 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.867 0.467 . . . . 0.0 110.781 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.9 p -149.24 159.5 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 123.717 0.807 . . . . 0.0 108.872 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.42 147.12 20.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.156 -0.34 . . . . 0.0 111.661 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 4.8 m-85 -121.13 171.79 8.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.394 1.092 . . . . 0.0 111.771 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.38 -20.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.252 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -143.94 141.98 30.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.228 0.611 . . . . 0.0 110.561 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.17 -25.02 63.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.9 -31.43 59.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.762 0.71 . . . . 0.0 111.009 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.71 -16.4 60.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.782 0.325 . . . . 0.0 110.183 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 26.6 ttp -79.83 -50.84 9.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.91 0.884 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 43.9 m -65.37 -19.76 66.09 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -72.57 -27.23 62.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.467 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.404 ' HB3' ' CE ' ' B' ' 141' ' ' MET . . . -75.03 -36.72 61.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 122.201 -0.312 . . . . 0.0 110.942 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.83 7.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . 0.579 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.5 ptm180 -138.39 -25.04 0.94 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.866 0.757 . . . . 0.0 112.224 -174.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.579 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.69 -27.42 10.32 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.367 0.531 . . . . 0.0 110.934 175.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -115.98 -1.12 12.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.897 0.879 . . . . 0.0 109.892 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.35 141.08 28.94 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.623 0.769 . . . . 0.0 109.056 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.35 26.91 12.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 111.802 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 52.0 p -137.25 172.56 12.81 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.126 0.57 . . . . 0.0 110.169 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -54.38 150.58 8.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.453 1.101 . . . . 0.0 113.965 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.588 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.4 t80 -141.68 162.06 36.4 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.873 2.069 . . . . 0.0 108.038 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 CA--C 1.521 -0.152 0 C-N-CA 123.897 0.879 . . . . 0.0 109.031 -171.112 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.65 158.35 17.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.506 1.123 . . . . 0.0 108.132 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.53 154.3 41.56 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.245 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.81 152.16 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.972 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.96 87.09 2.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.38 89.33 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 110.751 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.5 tttt -71.13 171.47 10.92 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 120.713 0.292 . . . . 0.0 111.037 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.462 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.8 p -65.28 -27.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.779 1.632 . . . . 0.0 114.67 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 128.199 2.599 . . . . 0.0 108.977 -174.173 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -54.05 167.47 0.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.844 1.258 . . . . 0.0 111.602 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -130.75 -97.33 0.34 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -153.53 -29.56 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -165.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.27 -35.81 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -165.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 39.73 158.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -153.55 142.54 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 127.428 2.291 . . . . 0.0 107.417 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -78.14 165.23 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.54 129.72 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 98.1 p -138.92 138.54 37.47 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.254 0.549 . . . . 0.0 111.504 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.92 0.28 7.69 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.51 145.08 21.6 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.588 1.155 . . . . 0.0 110.622 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.0 169.99 21.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.01 3.14 . . . . 0.0 109.621 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.92 -6.87 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.571 3.514 . . . . 0.0 115.793 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 30.1 m -138.16 5.46 2.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -54.97 153.66 10.83 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -147.32 168.9 20.6 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.302 -0.528 . . . . 0.0 110.978 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -65.35 -28.53 69.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.18 -46.27 74.46 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.364 0.529 . . . . 0.0 110.724 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -76.37 -16.26 59.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.381 -0.199 . . . . 0.0 111.165 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -34.57 71.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -76.55 -37.63 56.31 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.59 -1.71 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.205 1.002 . . . . 0.0 113.652 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.583 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.0 t60 -128.0 -36.25 1.99 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.767 0.712 . . . . 0.0 111.23 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' MET . . . . . 0.427 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 82.5 mmm -73.73 -12.17 60.63 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.889 -0.507 . . . . 0.0 110.434 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttm105 -44.87 -25.16 0.27 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.913 0.885 . . . . 0.0 112.489 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.3 -42.14 93.36 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.916 -0.49 . . . . 0.0 111.328 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.26 -31.23 69.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.092 0.557 . . . . 0.0 111.386 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.13 -171.35 41.17 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -80.45 72.94 7.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.903 0.859 . . . . 0.0 110.939 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.8 OUTLIER -63.14 146.53 12.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 36.8 t -130.75 -31.63 1.74 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.691 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . 0.435 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 6.2 t80 -137.15 161.53 35.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 110.458 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.86 169.87 23.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -148.14 155.34 41.31 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.467 HG23 ' H ' ' B' ' 154' ' ' ARG . 7.5 p -132.63 143.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.465 0.65 . . . . 0.0 109.944 -175.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -105.3 10.58 33.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.1 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.467 ' H ' HG23 ' B' ' 152' ' ' VAL . 35.4 mtp180 61.73 15.39 6.93 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.34 3.14 3.07 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.46 5.03 13.06 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -140.61 166.5 24.57 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.426 0.69 . . . . 0.0 110.511 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.88 -164.83 32.82 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.43 162.31 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.576 0.75 . . . . 0.0 110.45 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 12.6 p -144.27 160.08 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.1 141.62 24.33 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.453 0.701 . . . . 0.0 110.756 -168.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.5 m-85 -128.42 165.19 21.11 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.932 0.872 . . . . 0.0 110.59 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.6 -5.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.37 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -150.34 144.69 25.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.195 0.452 . . . . 0.0 110.125 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -70.82 -23.09 62.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.412 0.285 . . . . 0.0 111.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -88.7 -32.98 17.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.883 0.31 . . . . 0.0 111.726 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -74.37 -8.88 57.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.253 0.549 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 37.6 ttp -94.76 -42.3 8.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.11 1.364 . . . . 0.0 110.534 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 92.7 m -66.26 -17.42 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.601 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 42.8 t80 -72.4 -27.5 62.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.427 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -73.98 -38.09 64.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.378 -0.201 . . . . 0.0 110.567 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 m -73.16 5.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -134.23 -16.18 2.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.898 0.772 . . . . 0.0 112.857 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.601 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.2 mppt? -125.64 -21.09 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.31 1.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.85 144.31 31.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.777 0.831 . . . . 0.0 109.426 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.6 36.45 23.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.019 0.928 . . . . 0.0 112.709 174.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 33.5 p -133.69 178.96 6.53 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.361 0.664 . . . . 0.0 110.335 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -53.41 149.38 7.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.583 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 17.6 t80 -147.73 168.72 21.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.738 2.015 . . . . 0.0 107.749 168.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.423 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.199 0.523 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.78 -168.99 2.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.592 1.157 . . . . 0.0 108.319 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.63 142.47 51.49 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -129.55 133.02 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.499 0.666 . . . . 0.0 112.665 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -94.94 89.76 5.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.52 92.74 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.173 0.589 . . . . 0.0 110.13 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.459 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 6.5 tttp -75.36 173.02 11.47 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 111.224 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.459 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 2.8 p -65.85 -28.82 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.247 1.819 . . . . 0.0 114.436 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 20.9 t70 . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 127.38 2.272 . . . . 0.0 108.949 -173.668 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.355 0.122 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.68 167.6 0.72 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.715 1.206 . . . . 0.0 112.759 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.9 t -150.85 -124.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.266 0.627 . . . . 0.0 111.793 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.25 35.5 mt-10 -138.5 -15.23 1.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.513 1.525 . . . . 0.0 114.796 -167.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . 0.428 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.0 p30 -138.42 77.18 1.61 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.407 1.483 . . . . 0.0 110.995 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -79.44 154.0 29.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.58 1.952 . . . . 0.0 112.499 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.6 OUTLIER -145.07 133.66 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.811 2.045 . . . . 0.0 108.407 173.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 37.8 t -70.52 160.37 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-O 121.101 0.477 . . . . 0.0 109.774 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.51 107.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.1 p -118.23 147.94 42.9 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.04 -1.92 35.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.42 153.69 13.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 111.411 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.85 158.15 38.95 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.69 2.26 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.83 -17.71 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.039 2.493 . . . . 0.0 111.482 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 56.5 m -79.01 -10.94 59.98 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.788 0.835 . . . . 0.0 112.412 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.73 161.99 50.99 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 23.5 t -152.06 170.23 20.44 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.302 0.641 . . . . 0.0 109.817 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 41.5 p-90 -64.85 -28.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.96 -0.463 . . . . 0.0 111.525 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.75 -37.34 82.0 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.025 0.375 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.55 -29.52 27.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 111.299 0.111 . . . . 0.0 111.299 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -35.31 77.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.015 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -72.02 -41.95 66.95 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.61 2.79 1.64 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.347 1.459 . . . . 0.0 113.959 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -131.42 -38.24 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.773 0.715 . . . . 0.0 111.243 -175.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.9 mmm -69.84 -17.31 63.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.02 -0.425 . . . . 0.0 110.244 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -46.96 -19.29 0.1 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.959 0.903 . . . . 0.0 113.382 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.98 -41.43 95.44 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.148 0.579 . . . . 0.0 111.322 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.76 -26.18 67.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.366 0.666 . . . . 0.0 111.412 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.17 -171.73 33.99 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -74.08 114.77 12.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.282 0.541 . . . . 0.0 109.911 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -120.26 147.46 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.49 -17.05 2.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -135.49 153.85 51.6 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.764 1.165 . . . . 0.0 111.819 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -156.92 147.14 21.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.476 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -129.43 119.38 23.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.565 HG23 ' H ' ' B' ' 154' ' ' ARG . 5.9 p -106.66 148.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.487 -169.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -111.24 9.12 21.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.724 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.565 ' H ' HG23 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.37 25.88 0.05 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 126.789 2.036 . . . . 0.0 114.787 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -142.78 5.98 1.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.31 -4.85 6.76 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 121.813 -0.554 . . . . 0.0 113.006 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -143.43 162.91 34.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 109.725 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.69 -169.21 39.07 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.9 160.68 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 117.285 0.542 . . . . 0.0 109.623 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -146.24 156.2 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -150.52 145.82 26.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 111.91 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 44.6 m-85 -112.94 160.91 17.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.256 1.027 . . . . 0.0 112.799 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.42 -20.42 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.362 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -150.35 145.88 26.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 110.117 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.25 -24.81 65.84 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.88 -31.01 62.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.913 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.05 -17.06 61.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.669 0.271 . . . . 0.0 110.569 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 29.5 ttp -81.46 -52.79 6.88 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.761 0.824 . . . . 0.0 110.685 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.5 m -65.59 -17.19 64.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.53 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 22.1 t80 -73.3 -29.59 62.82 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.765 -0.585 . . . . 0.0 109.53 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.8 64.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.063 -0.398 . . . . 0.0 110.663 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.96 6.09 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -133.94 -15.56 2.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.623 0.647 . . . . 0.0 112.569 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.4 mppt? -125.4 -21.43 4.55 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.76 2.82 14.52 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.62 142.78 31.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.22 38.86 31.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.092 0.473 . . . . 0.0 111.752 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.3 p -137.6 169.36 17.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.247 1.419 . . . . 0.0 108.515 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -66.8 165.07 15.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.866 -170.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.489 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.9 t80 -150.72 172.78 15.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.173 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' B' ' 180' ' ' PHE . 15.2 tpt180 . . . . . 0 N--CA 1.457 -0.114 0 C-N-CA 123.573 0.749 . . . . 0.0 109.167 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.777 0.798 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.15 -163.97 1.21 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.999 1.72 . . . . 0.0 107.192 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.31 156.38 44.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 22.6 pt -131.78 146.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.76 0.79 . . . . 0.0 111.129 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -114.71 79.91 1.33 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 34.7 t -60.76 133.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.49 160.54 31.99 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.135 0.574 . . . . 0.0 110.178 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' B' ' 123' ' ' VAL . 0.1 OUTLIER -60.42 -37.38 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 24.4 t70 . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 109.712 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -55.71 167.04 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.54 0.736 . . . . 0.0 112.735 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 14.6 t -146.53 -122.56 0.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.337 0.655 . . . . 0.0 112.085 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -134.9 -22.86 1.59 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.599 1.56 . . . . 0.0 114.442 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.79 77.28 1.73 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.695 1.198 . . . . 0.0 110.668 -169.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -78.92 150.17 32.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.852 1.661 . . . . 0.0 113.013 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.61 129.26 29.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.877 1.671 . . . . 0.0 108.532 171.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.86 158.69 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.08 109.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 81.0 p -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.665 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.14 53.49 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.3 147.0 77.2 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 127.871 2.468 . . . . 0.0 111.034 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.14 160.49 33.07 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.903 2.402 . . . . 0.0 109.273 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 -9.99 25.88 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.83 2.353 . . . . 0.0 111.09 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -75.01 -11.81 60.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.261 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.71 164.9 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 121.732 0.629 . . . . 0.0 112.842 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.7 t -158.99 166.63 31.34 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.903 1.281 . . . . 0.0 108.004 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 40.5 p-90 -66.64 -30.2 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.523 0.601 . . . . 0.0 111.753 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -65.98 -32.08 73.35 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.414 0.552 . . . . 0.0 110.635 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -87.64 -20.62 26.08 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 117.738 0.245 . . . . 0.0 111.512 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -29.97 64.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -79.65 -39.79 30.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.77 -1.75 7.81 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.496 1.118 . . . . 0.0 113.429 -176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 14.0 t60 -129.52 -41.74 1.35 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.132 0.424 . . . . 0.0 111.12 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' MET . . . . . 0.402 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 85.1 mmm -65.48 -16.93 64.15 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -42.24 -27.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.683 1.593 . . . . 0.0 113.13 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.03 -41.49 96.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 111.573 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.93 -29.26 69.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.333 0.653 . . . . 0.0 111.751 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.88 -175.8 34.32 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -73.02 115.79 12.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 122.369 -0.489 . . . . 0.0 110.333 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -113.63 151.18 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.4 p -132.99 -26.04 1.76 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.915 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -134.33 152.94 52.1 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.81 1.186 . . . . 0.0 112.125 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -149.81 169.18 21.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.655 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -149.67 141.41 23.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 168.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.534 HG21 ' H ' ' B' ' 154' ' ' ARG . 4.8 p -122.41 142.54 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.629 0.728 . . . . 0.0 111.02 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -108.79 9.96 26.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.682 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.534 ' H ' HG21 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.0 24.57 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.215 2.206 . . . . 0.0 114.991 178.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.49 10.45 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.94 -4.21 7.93 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.106 0.412 . . . . 0.0 113.0 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.2 162.28 36.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.893 0.477 . . . . 0.0 110.415 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.28 -169.26 37.53 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.43 162.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.26 0.53 . . . . 0.0 110.755 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.2 p -149.75 158.53 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.898 0.879 . . . . 0.0 108.934 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.62 147.27 24.23 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.901 -0.499 . . . . 0.0 111.535 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 30.4 m-85 -116.49 168.5 10.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 122.281 1.038 . . . . 0.0 113.322 -172.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.3 m -75.67 -10.52 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.658 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -151.46 142.85 23.44 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.88 -23.53 66.67 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.31 -30.97 62.3 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.252 0.478 . . . . 0.0 110.86 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.06 -19.36 60.64 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 110.323 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 30.8 ttp -82.33 -53.44 6.02 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.764 0.826 . . . . 0.0 111.048 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -63.23 -21.79 66.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.512 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 29.2 t80 -73.53 -33.73 64.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.402 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -74.63 -14.41 60.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.066 0.546 . . . . 0.0 111.362 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . 0.261 8.2 p -116.07 33.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 111.198 174.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.3 ptm180 -143.64 -17.32 0.62 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.512 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -122.82 -27.36 4.3 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.326 0.65 . . . . 0.0 112.531 173.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.61 -7.52 19.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.35 147.16 40.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.8 0.84 . . . . 0.0 110.278 168.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 57.85 28.93 16.74 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.128 0.971 . . . . 0.0 112.367 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 63.6 p -136.95 174.55 10.5 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.88 0.472 . . . . 0.0 110.811 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -54.36 145.35 18.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 113.063 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.644 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 5.2 t80 -138.56 160.04 40.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.771 1.629 . . . . 0.0 108.144 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 CA--C 1.523 -0.074 0 C-N-CA 123.709 0.804 . . . . 0.0 109.795 -169.245 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.71 158.75 20.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.555 1.142 . . . . 0.0 108.143 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -71.17 161.28 31.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.424 0.631 . . . . 0.0 110.425 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 28.9 pt -130.18 156.0 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.429 169.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -122.02 87.06 2.68 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.429 1.092 . . . . 0.0 108.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.22 142.19 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.261 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -134.09 158.48 43.5 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.282 0.563 . . . . 0.0 110.725 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.9 3.81 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 126.286 1.835 . . . . 0.0 113.76 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 7.3 t0 . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 125.314 1.446 . . . . 0.0 110.377 171.424 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -53.91 168.69 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.704 1.202 . . . . 0.0 112.26 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.6 t -138.61 -93.84 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.292 15.1 mt-10 -159.01 -27.56 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -164.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -25.73 4.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -161.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 35.07 155.93 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.401 3.081 . . . . 0.0 119.278 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.78 122.66 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.634 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.46 158.96 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.97 112.96 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 83.2 p -122.18 152.64 39.74 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.7 35.8 3.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 13.0 tp -111.45 31.29 0.1 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 80.7 Cg_exo -46.93 -33.51 14.59 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.572 2.181 . . . . 0.0 116.307 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' B' ' 132' ' ' GLY . 89.5 Cg_exo -47.88 167.04 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.298 2.666 . . . . 0.0 114.094 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 7.0 t -71.27 19.68 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.77 0.828 . . . . 0.0 112.076 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' B' ' 130' ' ' PRO . . . -46.95 154.71 0.89 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.403 1.001 . . . . 0.0 113.206 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -146.69 166.13 27.52 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.131 0.972 . . . . 0.0 108.652 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -63.32 -28.64 70.15 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.849 -0.532 . . . . 0.0 111.289 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -67.59 -24.79 65.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.05 0.386 . . . . 0.0 111.528 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.14 -18.74 17.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.095 0.407 . . . . 0.0 111.612 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -29.18 64.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -77.63 -39.8 44.05 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.02 -0.69 9.98 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.259 1.024 . . . . 0.0 113.462 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -128.86 -35.11 1.9 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.341 0.519 . . . . 0.0 111.036 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 78.7 mmm -73.27 -14.64 61.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -47.14 -21.37 0.24 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 112.797 172.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.57 -41.23 96.41 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.274 0.63 . . . . 0.0 110.992 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.61 68.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.942 0.497 . . . . 0.0 111.567 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.43 -169.59 37.77 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.83 81.71 2.76 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.801 0.81 . . . . 0.0 110.759 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -76.78 146.37 8.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.3 p -131.34 -25.02 2.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.797 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -139.31 157.1 46.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.436 1.016 . . . . 0.0 111.594 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.26 167.75 26.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.905 174.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -148.32 137.15 21.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.496 HG23 ' H ' ' B' ' 154' ' ' ARG . 5.0 p -118.84 142.34 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.845 0.831 . . . . 0.0 110.373 -171.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.37 9.22 29.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.0 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.496 ' H ' HG23 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.42 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.606 1.962 . . . . 0.0 114.446 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.05 8.16 1.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.35 -5.98 6.72 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.24 0.473 . . . . 0.0 112.973 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.4 p -144.12 165.61 27.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.173 0.487 . . . . 0.0 110.459 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.33 -166.27 33.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.51 162.74 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 CA-C-N 117.228 0.514 . . . . 0.0 110.251 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.8 p -147.74 161.12 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.008 0.923 . . . . 0.0 108.806 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -153.4 151.96 30.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 110.64 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 3.7 m-85 -129.53 164.58 23.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.926 0.869 . . . . 0.0 110.138 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 25.5 m -66.19 -5.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.53 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -152.6 155.9 38.25 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.554 0.615 . . . . 0.0 110.24 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.18 -28.04 65.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.757 0.423 . . . . 0.0 112.039 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.76 -30.9 18.69 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.064 -0.397 . . . . 0.0 112.022 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -72.62 -9.75 58.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 41.4 ttp -98.27 -42.95 7.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.464 1.506 . . . . 0.0 110.958 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.0 m -63.12 -19.25 64.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.553 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 24.9 t80 -71.31 -28.56 64.19 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.931 -0.48 . . . . 0.0 109.993 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.53 -36.71 65.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.21 4.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -133.95 -16.48 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.5 mppt? -124.91 -21.57 4.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.14 0.94 13.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.011 0.524 . . . . 0.0 109.886 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.53 143.03 27.18 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.929 0.891 . . . . 0.0 109.099 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.65 24.99 14.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.279 1.032 . . . . 0.0 111.669 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 81.6 p -137.62 179.29 6.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.341 0.591 . . . . 0.0 111.707 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.36 144.88 34.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.901 1.681 . . . . 0.0 114.708 -170.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.514 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 3.7 t80 -143.43 161.45 38.36 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.104 1.762 . . . . 0.0 108.54 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 N--CA 1.457 -0.119 0 C-N-CA 124.282 1.033 . . . . 0.0 109.224 -171.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.29 160.87 16.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -72.07 148.25 45.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.0 139.33 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -100.59 86.07 3.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.33 1.052 . . . . 0.0 108.724 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 10.6 t -71.18 81.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.577 0.751 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.98 159.82 32.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.872 0.869 . . . . 0.0 110.721 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' B' ' 195' ' ' ASP . 19.1 m -75.18 3.46 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 126.03 1.732 . . . . 0.0 114.69 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 19.7 t70 . . . . . 0 C--N 1.326 -0.432 0 C-N-CA 126.402 1.881 . . . . 0.0 110.408 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -53.14 173.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.0 t -140.81 -127.67 0.1 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.368 1.067 . . . . 0.0 111.919 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -133.91 -28.36 1.39 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.336 1.455 . . . . 0.0 114.18 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . 0.426 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.8 p30 -127.3 82.78 2.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.744 1.218 . . . . 0.0 110.396 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -78.36 158.53 28.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.711 2.004 . . . . 0.0 112.87 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.418 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -150.08 142.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.792 2.437 . . . . 0.0 109.06 173.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -79.5 170.65 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.51 136.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.4 p -143.75 157.7 44.2 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 121.057 0.456 . . . . 0.0 112.078 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.96 53.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.53 123.23 88.95 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 127.5 2.32 . . . . 0.0 112.949 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.29 156.83 12.66 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.984 2.456 . . . . 0.0 111.422 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.34 -10.9 29.1 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.101 2.534 . . . . 0.0 110.705 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 68.1 m -75.19 -9.02 58.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.095 0.958 . . . . 0.0 112.616 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.34 165.44 41.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 44.5 t -157.39 167.98 28.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.241 1.016 . . . . 0.0 109.155 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -64.65 -29.93 70.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.738 -0.601 . . . . 0.0 110.057 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -68.4 -16.16 63.81 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.428 0.291 . . . . 0.0 111.49 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -104.03 -22.73 13.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 112.054 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.54 -30.7 66.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.942 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -73.94 -40.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.6 -1.92 7.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.464 1.106 . . . . 0.0 113.304 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.508 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 30.4 t60 -131.92 -33.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.641 0.655 . . . . 0.0 111.552 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -19.97 59.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -51.64 -18.88 1.31 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -59.0 -37.59 77.21 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.031 0.532 . . . . 0.0 110.852 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.406 ' HB3' ' CE2' ' B' ' 162' ' ' PHE . . . -65.82 -22.38 66.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.71 0.804 . . . . 0.0 111.307 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.98 -90.49 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -157.07 134.1 10.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -130.56 157.6 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 14.7 p -129.15 -35.63 1.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.014 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 7.9 t80 -132.69 159.02 40.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.61 1.096 . . . . 0.0 111.723 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.17 170.95 20.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.301 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -149.11 155.75 41.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.507 HG23 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -133.31 145.01 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.34 0.59 . . . . 0.0 110.483 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.55 22.11 16.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.208 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.507 ' H ' HG23 ' B' ' 152' ' ' VAL . 59.6 mtp180 74.83 -15.85 0.61 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 126.062 1.745 . . . . 0.0 113.123 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.04 138.63 2.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.667 0.667 . . . . 0.0 111.679 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 -31.26 0.69 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 166.39 28.4 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.91 1.355 . . . . 0.0 111.982 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.43 -171.29 41.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 163.19 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.485 0.642 . . . . 0.0 110.763 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 9.1 p -150.72 160.03 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.817 0.847 . . . . 0.0 109.365 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -152.08 136.39 16.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.088 -0.382 . . . . 0.0 111.618 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 80.4 m-85 -104.31 168.08 9.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.15 -11.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.621 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -151.73 137.21 17.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.73 -23.41 66.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.3 -32.92 55.7 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.226 0.466 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -75.21 -20.12 59.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.022 0.439 . . . . 0.0 109.841 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 36.5 ttp -76.17 -52.84 9.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 111.469 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 49.0 m -65.65 -20.69 66.4 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -71.92 -27.19 62.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.264 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.12 64.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.207 -0.308 . . . . 0.0 111.069 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.71 8.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . 0.562 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 15.1 ptm180 -137.74 -23.92 1.05 Allowed 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 121.704 -0.622 . . . . 0.0 112.191 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.562 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.97 -28.25 9.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.375 0.534 . . . . 0.0 111.191 175.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.01 -6.88 11.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.47 0.708 . . . . 0.0 109.729 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -85.12 144.09 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 64.53 23.88 12.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.91 0.884 . . . . 0.0 111.627 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 72.0 p -138.91 178.03 7.46 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.627 0.727 . . . . 0.0 111.247 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -61.54 148.59 41.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.017 1.327 . . . . 0.0 114.176 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.508 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.3 OUTLIER -143.74 145.28 32.29 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.115 1.766 . . . . 0.0 108.028 169.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 . . . . . 0 C--N 1.337 0.049 0 C-N-CA 124.006 0.923 . . . . 0.0 109.36 -170.442 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.897 0.38 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.58 165.98 29.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.572 1.149 . . . . 0.0 108.955 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -68.58 155.75 39.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.25 0.547 . . . . 0.0 110.998 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.91 152.4 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.774 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.361 1.064 . . . . 0.0 108.788 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.36 94.28 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.651 0.78 . . . . 0.0 110.761 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.4 tttt -74.37 171.14 14.24 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 122.552 0.341 . . . . 0.0 110.742 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.4 p -66.05 -27.12 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 126.298 1.839 . . . . 0.0 114.732 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.402 ' HA ' ' CG2' ' B' ' 124' ' ' VAL . 25.2 t70 . . . . . 0 N--CA 1.468 0.469 0 C-N-CA 128.463 2.705 . . . . 0.0 109.237 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.452 ' HD3' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt180 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -54.13 160.23 1.62 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.476 1.034 . . . . 0.0 112.607 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 -139.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 112.228 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.254 40.2 mt-10 -132.21 -18.99 2.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -165.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.37 77.25 1.64 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.976 1.31 . . . . 0.0 109.941 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtm-85 -83.37 148.27 27.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.452 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.79 129.55 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 126.508 1.923 . . . . 0.0 107.402 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.81 153.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.7 106.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 53.7 p -105.13 152.55 22.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.976 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.82 18.11 5.29 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 4.7 mp -95.79 13.72 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 90.5 Cg_exo -42.67 -38.33 6.34 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.586 2.191 . . . . 0.0 116.63 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.59 -61.72 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 6.0 t 179.41 -42.96 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.674 1.19 . . . . 0.0 107.822 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.24 -172.58 0.04 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.877 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -168.59 165.84 12.14 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.863 -0.786 . . . . 0.0 109.152 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -76.5 -30.28 57.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -68.51 -39.94 81.04 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.89 -26.97 54.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.484 -0.135 . . . . 0.0 110.847 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -34.93 78.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.452 ' HE3' ' HD3' ' B' ' 117' ' ' ARG . 9.6 mtpm? -74.38 -39.28 62.81 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -1.48 3.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.441 1.097 . . . . 0.0 113.713 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.596 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 38.5 t60 -129.89 -39.19 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.551 0.614 . . . . 0.0 111.523 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' MET . . . . . 0.436 ' CE ' ' HB3' ' B' ' 171' ' ' ALA . 84.0 mmm -70.39 -14.22 62.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.37 0.532 . . . . 0.0 109.987 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -47.72 -20.93 0.32 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.698 0.799 . . . . 0.0 112.599 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.97 -42.92 84.33 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.226 0.611 . . . . 0.0 111.132 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -27.74 65.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.639 0.776 . . . . 0.0 111.569 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.37 -166.46 36.53 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.28 79.3 9.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.86 148.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 52.0 t -128.08 -33.28 2.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.861 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -134.58 157.72 45.86 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.048 0.84 . . . . 0.0 110.787 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -152.74 164.27 38.1 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -145.4 151.32 38.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.581 HG23 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -130.54 140.02 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 121.743 0.782 . . . . 0.0 110.504 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -104.06 10.66 35.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.845 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.581 ' H ' HG23 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 41.73 26.25 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.51 2.324 . . . . 0.0 114.26 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -143.33 3.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.72 -10.32 3.98 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.154 0.434 . . . . 0.0 113.677 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -142.84 166.73 23.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.122 0.461 . . . . 0.0 110.639 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.86 -164.6 29.89 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.74 163.06 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 122.773 0.429 . . . . 0.0 111.344 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -156.04 154.91 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.374 1.069 . . . . 0.0 109.705 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.28 159.54 40.09 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -125.88 171.07 11.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 122.01 0.909 . . . . 0.0 112.202 -171.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.22 -9.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.443 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -149.7 139.3 21.64 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.028 0.531 . . . . 0.0 109.585 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.13 -22.67 66.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.77 -29.43 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.047 -0.408 . . . . 0.0 110.802 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.45 -20.4 60.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.14 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.416 ' HA ' ' CE1' ' B' ' 162' ' ' PHE . 29.8 ttp -79.48 -52.24 8.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -63.13 -21.84 66.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.55 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 43.5 t80 -74.77 -33.04 62.22 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.436 ' HB3' ' CE ' ' B' ' 141' ' ' MET . . . -73.56 -15.83 61.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.331 0.652 . . . . 0.0 111.701 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . 0.251 8.8 p -115.47 32.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.859 0.838 . . . . 0.0 111.643 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -142.63 -16.7 0.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.137 169.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.55 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -124.19 -25.37 4.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 112.534 173.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.49 -2.82 20.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.415 0.286 . . . . 0.0 110.248 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.6 143.41 42.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.118 0.967 . . . . 0.0 110.269 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.41 27.8 10.62 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.8 p -127.91 166.69 17.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.03 144.31 29.3 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.567 0.747 . . . . 0.0 111.952 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.596 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 2.5 t80 -137.48 161.23 36.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.275 1.83 . . . . 0.0 109.074 171.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 . . . . . 0 C--O 1.228 -0.043 0 C-N-CA 123.941 0.897 . . . . 0.0 109.537 -170.218 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.883 0.373 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.99 162.56 18.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.156 0.982 . . . . 0.0 108.669 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -69.46 152.02 45.37 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.106 -0.371 . . . . 0.0 110.555 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -127.48 114.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.446 0.641 . . . . 0.0 109.996 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -85.77 95.32 9.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.23 0.538 . . . . 0.0 109.91 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 8.0 t -67.29 146.56 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.188 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -135.04 158.08 45.28 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 121.015 0.436 . . . . 0.0 110.514 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.65 4.57 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.26 1.824 . . . . 0.0 113.628 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 125.367 1.467 . . . . 0.0 110.703 171.165 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.591 ' HG2' ' HG ' ' B' ' 148' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -56.92 171.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.669 1.188 . . . . 0.0 112.796 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 7.5 t -144.29 -129.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.0 -19.77 1.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.6 77.55 1.67 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.956 1.302 . . . . 0.0 110.953 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -77.75 148.48 34.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.229 1.812 . . . . 0.0 113.407 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.419 HG12 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -139.27 127.04 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.982 2.113 . . . . 0.0 108.37 172.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.51 159.03 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 O-C-N 121.787 -0.571 . . . . 0.0 109.614 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.01 116.17 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 85.4 p -125.67 143.69 50.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.094 0.473 . . . . 0.0 111.798 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.74 -1.7 26.02 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.34 147.88 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 127.522 2.329 . . . . 0.0 110.244 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.07 162.8 38.17 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.487 2.791 . . . . 0.0 111.421 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 -10.74 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 1 C-N-CA 125.379 4.053 . . . . 0.0 115.838 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -133.81 12.2 4.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.051 0.842 . . . . 0.0 112.91 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.57 167.28 4.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -148.68 166.94 26.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.243 -0.563 . . . . 0.0 110.489 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -75.32 -28.16 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.348 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -67.85 -38.06 82.67 Favored 'General case' 0 C--O 1.231 0.089 0 O-C-N 122.339 -0.226 . . . . 0.0 110.824 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -79.81 -19.65 47.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -29.8 66.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -78.75 -38.78 37.91 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.42 -1.78 5.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.4 1.08 . . . . 0.0 113.342 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.5 t60 -130.32 -36.53 1.48 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.702 0.683 . . . . 0.0 111.356 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.3 mmm -72.73 -10.93 60.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.122 0.419 . . . . 0.0 111.069 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -48.96 -16.59 0.14 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -71.75 -42.26 67.43 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.98 0.512 . . . . 0.0 111.02 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.74 -29.14 68.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.476 0.71 . . . . 0.0 111.168 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.93 -168.36 36.25 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -80.57 79.4 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 0.0 110.412 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.6 OUTLIER -64.1 149.68 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . 0.591 ' HG ' ' HG2' ' B' ' 117' ' ' ARG . 5.8 t -134.36 -35.98 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.214 -171.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 8.8 t80 -134.61 160.56 37.71 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.79 0.805 . . . . 0.0 110.17 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.09 168.67 26.55 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -148.1 158.43 44.06 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 168.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.549 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.7 p -135.57 143.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 121.176 0.512 . . . . 0.0 110.12 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -108.36 6.97 26.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.26 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.549 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.0 mtt-85 61.4 18.63 9.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.491 0.717 . . . . 0.0 112.209 170.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -137.64 6.26 2.71 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.32 22.13 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 121.555 -0.716 . . . . 0.0 112.194 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -141.16 160.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.241 0.616 . . . . 0.0 110.083 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.28 -164.42 30.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.99 162.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.257 0.528 . . . . 0.0 110.876 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.8 p -148.0 160.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.129 0.971 . . . . 0.0 108.65 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.53 152.84 26.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.056 -0.403 . . . . 0.0 110.819 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -126.43 170.56 11.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.689 0.757 . . . . 0.0 112.181 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.22 -9.63 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.369 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -149.99 139.76 21.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -64.65 -21.36 66.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.32 -31.51 58.2 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.311 0.505 . . . . 0.0 111.004 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -72.89 -21.49 60.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.107 0.479 . . . . 0.0 109.825 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.419 ' SD ' HG12 ' B' ' 123' ' ' VAL . 38.2 ttp -77.63 -52.58 8.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.356 0.663 . . . . 0.0 110.754 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 75.4 m -63.38 -18.71 63.97 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.531 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 30.6 t80 -75.37 -28.75 59.66 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.91 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.19 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 122.086 -0.384 . . . . 0.0 110.388 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.69 2.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.0 -16.26 2.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.531 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.7 mppt? -126.21 -21.63 4.22 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.84 3.54 12.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.867 0.467 . . . . 0.0 109.862 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.826 0.85 . . . . 0.0 108.819 172.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 58.44 35.93 25.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.005 0.522 . . . . 0.0 111.346 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 51.8 p -136.43 175.07 9.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 110.64 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -62.33 148.65 44.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.497 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 9.9 t80 -146.35 165.6 28.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.045 2.138 . . . . 0.0 107.439 167.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--N 1.334 -0.066 0 O-C-N 121.907 -0.495 . . . . 0.0 109.681 -174.099 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.993 0.425 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 -168.91 2.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.862 0.865 . . . . 0.0 108.896 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.21 149.93 47.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.59 108.51 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.213 0.53 . . . . 0.0 112.206 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -83.27 88.34 6.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 7.9 t -76.14 81.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.765 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.79 159.44 22.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.24 0.616 . . . . 0.0 111.534 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.403 ' HA ' HG11 ' B' ' 123' ' ' VAL . 27.1 m -73.0 5.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 126.514 1.926 . . . . 0.0 114.292 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 C--N 1.328 -0.335 0 O-C-N 124.833 1.333 . . . . 0.0 110.624 171.153 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -53.29 153.25 3.97 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.65 1.18 . . . . 0.0 112.069 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.0 t -135.86 -110.49 0.2 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.866 0.466 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -148.61 -26.12 0.32 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.24 -32.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -166.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 40.75 151.38 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.778 2.831 . . . . 0.0 118.162 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.447 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.1 OUTLIER -149.69 148.33 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.256 1.822 . . . . 0.0 108.828 174.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -90.92 171.95 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.37 142.96 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -143.82 150.92 39.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.299 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 103.24 -2.75 47.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -49.25 126.6 15.71 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 127.728 2.411 . . . . 0.0 109.742 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.84 155.13 53.76 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.883 2.389 . . . . 0.0 110.269 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.79 -22.12 28.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.483 2.789 . . . . 0.0 112.561 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m -73.34 -9.22 58.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.391 1.076 . . . . 0.0 112.462 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.44 165.81 39.36 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 121.545 0.525 . . . . 0.0 112.598 -174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -161.72 167.79 24.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.184 1.394 . . . . 0.0 107.445 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -64.42 -26.93 68.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.857 0.753 . . . . 0.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -70.05 -28.95 65.87 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.004 -0.435 . . . . 0.0 111.706 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -89.92 -13.65 35.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.766 0.257 . . . . 0.0 110.925 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.25 3.48 54.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.697 0.399 . . . . 0.0 111.024 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -110.26 -35.33 6.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.11 -3.88 11.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.32 1.048 . . . . 0.0 112.771 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.639 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 10.0 t60 -127.51 -36.44 2.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.286 0.494 . . . . 0.0 110.734 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 76.5 mmm -69.1 -19.07 64.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.577 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -48.57 -20.05 0.4 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.23 1.012 . . . . 0.0 112.811 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -41.76 97.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.002 0.521 . . . . 0.0 111.252 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.69 -29.76 69.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.563 . . . . 0.0 111.204 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.72 -177.49 35.31 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.14 118.0 14.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.998 0.399 . . . . 0.0 110.161 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -114.33 151.67 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 p -130.7 -21.71 2.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.295 -0.859 . . . . 0.0 111.729 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -126.02 149.51 48.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 119.122 0.874 . . . . 0.0 111.805 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.43 19.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 19.5 t0 -141.93 154.61 45.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.497 HG23 ' H ' ' B' ' 154' ' ' ARG . 9.9 p -132.19 145.61 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.185 0.517 . . . . 0.0 110.214 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.16 7.16 27.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.779 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.497 ' H ' HG23 ' B' ' 152' ' ' VAL . 24.6 mtp85 61.34 16.98 7.87 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.496 0.718 . . . . 0.0 112.77 170.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -137.95 -12.0 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.23 -2.99 2.13 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.799 0.727 . . . . 0.0 112.922 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.81 167.68 21.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.127 0.571 . . . . 0.0 109.799 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.74 -167.4 35.25 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 6.7 p -141.09 161.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.369 0.604 . . . . 0.0 110.613 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.7 159.93 2.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -157.75 154.12 27.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.01 -0.431 . . . . 0.0 111.527 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 22.7 m-85 -122.87 163.55 20.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.893 0.854 . . . . 0.0 112.248 -170.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.36 -8.82 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.43 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -152.9 154.72 35.63 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.071 0.549 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -69.15 -25.58 64.44 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -82.83 -31.77 27.91 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.197 0.453 . . . . 0.0 111.313 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -70.57 -2.28 13.71 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.699 0.4 . . . . 0.0 110.332 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.447 ' SD ' HG11 ' B' ' 123' ' ' VAL . 40.6 ttp -111.94 -46.85 3.18 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.864 1.265 . . . . 0.0 110.897 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 58.4 m -63.23 -20.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 6.3 t80 -70.57 -31.51 68.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.72 69.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.093 -0.38 . . . . 0.0 110.367 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.21 5.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -134.4 -19.02 1.93 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -19.5 5.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.81 2.73 13.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.136 0.574 . . . . 0.0 109.48 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.36 136.75 41.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.4 27.94 13.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.178 0.991 . . . . 0.0 111.255 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.3 p -138.09 179.46 6.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.438 0.695 . . . . 0.0 110.806 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -56.01 148.56 17.25 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.639 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 24.8 t80 -146.57 159.16 43.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.344 1.857 . . . . 0.0 108.179 168.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -170.332 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.15 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.92 -167.52 1.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.969 0.908 . . . . 0.0 108.784 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -115.02 155.06 27.69 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 30.8 pt -134.9 148.86 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.396 0.617 . . . . 0.0 110.778 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -113.33 84.63 2.04 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 107.997 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 t -67.81 87.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.959 0.904 . . . . 0.0 111.255 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.566 ' HD2' ' H ' ' B' ' 194' ' ' VAL . 50.5 tptt -76.68 160.24 29.53 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 110.748 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.566 ' H ' ' HD2' ' B' ' 193' ' ' LYS . 8.1 p -57.97 -27.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.302 2.641 . . . . 0.0 117.774 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.409 ' HA ' HG23 ' B' ' 124' ' ' VAL . 38.1 t70 . . . . . 0 N--CA 1.469 0.491 0 C-N-CA 127.183 2.193 . . . . 0.0 110.141 -170.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mtt-85 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' B' ' 118' ' ' ARG . 4.1 mmp_? -52.23 155.35 2.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.29 1.036 . . . . 0.0 113.697 -174.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.7 t -155.97 -137.04 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.447 0.699 . . . . 0.0 111.724 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -138.04 -26.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -167.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -131.1 80.54 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.081 0.953 . . . . 0.0 111.644 -170.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -78.66 148.83 33.01 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.577 . . . . 0.0 113.81 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.426 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -141.57 136.42 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.687 1.595 . . . . 0.0 110.017 171.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . 0.409 HG11 ' HE2' ' B' ' 193' ' ' LYS . 2.3 t -76.39 162.34 4.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.06 105.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -111.38 151.42 28.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.01 8.4 44.96 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 tp -60.51 146.99 84.03 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 126.69 1.996 . . . . 0.0 111.503 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.9 164.87 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.952 3.101 . . . . 0.0 109.689 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.9 -21.52 43.8 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.262 2.641 . . . . 0.0 111.631 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -73.46 -15.76 61.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.383 0.673 . . . . 0.0 112.09 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.12 148.27 24.88 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.5 t -155.76 165.65 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.585 0.754 . . . . 0.0 109.447 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -72.19 -27.04 62.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.931 -0.48 . . . . 0.0 111.702 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -65.16 -31.35 72.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.804 0.729 . . . . 0.0 111.151 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.14 -21.12 33.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.499 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -17.03 60.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.29 0.496 . . . . 0.0 111.109 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -89.15 -44.29 10.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.95 -11.64 60.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -120.45 -30.9 4.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.398 0.999 . . . . 0.0 111.221 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.5 mmm -76.81 -14.8 59.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.94 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -43.77 -21.02 0.03 OUTLIER 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.47 -42.23 87.84 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 123.589 0.755 . . . . 0.0 111.245 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.79 -28.87 69.33 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.01 0.524 . . . . 0.0 110.499 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.41 32.94 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.39 123.83 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.35 -0.5 . . . . 0.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -120.8 154.25 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 53.4 t -134.64 -24.86 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.526 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 71.3 t80 -127.15 153.68 45.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 118.992 0.814 . . . . 0.0 111.947 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.74 166.85 32.26 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.023 171.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . 0.4 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 26.5 t0 -152.07 160.26 43.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.511 HG21 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -135.84 145.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.051 0.453 . . . . 0.0 110.03 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -109.42 6.55 24.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.257 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.511 ' H ' HG21 ' B' ' 152' ' ' VAL . 16.6 mtt180 61.83 17.72 9.1 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.651 0.781 . . . . 0.0 112.611 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.39 10.19 2.5 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.6 6.01 27.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.572 0.624 . . . . 0.0 111.978 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.28 156.81 45.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.123 0.569 . . . . 0.0 109.586 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.51 -166.0 30.42 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 7.6 p -145.55 162.38 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.016 0.436 . . . . 0.0 111.539 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.6 p -151.17 157.62 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.354 1.062 . . . . 0.0 108.547 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -155.13 140.96 18.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.931 -0.481 . . . . 0.0 111.154 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 41.9 m-85 -110.25 167.61 10.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.809 0.814 . . . . 0.0 113.053 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.75 -11.08 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.306 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -150.5 141.97 23.43 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -65.18 -26.05 67.99 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.1 -31.15 64.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.035 0.38 . . . . 0.0 110.661 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.02 -20.35 60.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.815 0.341 . . . . 0.0 110.202 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.426 ' SD ' HG11 ' B' ' 123' ' ' VAL . 33.9 ttp -80.51 -55.37 4.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.371 0.669 . . . . 0.0 110.515 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 70.3 m -64.33 -18.26 64.46 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 5.4 t80 -73.48 -32.09 64.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.55 68.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.866 -0.521 . . . . 0.0 110.575 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.92 3.13 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -132.3 -17.26 2.67 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.04 0.836 . . . . 0.0 112.761 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -21.2 4.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.44 0.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.76 147.21 33.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.71 37.39 23.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.513 0.725 . . . . 0.0 112.913 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 66.9 p -133.26 167.59 20.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.128 0.49 . . . . 0.0 110.372 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -61.76 140.84 58.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.954 0.902 . . . . 0.0 113.175 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' B' ' 180' ' ' PHE . 0.1 OUTLIER -157.78 146.82 19.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.846 1.258 . . . . 0.0 110.284 169.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . 0.522 ' CB ' ' HA ' ' B' ' 187' ' ' THR . 46.8 ttt180 . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 128.123 2.569 . . . . 0.0 108.954 165.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' B' ' 181' ' ' ARG . 40.5 p . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.349 0.595 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.23 39.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.636 1.575 . . . . 0.0 107.477 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -67.61 145.46 54.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 110.676 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 38.1 pt -123.22 136.28 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.945 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -104.32 79.6 1.61 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.824 0.85 . . . . 0.0 108.733 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.88 131.1 26.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.409 ' HE2' HG11 ' B' ' 124' ' ' VAL . 55.2 pttt -133.67 165.36 25.11 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.74 47.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 114.385 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.915 174.165 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.69 171.96 0.79 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -134.42 -104.81 0.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -169.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -149.78 -25.18 0.27 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -166.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.15 -33.35 5.71 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -166.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 40.1 157.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.01 146.94 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.493 2.317 . . . . 0.0 107.849 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.72 168.63 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.0 p -137.45 130.47 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 58.3 p -138.42 153.53 48.88 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.36 6.01 53.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.27 139.16 97.52 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 127.811 2.444 . . . . 0.0 111.537 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.33 156.09 22.26 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.151 2.567 . . . . 0.0 110.145 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.69 -22.35 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.323 2.682 . . . . 0.0 112.07 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.9 m -73.08 7.5 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.319 1.448 . . . . 0.0 113.078 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 162.33 13.25 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.556 0.617 . . . . 0.0 111.585 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 45.1 t -156.67 173.11 17.44 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.12 0.968 . . . . 0.0 108.799 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -64.58 -30.59 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.657 -0.652 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -66.51 -23.72 66.29 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.912 0.324 . . . . 0.0 111.46 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -94.66 -24.1 17.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -23.27 61.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.227 -0.295 . . . . 0.0 110.584 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -80.82 -39.43 26.66 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.82 -0.15 5.09 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.812 1.245 . . . . 0.0 114.194 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 24.8 t60 -135.0 -38.51 0.78 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.461 0.573 . . . . 0.0 111.262 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' MET . . . . . 0.41 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 84.4 mmm -68.39 -11.78 60.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.564 173.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -45.02 -24.6 0.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.296 1.038 . . . . 0.0 112.536 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.49 -41.0 93.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.972 -0.455 . . . . 0.0 111.205 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.09 69.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.674 0.789 . . . . 0.0 111.475 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.54 -171.71 40.1 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -80.87 77.03 7.78 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.816 0.817 . . . . 0.0 110.593 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.43 143.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -126.57 -28.9 2.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.818 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -136.44 157.77 46.01 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 118.79 0.723 . . . . 0.0 111.018 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.88 166.93 31.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -147.51 147.48 30.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.582 HG21 ' H ' ' B' ' 154' ' ' ARG . 6.0 p -127.58 142.01 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 121.54 0.685 . . . . 0.0 111.195 -171.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -105.95 10.57 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.62 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.582 ' H ' HG21 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.31 24.23 0.03 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 127.177 2.191 . . . . 0.0 114.994 178.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.46 5.31 1.42 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.31 -9.62 4.1 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 118.167 0.439 . . . . 0.0 113.373 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.07 167.83 21.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.331 0.566 . . . . 0.0 110.665 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.93 40.07 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.77 159.38 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.8 p -148.64 157.32 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.96 157.14 34.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.756 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.7 m-85 -130.9 169.2 16.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.852 0.861 . . . . 0.0 110.641 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.2 -13.75 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.759 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.95 156.36 46.08 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.625 0.77 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.85 -28.5 40.05 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.625 0.77 . . . . 0.0 112.007 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.05 -31.07 25.58 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -77.62 7.24 5.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.737 0.415 . . . . 0.0 110.353 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.85 -44.55 3.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.355 1.462 . . . . 0.0 110.028 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -62.41 -23.62 66.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.85 -29.8 70.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.41 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -72.35 -37.45 68.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.152 -0.343 . . . . 0.0 110.578 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' B' ' 172' ' ' VAL 0.282 0.6 OUTLIER -82.91 28.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.447 0.641 . . . . 0.0 111.694 177.049 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . 0.577 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.6 ptm180 -148.0 -25.2 0.35 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.243 -0.911 . . . . 0.0 112.789 171.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.577 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.2 OUTLIER -108.89 -26.77 10.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.446 0.566 . . . . 0.0 111.99 176.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.28 0.53 13.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.22 0.608 . . . . 0.0 110.186 -172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -82.43 144.63 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.163 0.985 . . . . 0.0 109.708 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 26.2 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.792 0.837 . . . . 0.0 111.97 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -135.31 162.83 31.48 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.715 1.206 . . . . 0.0 108.6 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 18.2 ptmt -67.99 158.27 33.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.866 -1.515 . . . . 0.0 114.293 -168.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.438 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -143.98 148.04 34.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.235 167.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 C--O 1.23 0.073 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -172.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.301 0.572 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.51 160.51 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.79 1.236 . . . . 0.0 109.161 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 5.2 m-30 -65.91 151.16 47.35 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 39.8 pt -131.2 133.64 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.13 95.83 7.37 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.276 0.56 . . . . 0.0 109.823 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.95 116.08 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.9 tttt -90.57 171.88 9.08 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 173.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.4 p -66.98 -28.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 0.0 114.108 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 N--CA 1.466 0.325 0 C-N-CA 127.653 2.381 . . . . 0.0 109.391 -173.217 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' B' ' 119' ' ' SER . 0.2 OUTLIER 52.07 -173.48 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 126.379 1.872 . . . . 0.0 113.518 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.594 ' H ' ' HG3' ' B' ' 118' ' ' ARG . 0.8 OUTLIER -150.04 -178.39 6.46 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -176.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . 0.495 ' HB2' HD21 ' B' ' 121' ' ' ASN . 33.6 mt-10 -148.53 -29.3 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.39 1.876 . . . . 0.0 113.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . 0.495 HD21 ' HB2' ' B' ' 120' ' ' GLU . 1.3 p30 -140.98 78.53 1.65 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.663 2.385 . . . . 0.0 107.535 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -89.58 150.61 22.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.653 0.739 . . . . 0.0 112.757 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.36 127.57 32.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 126.445 1.898 . . . . 0.0 107.866 174.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.13 157.23 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.05 114.54 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.9 p -129.06 146.29 51.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.74 -0.94 39.11 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.08 144.69 48.16 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 128.054 2.542 . . . . 0.0 110.535 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.98 161.1 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.802 2.335 . . . . 0.0 109.478 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.05 -11.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.833 2.355 . . . . 0.0 110.687 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m -79.13 -8.15 58.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.575 1.15 . . . . 0.0 112.225 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.04 164.66 40.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.264 0.484 . . . . 0.0 111.987 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.1 t -157.68 168.85 26.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.117 0.967 . . . . 0.0 108.4 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -63.36 -27.24 69.18 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.545 0.611 . . . . 0.0 111.773 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -68.33 -46.77 69.28 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.186 0.448 . . . . 0.0 110.705 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.08 -24.39 63.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -20.76 60.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' B' ' 138' ' ' LYS . 50.1 mtpt -85.55 -34.89 21.38 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.566 0.621 . . . . 0.0 109.359 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.62 -40.43 66.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.494 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.2 t60 -81.03 -36.53 30.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.738 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.7 mmm -73.1 -20.65 60.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.398 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -51.27 -18.84 1.04 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.585 0.63 . . . . 0.0 112.403 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.81 -39.62 85.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.385 0.674 . . . . 0.0 111.39 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . 0.485 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.52 -18.63 65.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.588 0.755 . . . . 0.0 111.775 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 168.39 -95.67 0.11 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.37 133.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -119.8 153.08 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.137 0.494 . . . . 0.0 110.44 -175.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.8 -21.08 3.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.311 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 51.8 t80 -144.31 157.38 44.3 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 120.22 1.373 . . . . 0.0 112.19 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.61 169.65 22.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.628 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -148.76 152.94 37.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.471 HG21 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -131.31 140.68 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.415 0.626 . . . . 0.0 109.853 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.14 5.07 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.126 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.471 ' H ' HG21 ' B' ' 152' ' ' VAL . 7.4 mtt180 61.47 16.28 7.41 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.548 0.739 . . . . 0.0 112.709 170.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -135.44 5.83 3.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.97 3.9 15.12 Favored Glycine 0 C--N 1.337 0.597 0 O-C-N 121.881 -0.512 . . . . 0.0 112.197 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.5 p -142.31 161.78 37.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 110.573 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.58 -168.61 37.51 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.45 165.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 117.393 0.596 . . . . 0.0 110.734 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.9 p -153.7 156.67 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.108 0.963 . . . . 0.0 109.246 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.09 156.25 40.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.663 0.268 . . . . 0.0 111.612 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 39.8 m-85 -120.43 163.58 17.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.697 1.237 . . . . 0.0 114.171 -169.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.96 -12.74 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.502 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -152.68 142.28 21.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -63.8 -21.01 66.22 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.91 -29.79 58.53 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.876 -0.515 . . . . 0.0 110.952 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -74.15 -18.71 60.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 32.9 ttp -77.17 -53.13 8.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -61.03 -20.6 62.72 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.485 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 7.4 t80 -74.13 -30.83 62.48 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.893 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.15 -33.08 67.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.073 -0.392 . . . . 0.0 110.561 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.0 4.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -133.72 -18.91 2.11 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 121.319 -0.863 . . . . 0.0 112.552 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 -19.96 5.41 Favored 'General case' 0 N--CA 1.46 0.047 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.29 2.71 14.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.71 140.52 34.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.365 1.066 . . . . 0.0 108.428 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 65.42 25.06 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.555 0.693 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 53.8 p -135.27 169.58 17.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.9 1.28 . . . . 0.0 108.507 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 9.9 pttt -75.23 155.87 36.33 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.248 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.494 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -138.44 166.23 24.79 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.483 170.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 124.161 0.984 . . . . 0.0 110.157 -169.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.918 0.39 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.68 156.2 15.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.015 . . . . 0.0 108.9 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 2.6 m-30 -72.03 158.57 35.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.061 0.458 . . . . 0.0 111.118 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.03 145.08 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.113 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -102.73 102.39 12.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.976 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.9 79.72 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.047 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.22 158.29 23.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.153 0.501 . . . . 0.0 111.374 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' B' ' 195' ' ' ASP . 27.6 m -72.64 6.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 126.203 1.801 . . . . 0.0 113.705 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 3.8 t0 . . . . . 0 C--N 1.327 -0.397 0 O-C-N 124.995 1.435 . . . . 0.0 110.277 170.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . 0.31 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.1 169.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.849 1.259 . . . . 0.0 113.476 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -140.46 -133.3 0.11 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.775 0.83 . . . . 0.0 112.151 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.64 -19.55 1.84 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -165.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.01 75.43 1.55 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.814 1.245 . . . . 0.0 109.788 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 66.5 mtm-85 -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.436 1.494 . . . . 0.0 113.398 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.415 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.4 OUTLIER -139.21 132.86 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 126.604 1.962 . . . . 0.0 108.111 174.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.52 156.59 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 109.774 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.18 100.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 77.3 p -111.3 146.94 36.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.407 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.47 -0.46 32.69 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.17 149.82 44.56 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 128.12 2.568 . . . . 0.0 111.29 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.31 165.16 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.5 2.8 . . . . 0.0 109.668 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.95 -15.69 36.46 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.786 2.324 . . . . 0.0 110.25 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 73.2 m -79.66 -2.57 43.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.875 1.27 . . . . 0.0 112.024 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.75 168.64 54.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 3.9 p -159.75 166.36 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -73.21 -28.67 62.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.334 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -68.34 -40.47 81.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 117.964 0.347 . . . . 0.0 110.246 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -80.61 -19.73 44.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -34.05 70.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -74.65 -37.95 62.6 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.37 1.47 1.62 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.727 1.211 . . . . 0.0 113.5 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.549 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 12.0 t60 -132.96 -37.74 0.99 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.513 0.597 . . . . 0.0 111.403 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.5 mmm -71.63 -11.35 60.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.421 0.555 . . . . 0.0 110.189 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -47.59 -21.41 0.35 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 123.914 0.886 . . . . 0.0 113.114 171.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.4 -41.88 88.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.2 -27.81 67.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.15 -170.26 36.91 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -83.07 74.26 9.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.839 0.828 . . . . 0.0 110.565 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.4 OUTLIER -61.11 149.56 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 34.4 t -131.74 -33.37 1.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -136.37 158.89 43.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 110.609 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.45 166.28 33.19 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -145.19 150.52 36.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.549 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.8 p -129.49 141.38 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.599 0.714 . . . . 0.0 110.362 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.79 11.61 29.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.279 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.549 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.9 23.3 0.03 OUTLIER 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.954 2.101 . . . . 0.0 114.895 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.07 6.75 1.78 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.14 6.38 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 118.557 0.617 . . . . 0.0 113.202 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 2.9 p -142.73 163.46 32.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.271 0.536 . . . . 0.0 110.322 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.04 -168.29 35.43 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.91 162.29 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 122.94 0.496 . . . . 0.0 111.105 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -154.59 153.95 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 124.327 1.051 . . . . 0.0 109.472 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.403 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 17.1 pt-20 -154.47 160.15 41.42 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -122.73 171.72 8.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 122.061 0.934 . . . . 0.0 111.984 -171.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.05 -20.11 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.22 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -145.11 143.89 30.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.135 0.574 . . . . 0.0 110.371 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.02 -24.32 63.26 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.29 -29.53 62.78 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.546 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.83 -19.33 60.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' MET . . . . . 0.442 ' HA ' ' CE1' ' B' ' 162' ' ' PHE . 31.2 ttp -78.17 -52.79 8.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.181 0.592 . . . . 0.0 110.481 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.3 m -64.8 -19.27 65.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -73.91 -27.63 61.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.03 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.46 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.03 -0.419 . . . . 0.0 110.891 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.38 3.25 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . 0.604 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 5.1 ptm180 -134.44 -21.45 1.78 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.833 0.742 . . . . 0.0 112.491 -173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.604 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.1 OUTLIER -113.06 -26.3 8.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.945 0.339 . . . . 0.0 111.116 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -118.23 2.22 11.95 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.763 0.825 . . . . 0.0 109.955 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.0 152.39 29.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.107 0.563 . . . . 0.0 109.544 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.4 32.95 12.04 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 32.9 p -133.01 175.15 9.63 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.974 0.509 . . . . 0.0 110.632 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.75 147.19 28.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.899 0.88 . . . . 0.0 112.1 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.549 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.4 t80 -139.7 158.78 43.54 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.9 1.28 . . . . 0.0 109.639 170.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 . . . . . 0 CA--C 1.52 -0.209 0 C-N-CA 124.766 1.226 . . . . 0.0 108.715 -174.186 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.608 0.242 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.33 -159.43 0.58 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.404 0.681 . . . . 0.0 109.732 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.89 145.64 48.28 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.62 92.13 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.063 0 CA-C-O 121.535 0.683 . . . . 0.0 112.608 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.8 84.8 1.67 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.83 0.824 . . . . 0.0 109.489 170.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.55 133.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.134 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' B' ' 195' ' ' ASP . 54.6 mtmt -125.83 165.62 18.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.271 0.558 . . . . 0.0 112.114 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 18.0 m -76.77 32.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 126.7 2.0 . . . . 0.0 112.679 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' B' ' 193' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.759 173.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' B' ' 117' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.7 -175.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -138.67 -135.35 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.289 37.7 mt-10 -136.65 -17.58 1.47 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.659 1.983 . . . . 0.0 115.214 -165.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -131.43 80.85 1.95 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.559 1.544 . . . . 0.0 108.558 -169.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 61.6 mtm-85 -80.64 159.02 25.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.41 2.284 . . . . 0.0 113.429 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.7 138.87 17.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 128.722 2.809 . . . . 0.0 107.721 176.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.63 164.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.32 131.52 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 93.3 p -137.19 140.14 41.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.869 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 132.35 -1.02 4.83 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' B' ' 180' ' ' PHE . 1.6 mm? -53.54 149.21 15.81 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 123.352 0.661 . . . . 0.0 110.981 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.26 166.43 29.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.309 3.339 . . . . 0.0 110.669 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.79 -3.59 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 1 C-N-CA 125.443 4.095 . . . . 0.0 116.308 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.11 10.47 1.52 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.644 1.111 . . . . 0.0 113.261 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.36 158.79 7.01 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -148.43 170.3 18.31 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.37 -0.488 . . . . 0.0 110.594 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -66.69 -27.07 67.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.555 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -68.38 -35.22 77.37 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.348 0.522 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -84.03 -22.69 31.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.388 -0.195 . . . . 0.0 111.325 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -35.9 75.19 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -77.02 -36.62 56.12 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.44 -2.05 10.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.234 1.014 . . . . 0.0 112.962 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 17.9 t60 -126.99 -37.6 2.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 110.882 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mmm -70.89 -11.31 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.885 -0.509 . . . . 0.0 110.205 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -49.53 -21.34 0.94 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.228 0.611 . . . . 0.0 112.439 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.26 -43.62 81.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.148 0.579 . . . . 0.0 111.073 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.13 68.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.055 0.542 . . . . 0.0 110.929 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.47 -167.67 37.1 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.05 74.3 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.669 0.747 . . . . 0.0 110.402 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 1.2 p -60.33 149.03 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 29.1 p -138.29 -13.64 1.35 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.984 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.54 155.76 32.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.332 -0.855 . . . . 0.0 110.638 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.9 130.24 8.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.678 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.97 120.96 43.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . 0.476 HG21 ' H ' ' B' ' 154' ' ' ARG . 11.3 p -109.39 140.6 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.565 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.15 6.18 49.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.353 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.476 ' H ' HG21 ' B' ' 152' ' ' VAL . 13.8 mtt180 62.57 14.91 7.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.928 0.891 . . . . 0.0 112.669 172.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.59 -4.44 2.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 130.56 7.19 3.53 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 118.528 0.604 . . . . 0.0 113.118 177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 164.81 29.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.62 0.71 . . . . 0.0 110.614 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.85 -164.18 31.87 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.27 161.02 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 124.088 0.955 . . . . 0.0 108.423 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 p -152.03 156.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.405 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 13.6 pt-20 -156.18 159.6 39.12 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.2 m-85 -127.97 170.42 12.88 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.596 0.713 . . . . 0.0 111.314 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.58 -7.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -149.46 135.83 19.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.161 0.437 . . . . 0.0 110.119 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -66.81 -20.86 66.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.37 -31.96 54.65 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.507 -0.746 . . . . 0.0 110.56 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.61 -19.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 109.607 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.8 ttp -76.54 -52.45 9.73 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.017 0.927 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -65.19 -19.38 65.94 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' TYR . . . . . 0.589 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 37.9 t80 -73.55 -27.66 61.46 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.452 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.13 66.61 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.385 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.3 4.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.4 -17.18 2.05 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.393 -0.817 . . . . 0.0 112.872 -172.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.3 mppt? -124.94 -21.59 4.67 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 173.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.21 1.62 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.912 0.485 . . . . 0.0 109.945 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 140.59 29.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 62.06 34.49 16.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.807 0.843 . . . . 0.0 111.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.7 p -138.04 177.77 7.63 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.469 0.708 . . . . 0.0 110.543 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -57.01 155.52 8.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.701 1.201 . . . . 0.0 113.704 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' PHE . . . . . 0.649 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 23.7 t80 -143.25 161.87 37.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.472 1.909 . . . . 0.0 108.873 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 . . . . . 0 C--N 1.339 0.125 0 C-N-CA 124.19 0.996 . . . . 0.0 108.738 -173.235 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 56.1 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.39 0.614 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.84 -163.24 1.45 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.991 1.316 . . . . 0.0 107.755 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.03 156.34 38.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.07 146.53 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.577 0.703 . . . . 0.0 111.234 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -116.61 82.3 1.77 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 t -69.52 86.33 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.901 0.88 . . . . 0.0 111.219 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 193' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 12.7 tttt -71.08 169.32 15.24 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.02 -0.425 . . . . 0.0 110.869 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 194' ' ' VAL . . . . . 0.46 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 5.5 p -62.01 -28.67 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.062 1.745 . . . . 0.0 115.246 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 128.068 2.547 . . . . 0.0 109.067 -173.588 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 111.84 3.64 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.716 0 C5'-C4'-C3' 110.272 -3.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 O4'-C1'-N19 111.431 3.231 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.625 0 O4'-C1'-N19 112.054 3.854 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.433 ' C8 ' ' CZ2' ' B' ' 134' ' ' TRP . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C4'-C3'-C2' 98.124 -4.576 . 0.183 0i . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 3 O4'-C1'-N19 116.001 7.801 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.619 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.667 1 O4'-C1'-N19 112.74 4.54 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 C5'-C4'-C3' 111.863 -2.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 119.773 -0.156 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . 34.52 56.09 1.94 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.959 1.304 . . . . 0.0 113.186 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.46 167.28 25.8 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.286 2.657 . . . . 0.0 111.923 -174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' B' ' 111' ' ' ARG . 12.1 ptp85 -142.33 -8.26 0.88 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.56 177.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.31 19.34 59.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.52 0.581 . . . . 0.0 113.251 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.463 ' H ' ' HG3' ' B' ' 109' ' ' ARG . 82.9 mtt85 -146.69 169.29 19.33 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.252 1.021 . . . . 0.0 110.341 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -62.83 150.61 41.24 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.821 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.46 174.51 22.34 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.97 111.13 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.171 3.247 . . . . 0.0 110.225 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.75 -58.06 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.541 2.828 . . . . 0.0 116.432 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.18 -30.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -8.66 3.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -175.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.64 1.176 . . . . 0.0 112.586 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.49 ' HB3' ' CG ' ' B' ' 161' ' ' GLU . 0.0 OUTLIER -162.44 179.6 7.68 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . 0.473 ' HB2' HD21 ' B' ' 121' ' ' ASN . 26.5 mt-10 -149.35 -31.21 0.23 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.45 -1.704 . . . . 0.0 113.406 -172.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' B' ' 120' ' ' GLU . 1.6 p30 -140.49 78.74 1.67 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.325 1.85 . . . . 0.0 107.42 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -87.29 158.0 19.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.44 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.65 142.17 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 127.987 2.515 . . . . 0.0 107.279 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.91 159.48 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.07 102.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -117.79 150.65 38.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.193 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.95 -2.71 55.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 14.4 tp -53.42 145.18 28.57 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 128.14 2.576 . . . . 0.0 110.151 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.36 162.45 38.34 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.053 2.502 . . . . 0.0 109.448 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.33 -12.64 35.53 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.881 2.387 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -72.75 -23.0 60.77 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.091 0.957 . . . . 0.0 111.779 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.59 46.25 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.4 0.444 . . . . 0.0 112.645 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 43.8 t -158.12 168.66 26.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . 0.433 ' CZ2' ' C8 ' ' A' ' 5' ' ' ' G' . 34.6 p-90 -64.49 -30.13 71.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.446 0.566 . . . . 0.0 110.727 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -66.61 -37.07 84.1 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.938 0.335 . . . . 0.0 111.568 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.619 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 86.6 m-20 -84.67 -17.88 37.13 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.856 0.298 . . . . 0.0 111.441 -176.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -32.17 66.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -77.73 -38.57 46.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.97 1.57 0.9 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.531 1.132 . . . . 0.0 113.658 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.63 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.6 t60 -136.68 -40.37 0.62 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.413 0.551 . . . . 0.0 111.568 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' B' ' 171' ' ' ALA . 86.4 mmm -68.55 -11.6 60.16 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.413 0.551 . . . . 0.0 110.051 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -47.39 -21.38 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.885 0.874 . . . . 0.0 112.504 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.23 -42.74 88.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.824 -0.548 . . . . 0.0 111.164 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.45 -27.72 66.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.65 0.78 . . . . 0.0 111.666 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.5 -167.54 37.06 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -87.22 77.9 8.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.915 0.864 . . . . 0.0 110.157 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -62.96 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 43.5 t -128.06 -23.77 3.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.743 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -139.59 155.79 47.26 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 119.162 0.892 . . . . 0.0 110.331 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.86 165.12 35.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -147.62 153.61 39.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.48 HG21 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -132.35 147.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.113 0.482 . . . . 0.0 110.305 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.78 10.98 17.93 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.999 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.48 ' H ' HG21 ' B' ' 152' ' ' VAL . 28.0 mtt180 59.24 17.39 5.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.681 0.792 . . . . 0.0 113.053 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.11 15.16 3.28 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.0 52.35 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 11.8 p -140.69 159.19 42.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.352 0.661 . . . . 0.0 110.395 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.78 -170.27 38.39 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.5 161.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.804 0.442 . . . . 0.0 111.131 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -153.49 156.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 123.459 0.704 . . . . 0.0 109.885 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.49 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 1.2 tm-20 -152.39 155.39 37.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.944 0.498 . . . . 0.0 111.728 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -124.17 163.62 21.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.883 1.273 . . . . 0.0 111.73 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.7 -8.37 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.507 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -147.8 133.8 19.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -63.57 -20.66 65.82 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -76.02 -29.37 58.1 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.649 -0.657 . . . . 0.0 110.744 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.8 -19.01 60.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.426 ' HA ' ' CE1' ' B' ' 162' ' ' PHE . 31.7 ttp -77.97 -52.97 7.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.345 1.058 . . . . 0.0 110.674 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -63.46 -21.45 66.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.279 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.559 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 46.0 t80 -74.53 -31.72 62.23 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.413 ' HB3' ' CE ' ' B' ' 141' ' ' MET . . . -74.73 -17.56 60.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.288 0.635 . . . . 0.0 111.628 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.21 34.23 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.714 0.769 . . . . 0.0 111.702 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -143.28 -17.5 0.64 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.559 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -123.54 -25.82 4.3 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.39 0.676 . . . . 0.0 112.611 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.38 -2.64 21.96 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.357 0.263 . . . . 0.0 110.533 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.22 145.9 32.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.008 0.923 . . . . 0.0 109.013 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 29.67 17.85 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.435 0.694 . . . . 0.0 112.532 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 47.4 p -133.44 169.49 16.88 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.965 0.506 . . . . 0.0 110.701 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -57.85 149.47 22.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.63 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.0 t80 -141.71 161.1 38.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.982 1.713 . . . . 0.0 108.937 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.45 ' HD2' ' H ' ' B' ' 182' ' ' SER . 15.0 tpt180 -139.33 155.76 47.48 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 110.178 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.45 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 41.8 t -141.77 162.56 35.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.303 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.466 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 18.2 p-80 -59.75 -20.57 57.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.208 1.403 . . . . 0.0 113.319 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -72.0 -13.15 61.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.986 0.357 . . . . 0.0 111.573 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.35 20.51 13.38 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.615 -0.547 . . . . 0.0 113.017 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.18 171.48 14.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.103 0.951 . . . . 0.0 110.99 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -139.01 161.56 37.07 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 -173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.69 160.48 19.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.326 1.051 . . . . 0.0 108.849 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.98 157.23 38.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 110.346 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 26.9 pt -123.59 151.7 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.746 0.784 . . . . 0.0 109.64 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -118.41 78.76 1.29 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.78 144.54 10.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 5.3 tttp -126.68 168.78 13.89 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.432 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.0 p -60.22 -29.55 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.526 1.531 . . . . 0.0 114.603 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t70 143.59 163.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.71 2.404 . . . . 0.0 109.058 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.436 -1.758 . . . . 0.0 110.988 175.817 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 0 O4'-C1'-N19 109.948 1.748 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 O4'-C1'-N19 110.722 2.522 OUTLIER-DELTA 0.0 OUTLIER '7D dist 5d' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . 0.401 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.809 0 O4'-C1'-N19 111.985 3.785 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 O4'-C1'-N19 111.242 3.042 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.301 1 C4'-C3'-C2' 98.04 -4.66 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 2 O4'-C1'-N19 115.337 7.137 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.662 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.75 1 O4'-C1'-N19 113.416 5.216 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 C5'-C4'-C3' 112.983 -1.678 . 0.013 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.627 0.251 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' B' ' 109' ' ' ARG . . . -150.93 157.78 35.32 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.591 0.756 . . . . 0.0 109.13 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 10.8 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.929 3.086 . . . . 0.0 112.661 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' B' ' 107' ' ' ALA . 17.0 ptm180 -143.64 18.24 1.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.07 0.948 . . . . 0.0 110.731 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.19 34.41 0.35 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 mtm-85 -59.97 -18.1 43.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.65 7.42 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.404 0.547 . . . . 0.0 112.357 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.83 -173.31 45.5 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.28 160.78 47.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.908 2.405 . . . . 0.0 109.528 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.17 151.64 66.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.906 2.404 . . . . 0.0 109.703 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 3.0 m -160.57 159.29 30.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 53.52 4.59 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 169.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -53.9 159.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.167 0.894 . . . . 0.0 112.192 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' B' ' 120' ' ' GLU . 6.8 t -140.1 -94.37 0.16 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' B' ' 119' ' ' SER . 29.5 mt-10 -153.89 -30.51 0.12 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -165.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.94 -37.24 2.12 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -165.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . 0.484 ' H ' ' HG3' ' B' ' 161' ' ' GLU . 86.8 mtt180 46.3 165.33 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' B' ' 168' ' ' MET . 0.0 OUTLIER -159.17 134.65 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 129.59 3.156 . . . . 0.0 107.717 170.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.16 165.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.2 136.41 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 54.6 p -135.32 147.45 49.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.907 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.07 -2.34 31.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.72 140.44 38.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 127.133 2.173 . . . . 0.0 110.076 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.3 162.35 19.92 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.638 2.892 . . . . 0.0 110.11 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -14.77 32.71 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.865 2.377 . . . . 0.0 109.761 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -83.1 6.24 19.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.689 1.196 . . . . 0.0 111.738 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.45 165.09 12.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -159.49 170.67 21.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -61.68 -28.45 69.41 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -69.31 -35.05 75.57 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.662 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 70.7 m-20 -91.45 -19.59 22.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.25 0.477 . . . . 0.0 111.416 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.19 -26.48 59.04 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -75.22 -39.86 59.67 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.98 1.66 1.36 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.163 1.385 . . . . 0.0 113.179 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 8.4 t60 -135.38 -38.92 0.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.125 0.42 . . . . 0.0 111.37 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.0 mmm -68.14 -18.27 64.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.873 -0.517 . . . . 0.0 110.26 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -51.15 -19.88 1.32 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -56.57 -36.93 69.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.946 0.499 . . . . 0.0 111.169 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.424 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.2 -21.9 65.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.966 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.27 -93.82 0.11 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.902 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.8 121.1 6.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -121.84 150.54 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.02 -21.54 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.97 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -131.34 154.17 48.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.356 0.98 . . . . 0.0 111.801 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -158.28 161.48 37.71 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.413 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 18.0 t0 -145.56 148.46 33.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.55 HG21 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -128.45 141.97 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.208 0.528 . . . . 0.0 110.48 -172.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -103.3 5.82 37.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.497 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.55 ' H ' HG21 ' B' ' 152' ' ' VAL . 23.5 mtp85 62.55 17.21 9.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.461 0.705 . . . . 0.0 112.388 170.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -137.38 -11.96 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.06 -2.84 2.15 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 118.872 0.76 . . . . 0.0 113.181 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.2 165.85 26.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.51 -165.72 34.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 4.2 p -142.0 161.25 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 122.971 0.509 . . . . 0.0 110.02 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.5 p -147.62 159.63 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' B' ' 122' ' ' ARG . 42.9 tt0 -154.83 146.96 23.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.912 -0.492 . . . . 0.0 111.968 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 60.6 m-85 -117.94 156.93 27.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.595 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.1 m -61.71 -12.55 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.399 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -152.5 151.16 30.39 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.748 0.819 . . . . 0.0 109.07 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.67 -22.97 65.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.4 -32.83 48.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.597 0.635 . . . . 0.0 111.387 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.11 -17.66 61.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.123 0.487 . . . . 0.0 110.089 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.497 ' SD ' ' CG1' ' B' ' 123' ' ' VAL . 15.2 tmm? -82.95 -51.25 7.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.149 0.98 . . . . 0.0 111.202 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -61.75 -21.81 64.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.53 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 28.5 t80 -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.13 -12.47 60.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.204 0.602 . . . . 0.0 111.459 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . 0.258 13.3 p -118.57 33.22 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 111.514 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.11 -16.5 0.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.506 169.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.9 mppt? -123.58 -25.85 4.29 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.571 0.748 . . . . 0.0 112.428 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.24 -3.36 19.85 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.808 0.276 . . . . 0.0 110.461 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.95 143.64 43.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.716 0.806 . . . . 0.0 110.174 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.16 36.59 27.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 43.0 p -135.55 172.84 12.43 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.278 0.631 . . . . 0.0 110.301 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -58.75 146.31 37.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.937 0.895 . . . . 0.0 112.274 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.58 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 19.0 t80 -136.73 156.5 48.43 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.905 1.282 . . . . 0.0 109.36 169.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -145.44 142.15 29.03 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.788 1.235 . . . . 0.0 108.173 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.3 p -152.43 -176.11 5.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.958 0.503 . . . . 0.0 109.733 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.468 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 17.7 p-80 -58.3 -177.4 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.455 0.702 . . . . 0.0 112.031 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.402 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 3.5 mm-40 67.98 -13.38 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.783 1.633 . . . . 0.0 112.46 -173.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' B' ' 183' ' ' HIS . . . 94.23 27.37 12.17 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.459 171.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -128.85 176.07 8.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 72.1 p -137.71 166.61 23.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.332 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.8 -162.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.435 0.694 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.93 147.53 49.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 102.65 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.595 0.712 . . . . 0.0 112.449 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -80.16 89.11 5.42 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.88 138.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.86 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -117.47 162.43 17.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.74 -29.96 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.333 1.853 . . . . 0.0 114.913 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.8 t70 143.17 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.087 2.155 . . . . 0.0 108.826 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.216 -1.88 . . . . 0.0 111.064 175.348 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.949 1 O4'-C1'-N19 112.565 4.365 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.036 1 C3'-C2'-C1' 105.164 4.071 OUTLIER-EPSILON 0.074 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . 0.565 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.835 1 C5'-C4'-C3' 108.243 -4.838 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.848 0 C3'-C2'-C1' 105.076 3.973 . 0.056 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.471 1 C4'-C3'-C2' 98.509 -4.191 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.237 2 O4'-C1'-N19 113.309 5.109 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.642 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.788 2 C4'-C3'-C2' 98.317 -4.383 . 0.176 '#a' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . 0.429 " H3'" " H3'" ' A' ' 7' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.348 0 C5'-C4'-C3' 111.253 -2.831 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.2 155.42 33.24 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.83 0.452 . . . . 0.0 109.936 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.62 171.45 17.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.615 2.877 . . . . 0.0 110.822 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.35 170.35 16.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.894 0.878 . . . . 0.0 109.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 174.13 178.97 44.44 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -153.72 169.0 24.4 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.243 0.617 . . . . 0.0 110.462 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -147.91 14.21 1.04 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.081 0.552 . . . . 0.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.1 -169.25 24.08 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -44.35 136.93 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.727 3.618 . . . . 0.0 112.369 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.2 -43.36 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.83 2.353 . . . . 0.0 110.818 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 1.6 m -176.91 163.39 2.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 109.503 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.458 ' HB3' ' HG ' ' B' ' 148' ' ' CYS . 51.0 mtt180 54.91 -5.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -61.64 166.32 4.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.375 1.443 . . . . 0.0 112.417 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t -146.29 -126.2 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.434 0.694 . . . . 0.0 112.513 -172.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -133.97 -25.79 1.58 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 114.397 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . 0.428 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.9 p30 -130.31 79.97 1.93 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 110.052 -171.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -78.67 158.57 28.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.008 1.723 . . . . 0.0 112.895 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.405 HG12 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -149.92 142.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 127.733 2.413 . . . . 0.0 108.657 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.89 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.55 136.41 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.8 p -141.37 157.39 45.24 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.364 -0.21 . . . . 0.0 111.102 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 4.41 56.17 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.94 146.68 36.87 Favored Pre-proline 0 N--CA 1.452 -0.356 0 C-N-CA 125.287 1.435 . . . . 0.0 110.844 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.1 164.91 33.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.246 3.297 . . . . 0.0 110.948 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -54.17 -6.52 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 125.165 3.91 . . . . 0.0 116.257 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 13.03 1.16 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.604 1.093 . . . . 0.0 113.423 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -53.2 158.28 4.28 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -146.28 168.24 21.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.425 0.613 . . . . 0.0 110.44 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -65.54 -27.46 68.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.604 -0.236 . . . . 0.0 111.364 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -68.68 -40.11 80.27 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 117.928 0.331 . . . . 0.0 111.322 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.642 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 90.7 m-20 -80.07 -21.22 43.62 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.132 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -32.51 70.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -79.86 -37.26 35.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.78 3.04 2.12 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.363 1.065 . . . . 0.0 112.916 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.7 t60 -132.51 -41.17 0.97 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.386 0.539 . . . . 0.0 111.159 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' MET . . . . . 0.404 ' CE ' ' HB3' ' B' ' 171' ' ' ALA . 82.3 mmm -69.66 -12.48 61.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.196 0.453 . . . . 0.0 110.315 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -45.2 -24.96 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 112.196 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.91 -42.2 94.93 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.97 67.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.679 0.791 . . . . 0.0 111.505 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.9 -171.04 40.92 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -82.31 64.58 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.445 0.64 . . . . 0.0 111.254 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.3 OUTLIER -55.72 141.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . 0.458 ' HG ' ' HB3' ' B' ' 117' ' ' ARG . 37.5 t -123.52 -30.55 3.62 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -133.1 158.77 41.94 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.658 0.742 . . . . 0.0 111.59 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -154.11 168.95 24.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.493 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.409 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 41.3 t0 -150.04 154.51 38.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.489 HG23 ' H ' ' B' ' 154' ' ' ARG . 9.4 p -131.83 142.29 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.555 0.693 . . . . 0.0 110.473 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -105.07 5.69 32.67 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.11 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.489 ' H ' HG23 ' B' ' 152' ' ' VAL . 14.3 mtt-85 61.56 17.66 8.76 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.867 0.867 . . . . 0.0 112.421 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -137.06 0.67 2.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.01 2.89 7.7 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 118.504 0.593 . . . . 0.0 112.401 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.64 165.9 26.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.458 0.647 . . . . 0.0 110.316 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.89 -166.79 36.01 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 3.6 p -138.86 162.02 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.867 0.467 . . . . 0.0 110.781 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.9 p -149.24 159.5 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 123.717 0.807 . . . . 0.0 108.872 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.42 147.12 20.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.156 -0.34 . . . . 0.0 111.661 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 4.8 m-85 -121.13 171.79 8.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.394 1.092 . . . . 0.0 111.771 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.38 -20.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.252 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -143.94 141.98 30.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.228 0.611 . . . . 0.0 110.561 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.17 -25.02 63.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.9 -31.43 59.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.762 0.71 . . . . 0.0 111.009 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.71 -16.4 60.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.782 0.325 . . . . 0.0 110.183 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 26.6 ttp -79.83 -50.84 9.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.91 0.884 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 43.9 m -65.37 -19.76 66.09 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -72.57 -27.23 62.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.467 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.404 ' HB3' ' CE ' ' B' ' 141' ' ' MET . . . -75.03 -36.72 61.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 122.201 -0.312 . . . . 0.0 110.942 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.83 7.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . 0.579 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.5 ptm180 -138.39 -25.04 0.94 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.866 0.757 . . . . 0.0 112.224 -174.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.579 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.69 -27.42 10.32 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.367 0.531 . . . . 0.0 110.934 175.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -115.98 -1.12 12.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.897 0.879 . . . . 0.0 109.892 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.35 141.08 28.94 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.623 0.769 . . . . 0.0 109.056 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.35 26.91 12.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 111.802 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 52.0 p -137.25 172.56 12.81 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.126 0.57 . . . . 0.0 110.169 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -54.38 150.58 8.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.453 1.101 . . . . 0.0 113.965 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.588 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.4 t80 -141.68 162.06 36.4 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.873 2.069 . . . . 0.0 108.038 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -142.89 145.73 33.38 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.897 0.879 . . . . 0.0 109.031 -171.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 78.3 p -142.33 171.65 13.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.311 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.467 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.1 p-80 -58.69 -11.62 3.32 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.563 1.145 . . . . 0.0 113.015 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.18 -18.46 65.27 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.751 0.421 . . . . 0.0 110.989 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.02 9.5 55.96 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -136.61 -178.49 5.2 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.003 0.906 . . . . 0.0 112.018 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 57.3 p -134.43 161.94 33.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.212 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.65 158.35 17.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.506 1.123 . . . . 0.0 108.132 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.53 154.3 41.56 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.245 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.81 152.16 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.972 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.96 87.09 2.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.38 89.33 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 110.751 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.5 tttt -71.13 171.47 10.92 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 120.713 0.292 . . . . 0.0 111.037 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.462 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.8 p -65.28 -27.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.779 1.632 . . . . 0.0 114.67 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 23.5 t0 130.68 166.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.199 2.599 . . . . 0.0 108.977 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 117.463 -1.743 . . . . 0.0 110.818 175.21 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.859 0 C5'-C4'-C3' 110.835 -3.11 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 0 C5'-C4'-C3' 110.133 -3.578 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . 0.402 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 111.692 3.492 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 C5'-C4'-C3' 111.391 -2.739 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.467 1 C4'-C3'-C2' 98.688 -4.012 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 1 O4'-C1'-N19 112.686 4.486 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.632 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.782 1 O4'-C1'-N19 112.528 4.328 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 C5'-C4'-C3' 111.702 -2.532 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.15 155.6 33.4 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 122.885 0.474 . . . . 0.0 109.857 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.76 170.94 18.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.749 2.966 . . . . 0.0 111.053 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -145.27 9.47 1.24 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.739 0.416 . . . . 0.0 112.07 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.27 178.88 48.66 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -82.52 -6.16 59.16 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.761 0.424 . . . . 0.0 111.251 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 49.43 22.19 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.389 1.076 . . . . 0.0 112.652 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.34 -173.72 46.1 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.18 164.34 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.828 3.685 . . . . 0.0 112.961 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.96 -28.16 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.858 3.706 . . . . 0.0 114.558 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 17.8 m -167.23 -48.22 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 174.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.01 24.87 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.128 1.517 . . . . 0.0 112.89 166.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -54.05 167.47 0.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.844 1.258 . . . . 0.0 111.602 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -130.75 -97.33 0.34 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -153.53 -29.56 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -165.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.27 -35.81 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -165.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 39.73 158.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -153.55 142.54 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 127.428 2.291 . . . . 0.0 107.417 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -78.14 165.23 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.54 129.72 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 98.1 p -138.92 138.54 37.47 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.254 0.549 . . . . 0.0 111.504 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.92 0.28 7.69 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.51 145.08 21.6 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.588 1.155 . . . . 0.0 110.622 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.0 169.99 21.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.01 3.14 . . . . 0.0 109.621 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.92 -6.87 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.571 3.514 . . . . 0.0 115.793 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 30.1 m -138.16 5.46 2.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -54.97 153.66 10.83 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -147.32 168.9 20.6 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.302 -0.528 . . . . 0.0 110.978 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -65.35 -28.53 69.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.18 -46.27 74.46 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.364 0.529 . . . . 0.0 110.724 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.632 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 81.3 m-20 -76.37 -16.26 59.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.381 -0.199 . . . . 0.0 111.165 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -34.57 71.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -76.55 -37.63 56.31 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.59 -1.71 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.205 1.002 . . . . 0.0 113.652 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.583 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.0 t60 -128.0 -36.25 1.99 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.767 0.712 . . . . 0.0 111.23 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' MET . . . . . 0.427 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 82.5 mmm -73.73 -12.17 60.63 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.889 -0.507 . . . . 0.0 110.434 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttm105 -44.87 -25.16 0.27 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.913 0.885 . . . . 0.0 112.489 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.3 -42.14 93.36 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.916 -0.49 . . . . 0.0 111.328 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.26 -31.23 69.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.092 0.557 . . . . 0.0 111.386 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.13 -171.35 41.17 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -80.45 72.94 7.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.903 0.859 . . . . 0.0 110.939 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.8 OUTLIER -63.14 146.53 12.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 36.8 t -130.75 -31.63 1.74 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.691 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.435 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 6.2 t80 -137.15 161.53 35.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 110.458 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.86 169.87 23.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -148.14 155.34 41.31 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.467 HG23 ' H ' ' B' ' 154' ' ' ARG . 7.5 p -132.63 143.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.465 0.65 . . . . 0.0 109.944 -175.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -105.3 10.58 33.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.1 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.467 ' H ' HG23 ' B' ' 152' ' ' VAL . 35.4 mtp180 61.73 15.39 6.93 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.34 3.14 3.07 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.46 5.03 13.06 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -140.61 166.5 24.57 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.426 0.69 . . . . 0.0 110.511 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.88 -164.83 32.82 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.43 162.31 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.576 0.75 . . . . 0.0 110.45 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 12.6 p -144.27 160.08 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.1 141.62 24.33 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.453 0.701 . . . . 0.0 110.756 -168.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.5 m-85 -128.42 165.19 21.11 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.932 0.872 . . . . 0.0 110.59 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.6 -5.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.37 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -150.34 144.69 25.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.195 0.452 . . . . 0.0 110.125 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -70.82 -23.09 62.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.412 0.285 . . . . 0.0 111.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -88.7 -32.98 17.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.883 0.31 . . . . 0.0 111.726 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -74.37 -8.88 57.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.253 0.549 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 37.6 ttp -94.76 -42.3 8.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.11 1.364 . . . . 0.0 110.534 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 92.7 m -66.26 -17.42 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.601 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 42.8 t80 -72.4 -27.5 62.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.427 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -73.98 -38.09 64.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.378 -0.201 . . . . 0.0 110.567 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 m -73.16 5.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -134.23 -16.18 2.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.898 0.772 . . . . 0.0 112.857 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.601 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.2 mppt? -125.64 -21.09 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.31 1.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.85 144.31 31.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.777 0.831 . . . . 0.0 109.426 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.6 36.45 23.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.019 0.928 . . . . 0.0 112.709 174.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 33.5 p -133.69 178.96 6.53 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.361 0.664 . . . . 0.0 110.335 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -53.41 149.38 7.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.583 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 17.6 t80 -147.73 168.72 21.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.738 2.015 . . . . 0.0 107.749 168.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.441 ' HD2' ' H ' ' B' ' 182' ' ' SER . 15.2 tpt180 -148.22 149.75 32.48 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.441 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 30.8 t -128.21 153.62 46.72 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.249 0.547 . . . . 0.0 110.394 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.447 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 54.7 p-80 -58.72 -19.69 42.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.08 1.352 . . . . 0.0 113.524 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.418 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 22.7 pt-20 -156.04 26.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.19 0.45 . . . . 0.0 111.558 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.26 13.94 4.59 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.175 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 51.72 -170.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.32 1.048 . . . . 0.0 111.963 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 29.9 p -76.71 160.76 29.07 Favored 'General case' 0 C--O 1.231 0.105 0 O-C-N 121.775 -0.578 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.78 -168.99 2.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.592 1.157 . . . . 0.0 108.319 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.63 142.47 51.49 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -129.55 133.02 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.499 0.666 . . . . 0.0 112.665 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -94.94 89.76 5.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.52 92.74 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.173 0.589 . . . . 0.0 110.13 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.459 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 6.5 tttp -75.36 173.02 11.47 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 111.224 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.459 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 2.8 p -65.85 -28.82 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.247 1.819 . . . . 0.0 114.436 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 20.9 t70 141.56 163.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.38 2.272 . . . . 0.0 108.949 -173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.231 -1.872 . . . . 0.0 111.072 175.391 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.672 0 C5'-C4'-C3' 110.536 -3.309 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.093 0 C3'-C2'-C1' 104.329 3.144 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 O4'-C1'-N19 111.928 3.728 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C5'-C4'-C3' 111.776 -2.482 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.264 0 C4'-C3'-C2' 99.04 -3.66 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.209 2 O4'-C1'-N19 113.348 5.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.606 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.417 -3.038 0 O4'-C1'-N19 110.828 2.628 . 0.0 OUTLIER '7D dist #a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.166 0 C5'-C4'-C3' 110.514 -3.324 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.515 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -147.92 25.26 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 92.2 Cg_endo -73.0 157.99 50.34 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.65 1.567 . . . . 0.0 110.47 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 44.13 30.43 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.708 1.203 . . . . 0.0 113.121 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.62 -173.66 33.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -151.33 173.04 14.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.113 0.565 . . . . 0.0 110.612 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -148.66 177.97 9.04 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.013 0.925 . . . . 0.0 109.121 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -160.78 158.98 30.56 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.59 156.05 18.63 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.702 2.935 . . . . 0.0 111.466 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.19 155.73 33.24 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.535 2.823 . . . . 0.0 109.043 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -162.67 -41.19 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 O-C-N 122.179 -0.326 . . . . 0.0 111.75 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -147.27 12.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.237 1.015 . . . . 0.0 110.884 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.68 167.6 0.72 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.715 1.206 . . . . 0.0 112.759 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.9 t -150.85 -124.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.266 0.627 . . . . 0.0 111.793 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.25 35.5 mt-10 -138.5 -15.23 1.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.513 1.525 . . . . 0.0 114.796 -167.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . 0.428 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.0 p30 -138.42 77.18 1.61 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.407 1.483 . . . . 0.0 110.995 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -79.44 154.0 29.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.58 1.952 . . . . 0.0 112.499 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.6 OUTLIER -145.07 133.66 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.811 2.045 . . . . 0.0 108.407 173.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 37.8 t -70.52 160.37 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-O 121.101 0.477 . . . . 0.0 109.774 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.51 107.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.1 p -118.23 147.94 42.9 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.04 -1.92 35.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.42 153.69 13.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 111.411 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.85 158.15 38.95 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.69 2.26 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.83 -17.71 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.039 2.493 . . . . 0.0 111.482 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 56.5 m -79.01 -10.94 59.98 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.788 0.835 . . . . 0.0 112.412 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.73 161.99 50.99 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 23.5 t -152.06 170.23 20.44 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.302 0.641 . . . . 0.0 109.817 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 41.5 p-90 -64.85 -28.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.96 -0.463 . . . . 0.0 111.525 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.75 -37.34 82.0 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.025 0.375 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.606 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 83.3 m-20 -83.55 -29.52 27.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 111.299 0.111 . . . . 0.0 111.299 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -35.31 77.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.015 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -72.02 -41.95 66.95 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.61 2.79 1.64 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.347 1.459 . . . . 0.0 113.959 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -131.42 -38.24 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.773 0.715 . . . . 0.0 111.243 -175.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.9 mmm -69.84 -17.31 63.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.02 -0.425 . . . . 0.0 110.244 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -46.96 -19.29 0.1 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.959 0.903 . . . . 0.0 113.382 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.98 -41.43 95.44 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.148 0.579 . . . . 0.0 111.322 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.76 -26.18 67.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.366 0.666 . . . . 0.0 111.412 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.17 -171.73 33.99 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -74.08 114.77 12.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.282 0.541 . . . . 0.0 109.911 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -120.26 147.46 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.49 -17.05 2.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -135.49 153.85 51.6 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.764 1.165 . . . . 0.0 111.819 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -156.92 147.14 21.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.476 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -129.43 119.38 23.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.565 HG23 ' H ' ' B' ' 154' ' ' ARG . 5.9 p -106.66 148.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.487 -169.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -111.24 9.12 21.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.724 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.565 ' H ' HG23 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.37 25.88 0.05 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 126.789 2.036 . . . . 0.0 114.787 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -142.78 5.98 1.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.31 -4.85 6.76 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 121.813 -0.554 . . . . 0.0 113.006 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -143.43 162.91 34.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 109.725 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.69 -169.21 39.07 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.9 160.68 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 117.285 0.542 . . . . 0.0 109.623 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -146.24 156.2 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -150.52 145.82 26.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 111.91 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 44.6 m-85 -112.94 160.91 17.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.256 1.027 . . . . 0.0 112.799 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.42 -20.42 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.362 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -150.35 145.88 26.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 110.117 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.25 -24.81 65.84 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.88 -31.01 62.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.913 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.05 -17.06 61.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.669 0.271 . . . . 0.0 110.569 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 29.5 ttp -81.46 -52.79 6.88 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.761 0.824 . . . . 0.0 110.685 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.5 m -65.59 -17.19 64.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.53 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 22.1 t80 -73.3 -29.59 62.82 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.765 -0.585 . . . . 0.0 109.53 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.8 64.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.063 -0.398 . . . . 0.0 110.663 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.96 6.09 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -133.94 -15.56 2.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.623 0.647 . . . . 0.0 112.569 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.4 mppt? -125.4 -21.43 4.55 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.76 2.82 14.52 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.62 142.78 31.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.22 38.86 31.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.092 0.473 . . . . 0.0 111.752 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.3 p -137.6 169.36 17.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.247 1.419 . . . . 0.0 108.515 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -66.8 165.07 15.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.866 -170.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.489 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.9 t80 -150.72 172.78 15.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.173 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' B' ' 180' ' ' PHE . 15.2 tpt180 -148.53 143.55 26.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.573 0.749 . . . . 0.0 109.167 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 83.7 p -144.54 167.83 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.059 0.457 . . . . 0.0 110.905 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.474 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 11.1 p-80 -64.77 -179.67 0.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.01 -11.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.304 1.841 . . . . 0.0 113.648 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' B' ' 183' ' ' HIS . . . -162.98 -132.12 1.3 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.24 -145.43 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 111.325 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 49.8 p -80.69 168.02 19.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.979 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.15 -163.97 1.21 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.999 1.72 . . . . 0.0 107.192 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.31 156.38 44.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 22.6 pt -131.78 146.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.76 0.79 . . . . 0.0 111.129 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -114.71 79.91 1.33 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 34.7 t -60.76 133.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.49 160.54 31.99 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.135 0.574 . . . . 0.0 110.178 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' B' ' 123' ' ' VAL . 0.1 OUTLIER -60.42 -37.38 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 24.4 t70 131.38 155.97 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 109.712 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 117.522 -1.71 . . . . 0.0 111.335 174.041 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 0 C5'-C4'-C3' 109.694 -3.871 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.887 0 C5'-C4'-C3' 111.417 -2.722 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.543 0 O4'-C1'-N19 111.447 3.247 OUTLIER-DELTA 0.01 6g . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.523 " H1'" " H1'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C1'-N19 111.354 3.154 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.525 ' H21' ' HA ' ' B' ' 151' ' ' ASP . . . . . . . . 0 O4'--C4' 1.415 -3.135 3 O4'-C1'-N19 113.557 5.357 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.302 2 O4'-C1'-N19 113.739 5.539 . 0.01 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.419 -2.801 1 O4'-C1'-N19 112.517 4.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 C5'-C4'-C3' 111.78 -2.48 . 0.0 OUTLIER '7D dist 1[' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . 39.95 54.11 5.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.395 1.078 . . . . 0.0 113.38 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.09 -3.18 13.19 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.187 2.592 . . . . 0.0 112.143 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -152.23 162.27 41.39 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.336 0.655 . . . . 0.0 109.255 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.22 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.536 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -154.38 178.75 9.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.575 0.75 . . . . 0.0 109.761 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -143.61 11.36 1.66 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.498 0.319 . . . . 0.0 111.293 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.4 176.05 43.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 169.05 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.696 3.598 . . . . 0.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.89 -177.23 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.719 2.946 . . . . 0.0 110.177 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m -131.73 -42.39 1.03 Allowed 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -149.18 5.27 0.64 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.036 0.534 . . . . 0.0 112.106 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -55.71 167.04 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.54 0.736 . . . . 0.0 112.735 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 14.6 t -146.53 -122.56 0.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.337 0.655 . . . . 0.0 112.085 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -134.9 -22.86 1.59 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.599 1.56 . . . . 0.0 114.442 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.79 77.28 1.73 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.695 1.198 . . . . 0.0 110.668 -169.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -78.92 150.17 32.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.852 1.661 . . . . 0.0 113.013 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.61 129.26 29.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.877 1.671 . . . . 0.0 108.532 171.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.86 158.69 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.08 109.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 81.0 p -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.665 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.14 53.49 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.3 147.0 77.2 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 127.871 2.468 . . . . 0.0 111.034 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.14 160.49 33.07 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.903 2.402 . . . . 0.0 109.273 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 -9.99 25.88 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.83 2.353 . . . . 0.0 111.09 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -75.01 -11.81 60.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.261 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.71 164.9 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 121.732 0.629 . . . . 0.0 112.842 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.7 t -158.99 166.63 31.34 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.903 1.281 . . . . 0.0 108.004 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . 0.484 ' CZ2' " H2'" ' A' ' 5' ' ' ' G' . 40.5 p-90 -66.64 -30.2 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.523 0.601 . . . . 0.0 111.753 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -65.98 -32.08 73.35 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.414 0.552 . . . . 0.0 110.635 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 73.7 m-20 -87.64 -20.62 26.08 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 117.738 0.245 . . . . 0.0 111.512 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -29.97 64.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -79.65 -39.79 30.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.77 -1.75 7.81 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.496 1.118 . . . . 0.0 113.429 -176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 14.0 t60 -129.52 -41.74 1.35 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.132 0.424 . . . . 0.0 111.12 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' MET . . . . . 0.402 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 85.1 mmm -65.48 -16.93 64.15 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -42.24 -27.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.683 1.593 . . . . 0.0 113.13 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.03 -41.49 96.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 111.573 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.93 -29.26 69.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.333 0.653 . . . . 0.0 111.751 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.88 -175.8 34.32 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -73.02 115.79 12.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 122.369 -0.489 . . . . 0.0 110.333 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -113.63 151.18 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.4 p -132.99 -26.04 1.76 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.915 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -134.33 152.94 52.1 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.81 1.186 . . . . 0.0 112.125 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -149.81 169.18 21.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.655 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.525 ' HA ' ' H21' ' A' ' 5' ' ' ' G' . 35.5 t0 -149.67 141.41 23.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 168.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.534 HG21 ' H ' ' B' ' 154' ' ' ARG . 4.8 p -122.41 142.54 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.629 0.728 . . . . 0.0 111.02 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -108.79 9.96 26.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.682 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.534 ' H ' HG21 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.0 24.57 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.215 2.206 . . . . 0.0 114.991 178.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.49 10.45 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.94 -4.21 7.93 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.106 0.412 . . . . 0.0 113.0 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.2 162.28 36.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.893 0.477 . . . . 0.0 110.415 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.28 -169.26 37.53 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.43 162.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.26 0.53 . . . . 0.0 110.755 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.2 p -149.75 158.53 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.898 0.879 . . . . 0.0 108.934 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.62 147.27 24.23 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.901 -0.499 . . . . 0.0 111.535 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 30.4 m-85 -116.49 168.5 10.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 122.281 1.038 . . . . 0.0 113.322 -172.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.3 m -75.67 -10.52 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.658 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -151.46 142.85 23.44 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.88 -23.53 66.67 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.31 -30.97 62.3 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.252 0.478 . . . . 0.0 110.86 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.06 -19.36 60.64 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 110.323 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 30.8 ttp -82.33 -53.44 6.02 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.764 0.826 . . . . 0.0 111.048 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -63.23 -21.79 66.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.512 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 29.2 t80 -73.53 -33.73 64.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.402 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -74.63 -14.41 60.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.066 0.546 . . . . 0.0 111.362 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . 0.261 8.2 p -116.07 33.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 111.198 174.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.3 ptm180 -143.64 -17.32 0.62 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.512 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -122.82 -27.36 4.3 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.326 0.65 . . . . 0.0 112.531 173.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.61 -7.52 19.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.35 147.16 40.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.8 0.84 . . . . 0.0 110.278 168.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 57.85 28.93 16.74 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.128 0.971 . . . . 0.0 112.367 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 63.6 p -136.95 174.55 10.5 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.88 0.472 . . . . 0.0 110.811 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -54.36 145.35 18.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 113.063 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.644 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 5.2 t80 -138.56 160.04 40.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.771 1.629 . . . . 0.0 108.144 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.42 ' HD2' ' H ' ' B' ' 182' ' ' SER . 14.9 tpt180 -137.59 151.32 48.22 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.709 0.804 . . . . 0.0 109.795 -169.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 50.3 m -135.89 165.03 26.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.241 0.543 . . . . 0.0 111.174 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 12.7 p-80 -60.86 -16.35 40.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.061 1.344 . . . . 0.0 113.471 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -77.36 -13.09 60.0 Favored 'General case' 0 CA--C 1.526 0.037 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.44 20.15 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.115 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.39 172.26 12.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.982 0.891 . . . . 0.0 110.928 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -136.17 163.25 30.8 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.71 158.75 20.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.555 1.142 . . . . 0.0 108.143 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -71.17 161.28 31.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.424 0.631 . . . . 0.0 110.425 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 28.9 pt -130.18 156.0 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.429 169.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -122.02 87.06 2.68 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.429 1.092 . . . . 0.0 108.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.22 142.19 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.261 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -134.09 158.48 43.5 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.282 0.563 . . . . 0.0 110.725 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.9 3.81 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 126.286 1.835 . . . . 0.0 113.76 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 7.3 t0 90.32 158.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.314 1.446 . . . . 0.0 110.377 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 117.265 -1.853 . . . . 0.0 111.324 174.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.128 2 O4'-C1'-N19 113.642 5.442 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 O4'-C1'-N19 111.066 2.866 . 0.074 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 1 C5'-C4'-C3' 109.127 -4.249 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 P-O3'-C3' 123.682 3.318 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.504 ' H21' ' HA ' ' B' ' 151' ' ' ASP . . . . . . . . 0 O4'--C4' 1.412 -3.38 1 C4'-C3'-C2' 98.071 -4.629 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.252 2 O4'-C1'-N19 113.059 4.859 . 0.01 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.652 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.418 -2.881 0 O4'-C1'-N19 112.046 3.846 . 0.05 '#a' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 N19-C1'-C2' 109.28 -2.575 . 0.188 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 111.071 0.026 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.8 156.36 35.9 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.125 0.57 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.23 7.43 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.202 3.268 . . . . 0.0 112.202 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 48.2 36.16 6.36 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.719 0.808 . . . . 0.0 112.468 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.33 -174.56 13.53 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -64.95 -8.61 16.43 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -64.13 160.65 17.82 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.045 0.384 . . . . 0.0 110.901 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.18 174.46 49.59 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.11 119.38 6.13 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.574 2.85 . . . . 0.0 111.187 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.6 174.61 10.28 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.73 2.953 . . . . 0.0 110.229 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -154.86 -43.89 0.09 Allowed 'General case' 0 C--N 1.338 0.094 0 CA-C-O 120.857 0.36 . . . . 0.0 110.66 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -148.58 8.74 0.79 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.188 0.995 . . . . 0.0 111.003 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -53.91 168.69 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.704 1.202 . . . . 0.0 112.26 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.6 t -138.61 -93.84 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.292 15.1 mt-10 -159.01 -27.56 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -164.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -25.73 4.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -161.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 35.07 155.93 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.401 3.081 . . . . 0.0 119.278 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.78 122.66 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.634 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -67.46 158.96 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.97 112.96 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 83.2 p -122.18 152.64 39.74 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.7 35.8 3.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.467 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 13.0 tp -111.45 31.29 0.1 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 80.7 Cg_exo -46.93 -33.51 14.59 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.572 2.181 . . . . 0.0 116.307 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' B' ' 132' ' ' GLY . 89.5 Cg_exo -47.88 167.04 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.298 2.666 . . . . 0.0 114.094 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 7.0 t -71.27 19.68 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.77 0.828 . . . . 0.0 112.076 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' B' ' 130' ' ' PRO . . . -46.95 154.71 0.89 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.403 1.001 . . . . 0.0 113.206 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -146.69 166.13 27.52 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.131 0.972 . . . . 0.0 108.652 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . 0.427 ' CE3' ' C6 ' ' A' ' 5' ' ' ' G' . 39.4 p-90 -63.32 -28.64 70.15 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.849 -0.532 . . . . 0.0 111.289 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -67.59 -24.79 65.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.05 0.386 . . . . 0.0 111.528 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.652 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 68.5 m-20 -99.14 -18.74 17.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.095 0.407 . . . . 0.0 111.612 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -29.18 64.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -77.63 -39.8 44.05 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.02 -0.69 9.98 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.259 1.024 . . . . 0.0 113.462 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -128.86 -35.11 1.9 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.341 0.519 . . . . 0.0 111.036 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 78.7 mmm -73.27 -14.64 61.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -47.14 -21.37 0.24 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 112.797 172.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.57 -41.23 96.41 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.274 0.63 . . . . 0.0 110.992 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.61 68.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.942 0.497 . . . . 0.0 111.567 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.43 -169.59 37.77 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.83 81.71 2.76 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.801 0.81 . . . . 0.0 110.759 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -76.78 146.37 8.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.3 p -131.34 -25.02 2.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.797 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -139.31 157.1 46.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.436 1.016 . . . . 0.0 111.594 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.26 167.75 26.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.905 174.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.504 ' HA ' ' H21' ' A' ' 5' ' ' ' G' . 38.6 t0 -148.32 137.15 21.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 168.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.496 HG23 ' H ' ' B' ' 154' ' ' ARG . 5.0 p -118.84 142.34 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.845 0.831 . . . . 0.0 110.373 -171.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -107.37 9.22 29.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.0 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.496 ' H ' HG23 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.42 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.606 1.962 . . . . 0.0 114.446 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.05 8.16 1.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.35 -5.98 6.72 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.24 0.473 . . . . 0.0 112.973 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.4 p -144.12 165.61 27.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.173 0.487 . . . . 0.0 110.459 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.33 -166.27 33.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.51 162.74 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 CA-C-N 117.228 0.514 . . . . 0.0 110.251 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.8 p -147.74 161.12 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.008 0.923 . . . . 0.0 108.806 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -153.4 151.96 30.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 110.64 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 3.7 m-85 -129.53 164.58 23.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.926 0.869 . . . . 0.0 110.138 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 25.5 m -66.19 -5.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.53 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -152.6 155.9 38.25 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.554 0.615 . . . . 0.0 110.24 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.18 -28.04 65.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.757 0.423 . . . . 0.0 112.039 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.76 -30.9 18.69 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.064 -0.397 . . . . 0.0 112.022 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -72.62 -9.75 58.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 41.4 ttp -98.27 -42.95 7.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.464 1.506 . . . . 0.0 110.958 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.0 m -63.12 -19.25 64.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.553 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 24.9 t80 -71.31 -28.56 64.19 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.931 -0.48 . . . . 0.0 109.993 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.53 -36.71 65.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.21 4.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -133.95 -16.48 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.5 mppt? -124.91 -21.57 4.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.14 0.94 13.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.011 0.524 . . . . 0.0 109.886 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.53 143.03 27.18 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.929 0.891 . . . . 0.0 109.099 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.65 24.99 14.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.279 1.032 . . . . 0.0 111.669 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 81.6 p -137.62 179.29 6.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.341 0.591 . . . . 0.0 111.707 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.36 144.88 34.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.901 1.681 . . . . 0.0 114.708 -170.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.514 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 3.7 t80 -143.43 161.45 38.36 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.104 1.762 . . . . 0.0 108.54 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.46 ' HD2' ' H ' ' B' ' 182' ' ' SER . 12.5 tpt180 -142.54 156.63 45.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.282 1.033 . . . . 0.0 109.224 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.46 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 38.7 t -131.98 162.93 29.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 111.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.461 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 56.5 p-80 -66.92 14.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.608 1.963 . . . . 0.0 114.673 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -129.97 -20.96 3.06 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.05 0.841 . . . . 0.0 111.9 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 132.87 -19.18 4.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.704 171.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -76.1 156.47 33.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.673 0.736 . . . . 0.0 111.154 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 81.1 p -145.54 154.23 41.96 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.577 0.751 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.29 160.87 16.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -72.07 148.25 45.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.0 139.33 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -100.59 86.07 3.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.33 1.052 . . . . 0.0 108.724 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 10.6 t -71.18 81.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.577 0.751 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.98 159.82 32.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.872 0.869 . . . . 0.0 110.721 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' B' ' 195' ' ' ASP . 19.1 m -75.18 3.46 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 126.03 1.732 . . . . 0.0 114.69 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 19.7 t70 107.97 159.03 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.402 1.881 . . . . 0.0 110.408 170.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 117.129 -1.928 . . . . 0.0 110.964 173.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.115 2 O4'-C1'-N19 113.279 5.079 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 C4'-C3'-O3' 117.535 2.667 OUTLIER-EPSILON 0.344 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . 0.458 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 P-O3'-C3' 125.372 4.726 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.13 0 C3'-C2'-C1' 104.492 3.325 . 0.104 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.248 2 O4'-C1'-N19 113.018 4.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 3 O4'-C1'-N19 115.866 7.666 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.62 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.738 1 O4'-C1'-N19 112.649 4.449 . 0.0 OUTLIER '7D dist 6n' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.094 0 O4'-C1'-N19 110.325 2.125 . 0.01 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.72 155.99 32.81 Favored Pre-proline 0 C--O 1.233 0.199 0 C-N-CA 123.097 0.559 . . . . 0.0 109.953 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.24 166.15 30.18 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.277 2.651 . . . . 0.0 110.737 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 45.39 32.56 1.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.422 1.089 . . . . 0.0 112.619 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.43 7.51 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.746 -0.475 . . . . 0.0 112.481 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -138.48 1.73 2.18 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.815 0.807 . . . . 0.0 111.09 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -155.34 6.88 0.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.114 0.566 . . . . 0.0 111.603 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.4 176.84 46.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.85 161.64 43.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.237 3.291 . . . . 0.0 111.585 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.36 160.36 48.95 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.85 3.033 . . . . 0.0 111.696 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 9.3 p 150.42 145.41 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 128.711 2.804 . . . . 0.0 103.854 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.85 47.59 0.15 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 116.899 -1.92 . . . . 0.0 113.494 -160.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -53.14 173.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.0 t -140.81 -127.67 0.1 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.368 1.067 . . . . 0.0 111.919 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -133.91 -28.36 1.39 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.336 1.455 . . . . 0.0 114.18 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . 0.426 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.8 p30 -127.3 82.78 2.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.744 1.218 . . . . 0.0 110.396 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -78.36 158.53 28.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.711 2.004 . . . . 0.0 112.87 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.418 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -150.08 142.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.792 2.437 . . . . 0.0 109.06 173.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -79.5 170.65 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.51 136.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.4 p -143.75 157.7 44.2 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 121.057 0.456 . . . . 0.0 112.078 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.96 53.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.53 123.23 88.95 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 127.5 2.32 . . . . 0.0 112.949 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.29 156.83 12.66 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.984 2.456 . . . . 0.0 111.422 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.34 -10.9 29.1 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.101 2.534 . . . . 0.0 110.705 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 68.1 m -75.19 -9.02 58.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.095 0.958 . . . . 0.0 112.616 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.34 165.44 41.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 44.5 t -157.39 167.98 28.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.241 1.016 . . . . 0.0 109.155 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -64.65 -29.93 70.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.738 -0.601 . . . . 0.0 110.057 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -68.4 -16.16 63.81 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.428 0.291 . . . . 0.0 111.49 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.62 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 80.5 m-20 -104.03 -22.73 13.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 112.054 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.54 -30.7 66.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.942 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -73.94 -40.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.6 -1.92 7.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.464 1.106 . . . . 0.0 113.304 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.508 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 30.4 t60 -131.92 -33.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.641 0.655 . . . . 0.0 111.552 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -19.97 59.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -51.64 -18.88 1.31 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -59.0 -37.59 77.21 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.031 0.532 . . . . 0.0 110.852 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.406 ' HB3' ' CE2' ' B' ' 162' ' ' PHE . . . -65.82 -22.38 66.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.71 0.804 . . . . 0.0 111.307 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.98 -90.49 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -157.07 134.1 10.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -130.56 157.6 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 14.7 p -129.15 -35.63 1.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.014 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 7.9 t80 -132.69 159.02 40.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.61 1.096 . . . . 0.0 111.723 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.17 170.95 20.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.301 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -149.11 155.75 41.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.507 HG23 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -133.31 145.01 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.34 0.59 . . . . 0.0 110.483 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.55 22.11 16.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.208 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.507 ' H ' HG23 ' B' ' 152' ' ' VAL . 59.6 mtp180 74.83 -15.85 0.61 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 126.062 1.745 . . . . 0.0 113.123 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.04 138.63 2.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.667 0.667 . . . . 0.0 111.679 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 -31.26 0.69 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 166.39 28.4 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.91 1.355 . . . . 0.0 111.982 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.43 -171.29 41.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 163.19 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.485 0.642 . . . . 0.0 110.763 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 9.1 p -150.72 160.03 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.817 0.847 . . . . 0.0 109.365 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -152.08 136.39 16.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.088 -0.382 . . . . 0.0 111.618 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 80.4 m-85 -104.31 168.08 9.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.15 -11.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.621 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -151.73 137.21 17.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.73 -23.41 66.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.3 -32.92 55.7 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.226 0.466 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -75.21 -20.12 59.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.022 0.439 . . . . 0.0 109.841 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 36.5 ttp -76.17 -52.84 9.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 111.469 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 49.0 m -65.65 -20.69 66.4 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -71.92 -27.19 62.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.264 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.07 -37.12 64.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.207 -0.308 . . . . 0.0 111.069 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.71 8.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . 0.562 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 15.1 ptm180 -137.74 -23.92 1.05 Allowed 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 121.704 -0.622 . . . . 0.0 112.191 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.562 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.97 -28.25 9.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.375 0.534 . . . . 0.0 111.191 175.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.01 -6.88 11.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.47 0.708 . . . . 0.0 109.729 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -85.12 144.09 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 64.53 23.88 12.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.91 0.884 . . . . 0.0 111.627 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 72.0 p -138.91 178.03 7.46 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.627 0.727 . . . . 0.0 111.247 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -61.54 148.59 41.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.017 1.327 . . . . 0.0 114.176 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.508 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.3 OUTLIER -143.74 145.28 32.29 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.115 1.766 . . . . 0.0 108.028 169.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -123.96 157.15 35.03 Favored 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.006 0.923 . . . . 0.0 109.36 -170.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 88.4 p -138.79 165.79 26.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.542 0.687 . . . . 0.0 112.015 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.473 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 23.1 p-80 -68.35 -14.4 62.97 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.182 1.393 . . . . 0.0 113.162 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.91 -15.27 56.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.94 12.28 9.41 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.654 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.05 168.88 18.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.693 1.247 . . . . 0.0 111.918 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.01 157.3 43.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.948 0.899 . . . . 0.0 110.356 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.58 165.98 29.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.572 1.149 . . . . 0.0 108.955 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -68.58 155.75 39.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.25 0.547 . . . . 0.0 110.998 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.91 152.4 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.774 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.361 1.064 . . . . 0.0 108.788 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.36 94.28 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.651 0.78 . . . . 0.0 110.761 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.4 tttt -74.37 171.14 14.24 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 122.552 0.341 . . . . 0.0 110.742 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.4 p -66.05 -27.12 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 126.298 1.839 . . . . 0.0 114.732 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.402 ' HA ' ' CG2' ' B' ' 124' ' ' VAL . 25.2 t70 125.35 165.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.463 2.705 . . . . 0.0 109.237 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.895 175.272 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 C5'-C4'-C3' 112.753 -1.831 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 1 O4'-C1'-N19 113.736 5.536 . 0.109 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 C4'-C3'-C2' 99.377 -3.323 . 0.536 6n . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 111.242 3.042 . 0.197 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.253 1 C4'-C3'-C2' 98.158 -4.542 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . 0.462 ' H1 ' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.297 3 O4'-C1'-N19 116.513 8.313 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.621 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.675 1 O4'-C1'-N19 112.513 4.313 . 0.01 6n . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.189 -2.874 . 0.1 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.73 31.53 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.998 0.519 . . . . 0.0 109.956 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.39 170.36 20.09 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.466 2.778 . . . . 0.0 111.061 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -69.98 -11.92 61.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.964 0.506 . . . . 0.0 112.094 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.96 -17.35 0.26 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.714 -0.492 . . . . 0.0 112.505 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -153.18 155.18 36.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 117.86 0.83 . . . . 0.0 109.985 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -152.29 167.49 28.48 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.465 0.706 . . . . 0.0 109.595 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.99 -58.02 0.17 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.505 -0.609 . . . . 0.0 111.88 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.06 153.81 46.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.794 2.329 . . . . 0.0 110.288 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.28 -49.23 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.612 2.208 . . . . 0.0 111.045 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.4 m -174.26 155.95 2.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.34 1.056 . . . . 0.0 109.343 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.452 ' HD3' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt180 55.96 -1.37 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 167.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -54.13 160.23 1.62 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.476 1.034 . . . . 0.0 112.607 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 -139.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 112.228 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.254 40.2 mt-10 -132.21 -18.99 2.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -165.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.37 77.25 1.64 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.976 1.31 . . . . 0.0 109.941 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtm-85 -83.37 148.27 27.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.452 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.79 129.55 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 126.508 1.923 . . . . 0.0 107.402 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.81 153.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.7 106.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 53.7 p -105.13 152.55 22.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.976 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.82 18.11 5.29 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 4.7 mp -95.79 13.72 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 90.5 Cg_exo -42.67 -38.33 6.34 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.586 2.191 . . . . 0.0 116.63 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.59 -61.72 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 6.0 t 179.41 -42.96 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.674 1.19 . . . . 0.0 107.822 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.24 -172.58 0.04 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.877 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.441 ' HG ' ' N6 ' ' A' ' 7' ' ' ' A' . 2.7 p -168.59 165.84 12.14 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.863 -0.786 . . . . 0.0 109.152 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -76.5 -30.28 57.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -68.51 -39.94 81.04 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.621 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 81.2 m-20 -76.89 -26.97 54.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.484 -0.135 . . . . 0.0 110.847 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -34.93 78.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.452 ' HE3' ' HD3' ' B' ' 117' ' ' ARG . 9.6 mtpm? -74.38 -39.28 62.81 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.462 ' CG ' ' H1 ' ' A' ' 6' ' ' ' G' . 2.9 m-20 -66.68 -1.48 3.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.441 1.097 . . . . 0.0 113.713 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.596 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 38.5 t60 -129.89 -39.19 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.551 0.614 . . . . 0.0 111.523 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' MET . . . . . 0.436 ' CE ' ' HB3' ' B' ' 171' ' ' ALA . 84.0 mmm -70.39 -14.22 62.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.37 0.532 . . . . 0.0 109.987 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -47.72 -20.93 0.32 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.698 0.799 . . . . 0.0 112.599 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.97 -42.92 84.33 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.226 0.611 . . . . 0.0 111.132 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -27.74 65.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.639 0.776 . . . . 0.0 111.569 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.37 -166.46 36.53 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.28 79.3 9.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.86 148.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 52.0 t -128.08 -33.28 2.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.861 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -134.58 157.72 45.86 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.048 0.84 . . . . 0.0 110.787 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -152.74 164.27 38.1 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -145.4 151.32 38.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.581 HG23 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -130.54 140.02 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 121.743 0.782 . . . . 0.0 110.504 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -104.06 10.66 35.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.845 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.581 ' H ' HG23 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 41.73 26.25 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.51 2.324 . . . . 0.0 114.26 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -143.33 3.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.72 -10.32 3.98 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.154 0.434 . . . . 0.0 113.677 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -142.84 166.73 23.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.122 0.461 . . . . 0.0 110.639 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.86 -164.6 29.89 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.74 163.06 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 122.773 0.429 . . . . 0.0 111.344 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -156.04 154.91 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.374 1.069 . . . . 0.0 109.705 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.28 159.54 40.09 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -125.88 171.07 11.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 122.01 0.909 . . . . 0.0 112.202 -171.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.22 -9.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.443 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -149.7 139.3 21.64 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.028 0.531 . . . . 0.0 109.585 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.13 -22.67 66.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.77 -29.43 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.047 -0.408 . . . . 0.0 110.802 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.45 -20.4 60.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.14 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.416 ' HA ' ' CE1' ' B' ' 162' ' ' PHE . 29.8 ttp -79.48 -52.24 8.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -63.13 -21.84 66.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.55 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 43.5 t80 -74.77 -33.04 62.22 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.436 ' HB3' ' CE ' ' B' ' 141' ' ' MET . . . -73.56 -15.83 61.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.331 0.652 . . . . 0.0 111.701 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . 0.251 8.8 p -115.47 32.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.859 0.838 . . . . 0.0 111.643 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -142.63 -16.7 0.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.137 169.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.55 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -124.19 -25.37 4.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 112.534 173.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.49 -2.82 20.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.415 0.286 . . . . 0.0 110.248 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.6 143.41 42.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.118 0.967 . . . . 0.0 110.269 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.41 27.8 10.62 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.8 p -127.91 166.69 17.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.03 144.31 29.3 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.567 0.747 . . . . 0.0 111.952 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.596 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 2.5 t80 -137.48 161.23 36.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.275 1.83 . . . . 0.0 109.074 171.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.418 ' HD2' ' H ' ' B' ' 182' ' ' SER . 14.7 tpt180 -138.99 149.45 44.71 Favored 'General case' 0 C--O 1.228 -0.043 0 C-N-CA 123.941 0.897 . . . . 0.0 109.537 -170.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.418 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 93.2 p -138.57 170.11 16.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 111.733 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.449 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 14.7 p-80 -62.65 -15.33 51.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.765 1.226 . . . . 0.0 112.489 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.59 -43.36 99.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.049 0.452 . . . . 0.0 110.753 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.9 13.92 3.21 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -138.16 178.88 6.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.238 0.615 . . . . 0.0 111.641 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 68.1 p -144.41 158.88 43.53 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.541 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.99 162.56 18.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.156 0.982 . . . . 0.0 108.669 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -69.46 152.02 45.37 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.106 -0.371 . . . . 0.0 110.555 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -127.48 114.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.446 0.641 . . . . 0.0 109.996 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -85.77 95.32 9.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.23 0.538 . . . . 0.0 109.91 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 8.0 t -67.29 146.56 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.188 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -135.04 158.08 45.28 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 121.015 0.436 . . . . 0.0 110.514 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.65 4.57 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.26 1.824 . . . . 0.0 113.628 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.3 t70 90.97 157.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.367 1.467 . . . . 0.0 110.703 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.203 0 CA-C-O 117.274 -1.848 . . . . 0.0 111.19 174.51 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 C5'-C4'-C3' 112.032 -2.312 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 1 O4'-C1'-N19 112.242 4.042 . 0.372 5p . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O4'-C1'-N19 111.837 3.637 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 C5'-C4'-C3' 111.344 -2.77 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 1 C4'-C3'-C2' 98.112 -4.588 . 0.199 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 O4'-C1'-N19 112.813 4.613 . 0.404 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.604 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.416 -3.087 1 O4'-C1'-N19 112.648 4.448 . 0.03 '#a' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.778 0 C5'-C4'-C3' 110.804 -3.131 . 0.599 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.44 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -150.46 40.48 0.2 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.201 0.601 . . . . 0.0 112.118 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 76.7 Cg_endo -68.85 8.71 0.54 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.691 2.928 . . . . 0.0 112.603 -175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -141.59 9.63 2.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.469 0.708 . . . . 0.0 110.94 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.64 26.59 0.23 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -60.61 -15.56 29.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.769 0.827 . . . . 0.0 112.899 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -140.74 9.71 2.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.178 0.444 . . . . 0.0 112.167 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 175.86 -176.23 47.5 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' B' ' 116' ' ' SER . 56.2 Cg_endo -66.32 170.43 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.774 2.983 . . . . 0.0 110.686 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.01 11.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 1 C-N-CA 126.023 4.482 . . . . 0.0 116.721 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.469 ' C ' ' HD2' ' B' ' 117' ' ' ARG . 42.4 m -155.39 -2.17 0.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 109.054 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.591 ' HG2' ' HG ' ' B' ' 148' ' ' CYS . 0.2 OUTLIER 34.2 46.7 0.17 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.113 2.165 . . . . 0.0 116.484 167.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -56.92 171.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.669 1.188 . . . . 0.0 112.796 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 7.5 t -144.29 -129.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.0 -19.77 1.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.6 77.55 1.67 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.956 1.302 . . . . 0.0 110.953 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -77.75 148.48 34.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.229 1.812 . . . . 0.0 113.407 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.419 HG12 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -139.27 127.04 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.982 2.113 . . . . 0.0 108.37 172.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.51 159.03 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 O-C-N 121.787 -0.571 . . . . 0.0 109.614 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.01 116.17 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 85.4 p -125.67 143.69 50.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.094 0.473 . . . . 0.0 111.798 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.74 -1.7 26.02 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.34 147.88 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 127.522 2.329 . . . . 0.0 110.244 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.07 162.8 38.17 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.487 2.791 . . . . 0.0 111.421 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 -10.74 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 1 C-N-CA 125.379 4.053 . . . . 0.0 115.838 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -133.81 12.2 4.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.051 0.842 . . . . 0.0 112.91 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.57 167.28 4.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.442 ' HG ' ' N6 ' ' A' ' 7' ' ' ' A' . 1.4 p -148.68 166.94 26.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.243 -0.563 . . . . 0.0 110.489 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -75.32 -28.16 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.348 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -67.85 -38.06 82.67 Favored 'General case' 0 C--O 1.231 0.089 0 O-C-N 122.339 -0.226 . . . . 0.0 110.824 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.604 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 57.0 m-20 -79.81 -19.65 47.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -29.8 66.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -78.75 -38.78 37.91 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.42 -1.78 5.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.4 1.08 . . . . 0.0 113.342 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.5 t60 -130.32 -36.53 1.48 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.702 0.683 . . . . 0.0 111.356 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.3 mmm -72.73 -10.93 60.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.122 0.419 . . . . 0.0 111.069 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -48.96 -16.59 0.14 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -71.75 -42.26 67.43 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.98 0.512 . . . . 0.0 111.02 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.74 -29.14 68.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.476 0.71 . . . . 0.0 111.168 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.93 -168.36 36.25 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -80.57 79.4 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 0.0 110.412 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.6 OUTLIER -64.1 149.68 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . 0.591 ' HG ' ' HG2' ' B' ' 117' ' ' ARG . 5.8 t -134.36 -35.98 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.214 -171.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 8.8 t80 -134.61 160.56 37.71 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.79 0.805 . . . . 0.0 110.17 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.09 168.67 26.55 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -148.1 158.43 44.06 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 168.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.549 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.7 p -135.57 143.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 121.176 0.512 . . . . 0.0 110.12 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -108.36 6.97 26.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.26 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.549 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.0 mtt-85 61.4 18.63 9.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.491 0.717 . . . . 0.0 112.209 170.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -137.64 6.26 2.71 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.32 22.13 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 121.555 -0.716 . . . . 0.0 112.194 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -141.16 160.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.241 0.616 . . . . 0.0 110.083 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.28 -164.42 30.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.99 162.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.257 0.528 . . . . 0.0 110.876 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.8 p -148.0 160.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.129 0.971 . . . . 0.0 108.65 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.53 152.84 26.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.056 -0.403 . . . . 0.0 110.819 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -126.43 170.56 11.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.689 0.757 . . . . 0.0 112.181 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.22 -9.63 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.369 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -149.99 139.76 21.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -64.65 -21.36 66.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.32 -31.51 58.2 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.311 0.505 . . . . 0.0 111.004 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -72.89 -21.49 60.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.107 0.479 . . . . 0.0 109.825 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.419 ' SD ' HG12 ' B' ' 123' ' ' VAL . 38.2 ttp -77.63 -52.58 8.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.356 0.663 . . . . 0.0 110.754 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 75.4 m -63.38 -18.71 63.97 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.531 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 30.6 t80 -75.37 -28.75 59.66 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.91 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.19 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 122.086 -0.384 . . . . 0.0 110.388 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.69 2.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.0 -16.26 2.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.531 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.7 mppt? -126.21 -21.63 4.22 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.84 3.54 12.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.867 0.467 . . . . 0.0 109.862 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.826 0.85 . . . . 0.0 108.819 172.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 58.44 35.93 25.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.005 0.522 . . . . 0.0 111.346 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 51.8 p -136.43 175.07 9.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 110.64 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -62.33 148.65 44.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.497 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 9.9 t80 -146.35 165.6 28.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.045 2.138 . . . . 0.0 107.439 167.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -141.25 135.34 30.57 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.907 -0.495 . . . . 0.0 109.681 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.5 t -70.4 -174.83 0.9 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.06 0.944 . . . . 0.0 111.512 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.472 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 27.2 p-80 -117.39 11.64 14.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.134 0.573 . . . . 0.0 109.821 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -127.22 -13.74 5.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.036 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.36 155.78 7.01 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 56.86 -175.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.218 1.807 . . . . 0.0 114.724 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 23.3 p -122.88 171.05 9.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.548 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 -168.91 2.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.862 0.865 . . . . 0.0 108.896 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.21 149.93 47.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.59 108.51 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.213 0.53 . . . . 0.0 112.206 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -83.27 88.34 6.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 7.9 t -76.14 81.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.765 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.79 159.44 22.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.24 0.616 . . . . 0.0 111.534 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.403 ' HA ' HG11 ' B' ' 123' ' ' VAL . 27.1 m -73.0 5.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 126.514 1.926 . . . . 0.0 114.292 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 t0 88.2 155.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 124.833 1.333 . . . . 0.0 110.624 171.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.277 0 CA-C-O 117.108 -1.94 . . . . 0.0 111.013 174.641 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 110.343 -3.438 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C5'-C4'-C3' 110.676 -3.216 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . 0.497 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.835 0 C3'-C2'-C1' 104.485 3.316 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.423 " H1'" " H1'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 O4'-C1'-N19 112.023 3.823 . 0.103 2z . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.423 " H1'" " H1'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.41 -3.567 1 C1'-O4'-C4' 105.502 -4.554 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 O4'-C1'-N19 112.878 4.678 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.606 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 N19-C1'-C2' 107.787 -3.508 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 C5'-C4'-C3' 110.535 -3.31 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.44 167.11 15.17 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.162 0.985 . . . . 0.0 108.389 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -50.38 -18.97 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.845 3.03 . . . . 0.0 114.414 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -142.14 30.56 1.59 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.839 1.256 . . . . 0.0 109.736 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.02 30.62 1.9 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -69.07 -17.51 63.89 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.496 1.119 . . . . 0.0 111.648 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -146.98 -167.45 2.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.379 0.671 . . . . 0.0 110.097 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.84 -169.84 14.78 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.02 -42.21 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.188 3.258 . . . . 0.0 114.904 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.97 126.64 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.536 1.491 . . . . 0.0 110.786 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.8 m -158.67 172.65 17.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.114 1.365 . . . . 0.0 107.915 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 46.65 21.61 0.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 174.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -53.29 153.25 3.97 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.65 1.18 . . . . 0.0 112.069 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.0 t -135.86 -110.49 0.2 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.866 0.466 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -148.61 -26.12 0.32 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.24 -32.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -166.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 40.75 151.38 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.778 2.831 . . . . 0.0 118.162 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.447 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.1 OUTLIER -149.69 148.33 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.256 1.822 . . . . 0.0 108.828 174.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . 0.409 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -90.92 171.95 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.37 142.96 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -143.82 150.92 39.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.299 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 103.24 -2.75 47.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -49.25 126.6 15.71 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 127.728 2.411 . . . . 0.0 109.742 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.84 155.13 53.76 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.883 2.389 . . . . 0.0 110.269 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.79 -22.12 28.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.483 2.789 . . . . 0.0 112.561 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m -73.34 -9.22 58.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.391 1.076 . . . . 0.0 112.462 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.44 165.81 39.36 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 121.545 0.525 . . . . 0.0 112.598 -174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.403 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 30.1 t -161.72 167.79 24.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.184 1.394 . . . . 0.0 107.445 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -64.42 -26.93 68.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.857 0.753 . . . . 0.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -70.05 -28.95 65.87 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.004 -0.435 . . . . 0.0 111.706 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.606 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 75.1 m-20 -89.92 -13.65 35.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.766 0.257 . . . . 0.0 110.925 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.25 3.48 54.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.697 0.399 . . . . 0.0 111.024 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -110.26 -35.33 6.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.11 -3.88 11.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.32 1.048 . . . . 0.0 112.771 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.639 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 10.0 t60 -127.51 -36.44 2.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.286 0.494 . . . . 0.0 110.734 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 76.5 mmm -69.1 -19.07 64.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.577 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -48.57 -20.05 0.4 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.23 1.012 . . . . 0.0 112.811 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -41.76 97.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.002 0.521 . . . . 0.0 111.252 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.69 -29.76 69.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.563 . . . . 0.0 111.204 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.72 -177.49 35.31 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.14 118.0 14.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.998 0.399 . . . . 0.0 110.161 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -114.33 151.67 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 p -130.7 -21.71 2.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.295 -0.859 . . . . 0.0 111.729 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -126.02 149.51 48.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 119.122 0.874 . . . . 0.0 111.805 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.43 19.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 19.5 t0 -141.93 154.61 45.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.497 HG23 ' H ' ' B' ' 154' ' ' ARG . 9.9 p -132.19 145.61 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.185 0.517 . . . . 0.0 110.214 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.16 7.16 27.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.779 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.497 ' H ' HG23 ' B' ' 152' ' ' VAL . 24.6 mtp85 61.34 16.98 7.87 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.496 0.718 . . . . 0.0 112.77 170.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -137.95 -12.0 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.23 -2.99 2.13 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.799 0.727 . . . . 0.0 112.922 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.81 167.68 21.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.127 0.571 . . . . 0.0 109.799 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.74 -167.4 35.25 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 6.7 p -141.09 161.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.369 0.604 . . . . 0.0 110.613 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.7 159.93 2.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -157.75 154.12 27.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.01 -0.431 . . . . 0.0 111.527 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 22.7 m-85 -122.87 163.55 20.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.893 0.854 . . . . 0.0 112.248 -170.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.36 -8.82 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.43 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -152.9 154.72 35.63 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.071 0.549 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -69.15 -25.58 64.44 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -82.83 -31.77 27.91 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.197 0.453 . . . . 0.0 111.313 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -70.57 -2.28 13.71 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.699 0.4 . . . . 0.0 110.332 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.447 ' SD ' HG11 ' B' ' 123' ' ' VAL . 40.6 ttp -111.94 -46.85 3.18 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.864 1.265 . . . . 0.0 110.897 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 58.4 m -63.23 -20.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 6.3 t80 -70.57 -31.51 68.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.72 69.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.093 -0.38 . . . . 0.0 110.367 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.21 5.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -134.4 -19.02 1.93 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -19.5 5.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.81 2.73 13.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.136 0.574 . . . . 0.0 109.48 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.36 136.75 41.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.4 27.94 13.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.178 0.991 . . . . 0.0 111.255 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.3 p -138.09 179.46 6.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.438 0.695 . . . . 0.0 110.806 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -56.01 148.56 17.25 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.639 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 24.8 t80 -146.57 159.16 43.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.344 1.857 . . . . 0.0 108.179 168.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' B' ' 182' ' ' SER . 4.8 tmt_? -148.01 153.07 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -170.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.404 ' N ' ' HD3' ' B' ' 181' ' ' ARG . 16.6 m -135.65 170.37 16.08 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.467 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 14.3 p-80 -57.37 -19.56 23.79 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.987 1.315 . . . . 0.0 113.468 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -77.55 -11.02 59.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 117.957 0.344 . . . . 0.0 111.07 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.57 40.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.722 0.677 . . . . 0.0 111.908 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -75.04 170.86 15.17 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.338 0.59 . . . . 0.0 111.134 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 2.9 p -135.79 169.04 18.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.168 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.92 -167.52 1.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.969 0.908 . . . . 0.0 108.784 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -115.02 155.06 27.69 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 30.8 pt -134.9 148.86 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.396 0.617 . . . . 0.0 110.778 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -113.33 84.63 2.04 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 107.997 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 t -67.81 87.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.959 0.904 . . . . 0.0 111.255 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.566 ' HD2' ' H ' ' B' ' 194' ' ' VAL . 50.5 tptt -76.68 160.24 29.53 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 110.748 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.566 ' H ' ' HD2' ' B' ' 193' ' ' LYS . 8.1 p -57.97 -27.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.302 2.641 . . . . 0.0 117.774 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.409 ' HA ' HG23 ' B' ' 124' ' ' VAL . 38.1 t70 98.48 125.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.183 2.193 . . . . 0.0 110.141 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 CA-C-O 117.513 -1.715 . . . . 0.0 111.332 172.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 110.312 -3.459 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.247 2 C1'-O4'-C4' 105.156 -4.938 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . 0.441 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 O4'-C1'-N19 112.125 3.925 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.409 ' P ' HO2' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.278 0 O4'-C1'-N19 112.145 3.945 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.237 3 C4'-C3'-C2' 98.275 -4.425 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . 0.435 ' H21' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.417 -2.963 2 O4'-C1'-N19 113.717 5.517 . 0.01 5q . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.625 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 O4'-C1'-N19 111.258 3.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . 0.44 " H5'" ' C6 ' ' A' ' 8' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C5'-C4'-C3' 111.108 -2.928 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.526 0.203 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.25 154.08 31.77 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.975 0.51 . . . . 0.0 109.645 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.21 9.06 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.069 3.179 . . . . 0.0 112.816 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -62.58 -11.17 15.03 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.43 -161.11 35.29 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 118.495 0.589 . . . . 0.0 112.219 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -134.37 -10.43 2.51 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.107 0.563 . . . . 0.0 111.025 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 35.2 t80 49.38 14.35 0.1 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.375 1.47 . . . . 0.0 113.8 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.13 66.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.318 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.06 -40.64 33.83 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.626 2.884 . . . . 0.0 115.18 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.33 147.1 37.89 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.034 2.49 . . . . 0.0 112.572 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 20.4 m -157.44 168.32 27.67 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.582 0.753 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mtt-85 49.53 26.53 1.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' B' ' 118' ' ' ARG . 4.1 mmp_? -52.23 155.35 2.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.29 1.036 . . . . 0.0 113.697 -174.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.7 t -155.97 -137.04 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.447 0.699 . . . . 0.0 111.724 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -138.04 -26.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -167.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -131.1 80.54 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.081 0.953 . . . . 0.0 111.644 -170.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -78.66 148.83 33.01 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.577 . . . . 0.0 113.81 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.426 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -141.57 136.42 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.687 1.595 . . . . 0.0 110.017 171.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . 0.409 HG11 ' HE2' ' B' ' 193' ' ' LYS . 2.3 t -76.39 162.34 4.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.06 105.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -111.38 151.42 28.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.01 8.4 44.96 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 tp -60.51 146.99 84.03 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 126.69 1.996 . . . . 0.0 111.503 -174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.9 164.87 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.952 3.101 . . . . 0.0 109.689 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.9 -21.52 43.8 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.262 2.641 . . . . 0.0 111.631 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -73.46 -15.76 61.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.383 0.673 . . . . 0.0 112.09 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.12 148.27 24.88 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.5 t -155.76 165.65 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.585 0.754 . . . . 0.0 109.447 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -72.19 -27.04 62.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.931 -0.48 . . . . 0.0 111.702 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -65.16 -31.35 72.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.804 0.729 . . . . 0.0 111.151 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.625 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 55.2 m-20 -83.14 -21.12 33.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.499 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -17.03 60.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.29 0.496 . . . . 0.0 111.109 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -89.15 -44.29 10.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.435 ' CG ' ' H21' ' A' ' 6' ' ' ' G' . 4.2 m-20 -68.95 -11.64 60.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -120.45 -30.9 4.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.398 0.999 . . . . 0.0 111.221 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.5 mmm -76.81 -14.8 59.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.94 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -43.77 -21.02 0.03 OUTLIER 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.47 -42.23 87.84 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 123.589 0.755 . . . . 0.0 111.245 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.79 -28.87 69.33 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.01 0.524 . . . . 0.0 110.499 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.41 32.94 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.39 123.83 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.35 -0.5 . . . . 0.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -120.8 154.25 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 53.4 t -134.64 -24.86 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.526 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 71.3 t80 -127.15 153.68 45.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 118.992 0.814 . . . . 0.0 111.947 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.74 166.85 32.26 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.023 171.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.4 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 26.5 t0 -152.07 160.26 43.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.511 HG21 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -135.84 145.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.051 0.453 . . . . 0.0 110.03 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -109.42 6.55 24.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.257 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.511 ' H ' HG21 ' B' ' 152' ' ' VAL . 16.6 mtt180 61.83 17.72 9.1 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.651 0.781 . . . . 0.0 112.611 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.39 10.19 2.5 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.6 6.01 27.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.572 0.624 . . . . 0.0 111.978 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.28 156.81 45.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.123 0.569 . . . . 0.0 109.586 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.51 -166.0 30.42 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 7.6 p -145.55 162.38 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.016 0.436 . . . . 0.0 111.539 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.6 p -151.17 157.62 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.354 1.062 . . . . 0.0 108.547 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -155.13 140.96 18.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.931 -0.481 . . . . 0.0 111.154 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 41.9 m-85 -110.25 167.61 10.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.809 0.814 . . . . 0.0 113.053 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.75 -11.08 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.306 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -150.5 141.97 23.43 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -65.18 -26.05 67.99 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.1 -31.15 64.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.035 0.38 . . . . 0.0 110.661 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.02 -20.35 60.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.815 0.341 . . . . 0.0 110.202 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.426 ' SD ' HG11 ' B' ' 123' ' ' VAL . 33.9 ttp -80.51 -55.37 4.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.371 0.669 . . . . 0.0 110.515 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 70.3 m -64.33 -18.26 64.46 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 5.4 t80 -73.48 -32.09 64.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.55 68.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.866 -0.521 . . . . 0.0 110.575 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.92 3.13 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -132.3 -17.26 2.67 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.04 0.836 . . . . 0.0 112.761 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -21.2 4.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.44 0.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.76 147.21 33.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.71 37.39 23.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.513 0.725 . . . . 0.0 112.913 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 66.9 p -133.26 167.59 20.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.128 0.49 . . . . 0.0 110.372 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -61.76 140.84 58.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.954 0.902 . . . . 0.0 113.175 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' B' ' 180' ' ' PHE . 0.1 OUTLIER -157.78 146.82 19.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.846 1.258 . . . . 0.0 110.284 169.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.522 ' CB ' ' HA ' ' B' ' 187' ' ' THR . 46.8 ttt180 167.07 -62.29 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.123 2.569 . . . . 0.0 108.954 165.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.424 ' H ' HG21 ' B' ' 187' ' ' THR . 15.5 m 46.06 24.82 0.28 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 167.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 2.6 p-80 -143.37 2.91 1.3 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.88 1.673 . . . . 0.0 114.594 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -128.2 -15.33 4.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.203 0.91 . . . . 0.0 112.778 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.32 -12.88 1.06 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.591 0.596 . . . . 0.0 114.591 171.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' B' ' 181' ' ' ARG . 12.3 pt-20 -155.98 -157.45 0.72 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.923 0.862 . . . . 0.0 109.639 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' B' ' 181' ' ' ARG . 40.5 p -151.18 168.1 25.74 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.158 1.383 . . . . 0.0 110.604 174.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.23 39.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.636 1.575 . . . . 0.0 107.477 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -67.61 145.46 54.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 110.676 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 38.1 pt -123.22 136.28 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.945 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -104.32 79.6 1.61 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.824 0.85 . . . . 0.0 108.733 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.88 131.1 26.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.409 ' HE2' HG11 ' B' ' 124' ' ' VAL . 55.2 pttt -133.67 165.36 25.11 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.74 47.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 114.385 -174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 54.45 23.8 4.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.915 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 117.729 -1.595 . . . . 0.0 111.585 -172.269 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 110.865 -3.09 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.248 1 O4'-C1'-N19 113.044 4.844 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 O4'-C1'-N19 111.733 3.533 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 O4'-C1'-N19 110.659 2.459 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.298 0 C4'-C3'-C2' 98.972 -3.728 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.324 2 O4'-C1'-N19 114.172 5.972 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.608 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 P--O5' 1.617 2.421 0 N19-C1'-C2' 107.43 -3.731 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.156 0 C4'-C3'-C2' 100.241 -2.459 . 0.01 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.79 162.05 27.79 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.83 157.87 5.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.993 3.128 . . . . 0.0 113.376 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -145.92 178.95 7.8 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.855 1.262 . . . . 0.0 109.124 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.46 176.7 40.99 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 102.41 -5.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 127.871 2.468 . . . . 0.0 109.976 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -156.23 175.09 14.45 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.634 0.773 . . . . 0.0 110.026 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -175.83 -171.69 39.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.84 153.29 6.14 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.45 3.434 . . . . 0.0 112.768 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.8 166.07 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.852 3.035 . . . . 0.0 111.564 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 57.4 m -149.29 -42.93 0.14 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.442 0.697 . . . . 0.0 110.273 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -149.77 0.36 0.48 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.938 0.895 . . . . 0.0 112.336 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.69 171.96 0.79 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -134.42 -104.81 0.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -169.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -149.78 -25.18 0.27 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -166.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.15 -33.35 5.71 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -166.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 40.1 157.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.01 146.94 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.493 2.317 . . . . 0.0 107.849 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.72 168.63 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.0 p -137.45 130.47 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 58.3 p -138.42 153.53 48.88 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.36 6.01 53.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.27 139.16 97.52 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 127.811 2.444 . . . . 0.0 111.537 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.33 156.09 22.26 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.151 2.567 . . . . 0.0 110.145 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.69 -22.35 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.323 2.682 . . . . 0.0 112.07 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.9 m -73.08 7.5 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.319 1.448 . . . . 0.0 113.078 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 162.33 13.25 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.556 0.617 . . . . 0.0 111.585 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.401 ' CB ' ' N1 ' ' A' ' 7' ' ' ' A' . 45.1 t -156.67 173.11 17.44 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.12 0.968 . . . . 0.0 108.799 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -64.58 -30.59 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.657 -0.652 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -66.51 -23.72 66.29 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.912 0.324 . . . . 0.0 111.46 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.608 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 48.1 m-20 -94.66 -24.1 17.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -174.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -23.27 61.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.227 -0.295 . . . . 0.0 110.584 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -80.82 -39.43 26.66 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.82 -0.15 5.09 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.812 1.245 . . . . 0.0 114.194 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 24.8 t60 -135.0 -38.51 0.78 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.461 0.573 . . . . 0.0 111.262 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' MET . . . . . 0.41 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 84.4 mmm -68.39 -11.78 60.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.564 173.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -45.02 -24.6 0.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.296 1.038 . . . . 0.0 112.536 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.49 -41.0 93.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.972 -0.455 . . . . 0.0 111.205 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.09 69.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.674 0.789 . . . . 0.0 111.475 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.54 -171.71 40.1 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -80.87 77.03 7.78 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.816 0.817 . . . . 0.0 110.593 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.43 143.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -126.57 -28.9 2.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.818 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -136.44 157.77 46.01 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 118.79 0.723 . . . . 0.0 111.018 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.88 166.93 31.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -147.51 147.48 30.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.582 HG21 ' H ' ' B' ' 154' ' ' ARG . 6.0 p -127.58 142.01 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 121.54 0.685 . . . . 0.0 111.195 -171.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -105.95 10.57 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.62 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.582 ' H ' HG21 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.31 24.23 0.03 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 127.177 2.191 . . . . 0.0 114.994 178.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.46 5.31 1.42 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.31 -9.62 4.1 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 118.167 0.439 . . . . 0.0 113.373 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.07 167.83 21.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.331 0.566 . . . . 0.0 110.665 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.93 40.07 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.77 159.38 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.8 p -148.64 157.32 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.96 157.14 34.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.756 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.7 m-85 -130.9 169.2 16.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.852 0.861 . . . . 0.0 110.641 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.2 -13.75 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.759 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.95 156.36 46.08 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.625 0.77 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.85 -28.5 40.05 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.625 0.77 . . . . 0.0 112.007 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.05 -31.07 25.58 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -77.62 7.24 5.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.737 0.415 . . . . 0.0 110.353 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.85 -44.55 3.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.355 1.462 . . . . 0.0 110.028 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -62.41 -23.62 66.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.85 -29.8 70.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.41 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -72.35 -37.45 68.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.152 -0.343 . . . . 0.0 110.578 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' B' ' 172' ' ' VAL 0.282 0.6 OUTLIER -82.91 28.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.447 0.641 . . . . 0.0 111.694 177.049 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . 0.577 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.6 ptm180 -148.0 -25.2 0.35 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.243 -0.911 . . . . 0.0 112.789 171.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.577 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.2 OUTLIER -108.89 -26.77 10.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.446 0.566 . . . . 0.0 111.99 176.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.28 0.53 13.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.22 0.608 . . . . 0.0 110.186 -172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -82.43 144.63 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.163 0.985 . . . . 0.0 109.708 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 26.2 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.792 0.837 . . . . 0.0 111.97 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -135.31 162.83 31.48 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.715 1.206 . . . . 0.0 108.6 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 18.2 ptmt -67.99 158.27 33.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.866 -1.515 . . . . 0.0 114.293 -168.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.438 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -143.98 148.04 34.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.235 167.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' B' ' 182' ' ' SER . 3.4 tmm_? -130.84 137.31 49.33 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -172.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.411 ' N ' ' HD2' ' B' ' 181' ' ' ARG . 47.6 p -145.08 -170.23 3.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.759 -172.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.463 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.7 p-80 -59.67 -176.19 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.423 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 4.6 mm-40 65.6 -23.34 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.432 1.893 . . . . 0.0 112.726 -173.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 183' ' ' HIS . . . 111.11 26.66 4.55 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.983 170.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.76 178.21 7.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.437 1.119 . . . . 0.0 113.488 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.81 156.13 22.3 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.519 -177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.51 160.51 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.79 1.236 . . . . 0.0 109.161 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 5.2 m-30 -65.91 151.16 47.35 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 39.8 pt -131.2 133.64 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.13 95.83 7.37 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.276 0.56 . . . . 0.0 109.823 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.95 116.08 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.9 tttt -90.57 171.88 9.08 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 173.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.4 p -66.98 -28.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 0.0 114.108 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 24.0 t70 141.87 163.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.653 2.381 . . . . 0.0 109.391 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.27 0 CA-C-O 117.413 -1.77 . . . . 0.0 111.351 176.103 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 1 O4'-C1'-N19 114.088 5.888 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 1 O4'-C1'-N19 113.913 5.713 . 0.237 5z . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 O4'-C1'-N19 111.898 3.698 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.785 0 C5'-C4'-C3' 109.59 -3.94 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 C4'-C3'-C2' 97.873 -4.827 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.766 0 O4'-C1'-N19 112.153 3.953 . 0.24 7r . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.615 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 N19-C1'-C2' 107.931 -3.418 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 111.918 -2.388 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -151.9 45.67 0.33 Allowed Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.051 0.541 . . . . 0.0 111.829 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 92.6 Cg_endo -71.82 -6.92 20.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.078 2.519 . . . . 0.0 112.318 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -145.17 168.21 20.93 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.508 0.723 . . . . 0.0 110.165 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.58 39.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -136.02 16.27 3.27 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.048 0.539 . . . . 0.0 111.816 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -139.68 160.32 40.15 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.932 -0.48 . . . . 0.0 110.584 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.91 -171.25 39.47 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.35 160.36 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.183 3.255 . . . . 0.0 112.322 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.3 164.92 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.248 3.299 . . . . 0.0 113.551 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 59.2 m -75.99 -32.35 59.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.02 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -170.14 -30.18 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.199 1.4 . . . . 0.0 110.108 -168.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' B' ' 119' ' ' SER . 0.2 OUTLIER 52.07 -173.48 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 126.379 1.872 . . . . 0.0 113.518 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.594 ' H ' ' HG3' ' B' ' 118' ' ' ARG . 0.8 OUTLIER -150.04 -178.39 6.46 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -176.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . 0.495 ' HB2' HD21 ' B' ' 121' ' ' ASN . 33.6 mt-10 -148.53 -29.3 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.39 1.876 . . . . 0.0 113.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . 0.495 HD21 ' HB2' ' B' ' 120' ' ' GLU . 1.3 p30 -140.98 78.53 1.65 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.663 2.385 . . . . 0.0 107.535 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -89.58 150.61 22.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.653 0.739 . . . . 0.0 112.757 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.36 127.57 32.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 126.445 1.898 . . . . 0.0 107.866 174.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.13 157.23 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.05 114.54 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.9 p -129.06 146.29 51.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.74 -0.94 39.11 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.08 144.69 48.16 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 128.054 2.542 . . . . 0.0 110.535 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.98 161.1 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.802 2.335 . . . . 0.0 109.478 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.05 -11.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.833 2.355 . . . . 0.0 110.687 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m -79.13 -8.15 58.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.575 1.15 . . . . 0.0 112.225 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.04 164.66 40.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.264 0.484 . . . . 0.0 111.987 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.404 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 41.1 t -157.68 168.85 26.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.117 0.967 . . . . 0.0 108.4 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -63.36 -27.24 69.18 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.545 0.611 . . . . 0.0 111.773 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . 0.404 ' HB2' ' C6 ' ' A' ' 7' ' ' ' A' . 24.7 mp0 -68.33 -46.77 69.28 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.186 0.448 . . . . 0.0 110.705 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.615 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 81.9 m-20 -70.08 -24.39 63.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -20.76 60.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' B' ' 138' ' ' LYS . 50.1 mtpt -85.55 -34.89 21.38 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.566 0.621 . . . . 0.0 109.359 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.62 -40.43 66.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.494 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.2 t60 -81.03 -36.53 30.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.738 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.7 mmm -73.1 -20.65 60.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.398 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -51.27 -18.84 1.04 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.585 0.63 . . . . 0.0 112.403 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.81 -39.62 85.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.385 0.674 . . . . 0.0 111.39 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . 0.485 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.52 -18.63 65.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.588 0.755 . . . . 0.0 111.775 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 168.39 -95.67 0.11 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.37 133.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -119.8 153.08 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.137 0.494 . . . . 0.0 110.44 -175.423 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.8 -21.08 3.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.311 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 51.8 t80 -144.31 157.38 44.3 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 120.22 1.373 . . . . 0.0 112.19 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.61 169.65 22.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.628 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -148.76 152.94 37.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.471 HG21 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -131.31 140.68 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.415 0.626 . . . . 0.0 109.853 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.14 5.07 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.126 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.471 ' H ' HG21 ' B' ' 152' ' ' VAL . 7.4 mtt180 61.47 16.28 7.41 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.548 0.739 . . . . 0.0 112.709 170.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -135.44 5.83 3.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.97 3.9 15.12 Favored Glycine 0 C--N 1.337 0.597 0 O-C-N 121.881 -0.512 . . . . 0.0 112.197 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.5 p -142.31 161.78 37.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 110.573 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.58 -168.61 37.51 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.45 165.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 117.393 0.596 . . . . 0.0 110.734 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.9 p -153.7 156.67 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.108 0.963 . . . . 0.0 109.246 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.09 156.25 40.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.663 0.268 . . . . 0.0 111.612 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 39.8 m-85 -120.43 163.58 17.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.697 1.237 . . . . 0.0 114.171 -169.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.96 -12.74 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.502 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -152.68 142.28 21.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -63.8 -21.01 66.22 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.91 -29.79 58.53 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.876 -0.515 . . . . 0.0 110.952 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -74.15 -18.71 60.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 32.9 ttp -77.17 -53.13 8.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -61.03 -20.6 62.72 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.485 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 7.4 t80 -74.13 -30.83 62.48 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.893 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.15 -33.08 67.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.073 -0.392 . . . . 0.0 110.561 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.0 4.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -133.72 -18.91 2.11 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 121.319 -0.863 . . . . 0.0 112.552 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 -19.96 5.41 Favored 'General case' 0 N--CA 1.46 0.047 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.29 2.71 14.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.71 140.52 34.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.365 1.066 . . . . 0.0 108.428 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 65.42 25.06 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.555 0.693 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 53.8 p -135.27 169.58 17.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.9 1.28 . . . . 0.0 108.507 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 9.9 pttt -75.23 155.87 36.33 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.248 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.494 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -138.44 166.23 24.79 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.483 170.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' B' ' 182' ' ' SER . 14.9 tpt180 -133.85 151.63 51.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.161 0.984 . . . . 0.0 110.157 -169.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' SER . . . . . 0.442 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 42.4 m -133.62 164.42 27.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.21 0.529 . . . . 0.0 111.42 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.448 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 15.4 p-80 -62.78 -13.1 29.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.027 1.331 . . . . 0.0 113.75 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -84.15 -16.67 42.7 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.54 0.609 . . . . 0.0 112.416 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.39 19.27 8.49 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.471 -0.627 . . . . 0.0 113.951 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.04 171.23 14.49 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.53 1.165 . . . . 0.0 111.406 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 69.1 p -138.57 161.23 37.61 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.816 0.446 . . . . 0.0 111.481 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.68 156.2 15.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.015 . . . . 0.0 108.9 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 2.6 m-30 -72.03 158.57 35.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.061 0.458 . . . . 0.0 111.118 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.03 145.08 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.113 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -102.73 102.39 12.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.976 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.9 79.72 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.047 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.22 158.29 23.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.153 0.501 . . . . 0.0 111.374 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' B' ' 195' ' ' ASP . 27.6 m -72.64 6.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 126.203 1.801 . . . . 0.0 113.705 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 3.8 t0 91.05 157.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.995 1.435 . . . . 0.0 110.277 170.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.561 -1.688 . . . . 0.0 111.33 174.262 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 C5'-C4'-C3' 111.823 -2.451 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.473 1 O4'-C1'-N19 112.247 4.047 . 0.36 5p . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 C5'-C4'-C3' 110.372 -3.419 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.41 " H1'" " H1'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.336 0 O4'-C1'-N19 111.371 3.171 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.41 " H1'" " H1'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.412 -3.442 1 C4'-C3'-C2' 98.476 -4.224 . 0.247 0i . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 1 O4'-C1'-N19 113.134 4.934 . 0.351 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.633 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.422 -2.584 0 C5'-C4'-C3' 110.221 -3.519 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . 0.488 " H5'" ' C6 ' ' A' ' 8' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.06 0 O4'-C1'-N19 110.85 2.65 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.44 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -60.01 -36.51 39.09 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.454 -0.784 . . . . 0.0 113.014 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 34.4 Cg_exo -60.11 3.77 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.707 2.938 . . . . 0.0 114.286 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' B' ' 107' ' ' ALA . 98.6 mtt180 55.87 20.07 3.92 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.278 1.031 . . . . 0.0 112.277 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.06 177.38 47.7 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -152.16 12.25 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.602 0.361 . . . . 0.0 111.822 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -140.75 171.15 14.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.478 0.711 . . . . 0.0 110.338 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.88 -180.0 48.8 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.74 156.44 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.969 3.78 . . . . 0.0 112.92 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.02 -35.01 59.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 113.602 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 15.0 m -165.3 -38.49 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . 0.31 0.0 OUTLIER 161.83 27.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.736 3.214 . . . . 0.0 113.161 166.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.1 169.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.849 1.259 . . . . 0.0 113.476 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -140.46 -133.3 0.11 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.775 0.83 . . . . 0.0 112.151 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.64 -19.55 1.84 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -165.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.01 75.43 1.55 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.814 1.245 . . . . 0.0 109.788 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 66.5 mtm-85 -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.436 1.494 . . . . 0.0 113.398 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.415 HG11 ' SD ' ' B' ' 168' ' ' MET . 0.4 OUTLIER -139.21 132.86 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 126.604 1.962 . . . . 0.0 108.111 174.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.52 156.59 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 109.774 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.18 100.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 77.3 p -111.3 146.94 36.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.407 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.47 -0.46 32.69 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.17 149.82 44.56 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 128.12 2.568 . . . . 0.0 111.29 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.31 165.16 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.5 2.8 . . . . 0.0 109.668 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.95 -15.69 36.46 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.786 2.324 . . . . 0.0 110.25 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 73.2 m -79.66 -2.57 43.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.875 1.27 . . . . 0.0 112.024 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.75 168.64 54.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' B' ' 183' ' ' HIS . 3.9 p -159.75 166.36 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -73.21 -28.67 62.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.334 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -68.34 -40.47 81.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 117.964 0.347 . . . . 0.0 110.246 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.633 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 72.7 m-20 -80.61 -19.73 44.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -34.05 70.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -74.65 -37.95 62.6 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.37 1.47 1.62 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.727 1.211 . . . . 0.0 113.5 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.549 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 12.0 t60 -132.96 -37.74 0.99 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.513 0.597 . . . . 0.0 111.403 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.5 mmm -71.63 -11.35 60.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.421 0.555 . . . . 0.0 110.189 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -47.59 -21.41 0.35 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 123.914 0.886 . . . . 0.0 113.114 171.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.4 -41.88 88.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.2 -27.81 67.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.15 -170.26 36.91 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -83.07 74.26 9.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.839 0.828 . . . . 0.0 110.565 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.4 OUTLIER -61.11 149.56 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 34.4 t -131.74 -33.37 1.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -136.37 158.89 43.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 110.609 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.45 166.28 33.19 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -145.19 150.52 36.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.549 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.8 p -129.49 141.38 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.599 0.714 . . . . 0.0 110.362 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.79 11.61 29.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.279 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.549 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.9 23.3 0.03 OUTLIER 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.954 2.101 . . . . 0.0 114.895 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.07 6.75 1.78 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.14 6.38 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 118.557 0.617 . . . . 0.0 113.202 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 2.9 p -142.73 163.46 32.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.271 0.536 . . . . 0.0 110.322 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.04 -168.29 35.43 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.91 162.29 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 122.94 0.496 . . . . 0.0 111.105 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -154.59 153.95 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 124.327 1.051 . . . . 0.0 109.472 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.403 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 17.1 pt-20 -154.47 160.15 41.42 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -122.73 171.72 8.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 122.061 0.934 . . . . 0.0 111.984 -171.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.05 -20.11 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.22 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -145.11 143.89 30.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.135 0.574 . . . . 0.0 110.371 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.02 -24.32 63.26 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.29 -29.53 62.78 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.546 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.83 -19.33 60.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' MET . . . . . 0.442 ' HA ' ' CE1' ' B' ' 162' ' ' PHE . 31.2 ttp -78.17 -52.79 8.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.181 0.592 . . . . 0.0 110.481 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.3 m -64.8 -19.27 65.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -73.91 -27.63 61.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.03 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.46 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.03 -0.419 . . . . 0.0 110.891 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.38 3.25 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . 0.604 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 5.1 ptm180 -134.44 -21.45 1.78 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.833 0.742 . . . . 0.0 112.491 -173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.604 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.1 OUTLIER -113.06 -26.3 8.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.945 0.339 . . . . 0.0 111.116 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -118.23 2.22 11.95 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.763 0.825 . . . . 0.0 109.955 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.0 152.39 29.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.107 0.563 . . . . 0.0 109.544 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.4 32.95 12.04 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 32.9 p -133.01 175.15 9.63 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.974 0.509 . . . . 0.0 110.632 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.75 147.19 28.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.899 0.88 . . . . 0.0 112.1 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.549 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.4 t80 -139.7 158.78 43.54 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.9 1.28 . . . . 0.0 109.639 170.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -141.68 144.46 34.12 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.766 1.226 . . . . 0.0 108.715 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 77.3 p -148.64 -178.05 6.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.8 0.44 . . . . 0.0 110.075 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' B' ' 185' ' ' GLY . 24.1 p-80 -62.07 -174.99 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.974 0.51 . . . . 0.0 110.954 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 20.3 mm-40 69.55 -27.29 0.16 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.7 1.6 . . . . 0.0 111.623 -172.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' B' ' 183' ' ' HIS . . . 108.02 29.76 4.2 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.617 171.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -129.13 178.75 6.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.892 0.846 . . . . 0.0 112.361 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 51.0 p -145.93 166.78 25.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.42 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.33 -159.43 0.58 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.404 0.681 . . . . 0.0 109.732 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.89 145.64 48.28 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.62 92.13 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.063 0 CA-C-O 121.535 0.683 . . . . 0.0 112.608 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.8 84.8 1.67 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.83 0.824 . . . . 0.0 109.489 170.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.55 133.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.134 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' B' ' 195' ' ' ASP . 54.6 mtmt -125.83 165.62 18.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.271 0.558 . . . . 0.0 112.114 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 18.0 m -76.77 32.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 126.7 2.0 . . . . 0.0 112.679 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' B' ' 193' ' ' LYS . 1.0 OUTLIER 72.83 18.01 4.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.759 173.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.366 -1.797 . . . . 0.0 111.414 -173.308 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 111.802 3.602 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.769 0 O4'-C1'-N19 110.879 2.679 . 0.471 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 111.831 3.631 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.966 0 C5'-C4'-C3' 111.478 -2.681 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.953 0 C4'-C3'-C2' 100.098 -2.602 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ' G' . . . . . 0.485 ' H21' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.352 2 O4'-C1'-N19 113.888 5.688 . 0.148 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ' A' . . . . . 0.633 ' H61' ' CG ' ' B' ' 136' ' ' ASP . . . . . . . . 0 P--O5' 1.617 2.363 1 O4'-C1'-N19 112.372 4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 P-O3'-C3' 121.807 1.756 . 0.0 OUTLIER '7D dist 1L' 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.38 26.69 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.094 0.557 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.52 -13.97 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 124.573 3.516 . . . . 0.0 113.958 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 50.94 23.1 1.34 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 112.565 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.42 -178.01 47.82 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 43.28 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.115 1.766 . . . . 0.0 113.696 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -149.82 -0.61 0.45 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.752 0.421 . . . . 0.0 111.95 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.9 -171.3 44.32 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.4 161.44 43.23 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.715 2.943 . . . . 0.0 110.488 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.61 12.64 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.438 3.426 . . . . 0.0 113.153 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 3.5 p -175.35 141.01 0.51 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' B' ' 117' ' ' ARG . 0.0 OUTLIER -164.01 37.03 0.08 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 117.697 -1.601 . . . . 0.0 112.49 -159.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.7 -175.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -138.67 -135.35 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.289 37.7 mt-10 -136.65 -17.58 1.47 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.659 1.983 . . . . 0.0 115.214 -165.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -131.43 80.85 1.95 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.559 1.544 . . . . 0.0 108.558 -169.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 61.6 mtm-85 -80.64 159.02 25.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.41 2.284 . . . . 0.0 113.429 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.7 138.87 17.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 128.722 2.809 . . . . 0.0 107.721 176.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.63 164.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.32 131.52 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 93.3 p -137.19 140.14 41.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.869 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 132.35 -1.02 4.83 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' B' ' 180' ' ' PHE . 1.6 mm? -53.54 149.21 15.81 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 123.352 0.661 . . . . 0.0 110.981 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.26 166.43 29.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.309 3.339 . . . . 0.0 110.669 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.79 -3.59 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 1 C-N-CA 125.443 4.095 . . . . 0.0 116.308 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.11 10.47 1.52 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.644 1.111 . . . . 0.0 113.261 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.36 158.79 7.01 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -148.43 170.3 18.31 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.37 -0.488 . . . . 0.0 110.594 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -66.69 -27.07 67.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.555 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -68.38 -35.22 77.37 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.348 0.522 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.633 ' CG ' ' H61' ' A' ' 7' ' ' ' A' . 92.7 m-20 -84.03 -22.69 31.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.388 -0.195 . . . . 0.0 111.325 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -35.9 75.19 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -77.02 -36.62 56.12 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.485 ' CG ' ' H21' ' A' ' 6' ' ' ' G' . 4.1 m-20 -69.44 -2.05 10.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.234 1.014 . . . . 0.0 112.962 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 17.9 t60 -126.99 -37.6 2.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 110.882 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mmm -70.89 -11.31 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.885 -0.509 . . . . 0.0 110.205 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -49.53 -21.34 0.94 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.228 0.611 . . . . 0.0 112.439 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.26 -43.62 81.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.148 0.579 . . . . 0.0 111.073 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.13 68.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.055 0.542 . . . . 0.0 110.929 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.47 -167.67 37.1 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.05 74.3 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.669 0.747 . . . . 0.0 110.402 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 1.2 p -60.33 149.03 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 29.1 p -138.29 -13.64 1.35 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.984 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.54 155.76 32.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.332 -0.855 . . . . 0.0 110.638 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.9 130.24 8.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.678 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.97 120.96 43.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . 0.476 HG21 ' H ' ' B' ' 154' ' ' ARG . 11.3 p -109.39 140.6 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.565 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.15 6.18 49.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.353 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.476 ' H ' HG21 ' B' ' 152' ' ' VAL . 13.8 mtt180 62.57 14.91 7.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.928 0.891 . . . . 0.0 112.669 172.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.59 -4.44 2.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 130.56 7.19 3.53 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 118.528 0.604 . . . . 0.0 113.118 177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 164.81 29.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.62 0.71 . . . . 0.0 110.614 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.85 -164.18 31.87 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.27 161.02 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 124.088 0.955 . . . . 0.0 108.423 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 p -152.03 156.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.405 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 13.6 pt-20 -156.18 159.6 39.12 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.2 m-85 -127.97 170.42 12.88 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.596 0.713 . . . . 0.0 111.314 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.58 -7.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -149.46 135.83 19.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.161 0.437 . . . . 0.0 110.119 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -66.81 -20.86 66.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.37 -31.96 54.65 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.507 -0.746 . . . . 0.0 110.56 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.61 -19.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 109.607 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.8 ttp -76.54 -52.45 9.73 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.017 0.927 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -65.19 -19.38 65.94 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' TYR . . . . . 0.589 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 37.9 t80 -73.55 -27.66 61.46 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.452 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.13 66.61 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.385 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.3 4.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.4 -17.18 2.05 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.393 -0.817 . . . . 0.0 112.872 -172.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.3 mppt? -124.94 -21.59 4.67 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 173.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.21 1.62 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.912 0.485 . . . . 0.0 109.945 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 140.59 29.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 62.06 34.49 16.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.807 0.843 . . . . 0.0 111.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.7 p -138.04 177.77 7.63 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.469 0.708 . . . . 0.0 110.543 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -57.01 155.52 8.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.701 1.201 . . . . 0.0 113.704 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' PHE . . . . . 0.649 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 23.7 t80 -143.25 161.87 37.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.472 1.909 . . . . 0.0 108.873 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -146.56 146.22 30.4 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.19 0.996 . . . . 0.0 108.738 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 85.0 p -141.99 170.91 14.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.013 0.435 . . . . 0.0 111.872 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . 0.475 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.6 p-80 -59.41 -11.87 5.08 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.81 1.244 . . . . 0.0 113.135 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.27 -18.79 65.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.266 0.484 . . . . 0.0 111.148 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.74 14.44 34.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.61 178.68 7.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.788 0.794 . . . . 0.0 111.106 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 56.1 p -121.66 167.97 12.32 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.39 0.614 . . . . 0.0 111.329 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.84 -163.24 1.45 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.991 1.316 . . . . 0.0 107.755 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.03 156.34 38.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.07 146.53 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.577 0.703 . . . . 0.0 111.234 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -116.61 82.3 1.77 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 t -69.52 86.33 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.901 0.88 . . . . 0.0 111.219 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 12.7 tttt -71.08 169.32 15.24 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.02 -0.425 . . . . 0.0 110.869 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' VAL . . . . . 0.46 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 5.5 p -62.01 -28.67 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.062 1.745 . . . . 0.0 115.246 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 26.6 t70 134.6 167.36 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.068 2.547 . . . . 0.0 109.067 -173.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.258 0 CA-C-O 117.224 -1.875 . . . . 0.0 111.521 175.362 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -175.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.64 1.176 . . . . 0.0 112.586 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' B' ' 161' ' ' GLU . 0.0 OUTLIER -162.44 179.6 7.68 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 120' ' ' GLU . . . . . 0.575 ' HB2' HD22 ' B' ' 121' ' ' ASN . 26.5 mt-10 -149.35 -31.21 0.23 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.45 -1.704 . . . . 0.0 113.406 -172.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.6 p30 -140.49 78.74 1.67 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.325 1.85 . . . . 0.0 107.42 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -87.29 158.0 19.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.44 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.489 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -146.65 142.17 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 127.987 2.515 . . . . 0.0 107.279 176.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.91 159.48 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.07 102.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -117.79 150.65 38.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.193 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.95 -2.71 55.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 14.4 tp -53.42 145.18 28.57 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 128.14 2.576 . . . . 0.0 110.151 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.36 162.45 38.34 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.053 2.502 . . . . 0.0 109.448 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.33 -12.64 35.53 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.881 2.387 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -72.75 -23.0 60.77 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.091 0.957 . . . . 0.0 111.779 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.59 46.25 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.4 0.444 . . . . 0.0 112.645 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 43.8 t -158.12 168.66 26.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -64.49 -30.13 71.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.446 0.566 . . . . 0.0 110.727 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -66.61 -37.07 84.1 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.938 0.335 . . . . 0.0 111.568 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -84.67 -17.88 37.13 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.856 0.298 . . . . 0.0 111.441 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -32.17 66.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -77.73 -38.57 46.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.97 1.57 0.9 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.531 1.132 . . . . 0.0 113.658 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' HIS . . . . . 0.426 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 16.7 t-80 -136.68 -40.37 0.62 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.413 0.551 . . . . 0.0 111.568 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 86.4 mmm -68.55 -11.6 60.16 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.413 0.551 . . . . 0.0 110.051 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -47.39 -21.38 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.885 0.874 . . . . 0.0 112.504 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.23 -42.74 88.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.824 -0.548 . . . . 0.0 111.164 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.45 -27.72 66.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.65 0.78 . . . . 0.0 111.666 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.5 -167.54 37.06 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -87.22 77.9 8.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.915 0.864 . . . . 0.0 110.157 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -62.96 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 43.5 t -128.06 -23.77 3.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.743 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -139.59 155.79 47.26 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 119.162 0.892 . . . . 0.0 110.331 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.86 165.12 35.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -147.62 153.61 39.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.499 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -132.35 147.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.113 0.482 . . . . 0.0 110.305 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.78 10.98 17.93 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.999 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.499 ' H ' HG22 ' B' ' 152' ' ' VAL . 28.0 mtt180 59.24 17.39 5.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.681 0.792 . . . . 0.0 113.053 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.11 15.16 3.28 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.0 52.35 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 11.8 p -140.69 159.19 42.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.352 0.661 . . . . 0.0 110.395 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.78 -170.27 38.39 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.5 161.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.804 0.442 . . . . 0.0 111.131 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -153.49 156.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 123.459 0.704 . . . . 0.0 109.885 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.484 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 1.2 tm-20 -152.39 155.39 37.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.944 0.498 . . . . 0.0 111.728 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -124.17 163.62 21.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.883 1.273 . . . . 0.0 111.73 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.7 -8.37 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.507 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -147.8 133.8 19.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -63.57 -20.66 65.82 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -76.02 -29.37 58.1 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.649 -0.657 . . . . 0.0 110.744 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.8 -19.01 60.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.489 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.7 ttp -77.97 -52.97 7.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.345 1.058 . . . . 0.0 110.674 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -63.46 -21.45 66.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.279 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.592 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 46.0 t80 -74.53 -31.72 62.23 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.73 -17.56 60.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.288 0.635 . . . . 0.0 111.628 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 172' ' ' VAL . 14.5 p -113.21 34.23 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.714 0.769 . . . . 0.0 111.702 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.28 -17.5 0.64 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -123.54 -25.82 4.3 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.39 0.676 . . . . 0.0 112.611 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.38 -2.64 21.96 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.357 0.263 . . . . 0.0 110.533 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.22 145.9 32.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.008 0.923 . . . . 0.0 109.013 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 29.67 17.85 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.435 0.694 . . . . 0.0 112.532 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 47.4 p -133.44 169.49 16.88 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.965 0.506 . . . . 0.0 110.701 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -57.85 149.47 22.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' PHE . . . . . 0.426 ' HA ' ' NE2' ' B' ' 140' ' ' HIS . 6.0 t80 -141.71 161.1 38.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.982 1.713 . . . . 0.0 108.937 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 . . . . . 0 C--N 1.338 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 110.178 -170.05 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.69 160.48 19.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.326 1.051 . . . . 0.0 108.849 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.98 157.23 38.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 110.346 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 26.9 pt -123.59 151.7 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.746 0.784 . . . . 0.0 109.64 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -118.41 78.76 1.29 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.78 144.54 10.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 5.3 tttp -126.68 168.78 13.89 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.437 ' H ' HG12 ' B' ' 194' ' ' VAL . 3.0 p -60.22 -29.55 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.526 1.531 . . . . 0.0 114.603 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 127.71 2.404 . . . . 0.0 109.058 -173.316 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -53.9 159.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.167 0.894 . . . . 0.0 112.192 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -140.1 -94.37 0.16 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -153.89 -30.51 0.12 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -165.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.94 -37.24 2.12 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -165.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ARG . . . . . 0.52 ' H ' ' HG3' ' B' ' 161' ' ' GLU . 86.8 mtt180 46.3 165.33 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.619 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.0 OUTLIER -159.17 134.65 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 129.59 3.156 . . . . 0.0 107.717 170.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.16 165.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.2 136.41 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 54.6 p -135.32 147.45 49.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.907 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.07 -2.34 31.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.72 140.44 38.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 127.133 2.173 . . . . 0.0 110.076 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.3 162.35 19.92 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.638 2.892 . . . . 0.0 110.11 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -14.77 32.71 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.865 2.377 . . . . 0.0 109.761 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -83.1 6.24 19.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.689 1.196 . . . . 0.0 111.738 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.45 165.09 12.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -159.49 170.67 21.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -61.68 -28.45 69.41 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -69.31 -35.05 75.57 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.45 -19.59 22.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.25 0.477 . . . . 0.0 111.416 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.19 -26.48 59.04 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -75.22 -39.86 59.67 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.98 1.66 1.36 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.163 1.385 . . . . 0.0 113.179 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -135.38 -38.92 0.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.125 0.42 . . . . 0.0 111.37 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.0 mmm -68.14 -18.27 64.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.873 -0.517 . . . . 0.0 110.26 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -51.15 -19.88 1.32 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -56.57 -36.93 69.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.946 0.499 . . . . 0.0 111.169 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.2 -21.9 65.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.966 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.27 -93.82 0.11 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.902 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.8 121.1 6.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -121.84 150.54 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.02 -21.54 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.97 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -131.34 154.17 48.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.356 0.98 . . . . 0.0 111.801 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -158.28 161.48 37.71 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 18.0 t0 -145.56 148.46 33.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.632 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -128.45 141.97 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.208 0.528 . . . . 0.0 110.48 -172.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -103.3 5.82 37.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.497 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.632 ' H ' HG22 ' B' ' 152' ' ' VAL . 23.5 mtp85 62.55 17.21 9.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.461 0.705 . . . . 0.0 112.388 170.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -137.38 -11.96 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.06 -2.84 2.15 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 118.872 0.76 . . . . 0.0 113.181 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.2 165.85 26.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.51 -165.72 34.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 4.2 p -142.0 161.25 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 122.971 0.509 . . . . 0.0 110.02 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.5 p -147.62 159.63 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' B' ' 122' ' ' ARG . 42.9 tt0 -154.83 146.96 23.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.912 -0.492 . . . . 0.0 111.968 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 60.6 m-85 -117.94 156.93 27.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.595 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.1 m -61.71 -12.55 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.399 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -152.5 151.16 30.39 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.748 0.819 . . . . 0.0 109.07 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.67 -22.97 65.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.4 -32.83 48.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.597 0.635 . . . . 0.0 111.387 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.11 -17.66 61.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.123 0.487 . . . . 0.0 110.089 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.619 ' SD ' HG13 ' B' ' 123' ' ' VAL . 15.2 tmm? -82.95 -51.25 7.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.149 0.98 . . . . 0.0 111.202 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -61.75 -21.81 64.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.56 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 28.5 t80 -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.13 -12.47 60.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.204 0.602 . . . . 0.0 111.459 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.418 HG22 ' O ' ' B' ' 172' ' ' VAL 0.258 13.3 p -118.57 33.22 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 111.514 174.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.11 -16.5 0.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.506 169.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.9 mppt? -123.58 -25.85 4.29 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.571 0.748 . . . . 0.0 112.428 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.24 -3.36 19.85 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.808 0.276 . . . . 0.0 110.461 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.95 143.64 43.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.716 0.806 . . . . 0.0 110.174 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.16 36.59 27.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 43.0 p -135.55 172.84 12.43 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.278 0.631 . . . . 0.0 110.301 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -58.75 146.31 37.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.937 0.895 . . . . 0.0 112.274 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -136.73 156.5 48.43 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.905 1.282 . . . . 0.0 109.36 169.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 . . . . . 0 N--CA 1.457 -0.082 0 C-N-CA 124.788 1.235 . . . . 0.0 108.173 -173.519 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.086 0.469 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.8 -162.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.435 0.694 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.93 147.53 49.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 102.65 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.595 0.712 . . . . 0.0 112.449 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -80.16 89.11 5.42 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' VAL . . . . . 0.414 ' HB ' HG23 ' B' ' 172' ' ' VAL . 6.6 t -67.88 138.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.86 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -117.47 162.43 17.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.74 -29.96 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.333 1.853 . . . . 0.0 114.913 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 127.087 2.155 . . . . 0.0 108.826 -173.062 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 51.0 mtt180 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -61.64 166.32 4.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.375 1.443 . . . . 0.0 112.417 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t -146.29 -126.2 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.434 0.694 . . . . 0.0 112.513 -172.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -133.97 -25.79 1.58 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 114.397 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.443 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.0 OUTLIER -130.31 79.97 1.93 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 110.052 -171.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -78.67 158.57 28.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.008 1.723 . . . . 0.0 112.895 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -149.92 142.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 127.733 2.413 . . . . 0.0 108.657 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.5 t -80.89 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.55 136.41 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.8 p -141.37 157.39 45.24 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.364 -0.21 . . . . 0.0 111.102 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 4.41 56.17 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.94 146.68 36.87 Favored Pre-proline 0 N--CA 1.452 -0.356 0 C-N-CA 125.287 1.435 . . . . 0.0 110.844 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.1 164.91 33.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.246 3.297 . . . . 0.0 110.948 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -54.17 -6.52 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 125.165 3.91 . . . . 0.0 116.257 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 13.03 1.16 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.604 1.093 . . . . 0.0 113.423 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -53.2 158.28 4.28 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -146.28 168.24 21.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.425 0.613 . . . . 0.0 110.44 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -65.54 -27.46 68.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.604 -0.236 . . . . 0.0 111.364 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -68.68 -40.11 80.27 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 117.928 0.331 . . . . 0.0 111.322 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -80.07 -21.22 43.62 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.132 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -32.51 70.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -79.86 -37.26 35.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.78 3.04 2.12 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.363 1.065 . . . . 0.0 112.916 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -132.51 -41.17 0.97 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.386 0.539 . . . . 0.0 111.159 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.3 mmm -69.66 -12.48 61.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.196 0.453 . . . . 0.0 110.315 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -45.2 -24.96 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 112.196 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.91 -42.2 94.93 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -69.96 -29.97 67.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.679 0.791 . . . . 0.0 111.505 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.9 -171.04 40.92 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -82.31 64.58 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.445 0.64 . . . . 0.0 111.254 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.3 OUTLIER -55.72 141.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 148' ' ' CYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 37.5 t -123.52 -30.55 3.62 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -133.1 158.77 41.94 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.658 0.742 . . . . 0.0 111.59 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -154.11 168.95 24.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.493 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 41.3 t0 -150.04 154.51 38.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.4 p -131.83 142.29 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.555 0.693 . . . . 0.0 110.473 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -105.07 5.69 32.67 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.11 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 14.3 mtt-85 61.56 17.66 8.76 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.867 0.867 . . . . 0.0 112.421 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -137.06 0.67 2.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.01 2.89 7.7 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 118.504 0.593 . . . . 0.0 112.401 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.64 165.9 26.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.458 0.647 . . . . 0.0 110.316 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.89 -166.79 36.01 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 3.6 p -138.86 162.02 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.867 0.467 . . . . 0.0 110.781 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.9 p -149.24 159.5 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 123.717 0.807 . . . . 0.0 108.872 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.42 147.12 20.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.156 -0.34 . . . . 0.0 111.661 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 4.8 m-85 -121.13 171.79 8.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.394 1.092 . . . . 0.0 111.771 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.38 -20.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.252 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -143.94 141.98 30.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.228 0.611 . . . . 0.0 110.561 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.17 -25.02 63.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.9 -31.43 59.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.762 0.71 . . . . 0.0 111.009 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.71 -16.4 60.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.782 0.325 . . . . 0.0 110.183 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 26.6 ttp -79.83 -50.84 9.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.91 0.884 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 43.9 m -65.37 -19.76 66.09 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -72.57 -27.23 62.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.467 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.03 -36.72 61.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 122.201 -0.312 . . . . 0.0 110.942 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.83 7.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.584 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.5 ptm180 -138.39 -25.04 0.94 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.866 0.757 . . . . 0.0 112.224 -174.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.584 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.69 -27.42 10.32 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.367 0.531 . . . . 0.0 110.934 175.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.9 mm? -115.98 -1.12 12.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.897 0.879 . . . . 0.0 109.892 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.35 141.08 28.94 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.623 0.769 . . . . 0.0 109.056 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.35 26.91 12.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 111.802 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 52.0 p -137.25 172.56 12.81 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.126 0.57 . . . . 0.0 110.169 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -54.38 150.58 8.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.453 1.101 . . . . 0.0 113.965 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -141.68 162.06 36.4 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.873 2.069 . . . . 0.0 108.038 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 CA--C 1.521 -0.152 0 C-N-CA 123.897 0.879 . . . . 0.0 109.031 -171.112 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.65 158.35 17.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.506 1.123 . . . . 0.0 108.132 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.53 154.3 41.56 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.245 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.81 152.16 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.972 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.96 87.09 2.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.38 89.33 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 110.751 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.5 tttt -71.13 171.47 10.92 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 120.713 0.292 . . . . 0.0 111.037 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.456 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.8 p -65.28 -27.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.779 1.632 . . . . 0.0 114.67 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' B' ' 124' ' ' VAL . 23.5 t0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 128.199 2.599 . . . . 0.0 108.977 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -54.05 167.47 0.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.844 1.258 . . . . 0.0 111.602 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -130.75 -97.33 0.34 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -153.53 -29.56 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -165.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.27 -35.81 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -165.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 39.73 158.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -153.55 142.54 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 127.428 2.291 . . . . 0.0 107.417 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -78.14 165.23 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.54 129.72 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 98.1 p -138.92 138.54 37.47 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.254 0.549 . . . . 0.0 111.504 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.92 0.28 7.69 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.51 145.08 21.6 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.588 1.155 . . . . 0.0 110.622 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.0 169.99 21.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.01 3.14 . . . . 0.0 109.621 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.92 -6.87 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.571 3.514 . . . . 0.0 115.793 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 30.1 m -138.16 5.46 2.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -54.97 153.66 10.83 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -147.32 168.9 20.6 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.302 -0.528 . . . . 0.0 110.978 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -65.35 -28.53 69.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.18 -46.27 74.46 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.364 0.529 . . . . 0.0 110.724 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -76.37 -16.26 59.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.381 -0.199 . . . . 0.0 111.165 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -34.57 71.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -76.55 -37.63 56.31 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.59 -1.71 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.205 1.002 . . . . 0.0 113.652 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -128.0 -36.25 1.99 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.767 0.712 . . . . 0.0 111.23 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.5 mmm -73.73 -12.17 60.63 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.889 -0.507 . . . . 0.0 110.434 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttm105 -44.87 -25.16 0.27 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.913 0.885 . . . . 0.0 112.489 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.3 -42.14 93.36 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.916 -0.49 . . . . 0.0 111.328 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.26 -31.23 69.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.092 0.557 . . . . 0.0 111.386 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.13 -171.35 41.17 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -80.45 72.94 7.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.903 0.859 . . . . 0.0 110.939 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.8 OUTLIER -63.14 146.53 12.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 36.8 t -130.75 -31.63 1.74 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.691 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' TYR . . . . . 0.435 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 6.2 t80 -137.15 161.53 35.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 110.458 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.86 169.87 23.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -148.14 155.34 41.31 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.498 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.5 p -132.63 143.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.465 0.65 . . . . 0.0 109.944 -175.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -105.3 10.58 33.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.1 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.498 ' H ' HG22 ' B' ' 152' ' ' VAL . 35.4 mtp180 61.73 15.39 6.93 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.34 3.14 3.07 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.46 5.03 13.06 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -140.61 166.5 24.57 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.426 0.69 . . . . 0.0 110.511 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.88 -164.83 32.82 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.43 162.31 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.576 0.75 . . . . 0.0 110.45 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 12.6 p -144.27 160.08 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.1 141.62 24.33 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.453 0.701 . . . . 0.0 110.756 -168.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.5 m-85 -128.42 165.19 21.11 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.932 0.872 . . . . 0.0 110.59 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.6 -5.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.37 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -150.34 144.69 25.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.195 0.452 . . . . 0.0 110.125 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -70.82 -23.09 62.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.412 0.285 . . . . 0.0 111.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -88.7 -32.98 17.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.883 0.31 . . . . 0.0 111.726 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -74.37 -8.88 57.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.253 0.549 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.429 ' SD ' HG13 ' B' ' 123' ' ' VAL . 37.6 ttp -94.76 -42.3 8.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.11 1.364 . . . . 0.0 110.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 92.7 m -66.26 -17.42 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 42.8 t80 -72.4 -27.5 62.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -38.09 64.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.378 -0.201 . . . . 0.0 110.567 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 m -73.16 5.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -134.23 -16.18 2.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.898 0.772 . . . . 0.0 112.857 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.634 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.2 mppt? -125.64 -21.09 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.31 1.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.85 144.31 31.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.777 0.831 . . . . 0.0 109.426 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.6 36.45 23.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.019 0.928 . . . . 0.0 112.709 174.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 33.5 p -133.69 178.96 6.53 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.361 0.664 . . . . 0.0 110.335 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -53.41 149.38 7.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -147.73 168.72 21.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.738 2.015 . . . . 0.0 107.749 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.423 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.199 0.523 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.78 -168.99 2.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.592 1.157 . . . . 0.0 108.319 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.63 142.47 51.49 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -129.55 133.02 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.499 0.666 . . . . 0.0 112.665 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -94.94 89.76 5.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.52 92.74 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.173 0.589 . . . . 0.0 110.13 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 6.5 tttp -75.36 173.02 11.47 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 111.224 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.457 ' H ' HG12 ' B' ' 194' ' ' VAL . 2.8 p -65.85 -28.82 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.247 1.819 . . . . 0.0 114.436 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 20.9 t70 . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 127.38 2.272 . . . . 0.0 108.949 -173.668 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.355 0.122 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.68 167.6 0.72 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.715 1.206 . . . . 0.0 112.759 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.9 t -150.85 -124.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.266 0.627 . . . . 0.0 111.793 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.25 35.5 mt-10 -138.5 -15.23 1.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.513 1.525 . . . . 0.0 114.796 -167.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.0 OUTLIER -138.42 77.18 1.61 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.407 1.483 . . . . 0.0 110.995 -168.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -79.44 154.0 29.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.58 1.952 . . . . 0.0 112.499 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.6 OUTLIER -145.07 133.66 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.811 2.045 . . . . 0.0 108.407 173.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' B' ' 195' ' ' ASP . 37.8 t -70.52 160.37 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-O 121.101 0.477 . . . . 0.0 109.774 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.51 107.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.1 p -118.23 147.94 42.9 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.04 -1.92 35.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.42 153.69 13.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 111.411 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.85 158.15 38.95 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.69 2.26 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.83 -17.71 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.039 2.493 . . . . 0.0 111.482 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 56.5 m -79.01 -10.94 59.98 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.788 0.835 . . . . 0.0 112.412 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.73 161.99 50.99 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 23.5 t -152.06 170.23 20.44 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.302 0.641 . . . . 0.0 109.817 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 41.5 p-90 -64.85 -28.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.96 -0.463 . . . . 0.0 111.525 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.75 -37.34 82.0 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.025 0.375 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.55 -29.52 27.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 111.299 0.111 . . . . 0.0 111.299 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -35.31 77.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.015 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -72.02 -41.95 66.95 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.61 2.79 1.64 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.347 1.459 . . . . 0.0 113.959 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -131.42 -38.24 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.773 0.715 . . . . 0.0 111.243 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.9 mmm -69.84 -17.31 63.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.02 -0.425 . . . . 0.0 110.244 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -46.96 -19.29 0.1 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.959 0.903 . . . . 0.0 113.382 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.98 -41.43 95.44 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.148 0.579 . . . . 0.0 111.322 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.76 -26.18 67.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.366 0.666 . . . . 0.0 111.412 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.17 -171.73 33.99 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -74.08 114.77 12.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.282 0.541 . . . . 0.0 109.911 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -120.26 147.46 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.49 -17.05 2.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -135.49 153.85 51.6 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.764 1.165 . . . . 0.0 111.819 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -156.92 147.14 21.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.476 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -129.43 119.38 23.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.9 p -106.66 148.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.487 -169.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -111.24 9.12 21.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.724 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.37 25.88 0.05 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 126.789 2.036 . . . . 0.0 114.787 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -142.78 5.98 1.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.31 -4.85 6.76 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 121.813 -0.554 . . . . 0.0 113.006 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -143.43 162.91 34.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 109.725 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.69 -169.21 39.07 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.9 160.68 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 117.285 0.542 . . . . 0.0 109.623 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -146.24 156.2 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -150.52 145.82 26.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 111.91 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 44.6 m-85 -112.94 160.91 17.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.256 1.027 . . . . 0.0 112.799 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.42 -20.42 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.362 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -150.35 145.88 26.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 110.117 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.25 -24.81 65.84 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.88 -31.01 62.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.913 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.05 -17.06 61.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.669 0.271 . . . . 0.0 110.569 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.462 ' SD ' HG13 ' B' ' 123' ' ' VAL . 29.5 ttp -81.46 -52.79 6.88 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.761 0.824 . . . . 0.0 110.685 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.5 m -65.59 -17.19 64.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.553 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 22.1 t80 -73.3 -29.59 62.82 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.765 -0.585 . . . . 0.0 109.53 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.8 64.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.063 -0.398 . . . . 0.0 110.663 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.96 6.09 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -133.94 -15.56 2.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.623 0.647 . . . . 0.0 112.569 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.4 mppt? -125.4 -21.43 4.55 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.76 2.82 14.52 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.62 142.78 31.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.22 38.86 31.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.092 0.473 . . . . 0.0 111.752 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.3 p -137.6 169.36 17.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.247 1.419 . . . . 0.0 108.515 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -66.8 165.07 15.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.866 -170.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' B' ' 181' ' ' ARG . 7.9 t80 -150.72 172.78 15.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.173 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' B' ' 180' ' ' PHE . 15.2 tpt180 . . . . . 0 N--CA 1.457 -0.114 0 C-N-CA 123.573 0.749 . . . . 0.0 109.167 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.777 0.798 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.15 -163.97 1.21 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.999 1.72 . . . . 0.0 107.192 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.31 156.38 44.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 22.6 pt -131.78 146.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.76 0.79 . . . . 0.0 111.129 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -114.71 79.91 1.33 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 34.7 t -60.76 133.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.49 160.54 31.99 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.135 0.574 . . . . 0.0 110.178 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' B' ' 123' ' ' VAL . 0.1 OUTLIER -60.42 -37.38 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' B' ' 124' ' ' VAL . 24.4 t70 . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 109.712 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -55.71 167.04 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.54 0.736 . . . . 0.0 112.735 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 14.6 t -146.53 -122.56 0.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.337 0.655 . . . . 0.0 112.085 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -134.9 -22.86 1.59 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.599 1.56 . . . . 0.0 114.442 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.79 77.28 1.73 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.695 1.198 . . . . 0.0 110.668 -169.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -78.92 150.17 32.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.852 1.661 . . . . 0.0 113.013 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.494 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -139.61 129.26 29.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.877 1.671 . . . . 0.0 108.532 171.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.86 158.69 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.08 109.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 81.0 p -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.665 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.14 53.49 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.3 147.0 77.2 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 127.871 2.468 . . . . 0.0 111.034 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.14 160.49 33.07 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.903 2.402 . . . . 0.0 109.273 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 -9.99 25.88 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.83 2.353 . . . . 0.0 111.09 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -75.01 -11.81 60.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.261 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.71 164.9 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 121.732 0.629 . . . . 0.0 112.842 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.7 t -158.99 166.63 31.34 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.903 1.281 . . . . 0.0 108.004 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 40.5 p-90 -66.64 -30.2 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.523 0.601 . . . . 0.0 111.753 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -65.98 -32.08 73.35 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.414 0.552 . . . . 0.0 110.635 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -87.64 -20.62 26.08 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 117.738 0.245 . . . . 0.0 111.512 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -29.97 64.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -79.65 -39.79 30.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.77 -1.75 7.81 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.496 1.118 . . . . 0.0 113.429 -176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' HIS . . . . . 0.451 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 5.1 t-80 -129.52 -41.74 1.35 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.132 0.424 . . . . 0.0 111.12 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 85.1 mmm -65.48 -16.93 64.15 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -42.24 -27.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.683 1.593 . . . . 0.0 113.13 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.03 -41.49 96.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 111.573 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.407 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.93 -29.26 69.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.333 0.653 . . . . 0.0 111.751 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.88 -175.8 34.32 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -73.02 115.79 12.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 122.369 -0.489 . . . . 0.0 110.333 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -113.63 151.18 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.4 p -132.99 -26.04 1.76 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.915 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -134.33 152.94 52.1 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.81 1.186 . . . . 0.0 112.125 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -149.81 169.18 21.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.655 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -149.67 141.41 23.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 168.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.577 HG22 ' H ' ' B' ' 154' ' ' ARG . 4.8 p -122.41 142.54 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.629 0.728 . . . . 0.0 111.02 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -108.79 9.96 26.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.682 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.577 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.0 24.57 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.215 2.206 . . . . 0.0 114.991 178.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.49 10.45 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.94 -4.21 7.93 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.106 0.412 . . . . 0.0 113.0 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.2 162.28 36.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.893 0.477 . . . . 0.0 110.415 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.28 -169.26 37.53 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.43 162.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.26 0.53 . . . . 0.0 110.755 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.2 p -149.75 158.53 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.898 0.879 . . . . 0.0 108.934 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.62 147.27 24.23 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.901 -0.499 . . . . 0.0 111.535 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 30.4 m-85 -116.49 168.5 10.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 122.281 1.038 . . . . 0.0 113.322 -172.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.3 m -75.67 -10.52 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.658 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -151.46 142.85 23.44 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.88 -23.53 66.67 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.31 -30.97 62.3 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.252 0.478 . . . . 0.0 110.86 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.06 -19.36 60.64 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 110.323 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.494 ' CG ' HG13 ' B' ' 123' ' ' VAL . 30.8 ttp -82.33 -53.44 6.02 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.764 0.826 . . . . 0.0 111.048 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -63.23 -21.79 66.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.539 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 29.2 t80 -73.53 -33.73 64.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.41 60.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.066 0.546 . . . . 0.0 111.362 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 172' ' ' VAL 0.261 8.2 p -116.07 33.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 111.198 174.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.3 ptm180 -143.64 -17.32 0.62 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -122.82 -27.36 4.3 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.326 0.65 . . . . 0.0 112.531 173.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' B' ' 175' ' ' LEU . 2.6 mm? -104.61 -7.52 19.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' B' ' 172' ' ' VAL . 15.2 t70 -75.35 147.16 40.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.8 0.84 . . . . 0.0 110.278 168.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 57.85 28.93 16.74 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.128 0.971 . . . . 0.0 112.367 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 63.6 p -136.95 174.55 10.5 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.88 0.472 . . . . 0.0 110.811 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -54.36 145.35 18.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 113.063 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' PHE . . . . . 0.451 ' HA ' ' NE2' ' B' ' 140' ' ' HIS . 5.2 t80 -138.56 160.04 40.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.771 1.629 . . . . 0.0 108.144 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 CA--C 1.523 -0.074 0 C-N-CA 123.709 0.804 . . . . 0.0 109.795 -169.245 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.71 158.75 20.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.555 1.142 . . . . 0.0 108.143 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -71.17 161.28 31.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.424 0.631 . . . . 0.0 110.425 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 28.9 pt -130.18 156.0 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.429 169.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -122.02 87.06 2.68 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.429 1.092 . . . . 0.0 108.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.22 142.19 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.261 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -134.09 158.48 43.5 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.282 0.563 . . . . 0.0 110.725 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.5 m -74.9 3.81 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 126.286 1.835 . . . . 0.0 113.76 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 7.3 t0 . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 125.314 1.446 . . . . 0.0 110.377 171.424 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -53.91 168.69 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.704 1.202 . . . . 0.0 112.26 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.6 t -138.61 -93.84 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.292 15.1 mt-10 -159.01 -27.56 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -164.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -25.73 4.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -161.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 35.07 155.93 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.401 3.081 . . . . 0.0 119.278 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -147.78 122.66 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.634 174.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' B' ' 195' ' ' ASP . 24.2 t -67.46 158.96 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.97 112.96 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 83.2 p -122.18 152.64 39.74 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.7 35.8 3.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.503 ' N ' ' HD3' ' B' ' 129' ' ' PRO . 13.0 tp -111.45 31.29 0.1 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' B' ' 128' ' ' LEU . 80.7 Cg_exo -46.93 -33.51 14.59 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.572 2.181 . . . . 0.0 116.307 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.438 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 89.5 Cg_exo -47.88 167.04 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.298 2.666 . . . . 0.0 114.094 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 7.0 t -71.27 19.68 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.77 0.828 . . . . 0.0 112.076 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' B' ' 130' ' ' PRO . . . -46.95 154.71 0.89 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.403 1.001 . . . . 0.0 113.206 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -146.69 166.13 27.52 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.131 0.972 . . . . 0.0 108.652 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -63.32 -28.64 70.15 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.849 -0.532 . . . . 0.0 111.289 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -67.59 -24.79 65.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.05 0.386 . . . . 0.0 111.528 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.14 -18.74 17.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.095 0.407 . . . . 0.0 111.612 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -29.18 64.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -77.63 -39.8 44.05 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.02 -0.69 9.98 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.259 1.024 . . . . 0.0 113.462 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -128.86 -35.11 1.9 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.341 0.519 . . . . 0.0 111.036 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 78.7 mmm -73.27 -14.64 61.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -47.14 -21.37 0.24 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 112.797 172.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.57 -41.23 96.41 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.274 0.63 . . . . 0.0 110.992 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.61 68.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.942 0.497 . . . . 0.0 111.567 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.43 -169.59 37.77 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.83 81.71 2.76 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.801 0.81 . . . . 0.0 110.759 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -76.78 146.37 8.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.3 p -131.34 -25.02 2.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.797 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -139.31 157.1 46.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.436 1.016 . . . . 0.0 111.594 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.26 167.75 26.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.905 174.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -148.32 137.15 21.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.0 p -118.84 142.34 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.845 0.831 . . . . 0.0 110.373 -171.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' TYR . . . . . 0.405 ' C ' ' HD3' ' B' ' 154' ' ' ARG . 3.2 m-30 -107.37 9.22 29.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.0 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.42 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.606 1.962 . . . . 0.0 114.446 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.05 8.16 1.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.35 -5.98 6.72 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.24 0.473 . . . . 0.0 112.973 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.4 p -144.12 165.61 27.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.173 0.487 . . . . 0.0 110.459 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.33 -166.27 33.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.51 162.74 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 CA-C-N 117.228 0.514 . . . . 0.0 110.251 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.464 HG13 HG23 ' B' ' 123' ' ' VAL . 8.8 p -147.74 161.12 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.008 0.923 . . . . 0.0 108.806 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -153.4 151.96 30.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 110.64 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 3.7 m-85 -129.53 164.58 23.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.926 0.869 . . . . 0.0 110.138 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 25.5 m -66.19 -5.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.53 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -152.6 155.9 38.25 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.554 0.615 . . . . 0.0 110.24 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.18 -28.04 65.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.757 0.423 . . . . 0.0 112.039 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.76 -30.9 18.69 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.064 -0.397 . . . . 0.0 112.022 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -72.62 -9.75 58.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.407 ' SD ' HG13 ' B' ' 123' ' ' VAL . 41.4 ttp -98.27 -42.95 7.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.464 1.506 . . . . 0.0 110.958 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.0 m -63.12 -19.25 64.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 24.9 t80 -71.31 -28.56 64.19 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.931 -0.48 . . . . 0.0 109.993 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.53 -36.71 65.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.21 4.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -133.95 -16.48 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.5 mppt? -124.91 -21.57 4.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.14 0.94 13.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.011 0.524 . . . . 0.0 109.886 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.53 143.03 27.18 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.929 0.891 . . . . 0.0 109.099 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.65 24.99 14.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.279 1.032 . . . . 0.0 111.669 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 81.6 p -137.62 179.29 6.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.341 0.591 . . . . 0.0 111.707 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.36 144.88 34.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.901 1.681 . . . . 0.0 114.708 -170.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -143.43 161.45 38.36 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.104 1.762 . . . . 0.0 108.54 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 N--CA 1.457 -0.119 0 C-N-CA 124.282 1.033 . . . . 0.0 109.224 -171.213 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.29 160.87 16.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -72.07 148.25 45.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.0 139.33 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -100.59 86.07 3.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.33 1.052 . . . . 0.0 108.724 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 10.6 t -71.18 81.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.577 0.751 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.98 159.82 32.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.872 0.869 . . . . 0.0 110.721 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' B' ' 123' ' ' VAL . 19.1 m -75.18 3.46 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 126.03 1.732 . . . . 0.0 114.69 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.489 ' HA ' HG23 ' B' ' 124' ' ' VAL . 19.7 t70 . . . . . 0 C--N 1.326 -0.432 0 C-N-CA 126.402 1.881 . . . . 0.0 110.408 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -53.14 173.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 9.0 t -140.81 -127.67 0.1 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.368 1.067 . . . . 0.0 111.919 -175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -133.91 -28.36 1.39 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.336 1.455 . . . . 0.0 114.18 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.8 p30 -127.3 82.78 2.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.744 1.218 . . . . 0.0 110.396 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -78.36 158.53 28.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.711 2.004 . . . . 0.0 112.87 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.443 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -150.08 142.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.792 2.437 . . . . 0.0 109.06 173.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -79.5 170.65 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.51 136.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.4 p -143.75 157.7 44.2 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 121.057 0.456 . . . . 0.0 112.078 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.96 53.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.53 123.23 88.95 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 127.5 2.32 . . . . 0.0 112.949 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.29 156.83 12.66 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.984 2.456 . . . . 0.0 111.422 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.34 -10.9 29.1 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.101 2.534 . . . . 0.0 110.705 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 68.1 m -75.19 -9.02 58.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.095 0.958 . . . . 0.0 112.616 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.34 165.44 41.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 44.5 t -157.39 167.98 28.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.241 1.016 . . . . 0.0 109.155 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -64.65 -29.93 70.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.738 -0.601 . . . . 0.0 110.057 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -68.4 -16.16 63.81 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.428 0.291 . . . . 0.0 111.49 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -104.03 -22.73 13.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 112.054 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.54 -30.7 66.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.942 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -73.94 -40.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.6 -1.92 7.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.464 1.106 . . . . 0.0 113.304 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.92 -33.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.641 0.655 . . . . 0.0 111.552 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' B' ' 141' ' ' MET . 0.0 OUTLIER -74.86 -19.97 59.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -51.64 -18.88 1.31 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -59.0 -37.59 77.21 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.031 0.532 . . . . 0.0 110.852 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -65.82 -22.38 66.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.71 0.804 . . . . 0.0 111.307 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.98 -90.49 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -157.07 134.1 10.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -130.56 157.6 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 14.7 p -129.15 -35.63 1.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.014 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 7.9 t80 -132.69 159.02 40.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.61 1.096 . . . . 0.0 111.723 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.17 170.95 20.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.301 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -149.11 155.75 41.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.553 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -133.31 145.01 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.34 0.59 . . . . 0.0 110.483 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.55 22.11 16.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.208 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.553 ' H ' HG22 ' B' ' 152' ' ' VAL . 59.6 mtp180 74.83 -15.85 0.61 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 126.062 1.745 . . . . 0.0 113.123 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.04 138.63 2.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.667 0.667 . . . . 0.0 111.679 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 -31.26 0.69 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 166.39 28.4 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.91 1.355 . . . . 0.0 111.982 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.43 -171.29 41.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 163.19 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.485 0.642 . . . . 0.0 110.763 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 9.1 p -150.72 160.03 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.817 0.847 . . . . 0.0 109.365 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 32.4 tt0 -152.08 136.39 16.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.088 -0.382 . . . . 0.0 111.618 -172.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 80.4 m-85 -104.31 168.08 9.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.15 -11.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.621 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -151.73 137.21 17.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.73 -23.41 66.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.3 -32.92 55.7 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.226 0.466 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -75.21 -20.12 59.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.022 0.439 . . . . 0.0 109.841 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.445 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 36.5 ttp -76.17 -52.84 9.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 111.469 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 49.0 m -65.65 -20.69 66.4 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -71.92 -27.19 62.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.264 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' B' ' 175' ' ' LEU . . . -74.07 -37.12 64.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.207 -0.308 . . . . 0.0 111.069 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.71 8.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.566 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 15.1 ptm180 -137.74 -23.92 1.05 Allowed 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 121.704 -0.622 . . . . 0.0 112.191 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.566 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.97 -28.25 9.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.375 0.534 . . . . 0.0 111.191 175.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' B' ' 171' ' ' ALA . 1.7 mm? -116.01 -6.88 11.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.47 0.708 . . . . 0.0 109.729 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -85.12 144.09 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 64.53 23.88 12.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.91 0.884 . . . . 0.0 111.627 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 72.0 p -138.91 178.03 7.46 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.627 0.727 . . . . 0.0 111.247 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -61.54 148.59 41.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.017 1.327 . . . . 0.0 114.176 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.74 145.28 32.29 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.115 1.766 . . . . 0.0 108.028 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 . . . . . 0 C--N 1.337 0.049 0 C-N-CA 124.006 0.923 . . . . 0.0 109.36 -170.442 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.897 0.38 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.58 165.98 29.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.572 1.149 . . . . 0.0 108.955 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -68.58 155.75 39.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.25 0.547 . . . . 0.0 110.998 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.91 152.4 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.774 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.361 1.064 . . . . 0.0 108.788 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.36 94.28 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.651 0.78 . . . . 0.0 110.761 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.4 tttt -74.37 171.14 14.24 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 122.552 0.341 . . . . 0.0 110.742 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.446 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.4 p -66.05 -27.12 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 126.298 1.839 . . . . 0.0 114.732 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.491 ' HA ' HG23 ' B' ' 124' ' ' VAL . 25.2 t70 . . . . . 0 N--CA 1.468 0.469 0 C-N-CA 128.463 2.705 . . . . 0.0 109.237 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.44 ' HD3' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt180 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -54.13 160.23 1.62 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.476 1.034 . . . . 0.0 112.607 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 -139.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 112.228 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.254 40.2 mt-10 -132.21 -18.99 2.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -165.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.37 77.25 1.64 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.976 1.31 . . . . 0.0 109.941 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtm-85 -83.37 148.27 27.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.452 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.488 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -136.79 129.55 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 126.508 1.923 . . . . 0.0 107.402 173.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.81 153.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.7 106.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 53.7 p -105.13 152.55 22.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.976 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.82 18.11 5.29 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 4.7 mp -95.79 13.72 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 90.5 Cg_exo -42.67 -38.33 6.34 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.586 2.191 . . . . 0.0 116.63 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 82.4 Cg_exo -44.59 -61.72 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 6.0 t 179.41 -42.96 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.674 1.19 . . . . 0.0 107.822 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.24 -172.58 0.04 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.877 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -168.59 165.84 12.14 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.863 -0.786 . . . . 0.0 109.152 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -76.5 -30.28 57.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -68.51 -39.94 81.04 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.89 -26.97 54.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.484 -0.135 . . . . 0.0 110.847 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -34.93 78.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HD3' ' B' ' 117' ' ' ARG . 9.6 mtpm? -74.38 -39.28 62.81 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -1.48 3.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.441 1.097 . . . . 0.0 113.713 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -129.89 -39.19 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.551 0.614 . . . . 0.0 111.523 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' MET . . . . . 0.422 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 84.0 mmm -70.39 -14.22 62.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.37 0.532 . . . . 0.0 109.987 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -47.72 -20.93 0.32 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.698 0.799 . . . . 0.0 112.599 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.97 -42.92 84.33 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.226 0.611 . . . . 0.0 111.132 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -27.74 65.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.639 0.776 . . . . 0.0 111.569 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.37 -166.46 36.53 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.28 79.3 9.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.462 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.2 OUTLIER -65.86 148.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 52.0 t -128.08 -33.28 2.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.861 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -134.58 157.72 45.86 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.048 0.84 . . . . 0.0 110.787 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -152.74 164.27 38.1 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -145.4 151.32 38.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.604 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -130.54 140.02 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 121.743 0.782 . . . . 0.0 110.504 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -104.06 10.66 35.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.845 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.604 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 41.73 26.25 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.51 2.324 . . . . 0.0 114.26 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -143.33 3.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.72 -10.32 3.98 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.154 0.434 . . . . 0.0 113.677 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -142.84 166.73 23.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.122 0.461 . . . . 0.0 110.639 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.86 -164.6 29.89 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.412 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.0 p -142.74 163.06 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 122.773 0.429 . . . . 0.0 111.344 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -156.04 154.91 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.374 1.069 . . . . 0.0 109.705 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.28 159.54 40.09 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -125.88 171.07 11.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 122.01 0.909 . . . . 0.0 112.202 -171.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.22 -9.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.443 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -149.7 139.3 21.64 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.028 0.531 . . . . 0.0 109.585 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.13 -22.67 66.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.77 -29.43 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.047 -0.408 . . . . 0.0 110.802 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.45 -20.4 60.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.14 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.488 ' CG ' HG13 ' B' ' 123' ' ' VAL . 29.8 ttp -79.48 -52.24 8.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -63.13 -21.84 66.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 43.5 t80 -74.77 -33.04 62.22 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.422 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -73.56 -15.83 61.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.331 0.652 . . . . 0.0 111.701 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 172' ' ' VAL 0.251 8.8 p -115.47 32.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.859 0.838 . . . . 0.0 111.643 175.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -142.63 -16.7 0.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.137 169.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -124.19 -25.37 4.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 112.534 173.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.49 -2.82 20.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.415 0.286 . . . . 0.0 110.248 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.6 143.41 42.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.118 0.967 . . . . 0.0 110.269 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.41 27.8 10.62 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.8 p -127.91 166.69 17.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.03 144.31 29.3 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.567 0.747 . . . . 0.0 111.952 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -137.48 161.23 36.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.275 1.83 . . . . 0.0 109.074 171.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 . . . . . 0 C--O 1.228 -0.043 0 C-N-CA 123.941 0.897 . . . . 0.0 109.537 -170.218 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.883 0.373 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.99 162.56 18.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.156 0.982 . . . . 0.0 108.669 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -69.46 152.02 45.37 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.106 -0.371 . . . . 0.0 110.555 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -127.48 114.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.446 0.641 . . . . 0.0 109.996 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -85.77 95.32 9.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.23 0.538 . . . . 0.0 109.91 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 8.0 t -67.29 146.56 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.188 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -135.04 158.08 45.28 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 121.015 0.436 . . . . 0.0 110.514 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.3 m -73.65 4.57 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.26 1.824 . . . . 0.0 113.628 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 125.367 1.467 . . . . 0.0 110.703 171.165 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -56.92 171.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.669 1.188 . . . . 0.0 112.796 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 7.5 t -144.29 -129.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.0 -19.77 1.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -135.6 77.55 1.67 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.956 1.302 . . . . 0.0 110.953 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -77.75 148.48 34.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.229 1.812 . . . . 0.0 113.407 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -139.27 127.04 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.982 2.113 . . . . 0.0 108.37 172.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.461 HG23 ' HA ' ' B' ' 195' ' ' ASP . 54.0 t -63.51 159.03 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 O-C-N 121.787 -0.571 . . . . 0.0 109.614 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.01 116.17 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 85.4 p -125.67 143.69 50.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.094 0.473 . . . . 0.0 111.798 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.74 -1.7 26.02 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.34 147.88 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 127.522 2.329 . . . . 0.0 110.244 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.07 162.8 38.17 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.487 2.791 . . . . 0.0 111.421 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 -10.74 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 1 C-N-CA 125.379 4.053 . . . . 0.0 115.838 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -133.81 12.2 4.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.051 0.842 . . . . 0.0 112.91 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.57 167.28 4.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -148.68 166.94 26.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.243 -0.563 . . . . 0.0 110.489 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -75.32 -28.16 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.348 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -67.85 -38.06 82.67 Favored 'General case' 0 C--O 1.231 0.089 0 O-C-N 122.339 -0.226 . . . . 0.0 110.824 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -79.81 -19.65 47.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -29.8 66.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -78.75 -38.78 37.91 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.42 -1.78 5.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.4 1.08 . . . . 0.0 113.342 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -130.32 -36.53 1.48 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.702 0.683 . . . . 0.0 111.356 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.3 mmm -72.73 -10.93 60.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.122 0.419 . . . . 0.0 111.069 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -48.96 -16.59 0.14 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -71.75 -42.26 67.43 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.98 0.512 . . . . 0.0 111.02 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.74 -29.14 68.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.476 0.71 . . . . 0.0 111.168 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.93 -168.36 36.25 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -80.57 79.4 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 0.0 110.412 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.469 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.6 OUTLIER -64.1 149.68 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.8 t -134.36 -35.98 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.214 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 8.8 t80 -134.61 160.56 37.71 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.79 0.805 . . . . 0.0 110.17 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.09 168.67 26.55 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -148.1 158.43 44.06 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 168.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.7 p -135.57 143.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 121.176 0.512 . . . . 0.0 110.12 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -108.36 6.97 26.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.26 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.0 mtt-85 61.4 18.63 9.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.491 0.717 . . . . 0.0 112.209 170.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -137.64 6.26 2.71 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.32 22.13 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 121.555 -0.716 . . . . 0.0 112.194 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -141.16 160.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.241 0.616 . . . . 0.0 110.083 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.28 -164.42 30.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.99 162.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.257 0.528 . . . . 0.0 110.876 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.8 p -148.0 160.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.129 0.971 . . . . 0.0 108.65 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 37.7 tt0 -157.53 152.84 26.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.056 -0.403 . . . . 0.0 110.819 -170.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -126.43 170.56 11.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.689 0.757 . . . . 0.0 112.181 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.22 -9.63 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.369 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -149.99 139.76 21.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -64.65 -21.36 66.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.32 -31.51 58.2 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.311 0.505 . . . . 0.0 111.004 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -72.89 -21.49 60.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.107 0.479 . . . . 0.0 109.825 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.495 ' SD ' HG13 ' B' ' 123' ' ' VAL . 38.2 ttp -77.63 -52.58 8.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.356 0.663 . . . . 0.0 110.754 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 75.4 m -63.38 -18.71 63.97 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.564 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 30.6 t80 -75.37 -28.75 59.66 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.91 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.19 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 122.086 -0.384 . . . . 0.0 110.388 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.69 2.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.0 -16.26 2.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.564 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.7 mppt? -126.21 -21.63 4.22 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.84 3.54 12.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.867 0.467 . . . . 0.0 109.862 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.826 0.85 . . . . 0.0 108.819 172.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 58.44 35.93 25.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.005 0.522 . . . . 0.0 111.346 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 51.8 p -136.43 175.07 9.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 110.64 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -62.33 148.65 44.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -146.35 165.6 28.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.045 2.138 . . . . 0.0 107.439 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--N 1.334 -0.066 0 O-C-N 121.907 -0.495 . . . . 0.0 109.681 -174.099 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.993 0.425 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 -168.91 2.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.862 0.865 . . . . 0.0 108.896 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.21 149.93 47.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.59 108.51 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.213 0.53 . . . . 0.0 112.206 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -83.27 88.34 6.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 7.9 t -76.14 81.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.765 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.79 159.44 22.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.24 0.616 . . . . 0.0 111.534 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.1 m -73.0 5.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 126.514 1.926 . . . . 0.0 114.292 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.461 ' HA ' HG23 ' B' ' 124' ' ' VAL . 4.4 t0 . . . . . 0 C--N 1.328 -0.335 0 O-C-N 124.833 1.333 . . . . 0.0 110.624 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 14.6 mtt-85 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -53.29 153.25 3.97 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.65 1.18 . . . . 0.0 112.069 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.0 t -135.86 -110.49 0.2 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.866 0.466 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -148.61 -26.12 0.32 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.419 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -122.24 -32.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -166.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 40.75 151.38 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.778 2.831 . . . . 0.0 118.162 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.497 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.1 OUTLIER -149.69 148.33 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.256 1.822 . . . . 0.0 108.828 174.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -90.92 171.95 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.37 142.96 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -143.82 150.92 39.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.299 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 103.24 -2.75 47.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -49.25 126.6 15.71 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 127.728 2.411 . . . . 0.0 109.742 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.84 155.13 53.76 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.883 2.389 . . . . 0.0 110.269 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.79 -22.12 28.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.483 2.789 . . . . 0.0 112.561 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m -73.34 -9.22 58.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.391 1.076 . . . . 0.0 112.462 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.44 165.81 39.36 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 121.545 0.525 . . . . 0.0 112.598 -174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -161.72 167.79 24.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.184 1.394 . . . . 0.0 107.445 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -64.42 -26.93 68.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.857 0.753 . . . . 0.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -70.05 -28.95 65.87 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.004 -0.435 . . . . 0.0 111.706 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -89.92 -13.65 35.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.766 0.257 . . . . 0.0 110.925 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.25 3.48 54.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.697 0.399 . . . . 0.0 111.024 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -110.26 -35.33 6.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.11 -3.88 11.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.32 1.048 . . . . 0.0 112.771 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' HIS . . . . . 0.44 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 6.4 t-80 -127.51 -36.44 2.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.286 0.494 . . . . 0.0 110.734 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 76.5 mmm -69.1 -19.07 64.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.577 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -48.57 -20.05 0.4 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.23 1.012 . . . . 0.0 112.811 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -41.76 97.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.002 0.521 . . . . 0.0 111.252 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.484 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.69 -29.76 69.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.563 . . . . 0.0 111.204 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.72 -177.49 35.31 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.14 118.0 14.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.998 0.399 . . . . 0.0 110.161 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -114.33 151.67 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 148' ' ' CYS . . . . . 0.417 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 7.4 p -130.7 -21.71 2.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.295 -0.859 . . . . 0.0 111.729 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -126.02 149.51 48.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 119.122 0.874 . . . . 0.0 111.805 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.43 19.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.436 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 19.5 t0 -141.93 154.61 45.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.528 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.9 p -132.19 145.61 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.185 0.517 . . . . 0.0 110.214 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.16 7.16 27.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.779 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.528 ' H ' HG22 ' B' ' 152' ' ' VAL . 24.6 mtp85 61.34 16.98 7.87 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.496 0.718 . . . . 0.0 112.77 170.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -137.95 -12.0 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.23 -2.99 2.13 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.799 0.727 . . . . 0.0 112.922 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.81 167.68 21.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.127 0.571 . . . . 0.0 109.799 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.74 -167.4 35.25 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 6.7 p -141.09 161.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.369 0.604 . . . . 0.0 110.613 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.7 159.93 2.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -157.75 154.12 27.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.01 -0.431 . . . . 0.0 111.527 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 22.7 m-85 -122.87 163.55 20.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.893 0.854 . . . . 0.0 112.248 -170.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.36 -8.82 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.43 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -152.9 154.72 35.63 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.071 0.549 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -69.15 -25.58 64.44 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -82.83 -31.77 27.91 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.197 0.453 . . . . 0.0 111.313 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -70.57 -2.28 13.71 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.699 0.4 . . . . 0.0 110.332 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.497 ' SD ' HG13 ' B' ' 123' ' ' VAL . 40.6 ttp -111.94 -46.85 3.18 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.864 1.265 . . . . 0.0 110.897 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 58.4 m -63.23 -20.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 6.3 t80 -70.57 -31.51 68.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.72 69.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.093 -0.38 . . . . 0.0 110.367 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.21 5.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -134.4 -19.02 1.93 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -19.5 5.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.81 2.73 13.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.136 0.574 . . . . 0.0 109.48 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.36 136.75 41.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.4 27.94 13.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.178 0.991 . . . . 0.0 111.255 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.3 p -138.09 179.46 6.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.438 0.695 . . . . 0.0 110.806 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -56.01 148.56 17.25 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' PHE . . . . . 0.44 ' HA ' ' NE2' ' B' ' 140' ' ' HIS . 24.8 t80 -146.57 159.16 43.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.344 1.857 . . . . 0.0 108.179 168.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -170.332 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.15 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.92 -167.52 1.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.969 0.908 . . . . 0.0 108.784 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -115.02 155.06 27.69 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 30.8 pt -134.9 148.86 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.396 0.617 . . . . 0.0 110.778 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -113.33 84.63 2.04 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 107.997 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 t -67.81 87.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.959 0.904 . . . . 0.0 111.255 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' B' ' 194' ' ' VAL . 50.5 tptt -76.68 160.24 29.53 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 110.748 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.572 ' H ' ' HD2' ' B' ' 193' ' ' LYS . 8.1 p -57.97 -27.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.302 2.641 . . . . 0.0 117.774 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.557 ' HA ' HG23 ' B' ' 124' ' ' VAL . 38.1 t70 . . . . . 0 N--CA 1.469 0.491 0 C-N-CA 127.183 2.193 . . . . 0.0 110.141 -170.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 20.8 mtt-85 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' ARG . . . . . 0.544 ' CZ ' ' HA ' ' B' ' 118' ' ' ARG . 4.1 mmp_? -52.23 155.35 2.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.29 1.036 . . . . 0.0 113.697 -174.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.7 t -155.97 -137.04 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.447 0.699 . . . . 0.0 111.724 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -138.04 -26.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -167.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.404 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.1 p30 -131.1 80.54 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.081 0.953 . . . . 0.0 111.644 -170.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -78.66 148.83 33.01 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.577 . . . . 0.0 113.81 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.479 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -141.57 136.42 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.687 1.595 . . . . 0.0 110.017 171.421 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' B' ' 193' ' ' LYS . 2.3 t -76.39 162.34 4.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.06 105.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -111.38 151.42 28.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.01 8.4 44.96 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 128' ' ' LEU . 5.6 tp -60.51 146.99 84.03 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 126.69 1.996 . . . . 0.0 111.503 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.9 164.87 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.952 3.101 . . . . 0.0 109.689 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.9 -21.52 43.8 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.262 2.641 . . . . 0.0 111.631 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -73.46 -15.76 61.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.383 0.673 . . . . 0.0 112.09 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.12 148.27 24.88 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.5 t -155.76 165.65 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.585 0.754 . . . . 0.0 109.447 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -72.19 -27.04 62.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.931 -0.48 . . . . 0.0 111.702 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -65.16 -31.35 72.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.804 0.729 . . . . 0.0 111.151 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.14 -21.12 33.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.499 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 137' ' ' LEU . 1.0 OUTLIER -75.28 -17.03 60.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.29 0.496 . . . . 0.0 111.109 -176.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -89.15 -44.29 10.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.95 -11.64 60.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -120.45 -30.9 4.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.398 0.999 . . . . 0.0 111.221 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.5 mmm -76.81 -14.8 59.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.94 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -43.77 -21.02 0.03 OUTLIER 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.47 -42.23 87.84 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 123.589 0.755 . . . . 0.0 111.245 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.495 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.79 -28.87 69.33 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.01 0.524 . . . . 0.0 110.499 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.41 32.94 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.39 123.83 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.35 -0.5 . . . . 0.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -120.8 154.25 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 148' ' ' CYS . . . . . 0.408 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 53.4 t -134.64 -24.86 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.526 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 149' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 71.3 t80 -127.15 153.68 45.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 118.992 0.814 . . . . 0.0 111.947 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.74 166.85 32.26 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.023 171.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.408 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 26.5 t0 -152.07 160.26 43.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.559 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -135.84 145.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.051 0.453 . . . . 0.0 110.03 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -109.42 6.55 24.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.257 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.559 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.6 mtt180 61.83 17.72 9.1 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.651 0.781 . . . . 0.0 112.611 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.39 10.19 2.5 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.6 6.01 27.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.572 0.624 . . . . 0.0 111.978 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.28 156.81 45.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.123 0.569 . . . . 0.0 109.586 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.51 -166.0 30.42 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 7.6 p -145.55 162.38 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.016 0.436 . . . . 0.0 111.539 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.6 p -151.17 157.62 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.354 1.062 . . . . 0.0 108.547 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -155.13 140.96 18.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.931 -0.481 . . . . 0.0 111.154 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 41.9 m-85 -110.25 167.61 10.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.809 0.814 . . . . 0.0 113.053 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.75 -11.08 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.306 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -150.5 141.97 23.43 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -65.18 -26.05 67.99 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.1 -31.15 64.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.035 0.38 . . . . 0.0 110.661 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.02 -20.35 60.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.815 0.341 . . . . 0.0 110.202 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.479 ' CG ' HG13 ' B' ' 123' ' ' VAL . 33.9 ttp -80.51 -55.37 4.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.371 0.669 . . . . 0.0 110.515 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 70.3 m -64.33 -18.26 64.46 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 5.4 t80 -73.48 -32.09 64.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.55 68.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.866 -0.521 . . . . 0.0 110.575 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.92 3.13 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -132.3 -17.26 2.67 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.04 0.836 . . . . 0.0 112.761 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -21.2 4.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.44 0.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.76 147.21 33.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.71 37.39 23.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.513 0.725 . . . . 0.0 112.913 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 66.9 p -133.26 167.59 20.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.128 0.49 . . . . 0.0 110.372 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -61.76 140.84 58.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.954 0.902 . . . . 0.0 113.175 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' B' ' 180' ' ' PHE . 0.1 OUTLIER -157.78 146.82 19.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.846 1.258 . . . . 0.0 110.284 169.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 181' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' B' ' 187' ' ' THR . 46.8 ttt180 . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 128.123 2.569 . . . . 0.0 108.954 165.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 187' ' ' THR . . . . . 0.568 ' HA ' ' HB3' ' B' ' 181' ' ' ARG . 40.5 p . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.349 0.595 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.23 39.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.636 1.575 . . . . 0.0 107.477 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -67.61 145.46 54.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 110.676 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 38.1 pt -123.22 136.28 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.945 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -104.32 79.6 1.61 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.824 0.85 . . . . 0.0 108.733 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.88 131.1 26.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.454 ' HE2' HG11 ' B' ' 124' ' ' VAL . 55.2 pttt -133.67 165.36 25.11 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.428 HG22 ' H ' ' B' ' 194' ' ' VAL . 17.8 m -74.74 47.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 114.385 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.915 174.165 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.69 171.96 0.79 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -134.42 -104.81 0.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -169.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -149.78 -25.18 0.27 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -166.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.15 -33.35 5.71 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -166.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 40.1 157.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.01 146.94 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.493 2.317 . . . . 0.0 107.849 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.72 168.63 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.0 p -137.45 130.47 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 58.3 p -138.42 153.53 48.88 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.36 6.01 53.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.27 139.16 97.52 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 127.811 2.444 . . . . 0.0 111.537 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.33 156.09 22.26 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.151 2.567 . . . . 0.0 110.145 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.69 -22.35 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.323 2.682 . . . . 0.0 112.07 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.9 m -73.08 7.5 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.319 1.448 . . . . 0.0 113.078 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 162.33 13.25 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.556 0.617 . . . . 0.0 111.585 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 45.1 t -156.67 173.11 17.44 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.12 0.968 . . . . 0.0 108.799 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -64.58 -30.59 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.657 -0.652 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -66.51 -23.72 66.29 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.912 0.324 . . . . 0.0 111.46 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -94.66 -24.1 17.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -23.27 61.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.227 -0.295 . . . . 0.0 110.584 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -80.82 -39.43 26.66 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.82 -0.15 5.09 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.812 1.245 . . . . 0.0 114.194 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -135.0 -38.51 0.78 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.461 0.573 . . . . 0.0 111.262 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 84.4 mmm -68.39 -11.78 60.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.564 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -45.02 -24.6 0.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.296 1.038 . . . . 0.0 112.536 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.49 -41.0 93.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.972 -0.455 . . . . 0.0 111.205 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -68.74 -31.09 69.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.674 0.789 . . . . 0.0 111.475 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.54 -171.71 40.1 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -80.87 77.03 7.78 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.816 0.817 . . . . 0.0 110.593 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.43 143.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.281 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -126.57 -28.9 2.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.818 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -136.44 157.77 46.01 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 118.79 0.723 . . . . 0.0 111.018 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.88 166.93 31.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 49.3 t0 -147.51 147.48 30.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.62 HG22 ' H ' ' B' ' 154' ' ' ARG . 6.0 p -127.58 142.01 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 121.54 0.685 . . . . 0.0 111.195 -171.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -105.95 10.57 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.62 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.62 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.31 24.23 0.03 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 127.177 2.191 . . . . 0.0 114.994 178.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.46 5.31 1.42 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.31 -9.62 4.1 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 118.167 0.439 . . . . 0.0 113.373 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.07 167.83 21.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.331 0.566 . . . . 0.0 110.665 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.93 40.07 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 2.6 p -134.77 159.38 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.8 p -148.64 157.32 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.96 157.14 34.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.756 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.7 m-85 -130.9 169.2 16.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.852 0.861 . . . . 0.0 110.641 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.2 -13.75 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.759 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.95 156.36 46.08 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.625 0.77 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.85 -28.5 40.05 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.625 0.77 . . . . 0.0 112.007 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.05 -31.07 25.58 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -77.62 7.24 5.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.737 0.415 . . . . 0.0 110.353 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.85 -44.55 3.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.355 1.462 . . . . 0.0 110.028 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -62.41 -23.62 66.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.85 -29.8 70.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.35 -37.45 68.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.152 -0.343 . . . . 0.0 110.578 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.506 HG22 ' O ' ' B' ' 172' ' ' VAL 0.282 0.6 OUTLIER -82.91 28.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.447 0.641 . . . . 0.0 111.694 177.049 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.585 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.6 ptm180 -148.0 -25.2 0.35 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.243 -0.911 . . . . 0.0 112.789 171.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.585 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.2 OUTLIER -108.89 -26.77 10.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.446 0.566 . . . . 0.0 111.99 176.06 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.8 mm? -115.28 0.53 13.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.22 0.608 . . . . 0.0 110.186 -172.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -82.43 144.63 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.163 0.985 . . . . 0.0 109.708 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 26.2 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.792 0.837 . . . . 0.0 111.97 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -135.31 162.83 31.48 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.715 1.206 . . . . 0.0 108.6 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 18.2 ptmt -67.99 158.27 33.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.866 -1.515 . . . . 0.0 114.293 -168.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 148.04 34.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.235 167.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 C--O 1.23 0.073 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -172.775 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.301 0.572 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.51 160.51 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.79 1.236 . . . . 0.0 109.161 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 189' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 5.2 m-30 -65.91 151.16 47.35 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 39.8 pt -131.2 133.64 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.13 95.83 7.37 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.276 0.56 . . . . 0.0 109.823 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.95 116.08 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.9 tttt -90.57 171.88 9.08 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 173.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.417 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.4 p -66.98 -28.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 0.0 114.108 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 N--CA 1.466 0.325 0 C-N-CA 127.653 2.381 . . . . 0.0 109.391 -173.217 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 118' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' B' ' 119' ' ' SER . 0.2 OUTLIER 52.07 -173.48 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 126.379 1.872 . . . . 0.0 113.518 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.595 ' H ' ' HG3' ' B' ' 118' ' ' ARG . 0.8 OUTLIER -150.04 -178.39 6.46 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -176.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 120' ' ' GLU . . . . . 0.563 ' HB2' HD22 ' B' ' 121' ' ' ASN . 33.6 mt-10 -148.53 -29.3 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.39 1.876 . . . . 0.0 113.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.3 p30 -140.98 78.53 1.65 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.663 2.385 . . . . 0.0 107.535 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -89.58 150.61 22.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.653 0.739 . . . . 0.0 112.757 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -138.36 127.57 32.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 126.445 1.898 . . . . 0.0 107.866 174.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' B' ' 195' ' ' ASP . 74.1 t -68.13 157.23 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.05 114.54 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.9 p -129.06 146.29 51.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.74 -0.94 39.11 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.08 144.69 48.16 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 128.054 2.542 . . . . 0.0 110.535 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.98 161.1 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.802 2.335 . . . . 0.0 109.478 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.05 -11.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.833 2.355 . . . . 0.0 110.687 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m -79.13 -8.15 58.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.575 1.15 . . . . 0.0 112.225 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.04 164.66 40.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.264 0.484 . . . . 0.0 111.987 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.1 t -157.68 168.85 26.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.117 0.967 . . . . 0.0 108.4 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -63.36 -27.24 69.18 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.545 0.611 . . . . 0.0 111.773 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -68.33 -46.77 69.28 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.186 0.448 . . . . 0.0 110.705 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.08 -24.39 63.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -20.76 60.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' B' ' 138' ' ' LYS . 50.1 mtpt -85.55 -34.89 21.38 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.566 0.621 . . . . 0.0 109.359 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.62 -40.43 66.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -81.03 -36.53 30.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.738 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.7 mmm -73.1 -20.65 60.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.398 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -51.27 -18.84 1.04 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.585 0.63 . . . . 0.0 112.403 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.81 -39.62 85.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.385 0.674 . . . . 0.0 111.39 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.52 -18.63 65.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.588 0.755 . . . . 0.0 111.775 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 168.39 -95.67 0.11 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.37 133.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -119.8 153.08 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.137 0.494 . . . . 0.0 110.44 -175.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.8 -21.08 3.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.311 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 149' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 51.8 t80 -144.31 157.38 44.3 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 120.22 1.373 . . . . 0.0 112.19 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.61 169.65 22.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.628 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -148.76 152.94 37.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.506 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -131.31 140.68 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.415 0.626 . . . . 0.0 109.853 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.14 5.07 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.126 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.506 ' H ' HG22 ' B' ' 152' ' ' VAL . 7.4 mtt180 61.47 16.28 7.41 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.548 0.739 . . . . 0.0 112.709 170.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -135.44 5.83 3.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.97 3.9 15.12 Favored Glycine 0 C--N 1.337 0.597 0 O-C-N 121.881 -0.512 . . . . 0.0 112.197 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.5 p -142.31 161.78 37.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 110.573 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.58 -168.61 37.51 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.3 p -141.45 165.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 117.393 0.596 . . . . 0.0 110.734 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.9 p -153.7 156.67 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.108 0.963 . . . . 0.0 109.246 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -151.09 156.25 40.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.663 0.268 . . . . 0.0 111.612 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 39.8 m-85 -120.43 163.58 17.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.697 1.237 . . . . 0.0 114.171 -169.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.96 -12.74 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.502 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -152.68 142.28 21.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -63.8 -21.01 66.22 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.91 -29.79 58.53 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.876 -0.515 . . . . 0.0 110.952 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -74.15 -18.71 60.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.433 ' CG ' HG13 ' B' ' 123' ' ' VAL . 32.9 ttp -77.17 -53.13 8.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -61.03 -20.6 62.72 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 7.4 t80 -74.13 -30.83 62.48 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.893 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.15 -33.08 67.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.073 -0.392 . . . . 0.0 110.561 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.0 4.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -133.72 -18.91 2.11 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 121.319 -0.863 . . . . 0.0 112.552 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 -19.96 5.41 Favored 'General case' 0 N--CA 1.46 0.047 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.29 2.71 14.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.71 140.52 34.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.365 1.066 . . . . 0.0 108.428 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 65.42 25.06 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.555 0.693 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 53.8 p -135.27 169.58 17.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.9 1.28 . . . . 0.0 108.507 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 9.9 pttt -75.23 155.87 36.33 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.248 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.44 166.23 24.79 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.483 170.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 124.161 0.984 . . . . 0.0 110.157 -169.654 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.918 0.39 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.68 156.2 15.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.015 . . . . 0.0 108.9 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 189' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 2.6 m-30 -72.03 158.57 35.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.061 0.458 . . . . 0.0 111.118 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.03 145.08 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.113 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -102.73 102.39 12.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.976 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.9 79.72 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.047 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.22 158.29 23.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.153 0.501 . . . . 0.0 111.374 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.524 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.6 m -72.64 6.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 126.203 1.801 . . . . 0.0 113.705 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 3.8 t0 . . . . . 0 C--N 1.327 -0.397 0 O-C-N 124.995 1.435 . . . . 0.0 110.277 170.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . 0.31 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.1 169.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.849 1.259 . . . . 0.0 113.476 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -140.46 -133.3 0.11 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.775 0.83 . . . . 0.0 112.151 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.64 -19.55 1.84 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -165.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.01 75.43 1.55 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.814 1.245 . . . . 0.0 109.788 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 66.5 mtm-85 -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.436 1.494 . . . . 0.0 113.398 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.4 OUTLIER -139.21 132.86 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 126.604 1.962 . . . . 0.0 108.111 174.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.2 t -66.52 156.59 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 109.774 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.18 100.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 77.3 p -111.3 146.94 36.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.407 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.47 -0.46 32.69 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.17 149.82 44.56 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 128.12 2.568 . . . . 0.0 111.29 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.31 165.16 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.5 2.8 . . . . 0.0 109.668 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.95 -15.69 36.46 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.786 2.324 . . . . 0.0 110.25 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 73.2 m -79.66 -2.57 43.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.875 1.27 . . . . 0.0 112.024 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.75 168.64 54.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 3.9 p -159.75 166.36 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -73.21 -28.67 62.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.334 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -68.34 -40.47 81.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 117.964 0.347 . . . . 0.0 110.246 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -80.61 -19.73 44.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -34.05 70.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -74.65 -37.95 62.6 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.37 1.47 1.62 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.727 1.211 . . . . 0.0 113.5 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -132.96 -37.74 0.99 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.513 0.597 . . . . 0.0 111.403 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.5 mmm -71.63 -11.35 60.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.421 0.555 . . . . 0.0 110.189 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -47.59 -21.41 0.35 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 123.914 0.886 . . . . 0.0 113.114 171.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.4 -41.88 88.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -67.2 -27.81 67.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.15 -170.26 36.91 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -83.07 74.26 9.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.839 0.828 . . . . 0.0 110.565 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.4 OUTLIER -61.11 149.56 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 34.4 t -131.74 -33.37 1.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -136.37 158.89 43.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 110.609 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.45 166.28 33.19 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -145.19 150.52 36.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.576 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.8 p -129.49 141.38 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.599 0.714 . . . . 0.0 110.362 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.79 11.61 29.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.279 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.576 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.9 23.3 0.03 OUTLIER 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.954 2.101 . . . . 0.0 114.895 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.07 6.75 1.78 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.14 6.38 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 118.557 0.617 . . . . 0.0 113.202 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 2.9 p -142.73 163.46 32.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.271 0.536 . . . . 0.0 110.322 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.04 -168.29 35.43 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 160' ' ' VAL . 6.6 p -140.91 162.29 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 122.94 0.496 . . . . 0.0 111.105 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -154.59 153.95 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 124.327 1.051 . . . . 0.0 109.472 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 17.1 pt-20 -154.47 160.15 41.42 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -122.73 171.72 8.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 122.061 0.934 . . . . 0.0 111.984 -171.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.05 -20.11 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.22 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -145.11 143.89 30.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.135 0.574 . . . . 0.0 110.371 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.02 -24.32 63.26 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.29 -29.53 62.78 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.546 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.83 -19.33 60.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.478 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.2 ttp -78.17 -52.79 8.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.181 0.592 . . . . 0.0 110.481 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.3 m -64.8 -19.27 65.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -73.91 -27.63 61.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.03 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.46 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.03 -0.419 . . . . 0.0 110.891 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.38 3.25 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 173' ' ' ARG . . . . . 0.609 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 5.1 ptm180 -134.44 -21.45 1.78 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.833 0.742 . . . . 0.0 112.491 -173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.609 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.1 OUTLIER -113.06 -26.3 8.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.945 0.339 . . . . 0.0 111.116 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' B' ' 174' ' ' LYS . 1.8 mm? -118.23 2.22 11.95 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.763 0.825 . . . . 0.0 109.955 -172.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.0 152.39 29.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.107 0.563 . . . . 0.0 109.544 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.4 32.95 12.04 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 32.9 p -133.01 175.15 9.63 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.974 0.509 . . . . 0.0 110.632 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.75 147.19 28.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.899 0.88 . . . . 0.0 112.1 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -139.7 158.78 43.54 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.9 1.28 . . . . 0.0 109.639 170.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 . . . . . 0 CA--C 1.52 -0.209 0 C-N-CA 124.766 1.226 . . . . 0.0 108.715 -174.186 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.608 0.242 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.33 -159.43 0.58 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.404 0.681 . . . . 0.0 109.732 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.89 145.64 48.28 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.62 92.13 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.063 0 CA-C-O 121.535 0.683 . . . . 0.0 112.608 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.8 84.8 1.67 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.83 0.824 . . . . 0.0 109.489 170.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.55 133.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.134 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' B' ' 195' ' ' ASP . 54.6 mtmt -125.83 165.62 18.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.271 0.558 . . . . 0.0 112.114 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.421 HG22 ' H ' ' B' ' 194' ' ' VAL . 18.0 m -76.77 32.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 126.7 2.0 . . . . 0.0 112.679 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.501 ' HA ' HG23 ' B' ' 124' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.759 173.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' B' ' 117' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.7 -175.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -138.67 -135.35 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.289 37.7 mt-10 -136.65 -17.58 1.47 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.659 1.983 . . . . 0.0 115.214 -165.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 80.85 1.95 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.559 1.544 . . . . 0.0 108.558 -169.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -80.64 159.02 25.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.41 2.284 . . . . 0.0 113.429 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.437 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -147.7 138.87 17.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 128.722 2.809 . . . . 0.0 107.721 176.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' CA ' ' B' ' 195' ' ' ASP . 2.4 t -72.63 164.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.32 131.52 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.41 ' HB3' HG22 ' B' ' 157' ' ' THR . 93.3 p -137.19 140.14 41.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.869 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 132.35 -1.02 4.83 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.491 HD12 ' CE2' ' B' ' 180' ' ' PHE . 1.6 mm? -53.54 149.21 15.81 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 123.352 0.661 . . . . 0.0 110.981 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.26 166.43 29.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.309 3.339 . . . . 0.0 110.669 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.79 -3.59 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 1 C-N-CA 125.443 4.095 . . . . 0.0 116.308 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.11 10.47 1.52 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.644 1.111 . . . . 0.0 113.261 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.36 158.79 7.01 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -148.43 170.3 18.31 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.37 -0.488 . . . . 0.0 110.594 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -66.69 -27.07 67.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.555 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -68.38 -35.22 77.37 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.348 0.522 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -84.03 -22.69 31.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.388 -0.195 . . . . 0.0 111.325 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -35.9 75.19 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -77.02 -36.62 56.12 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.44 -2.05 10.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.234 1.014 . . . . 0.0 112.962 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' HIS . . . . . 0.455 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 7.6 t-80 -126.99 -37.6 2.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 110.882 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mmm -70.89 -11.31 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.885 -0.509 . . . . 0.0 110.205 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -49.53 -21.34 0.94 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.228 0.611 . . . . 0.0 112.439 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.26 -43.62 81.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.148 0.579 . . . . 0.0 111.073 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.13 68.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.055 0.542 . . . . 0.0 110.929 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.47 -167.67 37.1 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.05 74.3 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.669 0.747 . . . . 0.0 110.402 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 1.2 p -60.33 149.03 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 29.1 p -138.29 -13.64 1.35 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.984 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.54 155.76 32.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.332 -0.855 . . . . 0.0 110.638 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.9 130.24 8.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.678 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.97 120.96 43.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.534 HG22 ' H ' ' B' ' 154' ' ' ARG . 11.3 p -109.39 140.6 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.565 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.15 6.18 49.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.353 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.534 ' H ' HG22 ' B' ' 152' ' ' VAL . 13.8 mtt180 62.57 14.91 7.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.928 0.891 . . . . 0.0 112.669 172.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.59 -4.44 2.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 130.56 7.19 3.53 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 118.528 0.604 . . . . 0.0 113.118 177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 157' ' ' THR . . . . . 0.41 HG22 ' HB3' ' B' ' 126' ' ' SER . 0.1 OUTLIER -143.26 164.81 29.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.62 0.71 . . . . 0.0 110.614 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.85 -164.18 31.87 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.27 161.02 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 124.088 0.955 . . . . 0.0 108.423 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 p -152.03 156.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -156.18 159.6 39.12 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 162' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.2 m-85 -127.97 170.42 12.88 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.596 0.713 . . . . 0.0 111.314 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.58 -7.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -149.46 135.83 19.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.161 0.437 . . . . 0.0 110.119 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -66.81 -20.86 66.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.37 -31.96 54.65 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.507 -0.746 . . . . 0.0 110.56 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.61 -19.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 109.607 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 168' ' ' MET . . . . . 0.437 ' CG ' HG13 ' B' ' 123' ' ' VAL . 34.8 ttp -76.54 -52.45 9.73 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.017 0.927 . . . . 0.0 110.611 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -65.19 -19.38 65.94 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' TYR . . . . . 0.624 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 37.9 t80 -73.55 -27.66 61.46 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.452 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.13 66.61 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.385 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.3 4.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.4 -17.18 2.05 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.393 -0.817 . . . . 0.0 112.872 -172.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.624 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.3 mppt? -124.94 -21.59 4.67 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 173.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.21 1.62 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.912 0.485 . . . . 0.0 109.945 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 140.59 29.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 62.06 34.49 16.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.807 0.843 . . . . 0.0 111.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.7 p -138.04 177.77 7.63 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.469 0.708 . . . . 0.0 110.543 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -57.01 155.52 8.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.701 1.201 . . . . 0.0 113.704 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' PHE . . . . . 0.491 ' CE2' HD12 ' B' ' 128' ' ' LEU . 23.7 t80 -143.25 161.87 37.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.472 1.909 . . . . 0.0 108.873 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 . . . . . 0 C--N 1.339 0.125 0 C-N-CA 124.19 0.996 . . . . 0.0 108.738 -173.235 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 56.1 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.39 0.614 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.84 -163.24 1.45 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.991 1.316 . . . . 0.0 107.755 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.03 156.34 38.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.07 146.53 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.577 0.703 . . . . 0.0 111.234 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -116.61 82.3 1.77 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 t -69.52 86.33 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.901 0.88 . . . . 0.0 111.219 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 193' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 12.7 tttt -71.08 169.32 15.24 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.02 -0.425 . . . . 0.0 110.869 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 194' ' ' VAL . . . . . 0.447 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 5.5 p -62.01 -28.67 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.062 1.745 . . . . 0.0 115.246 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.439 ' CA ' HG23 ' B' ' 124' ' ' VAL . 26.6 t70 . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 128.068 2.547 . . . . 0.0 109.067 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 111.84 3.64 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.716 0 C5'-C4'-C3' 110.272 -3.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 O4'-C1'-N19 111.431 3.231 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.625 0 O4'-C1'-N19 112.054 3.854 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . 0.433 ' C8 ' ' CZ2' ' B' ' 134' ' ' TRP . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C4'-C3'-C2' 98.124 -4.576 . 0.183 0i . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 3 O4'-C1'-N19 116.001 7.801 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.619 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.667 1 O4'-C1'-N19 112.74 4.54 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 C5'-C4'-C3' 111.863 -2.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 119.773 -0.156 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . 34.52 56.09 1.94 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.959 1.304 . . . . 0.0 113.186 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.46 167.28 25.8 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.286 2.657 . . . . 0.0 111.923 -174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' B' ' 111' ' ' ARG . 12.1 ptp85 -142.33 -8.26 0.88 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.56 177.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.31 19.34 59.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.52 0.581 . . . . 0.0 113.251 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' B' ' 109' ' ' ARG . 82.9 mtt85 -146.69 169.29 19.33 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.252 1.021 . . . . 0.0 110.341 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -62.83 150.61 41.24 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.821 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.46 174.51 22.34 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.97 111.13 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.171 3.247 . . . . 0.0 110.225 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.75 -58.06 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.541 2.828 . . . . 0.0 116.432 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.18 -30.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -8.66 3.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -175.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.64 1.176 . . . . 0.0 112.586 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' B' ' 161' ' ' GLU . 0.0 OUTLIER -162.44 179.6 7.68 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 120' ' ' GLU . . . . . 0.575 ' HB2' HD22 ' B' ' 121' ' ' ASN . 26.5 mt-10 -149.35 -31.21 0.23 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.45 -1.704 . . . . 0.0 113.406 -172.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.6 p30 -140.49 78.74 1.67 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.325 1.85 . . . . 0.0 107.42 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -87.29 158.0 19.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.44 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.489 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -146.65 142.17 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 127.987 2.515 . . . . 0.0 107.279 176.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.91 159.48 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.07 102.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -117.79 150.65 38.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.193 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.95 -2.71 55.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 14.4 tp -53.42 145.18 28.57 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 128.14 2.576 . . . . 0.0 110.151 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.36 162.45 38.34 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.053 2.502 . . . . 0.0 109.448 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.33 -12.64 35.53 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.881 2.387 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -72.75 -23.0 60.77 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.091 0.957 . . . . 0.0 111.779 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.59 46.25 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.4 0.444 . . . . 0.0 112.645 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 43.8 t -158.12 168.66 26.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' TRP . . . . . 0.433 ' CZ2' ' C8 ' ' A' ' 5' ' ' ' G' . 34.6 p-90 -64.49 -30.13 71.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.446 0.566 . . . . 0.0 110.727 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -66.61 -37.07 84.1 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.938 0.335 . . . . 0.0 111.568 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.619 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 86.6 m-20 -84.67 -17.88 37.13 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.856 0.298 . . . . 0.0 111.441 -176.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -32.17 66.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -77.73 -38.57 46.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.97 1.57 0.9 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.531 1.132 . . . . 0.0 113.658 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' HIS . . . . . 0.426 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 16.7 t-80 -136.68 -40.37 0.62 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.413 0.551 . . . . 0.0 111.568 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 86.4 mmm -68.55 -11.6 60.16 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.413 0.551 . . . . 0.0 110.051 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -47.39 -21.38 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.885 0.874 . . . . 0.0 112.504 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.23 -42.74 88.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.824 -0.548 . . . . 0.0 111.164 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.45 -27.72 66.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.65 0.78 . . . . 0.0 111.666 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.5 -167.54 37.06 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -87.22 77.9 8.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.915 0.864 . . . . 0.0 110.157 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -62.96 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 43.5 t -128.06 -23.77 3.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.743 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -139.59 155.79 47.26 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 119.162 0.892 . . . . 0.0 110.331 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.86 165.12 35.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -147.62 153.61 39.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.499 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -132.35 147.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.113 0.482 . . . . 0.0 110.305 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.78 10.98 17.93 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.999 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.499 ' H ' HG22 ' B' ' 152' ' ' VAL . 28.0 mtt180 59.24 17.39 5.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.681 0.792 . . . . 0.0 113.053 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.11 15.16 3.28 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.0 52.35 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 11.8 p -140.69 159.19 42.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.352 0.661 . . . . 0.0 110.395 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.78 -170.27 38.39 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.5 161.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.804 0.442 . . . . 0.0 111.131 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -153.49 156.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 123.459 0.704 . . . . 0.0 109.885 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.484 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 1.2 tm-20 -152.39 155.39 37.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.944 0.498 . . . . 0.0 111.728 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -124.17 163.62 21.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.883 1.273 . . . . 0.0 111.73 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.7 -8.37 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.507 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -147.8 133.8 19.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -63.57 -20.66 65.82 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -76.02 -29.37 58.1 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.649 -0.657 . . . . 0.0 110.744 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.8 -19.01 60.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.489 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.7 ttp -77.97 -52.97 7.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.345 1.058 . . . . 0.0 110.674 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -63.46 -21.45 66.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.279 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.592 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 46.0 t80 -74.53 -31.72 62.23 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.73 -17.56 60.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.288 0.635 . . . . 0.0 111.628 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.431 ' O ' HG22 ' B' ' 172' ' ' VAL . 14.5 p -113.21 34.23 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.714 0.769 . . . . 0.0 111.702 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.28 -17.5 0.64 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -123.54 -25.82 4.3 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.39 0.676 . . . . 0.0 112.611 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.38 -2.64 21.96 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.357 0.263 . . . . 0.0 110.533 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.22 145.9 32.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.008 0.923 . . . . 0.0 109.013 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 29.67 17.85 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.435 0.694 . . . . 0.0 112.532 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 47.4 p -133.44 169.49 16.88 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.965 0.506 . . . . 0.0 110.701 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -57.85 149.47 22.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' PHE . . . . . 0.426 ' HA ' ' NE2' ' B' ' 140' ' ' HIS . 6.0 t80 -141.71 161.1 38.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.982 1.713 . . . . 0.0 108.937 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ARG . . . . . 0.404 ' HD2' ' H ' ' B' ' 182' ' ' SER . 15.0 tpt180 -139.33 155.76 47.48 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 110.178 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.404 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 41.8 t -141.77 162.56 35.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.303 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.466 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 18.2 p-80 -59.75 -20.57 57.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.208 1.403 . . . . 0.0 113.319 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.42 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 46.8 mm-40 -72.0 -13.15 61.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.986 0.357 . . . . 0.0 111.573 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.35 20.51 13.38 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.615 -0.547 . . . . 0.0 113.017 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.18 171.48 14.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.103 0.951 . . . . 0.0 110.99 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -139.01 161.56 37.07 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 -173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.69 160.48 19.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.326 1.051 . . . . 0.0 108.849 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.98 157.23 38.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 110.346 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 26.9 pt -123.59 151.7 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.746 0.784 . . . . 0.0 109.64 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -118.41 78.76 1.29 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.78 144.54 10.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 5.3 tttp -126.68 168.78 13.89 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.437 ' H ' HG12 ' B' ' 194' ' ' VAL . 3.0 p -60.22 -29.55 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.526 1.531 . . . . 0.0 114.603 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t70 143.59 163.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.71 2.404 . . . . 0.0 109.058 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.436 -1.758 . . . . 0.0 110.988 175.817 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 0 O4'-C1'-N19 109.948 1.748 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 O4'-C1'-N19 110.722 2.522 OUTLIER-DELTA 0.0 OUTLIER '7D dist 5d' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.405 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.809 0 O4'-C1'-N19 111.985 3.785 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 O4'-C1'-N19 111.242 3.042 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.301 1 C4'-C3'-C2' 98.04 -4.66 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 2 O4'-C1'-N19 115.337 7.137 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.608 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.75 1 O4'-C1'-N19 113.416 5.216 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 C5'-C4'-C3' 112.983 -1.678 . 0.013 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.627 0.251 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.93 157.78 35.32 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.591 0.756 . . . . 0.0 109.13 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 10.8 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.929 3.086 . . . . 0.0 112.661 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -143.64 18.24 1.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.07 0.948 . . . . 0.0 110.731 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.19 34.41 0.35 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 mtm-85 -59.97 -18.1 43.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.65 7.42 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.404 0.547 . . . . 0.0 112.357 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.83 -173.31 45.5 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.28 160.78 47.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.908 2.405 . . . . 0.0 109.528 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.17 151.64 66.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.906 2.404 . . . . 0.0 109.703 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 3.0 m -160.57 159.29 30.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 53.52 4.59 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 169.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -53.9 159.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.167 0.894 . . . . 0.0 112.192 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -140.1 -94.37 0.16 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -153.89 -30.51 0.12 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -165.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.94 -37.24 2.12 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -165.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ARG . . . . . 0.52 ' H ' ' HG3' ' B' ' 161' ' ' GLU . 86.8 mtt180 46.3 165.33 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.619 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.0 OUTLIER -159.17 134.65 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 129.59 3.156 . . . . 0.0 107.717 170.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.16 165.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.2 136.41 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 54.6 p -135.32 147.45 49.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.907 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.07 -2.34 31.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.72 140.44 38.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 127.133 2.173 . . . . 0.0 110.076 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.3 162.35 19.92 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.638 2.892 . . . . 0.0 110.11 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -14.77 32.71 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.865 2.377 . . . . 0.0 109.761 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -83.1 6.24 19.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.689 1.196 . . . . 0.0 111.738 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.45 165.09 12.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -159.49 170.67 21.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -61.68 -28.45 69.41 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -69.31 -35.05 75.57 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.608 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 70.7 m-20 -91.45 -19.59 22.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.25 0.477 . . . . 0.0 111.416 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.19 -26.48 59.04 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -75.22 -39.86 59.67 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.98 1.66 1.36 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.163 1.385 . . . . 0.0 113.179 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -135.38 -38.92 0.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.125 0.42 . . . . 0.0 111.37 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.0 mmm -68.14 -18.27 64.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.873 -0.517 . . . . 0.0 110.26 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -51.15 -19.88 1.32 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -56.57 -36.93 69.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.946 0.499 . . . . 0.0 111.169 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.2 -21.9 65.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.966 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.27 -93.82 0.11 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.902 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.8 121.1 6.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -121.84 150.54 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.02 -21.54 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.97 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -131.34 154.17 48.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.356 0.98 . . . . 0.0 111.801 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -158.28 161.48 37.71 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 18.0 t0 -145.56 148.46 33.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.632 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -128.45 141.97 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.208 0.528 . . . . 0.0 110.48 -172.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -103.3 5.82 37.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.497 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.632 ' H ' HG22 ' B' ' 152' ' ' VAL . 23.5 mtp85 62.55 17.21 9.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.461 0.705 . . . . 0.0 112.388 170.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -137.38 -11.96 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.06 -2.84 2.15 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 118.872 0.76 . . . . 0.0 113.181 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.2 165.85 26.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.51 -165.72 34.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 4.2 p -142.0 161.25 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 122.971 0.509 . . . . 0.0 110.02 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.5 p -147.62 159.63 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' B' ' 122' ' ' ARG . 42.9 tt0 -154.83 146.96 23.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.912 -0.492 . . . . 0.0 111.968 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 60.6 m-85 -117.94 156.93 27.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.595 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.1 m -61.71 -12.55 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.399 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -152.5 151.16 30.39 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.748 0.819 . . . . 0.0 109.07 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.67 -22.97 65.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.4 -32.83 48.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.597 0.635 . . . . 0.0 111.387 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.11 -17.66 61.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.123 0.487 . . . . 0.0 110.089 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.619 ' SD ' HG13 ' B' ' 123' ' ' VAL . 15.2 tmm? -82.95 -51.25 7.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.149 0.98 . . . . 0.0 111.202 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -61.75 -21.81 64.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.56 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 28.5 t80 -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.13 -12.47 60.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.204 0.602 . . . . 0.0 111.459 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.418 HG22 ' O ' ' B' ' 172' ' ' VAL 0.258 13.3 p -118.57 33.22 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 111.514 174.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.11 -16.5 0.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.506 169.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.9 mppt? -123.58 -25.85 4.29 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.571 0.748 . . . . 0.0 112.428 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.24 -3.36 19.85 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.808 0.276 . . . . 0.0 110.461 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.95 143.64 43.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.716 0.806 . . . . 0.0 110.174 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.16 36.59 27.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 43.0 p -135.55 172.84 12.43 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.278 0.631 . . . . 0.0 110.301 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -58.75 146.31 37.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.937 0.895 . . . . 0.0 112.274 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -136.73 156.5 48.43 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.905 1.282 . . . . 0.0 109.36 169.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -145.44 142.15 29.03 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.788 1.235 . . . . 0.0 108.173 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.3 p -152.43 -176.11 5.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.958 0.503 . . . . 0.0 109.733 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.468 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 17.7 p-80 -58.3 -177.4 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.455 0.702 . . . . 0.0 112.031 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 3.5 mm-40 67.98 -13.38 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.783 1.633 . . . . 0.0 112.46 -173.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 94.23 27.37 12.17 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.459 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -128.85 176.07 8.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 72.1 p -137.71 166.61 23.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.332 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.8 -162.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.435 0.694 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.93 147.53 49.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 102.65 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.595 0.712 . . . . 0.0 112.449 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -80.16 89.11 5.42 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' VAL . . . . . 0.414 ' HB ' HG23 ' B' ' 172' ' ' VAL . 6.6 t -67.88 138.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.86 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -117.47 162.43 17.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.74 -29.96 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.333 1.853 . . . . 0.0 114.913 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.8 t70 143.17 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.087 2.155 . . . . 0.0 108.826 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.216 -1.88 . . . . 0.0 111.064 175.348 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.949 1 O4'-C1'-N19 112.565 4.365 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.036 1 C3'-C2'-C1' 105.164 4.071 OUTLIER-EPSILON 0.074 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.571 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.835 1 C5'-C4'-C3' 108.243 -4.838 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.848 0 C3'-C2'-C1' 105.076 3.973 . 0.056 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.471 1 C4'-C3'-C2' 98.509 -4.191 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.237 2 O4'-C1'-N19 113.309 5.109 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.788 2 C4'-C3'-C2' 98.317 -4.383 . 0.176 '#a' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.348 0 C5'-C4'-C3' 111.253 -2.831 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.2 155.42 33.24 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.83 0.452 . . . . 0.0 109.936 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.62 171.45 17.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.615 2.877 . . . . 0.0 110.822 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.35 170.35 16.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.894 0.878 . . . . 0.0 109.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 174.13 178.97 44.44 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -153.72 169.0 24.4 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.243 0.617 . . . . 0.0 110.462 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -147.91 14.21 1.04 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.081 0.552 . . . . 0.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.1 -169.25 24.08 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -44.35 136.93 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.727 3.618 . . . . 0.0 112.369 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.2 -43.36 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.83 2.353 . . . . 0.0 110.818 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 1.6 m -176.91 163.39 2.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 109.503 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 51.0 mtt180 54.91 -5.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -61.64 166.32 4.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.375 1.443 . . . . 0.0 112.417 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t -146.29 -126.2 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.434 0.694 . . . . 0.0 112.513 -172.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -133.97 -25.79 1.58 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 114.397 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.443 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.0 OUTLIER -130.31 79.97 1.93 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 110.052 -171.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -78.67 158.57 28.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.008 1.723 . . . . 0.0 112.895 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -149.92 142.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 127.733 2.413 . . . . 0.0 108.657 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.5 t -80.89 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.55 136.41 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.8 p -141.37 157.39 45.24 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.364 -0.21 . . . . 0.0 111.102 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 4.41 56.17 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.94 146.68 36.87 Favored Pre-proline 0 N--CA 1.452 -0.356 0 C-N-CA 125.287 1.435 . . . . 0.0 110.844 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.1 164.91 33.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.246 3.297 . . . . 0.0 110.948 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -54.17 -6.52 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 125.165 3.91 . . . . 0.0 116.257 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 13.03 1.16 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.604 1.093 . . . . 0.0 113.423 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -53.2 158.28 4.28 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -146.28 168.24 21.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.425 0.613 . . . . 0.0 110.44 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -65.54 -27.46 68.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.604 -0.236 . . . . 0.0 111.364 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -68.68 -40.11 80.27 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 117.928 0.331 . . . . 0.0 111.322 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 90.7 m-20 -80.07 -21.22 43.62 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.132 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -32.51 70.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -79.86 -37.26 35.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.78 3.04 2.12 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.363 1.065 . . . . 0.0 112.916 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -132.51 -41.17 0.97 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.386 0.539 . . . . 0.0 111.159 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.3 mmm -69.66 -12.48 61.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.196 0.453 . . . . 0.0 110.315 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -45.2 -24.96 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 112.196 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.91 -42.2 94.93 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -69.96 -29.97 67.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.679 0.791 . . . . 0.0 111.505 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.9 -171.04 40.92 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -82.31 64.58 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.445 0.64 . . . . 0.0 111.254 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.3 OUTLIER -55.72 141.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 148' ' ' CYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 37.5 t -123.52 -30.55 3.62 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -133.1 158.77 41.94 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.658 0.742 . . . . 0.0 111.59 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -154.11 168.95 24.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.493 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 41.3 t0 -150.04 154.51 38.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.4 p -131.83 142.29 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.555 0.693 . . . . 0.0 110.473 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -105.07 5.69 32.67 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.11 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 14.3 mtt-85 61.56 17.66 8.76 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.867 0.867 . . . . 0.0 112.421 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -137.06 0.67 2.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.01 2.89 7.7 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 118.504 0.593 . . . . 0.0 112.401 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.64 165.9 26.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.458 0.647 . . . . 0.0 110.316 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.89 -166.79 36.01 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 3.6 p -138.86 162.02 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.867 0.467 . . . . 0.0 110.781 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.9 p -149.24 159.5 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 123.717 0.807 . . . . 0.0 108.872 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.42 147.12 20.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.156 -0.34 . . . . 0.0 111.661 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 4.8 m-85 -121.13 171.79 8.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.394 1.092 . . . . 0.0 111.771 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.38 -20.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.252 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -143.94 141.98 30.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.228 0.611 . . . . 0.0 110.561 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.17 -25.02 63.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.9 -31.43 59.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.762 0.71 . . . . 0.0 111.009 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.71 -16.4 60.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.782 0.325 . . . . 0.0 110.183 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 26.6 ttp -79.83 -50.84 9.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.91 0.884 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 43.9 m -65.37 -19.76 66.09 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -72.57 -27.23 62.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.467 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.03 -36.72 61.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 122.201 -0.312 . . . . 0.0 110.942 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.83 7.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.584 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.5 ptm180 -138.39 -25.04 0.94 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.866 0.757 . . . . 0.0 112.224 -174.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.584 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.69 -27.42 10.32 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.367 0.531 . . . . 0.0 110.934 175.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.9 mm? -115.98 -1.12 12.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.897 0.879 . . . . 0.0 109.892 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.35 141.08 28.94 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.623 0.769 . . . . 0.0 109.056 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.35 26.91 12.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 111.802 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 52.0 p -137.25 172.56 12.81 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.126 0.57 . . . . 0.0 110.169 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -54.38 150.58 8.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.453 1.101 . . . . 0.0 113.965 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -141.68 162.06 36.4 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.873 2.069 . . . . 0.0 108.038 169.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -142.89 145.73 33.38 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.897 0.879 . . . . 0.0 109.031 -171.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 78.3 p -142.33 171.65 13.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.311 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.467 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.1 p-80 -58.69 -11.62 3.32 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.563 1.145 . . . . 0.0 113.015 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.18 -18.46 65.27 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.751 0.421 . . . . 0.0 110.989 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.02 9.5 55.96 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -136.61 -178.49 5.2 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.003 0.906 . . . . 0.0 112.018 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 57.3 p -134.43 161.94 33.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.212 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.65 158.35 17.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.506 1.123 . . . . 0.0 108.132 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.53 154.3 41.56 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.245 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.81 152.16 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.972 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.96 87.09 2.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.38 89.33 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 110.751 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.5 tttt -71.13 171.47 10.92 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 120.713 0.292 . . . . 0.0 111.037 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.456 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.8 p -65.28 -27.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.779 1.632 . . . . 0.0 114.67 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' B' ' 124' ' ' VAL . 23.5 t0 130.68 166.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.199 2.599 . . . . 0.0 108.977 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 117.463 -1.743 . . . . 0.0 110.818 175.21 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.458 " H3'" H5'' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.859 0 C5'-C4'-C3' 110.835 -3.11 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . 0.458 H5'' " H3'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.98 0 C5'-C4'-C3' 110.133 -3.578 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.407 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 111.692 3.492 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 C5'-C4'-C3' 111.391 -2.739 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.467 1 C4'-C3'-C2' 98.688 -4.012 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 1 O4'-C1'-N19 112.686 4.486 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.782 1 O4'-C1'-N19 112.528 4.328 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 C5'-C4'-C3' 111.702 -2.532 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.15 155.6 33.4 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 122.885 0.474 . . . . 0.0 109.857 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.76 170.94 18.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.749 2.966 . . . . 0.0 111.053 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -145.27 9.47 1.24 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.739 0.416 . . . . 0.0 112.07 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.27 178.88 48.66 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -82.52 -6.16 59.16 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.761 0.424 . . . . 0.0 111.251 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 49.43 22.19 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.389 1.076 . . . . 0.0 112.652 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.34 -173.72 46.1 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.18 164.34 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.828 3.685 . . . . 0.0 112.961 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.96 -28.16 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.858 3.706 . . . . 0.0 114.558 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' B' ' 117' ' ' ARG . 17.8 m -167.23 -48.22 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' B' ' 116' ' ' SER . 0.0 OUTLIER -173.01 24.87 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.128 1.517 . . . . 0.0 112.89 166.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -54.05 167.47 0.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.844 1.258 . . . . 0.0 111.602 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -130.75 -97.33 0.34 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -153.53 -29.56 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -165.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.27 -35.81 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -165.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 39.73 158.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -153.55 142.54 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 127.428 2.291 . . . . 0.0 107.417 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -78.14 165.23 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.54 129.72 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 98.1 p -138.92 138.54 37.47 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.254 0.549 . . . . 0.0 111.504 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.92 0.28 7.69 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.51 145.08 21.6 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.588 1.155 . . . . 0.0 110.622 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.0 169.99 21.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.01 3.14 . . . . 0.0 109.621 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.92 -6.87 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.571 3.514 . . . . 0.0 115.793 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 30.1 m -138.16 5.46 2.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -54.97 153.66 10.83 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -147.32 168.9 20.6 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.302 -0.528 . . . . 0.0 110.978 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -65.35 -28.53 69.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.18 -46.27 74.46 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.364 0.529 . . . . 0.0 110.724 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 81.3 m-20 -76.37 -16.26 59.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.381 -0.199 . . . . 0.0 111.165 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -34.57 71.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -76.55 -37.63 56.31 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.59 -1.71 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.205 1.002 . . . . 0.0 113.652 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -128.0 -36.25 1.99 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.767 0.712 . . . . 0.0 111.23 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.5 mmm -73.73 -12.17 60.63 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.889 -0.507 . . . . 0.0 110.434 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttm105 -44.87 -25.16 0.27 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.913 0.885 . . . . 0.0 112.489 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.3 -42.14 93.36 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.916 -0.49 . . . . 0.0 111.328 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.26 -31.23 69.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.092 0.557 . . . . 0.0 111.386 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.13 -171.35 41.17 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -80.45 72.94 7.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.903 0.859 . . . . 0.0 110.939 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.8 OUTLIER -63.14 146.53 12.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 36.8 t -130.75 -31.63 1.74 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.691 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.435 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 6.2 t80 -137.15 161.53 35.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 110.458 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.86 169.87 23.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -148.14 155.34 41.31 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.498 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.5 p -132.63 143.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.465 0.65 . . . . 0.0 109.944 -175.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -105.3 10.58 33.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.1 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.498 ' H ' HG22 ' B' ' 152' ' ' VAL . 35.4 mtp180 61.73 15.39 6.93 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.34 3.14 3.07 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.46 5.03 13.06 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -140.61 166.5 24.57 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.426 0.69 . . . . 0.0 110.511 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.88 -164.83 32.82 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.43 162.31 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.576 0.75 . . . . 0.0 110.45 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 12.6 p -144.27 160.08 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.1 141.62 24.33 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.453 0.701 . . . . 0.0 110.756 -168.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.5 m-85 -128.42 165.19 21.11 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.932 0.872 . . . . 0.0 110.59 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.6 -5.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.37 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -150.34 144.69 25.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.195 0.452 . . . . 0.0 110.125 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -70.82 -23.09 62.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.412 0.285 . . . . 0.0 111.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -88.7 -32.98 17.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.883 0.31 . . . . 0.0 111.726 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -74.37 -8.88 57.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.253 0.549 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.429 ' SD ' HG13 ' B' ' 123' ' ' VAL . 37.6 ttp -94.76 -42.3 8.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.11 1.364 . . . . 0.0 110.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 92.7 m -66.26 -17.42 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 42.8 t80 -72.4 -27.5 62.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -38.09 64.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.378 -0.201 . . . . 0.0 110.567 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 m -73.16 5.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -134.23 -16.18 2.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.898 0.772 . . . . 0.0 112.857 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.634 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.2 mppt? -125.64 -21.09 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.31 1.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.85 144.31 31.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.777 0.831 . . . . 0.0 109.426 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.6 36.45 23.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.019 0.928 . . . . 0.0 112.709 174.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 33.5 p -133.69 178.96 6.53 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.361 0.664 . . . . 0.0 110.335 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -53.41 149.38 7.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -147.73 168.72 21.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.738 2.015 . . . . 0.0 107.749 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -148.22 149.75 32.48 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.8 t -128.21 153.62 46.72 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.249 0.547 . . . . 0.0 110.394 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.47 ' CD2' ' HG2' ' B' ' 184' ' ' GLU . 54.7 p-80 -58.72 -19.69 42.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.08 1.352 . . . . 0.0 113.524 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.47 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 22.7 pt-20 -156.04 26.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.19 0.45 . . . . 0.0 111.558 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.26 13.94 4.59 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.175 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 51.72 -170.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.32 1.048 . . . . 0.0 111.963 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 29.9 p -76.71 160.76 29.07 Favored 'General case' 0 C--O 1.231 0.105 0 O-C-N 121.775 -0.578 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.78 -168.99 2.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.592 1.157 . . . . 0.0 108.319 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.63 142.47 51.49 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -129.55 133.02 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.499 0.666 . . . . 0.0 112.665 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -94.94 89.76 5.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.52 92.74 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.173 0.589 . . . . 0.0 110.13 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 6.5 tttp -75.36 173.02 11.47 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 111.224 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.457 ' H ' HG12 ' B' ' 194' ' ' VAL . 2.8 p -65.85 -28.82 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.247 1.819 . . . . 0.0 114.436 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 20.9 t70 141.56 163.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.38 2.272 . . . . 0.0 108.949 -173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.231 -1.872 . . . . 0.0 111.072 175.391 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.672 0 C5'-C4'-C3' 110.536 -3.309 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.093 0 C3'-C2'-C1' 104.329 3.144 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 O4'-C1'-N19 111.928 3.728 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C5'-C4'-C3' 111.776 -2.482 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.264 0 C4'-C3'-C2' 99.04 -3.66 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.209 2 O4'-C1'-N19 113.348 5.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.606 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.417 -3.038 0 O4'-C1'-N19 110.828 2.628 . 0.0 OUTLIER '7D dist #a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.166 0 C5'-C4'-C3' 110.514 -3.324 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.515 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -147.92 25.26 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 92.2 Cg_endo -73.0 157.99 50.34 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.65 1.567 . . . . 0.0 110.47 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 44.13 30.43 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.708 1.203 . . . . 0.0 113.121 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.62 -173.66 33.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -151.33 173.04 14.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.113 0.565 . . . . 0.0 110.612 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -148.66 177.97 9.04 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.013 0.925 . . . . 0.0 109.121 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -160.78 158.98 30.56 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.59 156.05 18.63 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.702 2.935 . . . . 0.0 111.466 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.19 155.73 33.24 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.535 2.823 . . . . 0.0 109.043 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -162.67 -41.19 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 O-C-N 122.179 -0.326 . . . . 0.0 111.75 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -147.27 12.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.237 1.015 . . . . 0.0 110.884 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.68 167.6 0.72 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.715 1.206 . . . . 0.0 112.759 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.9 t -150.85 -124.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.266 0.627 . . . . 0.0 111.793 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.25 35.5 mt-10 -138.5 -15.23 1.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.513 1.525 . . . . 0.0 114.796 -167.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.0 OUTLIER -138.42 77.18 1.61 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.407 1.483 . . . . 0.0 110.995 -168.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -79.44 154.0 29.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.58 1.952 . . . . 0.0 112.499 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.6 OUTLIER -145.07 133.66 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.811 2.045 . . . . 0.0 108.407 173.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' B' ' 195' ' ' ASP . 37.8 t -70.52 160.37 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-O 121.101 0.477 . . . . 0.0 109.774 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.51 107.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.1 p -118.23 147.94 42.9 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.04 -1.92 35.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.42 153.69 13.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 111.411 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.85 158.15 38.95 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.69 2.26 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.83 -17.71 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.039 2.493 . . . . 0.0 111.482 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 56.5 m -79.01 -10.94 59.98 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.788 0.835 . . . . 0.0 112.412 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.73 161.99 50.99 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 23.5 t -152.06 170.23 20.44 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.302 0.641 . . . . 0.0 109.817 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 41.5 p-90 -64.85 -28.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.96 -0.463 . . . . 0.0 111.525 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.75 -37.34 82.0 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.025 0.375 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.606 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 83.3 m-20 -83.55 -29.52 27.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 111.299 0.111 . . . . 0.0 111.299 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -35.31 77.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.015 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -72.02 -41.95 66.95 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.61 2.79 1.64 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.347 1.459 . . . . 0.0 113.959 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -131.42 -38.24 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.773 0.715 . . . . 0.0 111.243 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.9 mmm -69.84 -17.31 63.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.02 -0.425 . . . . 0.0 110.244 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -46.96 -19.29 0.1 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.959 0.903 . . . . 0.0 113.382 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.98 -41.43 95.44 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.148 0.579 . . . . 0.0 111.322 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.76 -26.18 67.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.366 0.666 . . . . 0.0 111.412 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.17 -171.73 33.99 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -74.08 114.77 12.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.282 0.541 . . . . 0.0 109.911 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -120.26 147.46 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.49 -17.05 2.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -135.49 153.85 51.6 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.764 1.165 . . . . 0.0 111.819 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -156.92 147.14 21.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.476 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -129.43 119.38 23.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.9 p -106.66 148.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.487 -169.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -111.24 9.12 21.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.724 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.37 25.88 0.05 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 126.789 2.036 . . . . 0.0 114.787 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -142.78 5.98 1.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.31 -4.85 6.76 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 121.813 -0.554 . . . . 0.0 113.006 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -143.43 162.91 34.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 109.725 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.69 -169.21 39.07 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.9 160.68 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 117.285 0.542 . . . . 0.0 109.623 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -146.24 156.2 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -150.52 145.82 26.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 111.91 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 44.6 m-85 -112.94 160.91 17.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.256 1.027 . . . . 0.0 112.799 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.42 -20.42 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.362 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -150.35 145.88 26.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 110.117 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.25 -24.81 65.84 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.88 -31.01 62.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.913 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.05 -17.06 61.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.669 0.271 . . . . 0.0 110.569 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.462 ' SD ' HG13 ' B' ' 123' ' ' VAL . 29.5 ttp -81.46 -52.79 6.88 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.761 0.824 . . . . 0.0 110.685 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.5 m -65.59 -17.19 64.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.553 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 22.1 t80 -73.3 -29.59 62.82 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.765 -0.585 . . . . 0.0 109.53 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.8 64.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.063 -0.398 . . . . 0.0 110.663 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.96 6.09 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -133.94 -15.56 2.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.623 0.647 . . . . 0.0 112.569 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.4 mppt? -125.4 -21.43 4.55 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.76 2.82 14.52 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.62 142.78 31.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.22 38.86 31.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.092 0.473 . . . . 0.0 111.752 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.3 p -137.6 169.36 17.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.247 1.419 . . . . 0.0 108.515 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -66.8 165.07 15.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.866 -170.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' B' ' 181' ' ' ARG . 7.9 t80 -150.72 172.78 15.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.173 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' B' ' 180' ' ' PHE . 15.2 tpt180 -148.53 143.55 26.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.573 0.749 . . . . 0.0 109.167 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 83.7 p -144.54 167.83 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.059 0.457 . . . . 0.0 110.905 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.474 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 11.1 p-80 -64.77 -179.67 0.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.01 -11.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.304 1.841 . . . . 0.0 113.648 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -162.98 -132.12 1.3 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.24 -145.43 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 111.325 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 49.8 p -80.69 168.02 19.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.979 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.15 -163.97 1.21 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.999 1.72 . . . . 0.0 107.192 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.31 156.38 44.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 22.6 pt -131.78 146.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.76 0.79 . . . . 0.0 111.129 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -114.71 79.91 1.33 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 34.7 t -60.76 133.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.49 160.54 31.99 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.135 0.574 . . . . 0.0 110.178 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' B' ' 123' ' ' VAL . 0.1 OUTLIER -60.42 -37.38 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' B' ' 124' ' ' VAL . 24.4 t70 131.38 155.97 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 109.712 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 117.522 -1.71 . . . . 0.0 111.335 174.041 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 0 C5'-C4'-C3' 109.694 -3.871 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.887 0 C5'-C4'-C3' 111.417 -2.722 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.543 0 O4'-C1'-N19 111.447 3.247 OUTLIER-DELTA 0.01 6g . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.477 " H1'" " H1'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C1'-N19 111.354 3.154 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . 0.545 ' H22' ' HA ' ' B' ' 151' ' ' ASP . . . . . . . . 0 O4'--C4' 1.415 -3.135 3 O4'-C1'-N19 113.557 5.357 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . 0.401 ' H22' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.302 2 O4'-C1'-N19 113.739 5.539 . 0.01 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.419 -2.801 1 O4'-C1'-N19 112.517 4.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 C5'-C4'-C3' 111.78 -2.48 . 0.0 OUTLIER '7D dist 1[' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . 39.95 54.11 5.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.395 1.078 . . . . 0.0 113.38 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.09 -3.18 13.19 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.187 2.592 . . . . 0.0 112.143 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -152.23 162.27 41.39 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.336 0.655 . . . . 0.0 109.255 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.22 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.536 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -154.38 178.75 9.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.575 0.75 . . . . 0.0 109.761 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -143.61 11.36 1.66 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.498 0.319 . . . . 0.0 111.293 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.4 176.05 43.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 169.05 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.696 3.598 . . . . 0.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.89 -177.23 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.719 2.946 . . . . 0.0 110.177 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m -131.73 -42.39 1.03 Allowed 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -149.18 5.27 0.64 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.036 0.534 . . . . 0.0 112.106 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -55.71 167.04 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.54 0.736 . . . . 0.0 112.735 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 14.6 t -146.53 -122.56 0.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.337 0.655 . . . . 0.0 112.085 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -134.9 -22.86 1.59 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.599 1.56 . . . . 0.0 114.442 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.79 77.28 1.73 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.695 1.198 . . . . 0.0 110.668 -169.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -78.92 150.17 32.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.852 1.661 . . . . 0.0 113.013 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.494 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -139.61 129.26 29.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.877 1.671 . . . . 0.0 108.532 171.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.86 158.69 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.08 109.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 81.0 p -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.665 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.14 53.49 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.3 147.0 77.2 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 127.871 2.468 . . . . 0.0 111.034 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.14 160.49 33.07 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.903 2.402 . . . . 0.0 109.273 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 -9.99 25.88 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.83 2.353 . . . . 0.0 111.09 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -75.01 -11.81 60.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.261 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.71 164.9 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 121.732 0.629 . . . . 0.0 112.842 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.7 t -158.99 166.63 31.34 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.903 1.281 . . . . 0.0 108.004 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' TRP . . . . . 0.452 ' CZ2' " H2'" ' A' ' 5' ' ' ' G' . 40.5 p-90 -66.64 -30.2 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.523 0.601 . . . . 0.0 111.753 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -65.98 -32.08 73.35 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.414 0.552 . . . . 0.0 110.635 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 73.7 m-20 -87.64 -20.62 26.08 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 117.738 0.245 . . . . 0.0 111.512 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -29.97 64.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -79.65 -39.79 30.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.401 ' CG ' ' H22' ' A' ' 6' ' ' ' G' . 6.6 m-20 -68.77 -1.75 7.81 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.496 1.118 . . . . 0.0 113.429 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' HIS . . . . . 0.451 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 5.1 t-80 -129.52 -41.74 1.35 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.132 0.424 . . . . 0.0 111.12 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 85.1 mmm -65.48 -16.93 64.15 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -42.24 -27.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.683 1.593 . . . . 0.0 113.13 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.03 -41.49 96.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 111.573 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.407 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.93 -29.26 69.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.333 0.653 . . . . 0.0 111.751 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.88 -175.8 34.32 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -73.02 115.79 12.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 122.369 -0.489 . . . . 0.0 110.333 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -113.63 151.18 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.4 p -132.99 -26.04 1.76 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.915 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -134.33 152.94 52.1 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.81 1.186 . . . . 0.0 112.125 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -149.81 169.18 21.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.655 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.545 ' HA ' ' H22' ' A' ' 5' ' ' ' G' . 35.5 t0 -149.67 141.41 23.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 168.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.577 HG22 ' H ' ' B' ' 154' ' ' ARG . 4.8 p -122.41 142.54 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.629 0.728 . . . . 0.0 111.02 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -108.79 9.96 26.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.682 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.577 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.0 24.57 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.215 2.206 . . . . 0.0 114.991 178.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.49 10.45 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.94 -4.21 7.93 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.106 0.412 . . . . 0.0 113.0 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.2 162.28 36.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.893 0.477 . . . . 0.0 110.415 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.28 -169.26 37.53 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.43 162.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.26 0.53 . . . . 0.0 110.755 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.2 p -149.75 158.53 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.898 0.879 . . . . 0.0 108.934 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.62 147.27 24.23 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.901 -0.499 . . . . 0.0 111.535 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 30.4 m-85 -116.49 168.5 10.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 122.281 1.038 . . . . 0.0 113.322 -172.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.3 m -75.67 -10.52 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.658 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -151.46 142.85 23.44 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.88 -23.53 66.67 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.31 -30.97 62.3 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.252 0.478 . . . . 0.0 110.86 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.06 -19.36 60.64 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 110.323 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.494 ' CG ' HG13 ' B' ' 123' ' ' VAL . 30.8 ttp -82.33 -53.44 6.02 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.764 0.826 . . . . 0.0 111.048 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -63.23 -21.79 66.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.539 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 29.2 t80 -73.53 -33.73 64.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.41 60.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.066 0.546 . . . . 0.0 111.362 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.438 ' O ' HG22 ' B' ' 172' ' ' VAL 0.261 8.2 p -116.07 33.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 111.198 174.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.3 ptm180 -143.64 -17.32 0.62 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -122.82 -27.36 4.3 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.326 0.65 . . . . 0.0 112.531 173.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' B' ' 175' ' ' LEU . 2.6 mm? -104.61 -7.52 19.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' B' ' 172' ' ' VAL . 15.2 t70 -75.35 147.16 40.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.8 0.84 . . . . 0.0 110.278 168.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 57.85 28.93 16.74 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.128 0.971 . . . . 0.0 112.367 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 63.6 p -136.95 174.55 10.5 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.88 0.472 . . . . 0.0 110.811 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -54.36 145.35 18.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 113.063 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' PHE . . . . . 0.451 ' HA ' ' NE2' ' B' ' 140' ' ' HIS . 5.2 t80 -138.56 160.04 40.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.771 1.629 . . . . 0.0 108.144 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -137.59 151.32 48.22 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.709 0.804 . . . . 0.0 109.795 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -135.89 165.03 26.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.241 0.543 . . . . 0.0 111.174 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 12.7 p-80 -60.86 -16.35 40.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.061 1.344 . . . . 0.0 113.471 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.43 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 41.1 mm-40 -77.36 -13.09 60.0 Favored 'General case' 0 CA--C 1.526 0.037 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.44 20.15 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.115 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.39 172.26 12.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.982 0.891 . . . . 0.0 110.928 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -136.17 163.25 30.8 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.71 158.75 20.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.555 1.142 . . . . 0.0 108.143 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -71.17 161.28 31.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.424 0.631 . . . . 0.0 110.425 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 28.9 pt -130.18 156.0 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.429 169.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -122.02 87.06 2.68 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.429 1.092 . . . . 0.0 108.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.22 142.19 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.261 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -134.09 158.48 43.5 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.282 0.563 . . . . 0.0 110.725 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.5 m -74.9 3.81 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 126.286 1.835 . . . . 0.0 113.76 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 7.3 t0 90.32 158.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.314 1.446 . . . . 0.0 110.377 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 117.265 -1.853 . . . . 0.0 111.324 174.606 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.128 2 O4'-C1'-N19 113.642 5.442 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 O4'-C1'-N19 111.066 2.866 . 0.074 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 1 C5'-C4'-C3' 109.127 -4.249 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 P-O3'-C3' 123.682 3.318 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . 0.527 ' H22' ' HA ' ' B' ' 151' ' ' ASP . . . . . . . . 0 O4'--C4' 1.412 -3.38 1 C4'-C3'-C2' 98.071 -4.629 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.252 2 O4'-C1'-N19 113.059 4.859 . 0.01 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.617 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.418 -2.881 0 O4'-C1'-N19 112.046 3.846 . 0.05 '#a' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 N19-C1'-C2' 109.28 -2.575 . 0.188 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 111.071 0.026 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.8 156.36 35.9 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.125 0.57 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.23 7.43 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.202 3.268 . . . . 0.0 112.202 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 48.2 36.16 6.36 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.719 0.808 . . . . 0.0 112.468 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.33 -174.56 13.53 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -64.95 -8.61 16.43 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -64.13 160.65 17.82 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.045 0.384 . . . . 0.0 110.901 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.18 174.46 49.59 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.11 119.38 6.13 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.574 2.85 . . . . 0.0 111.187 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.6 174.61 10.28 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.73 2.953 . . . . 0.0 110.229 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -154.86 -43.89 0.09 Allowed 'General case' 0 C--N 1.338 0.094 0 CA-C-O 120.857 0.36 . . . . 0.0 110.66 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -148.58 8.74 0.79 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.188 0.995 . . . . 0.0 111.003 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -53.91 168.69 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.704 1.202 . . . . 0.0 112.26 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.6 t -138.61 -93.84 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.292 15.1 mt-10 -159.01 -27.56 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -164.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -25.73 4.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -161.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 35.07 155.93 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.401 3.081 . . . . 0.0 119.278 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -147.78 122.66 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.634 174.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' B' ' 195' ' ' ASP . 24.2 t -67.46 158.96 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.97 112.96 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 83.2 p -122.18 152.64 39.74 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.7 35.8 3.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.503 ' N ' ' HD3' ' B' ' 129' ' ' PRO . 13.0 tp -111.45 31.29 0.1 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' B' ' 128' ' ' LEU . 80.7 Cg_exo -46.93 -33.51 14.59 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.572 2.181 . . . . 0.0 116.307 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.438 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 89.5 Cg_exo -47.88 167.04 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.298 2.666 . . . . 0.0 114.094 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 7.0 t -71.27 19.68 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.77 0.828 . . . . 0.0 112.076 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' B' ' 130' ' ' PRO . . . -46.95 154.71 0.89 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.403 1.001 . . . . 0.0 113.206 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -146.69 166.13 27.52 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.131 0.972 . . . . 0.0 108.652 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' TRP . . . . . 0.427 ' CE3' ' C6 ' ' A' ' 5' ' ' ' G' . 39.4 p-90 -63.32 -28.64 70.15 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.849 -0.532 . . . . 0.0 111.289 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -67.59 -24.79 65.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.05 0.386 . . . . 0.0 111.528 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.617 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 68.5 m-20 -99.14 -18.74 17.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.095 0.407 . . . . 0.0 111.612 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -29.18 64.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -77.63 -39.8 44.05 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.02 -0.69 9.98 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.259 1.024 . . . . 0.0 113.462 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -128.86 -35.11 1.9 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.341 0.519 . . . . 0.0 111.036 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 78.7 mmm -73.27 -14.64 61.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -47.14 -21.37 0.24 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 112.797 172.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.57 -41.23 96.41 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.274 0.63 . . . . 0.0 110.992 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.61 68.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.942 0.497 . . . . 0.0 111.567 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.43 -169.59 37.77 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.83 81.71 2.76 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.801 0.81 . . . . 0.0 110.759 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -76.78 146.37 8.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.3 p -131.34 -25.02 2.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.797 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -139.31 157.1 46.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.436 1.016 . . . . 0.0 111.594 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.26 167.75 26.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.905 174.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.527 ' HA ' ' H22' ' A' ' 5' ' ' ' G' . 38.6 t0 -148.32 137.15 21.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 168.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.0 p -118.84 142.34 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.845 0.831 . . . . 0.0 110.373 -171.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' TYR . . . . . 0.405 ' C ' ' HD3' ' B' ' 154' ' ' ARG . 3.2 m-30 -107.37 9.22 29.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.0 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.42 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.606 1.962 . . . . 0.0 114.446 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.05 8.16 1.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.35 -5.98 6.72 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.24 0.473 . . . . 0.0 112.973 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.4 p -144.12 165.61 27.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.173 0.487 . . . . 0.0 110.459 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.33 -166.27 33.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.51 162.74 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 CA-C-N 117.228 0.514 . . . . 0.0 110.251 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.464 HG13 HG23 ' B' ' 123' ' ' VAL . 8.8 p -147.74 161.12 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.008 0.923 . . . . 0.0 108.806 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -153.4 151.96 30.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 110.64 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 3.7 m-85 -129.53 164.58 23.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.926 0.869 . . . . 0.0 110.138 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 25.5 m -66.19 -5.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.53 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -152.6 155.9 38.25 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.554 0.615 . . . . 0.0 110.24 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.18 -28.04 65.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.757 0.423 . . . . 0.0 112.039 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.76 -30.9 18.69 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.064 -0.397 . . . . 0.0 112.022 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -72.62 -9.75 58.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.407 ' SD ' HG13 ' B' ' 123' ' ' VAL . 41.4 ttp -98.27 -42.95 7.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.464 1.506 . . . . 0.0 110.958 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.0 m -63.12 -19.25 64.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 24.9 t80 -71.31 -28.56 64.19 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.931 -0.48 . . . . 0.0 109.993 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.53 -36.71 65.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.21 4.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -133.95 -16.48 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.5 mppt? -124.91 -21.57 4.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.14 0.94 13.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.011 0.524 . . . . 0.0 109.886 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.53 143.03 27.18 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.929 0.891 . . . . 0.0 109.099 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.65 24.99 14.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.279 1.032 . . . . 0.0 111.669 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 81.6 p -137.62 179.29 6.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.341 0.591 . . . . 0.0 111.707 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.36 144.88 34.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.901 1.681 . . . . 0.0 114.708 -170.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -143.43 161.45 38.36 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.104 1.762 . . . . 0.0 108.54 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ARG . . . . . 0.413 ' HD2' ' H ' ' B' ' 182' ' ' SER . 12.5 tpt180 -142.54 156.63 45.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.282 1.033 . . . . 0.0 109.224 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.413 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 38.7 t -131.98 162.93 29.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 111.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.461 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 56.5 p-80 -66.92 14.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.608 1.963 . . . . 0.0 114.673 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -129.97 -20.96 3.06 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.05 0.841 . . . . 0.0 111.9 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 132.87 -19.18 4.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.704 171.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -76.1 156.47 33.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.673 0.736 . . . . 0.0 111.154 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 81.1 p -145.54 154.23 41.96 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.577 0.751 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.29 160.87 16.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -72.07 148.25 45.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.0 139.33 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -100.59 86.07 3.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.33 1.052 . . . . 0.0 108.724 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 10.6 t -71.18 81.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.577 0.751 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.98 159.82 32.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.872 0.869 . . . . 0.0 110.721 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' B' ' 123' ' ' VAL . 19.1 m -75.18 3.46 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 126.03 1.732 . . . . 0.0 114.69 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.489 ' HA ' HG23 ' B' ' 124' ' ' VAL . 19.7 t70 107.97 159.03 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.402 1.881 . . . . 0.0 110.408 170.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 117.129 -1.928 . . . . 0.0 110.964 173.847 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.115 2 O4'-C1'-N19 113.279 5.079 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 C4'-C3'-O3' 117.535 2.667 OUTLIER-EPSILON 0.344 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.464 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 P-O3'-C3' 125.372 4.726 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.13 0 C3'-C2'-C1' 104.492 3.325 . 0.104 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.248 2 O4'-C1'-N19 113.018 4.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 3 O4'-C1'-N19 115.866 7.666 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.62 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.738 1 O4'-C1'-N19 112.649 4.449 . 0.0 OUTLIER '7D dist 6n' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.094 0 O4'-C1'-N19 110.325 2.125 . 0.01 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.72 155.99 32.81 Favored Pre-proline 0 C--O 1.233 0.199 0 C-N-CA 123.097 0.559 . . . . 0.0 109.953 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.24 166.15 30.18 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.277 2.651 . . . . 0.0 110.737 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 45.39 32.56 1.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.422 1.089 . . . . 0.0 112.619 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.43 7.51 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.746 -0.475 . . . . 0.0 112.481 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -138.48 1.73 2.18 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.815 0.807 . . . . 0.0 111.09 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -155.34 6.88 0.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.114 0.566 . . . . 0.0 111.603 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.4 176.84 46.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.85 161.64 43.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.237 3.291 . . . . 0.0 111.585 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.36 160.36 48.95 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.85 3.033 . . . . 0.0 111.696 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 9.3 p 150.42 145.41 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 128.711 2.804 . . . . 0.0 103.854 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.85 47.59 0.15 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 116.899 -1.92 . . . . 0.0 113.494 -160.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -53.14 173.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 9.0 t -140.81 -127.67 0.1 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.368 1.067 . . . . 0.0 111.919 -175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -133.91 -28.36 1.39 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.336 1.455 . . . . 0.0 114.18 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.8 p30 -127.3 82.78 2.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.744 1.218 . . . . 0.0 110.396 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -78.36 158.53 28.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.711 2.004 . . . . 0.0 112.87 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.443 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -150.08 142.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.792 2.437 . . . . 0.0 109.06 173.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -79.5 170.65 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.51 136.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.4 p -143.75 157.7 44.2 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 121.057 0.456 . . . . 0.0 112.078 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.96 53.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.53 123.23 88.95 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 127.5 2.32 . . . . 0.0 112.949 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.29 156.83 12.66 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.984 2.456 . . . . 0.0 111.422 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.34 -10.9 29.1 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.101 2.534 . . . . 0.0 110.705 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 68.1 m -75.19 -9.02 58.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.095 0.958 . . . . 0.0 112.616 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.34 165.44 41.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 44.5 t -157.39 167.98 28.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.241 1.016 . . . . 0.0 109.155 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -64.65 -29.93 70.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.738 -0.601 . . . . 0.0 110.057 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -68.4 -16.16 63.81 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.428 0.291 . . . . 0.0 111.49 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.62 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 80.5 m-20 -104.03 -22.73 13.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 112.054 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.54 -30.7 66.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.942 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -73.94 -40.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.6 -1.92 7.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.464 1.106 . . . . 0.0 113.304 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -131.92 -33.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.641 0.655 . . . . 0.0 111.552 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' B' ' 141' ' ' MET . 0.0 OUTLIER -74.86 -19.97 59.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -51.64 -18.88 1.31 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -59.0 -37.59 77.21 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.031 0.532 . . . . 0.0 110.852 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -65.82 -22.38 66.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.71 0.804 . . . . 0.0 111.307 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.98 -90.49 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -157.07 134.1 10.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -130.56 157.6 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 14.7 p -129.15 -35.63 1.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.014 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 7.9 t80 -132.69 159.02 40.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.61 1.096 . . . . 0.0 111.723 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.17 170.95 20.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.301 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -149.11 155.75 41.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.553 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -133.31 145.01 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.34 0.59 . . . . 0.0 110.483 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.55 22.11 16.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.208 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.553 ' H ' HG22 ' B' ' 152' ' ' VAL . 59.6 mtp180 74.83 -15.85 0.61 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 126.062 1.745 . . . . 0.0 113.123 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.04 138.63 2.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.667 0.667 . . . . 0.0 111.679 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 -31.26 0.69 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 166.39 28.4 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.91 1.355 . . . . 0.0 111.982 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.43 -171.29 41.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 163.19 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.485 0.642 . . . . 0.0 110.763 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 9.1 p -150.72 160.03 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.817 0.847 . . . . 0.0 109.365 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 32.4 tt0 -152.08 136.39 16.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.088 -0.382 . . . . 0.0 111.618 -172.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 80.4 m-85 -104.31 168.08 9.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.15 -11.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.621 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -151.73 137.21 17.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.73 -23.41 66.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.3 -32.92 55.7 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.226 0.466 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -75.21 -20.12 59.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.022 0.439 . . . . 0.0 109.841 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.445 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 36.5 ttp -76.17 -52.84 9.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 111.469 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 49.0 m -65.65 -20.69 66.4 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -71.92 -27.19 62.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.264 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' B' ' 175' ' ' LEU . . . -74.07 -37.12 64.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.207 -0.308 . . . . 0.0 111.069 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.71 8.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.566 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 15.1 ptm180 -137.74 -23.92 1.05 Allowed 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 121.704 -0.622 . . . . 0.0 112.191 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.566 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.97 -28.25 9.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.375 0.534 . . . . 0.0 111.191 175.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' B' ' 171' ' ' ALA . 1.7 mm? -116.01 -6.88 11.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.47 0.708 . . . . 0.0 109.729 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -85.12 144.09 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 64.53 23.88 12.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.91 0.884 . . . . 0.0 111.627 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 72.0 p -138.91 178.03 7.46 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.627 0.727 . . . . 0.0 111.247 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -61.54 148.59 41.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.017 1.327 . . . . 0.0 114.176 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.74 145.28 32.29 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.115 1.766 . . . . 0.0 108.028 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -123.96 157.15 35.03 Favored 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.006 0.923 . . . . 0.0 109.36 -170.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 88.4 p -138.79 165.79 26.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.542 0.687 . . . . 0.0 112.015 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.473 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 23.1 p-80 -68.35 -14.4 62.97 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.182 1.393 . . . . 0.0 113.162 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.91 -15.27 56.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.94 12.28 9.41 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.654 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.05 168.88 18.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.693 1.247 . . . . 0.0 111.918 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.01 157.3 43.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.948 0.899 . . . . 0.0 110.356 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.58 165.98 29.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.572 1.149 . . . . 0.0 108.955 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -68.58 155.75 39.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.25 0.547 . . . . 0.0 110.998 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.91 152.4 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.774 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.361 1.064 . . . . 0.0 108.788 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.36 94.28 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.651 0.78 . . . . 0.0 110.761 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.4 tttt -74.37 171.14 14.24 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 122.552 0.341 . . . . 0.0 110.742 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.446 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.4 p -66.05 -27.12 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 126.298 1.839 . . . . 0.0 114.732 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.491 ' HA ' HG23 ' B' ' 124' ' ' VAL . 25.2 t70 125.35 165.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.463 2.705 . . . . 0.0 109.237 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.895 175.272 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 C5'-C4'-C3' 112.753 -1.831 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 1 O4'-C1'-N19 113.736 5.536 . 0.109 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.416 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 C4'-C3'-C2' 99.377 -3.323 . 0.536 6n . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.416 ' C8 ' " H2'" ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 111.242 3.042 . 0.197 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.253 1 C4'-C3'-C2' 98.158 -4.542 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . 0.479 ' H1 ' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.297 3 O4'-C1'-N19 116.513 8.313 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.607 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.675 1 O4'-C1'-N19 112.513 4.313 . 0.01 6n . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.189 -2.874 . 0.1 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.73 31.53 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.998 0.519 . . . . 0.0 109.956 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.39 170.36 20.09 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.466 2.778 . . . . 0.0 111.061 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -69.98 -11.92 61.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.964 0.506 . . . . 0.0 112.094 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.96 -17.35 0.26 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.714 -0.492 . . . . 0.0 112.505 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -153.18 155.18 36.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 117.86 0.83 . . . . 0.0 109.985 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -152.29 167.49 28.48 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.465 0.706 . . . . 0.0 109.595 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.99 -58.02 0.17 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.505 -0.609 . . . . 0.0 111.88 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.06 153.81 46.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.794 2.329 . . . . 0.0 110.288 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.28 -49.23 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.612 2.208 . . . . 0.0 111.045 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.4 m -174.26 155.95 2.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.34 1.056 . . . . 0.0 109.343 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.44 ' HD3' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt180 55.96 -1.37 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 167.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -54.13 160.23 1.62 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.476 1.034 . . . . 0.0 112.607 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 -139.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 112.228 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.254 40.2 mt-10 -132.21 -18.99 2.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -165.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.37 77.25 1.64 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.976 1.31 . . . . 0.0 109.941 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtm-85 -83.37 148.27 27.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.452 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.488 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -136.79 129.55 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 126.508 1.923 . . . . 0.0 107.402 173.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.81 153.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.7 106.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 53.7 p -105.13 152.55 22.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.976 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.82 18.11 5.29 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 4.7 mp -95.79 13.72 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 90.5 Cg_exo -42.67 -38.33 6.34 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.586 2.191 . . . . 0.0 116.63 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 82.4 Cg_exo -44.59 -61.72 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 6.0 t 179.41 -42.96 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.674 1.19 . . . . 0.0 107.822 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.24 -172.58 0.04 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.877 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -168.59 165.84 12.14 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.863 -0.786 . . . . 0.0 109.152 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -76.5 -30.28 57.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -68.51 -39.94 81.04 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.607 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 81.2 m-20 -76.89 -26.97 54.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.484 -0.135 . . . . 0.0 110.847 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -34.93 78.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HD3' ' B' ' 117' ' ' ARG . 9.6 mtpm? -74.38 -39.28 62.81 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.479 ' CG ' ' H1 ' ' A' ' 6' ' ' ' G' . 2.9 m-20 -66.68 -1.48 3.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.441 1.097 . . . . 0.0 113.713 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -129.89 -39.19 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.551 0.614 . . . . 0.0 111.523 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' MET . . . . . 0.422 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 84.0 mmm -70.39 -14.22 62.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.37 0.532 . . . . 0.0 109.987 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -47.72 -20.93 0.32 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.698 0.799 . . . . 0.0 112.599 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.97 -42.92 84.33 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.226 0.611 . . . . 0.0 111.132 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -27.74 65.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.639 0.776 . . . . 0.0 111.569 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.37 -166.46 36.53 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.28 79.3 9.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.462 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.2 OUTLIER -65.86 148.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 52.0 t -128.08 -33.28 2.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.861 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -134.58 157.72 45.86 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.048 0.84 . . . . 0.0 110.787 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -152.74 164.27 38.1 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -145.4 151.32 38.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.604 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -130.54 140.02 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 121.743 0.782 . . . . 0.0 110.504 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -104.06 10.66 35.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.845 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.604 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 41.73 26.25 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.51 2.324 . . . . 0.0 114.26 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -143.33 3.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.72 -10.32 3.98 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.154 0.434 . . . . 0.0 113.677 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -142.84 166.73 23.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.122 0.461 . . . . 0.0 110.639 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.86 -164.6 29.89 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.412 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.0 p -142.74 163.06 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 122.773 0.429 . . . . 0.0 111.344 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -156.04 154.91 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.374 1.069 . . . . 0.0 109.705 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.28 159.54 40.09 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -125.88 171.07 11.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 122.01 0.909 . . . . 0.0 112.202 -171.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.22 -9.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.443 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -149.7 139.3 21.64 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.028 0.531 . . . . 0.0 109.585 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.13 -22.67 66.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.77 -29.43 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.047 -0.408 . . . . 0.0 110.802 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.45 -20.4 60.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.14 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.488 ' CG ' HG13 ' B' ' 123' ' ' VAL . 29.8 ttp -79.48 -52.24 8.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -63.13 -21.84 66.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 43.5 t80 -74.77 -33.04 62.22 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.422 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -73.56 -15.83 61.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.331 0.652 . . . . 0.0 111.701 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.422 ' O ' HG22 ' B' ' 172' ' ' VAL 0.251 8.8 p -115.47 32.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.859 0.838 . . . . 0.0 111.643 175.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -142.63 -16.7 0.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.137 169.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -124.19 -25.37 4.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 112.534 173.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.49 -2.82 20.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.415 0.286 . . . . 0.0 110.248 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.6 143.41 42.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.118 0.967 . . . . 0.0 110.269 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.41 27.8 10.62 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.8 p -127.91 166.69 17.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.03 144.31 29.3 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.567 0.747 . . . . 0.0 111.952 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -137.48 161.23 36.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.275 1.83 . . . . 0.0 109.074 171.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -138.99 149.45 44.71 Favored 'General case' 0 C--O 1.228 -0.043 0 C-N-CA 123.941 0.897 . . . . 0.0 109.537 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 93.2 p -138.57 170.11 16.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 111.733 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.449 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 14.7 p-80 -62.65 -15.33 51.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.765 1.226 . . . . 0.0 112.489 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.59 -43.36 99.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.049 0.452 . . . . 0.0 110.753 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.9 13.92 3.21 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -138.16 178.88 6.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.238 0.615 . . . . 0.0 111.641 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 68.1 p -144.41 158.88 43.53 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.541 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.99 162.56 18.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.156 0.982 . . . . 0.0 108.669 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -69.46 152.02 45.37 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.106 -0.371 . . . . 0.0 110.555 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -127.48 114.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.446 0.641 . . . . 0.0 109.996 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -85.77 95.32 9.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.23 0.538 . . . . 0.0 109.91 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 8.0 t -67.29 146.56 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.188 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -135.04 158.08 45.28 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 121.015 0.436 . . . . 0.0 110.514 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.3 m -73.65 4.57 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.26 1.824 . . . . 0.0 113.628 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.3 t70 90.97 157.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.367 1.467 . . . . 0.0 110.703 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.203 0 CA-C-O 117.274 -1.848 . . . . 0.0 111.19 174.51 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 C5'-C4'-C3' 112.032 -2.312 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 1 O4'-C1'-N19 112.242 4.042 . 0.372 5p . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O4'-C1'-N19 111.837 3.637 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 C5'-C4'-C3' 111.344 -2.77 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 1 C4'-C3'-C2' 98.112 -4.588 . 0.199 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 O4'-C1'-N19 112.813 4.613 . 0.404 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.604 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.416 -3.087 1 O4'-C1'-N19 112.648 4.448 . 0.03 '#a' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.778 0 C5'-C4'-C3' 110.804 -3.131 . 0.599 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.44 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -150.46 40.48 0.2 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.201 0.601 . . . . 0.0 112.118 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 76.7 Cg_endo -68.85 8.71 0.54 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.691 2.928 . . . . 0.0 112.603 -175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -141.59 9.63 2.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.469 0.708 . . . . 0.0 110.94 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.64 26.59 0.23 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -60.61 -15.56 29.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.769 0.827 . . . . 0.0 112.899 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -140.74 9.71 2.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.178 0.444 . . . . 0.0 112.167 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 175.86 -176.23 47.5 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.32 170.43 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.774 2.983 . . . . 0.0 110.686 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.01 11.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 1 C-N-CA 126.023 4.482 . . . . 0.0 116.721 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.483 ' C ' ' HD2' ' B' ' 117' ' ' ARG . 42.4 m -155.39 -2.17 0.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 109.054 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' B' ' 116' ' ' SER . 0.2 OUTLIER 34.2 46.7 0.17 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.113 2.165 . . . . 0.0 116.484 167.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -56.92 171.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.669 1.188 . . . . 0.0 112.796 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 7.5 t -144.29 -129.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.0 -19.77 1.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -135.6 77.55 1.67 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.956 1.302 . . . . 0.0 110.953 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -77.75 148.48 34.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.229 1.812 . . . . 0.0 113.407 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -139.27 127.04 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.982 2.113 . . . . 0.0 108.37 172.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.461 HG23 ' HA ' ' B' ' 195' ' ' ASP . 54.0 t -63.51 159.03 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 O-C-N 121.787 -0.571 . . . . 0.0 109.614 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.01 116.17 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 85.4 p -125.67 143.69 50.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.094 0.473 . . . . 0.0 111.798 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.74 -1.7 26.02 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.34 147.88 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 127.522 2.329 . . . . 0.0 110.244 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.07 162.8 38.17 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.487 2.791 . . . . 0.0 111.421 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 -10.74 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 1 C-N-CA 125.379 4.053 . . . . 0.0 115.838 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' B' ' 184' ' ' GLU . 14.9 m -133.81 12.2 4.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.051 0.842 . . . . 0.0 112.91 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.57 167.28 4.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -148.68 166.94 26.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.243 -0.563 . . . . 0.0 110.489 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -75.32 -28.16 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.348 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -67.85 -38.06 82.67 Favored 'General case' 0 C--O 1.231 0.089 0 O-C-N 122.339 -0.226 . . . . 0.0 110.824 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.604 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 57.0 m-20 -79.81 -19.65 47.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -29.8 66.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -78.75 -38.78 37.91 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.42 -1.78 5.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.4 1.08 . . . . 0.0 113.342 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -130.32 -36.53 1.48 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.702 0.683 . . . . 0.0 111.356 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.3 mmm -72.73 -10.93 60.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.122 0.419 . . . . 0.0 111.069 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -48.96 -16.59 0.14 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -71.75 -42.26 67.43 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.98 0.512 . . . . 0.0 111.02 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.74 -29.14 68.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.476 0.71 . . . . 0.0 111.168 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.93 -168.36 36.25 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -80.57 79.4 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 0.0 110.412 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.469 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.6 OUTLIER -64.1 149.68 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.8 t -134.36 -35.98 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.214 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 8.8 t80 -134.61 160.56 37.71 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.79 0.805 . . . . 0.0 110.17 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.09 168.67 26.55 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -148.1 158.43 44.06 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 168.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.7 p -135.57 143.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 121.176 0.512 . . . . 0.0 110.12 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -108.36 6.97 26.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.26 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.0 mtt-85 61.4 18.63 9.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.491 0.717 . . . . 0.0 112.209 170.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -137.64 6.26 2.71 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.32 22.13 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 121.555 -0.716 . . . . 0.0 112.194 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -141.16 160.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.241 0.616 . . . . 0.0 110.083 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.28 -164.42 30.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.99 162.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.257 0.528 . . . . 0.0 110.876 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.8 p -148.0 160.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.129 0.971 . . . . 0.0 108.65 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 37.7 tt0 -157.53 152.84 26.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.056 -0.403 . . . . 0.0 110.819 -170.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -126.43 170.56 11.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.689 0.757 . . . . 0.0 112.181 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.22 -9.63 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.369 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -149.99 139.76 21.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -64.65 -21.36 66.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.32 -31.51 58.2 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.311 0.505 . . . . 0.0 111.004 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -72.89 -21.49 60.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.107 0.479 . . . . 0.0 109.825 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.495 ' SD ' HG13 ' B' ' 123' ' ' VAL . 38.2 ttp -77.63 -52.58 8.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.356 0.663 . . . . 0.0 110.754 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 75.4 m -63.38 -18.71 63.97 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.564 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 30.6 t80 -75.37 -28.75 59.66 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.91 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.19 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 122.086 -0.384 . . . . 0.0 110.388 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.69 2.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.0 -16.26 2.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.564 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.7 mppt? -126.21 -21.63 4.22 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.84 3.54 12.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.867 0.467 . . . . 0.0 109.862 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.826 0.85 . . . . 0.0 108.819 172.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 58.44 35.93 25.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.005 0.522 . . . . 0.0 111.346 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 51.8 p -136.43 175.07 9.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 110.64 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -62.33 148.65 44.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -146.35 165.6 28.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.045 2.138 . . . . 0.0 107.439 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -141.25 135.34 30.57 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.907 -0.495 . . . . 0.0 109.681 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.5 t -70.4 -174.83 0.9 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.06 0.944 . . . . 0.0 111.512 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.472 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 27.2 p-80 -117.39 11.64 14.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.134 0.573 . . . . 0.0 109.821 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' B' ' 131' ' ' SER . 33.1 mm-40 -127.22 -13.74 5.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.036 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.36 155.78 7.01 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 56.86 -175.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.218 1.807 . . . . 0.0 114.724 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 23.3 p -122.88 171.05 9.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.548 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 -168.91 2.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.862 0.865 . . . . 0.0 108.896 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.21 149.93 47.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.59 108.51 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.213 0.53 . . . . 0.0 112.206 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -83.27 88.34 6.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 7.9 t -76.14 81.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.765 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.79 159.44 22.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.24 0.616 . . . . 0.0 111.534 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.1 m -73.0 5.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 126.514 1.926 . . . . 0.0 114.292 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.461 ' HA ' HG23 ' B' ' 124' ' ' VAL . 4.4 t0 88.2 155.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 124.833 1.333 . . . . 0.0 110.624 171.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.277 0 CA-C-O 117.108 -1.94 . . . . 0.0 111.013 174.641 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 110.343 -3.438 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . 0.56 HO2' ' N ' ' B' ' 106' ' ' MET . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C5'-C4'-C3' 110.676 -3.216 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.501 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.835 0 C3'-C2'-C1' 104.485 3.316 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 O4'-C1'-N19 112.023 3.823 . 0.103 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.567 1 C1'-O4'-C4' 105.502 -4.554 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 O4'-C1'-N19 112.878 4.678 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.606 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 N19-C1'-C2' 107.787 -3.508 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 C5'-C4'-C3' 110.535 -3.31 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.56 ' N ' HO2' ' A' ' 2' ' ' ' G' . 1.7 mpt? . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.44 167.11 15.17 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.162 0.985 . . . . 0.0 108.389 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -50.38 -18.97 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.845 3.03 . . . . 0.0 114.414 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -142.14 30.56 1.59 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.839 1.256 . . . . 0.0 109.736 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.02 30.62 1.9 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -69.07 -17.51 63.89 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.496 1.119 . . . . 0.0 111.648 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -146.98 -167.45 2.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.379 0.671 . . . . 0.0 110.097 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.84 -169.84 14.78 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.414 ' N ' ' HD2' ' B' ' 115' ' ' PRO . 87.7 Cg_exo -45.02 -42.21 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.188 3.258 . . . . 0.0 114.904 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' B' ' 114' ' ' PRO . 96.6 Cg_endo -75.97 126.64 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.536 1.491 . . . . 0.0 110.786 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.8 m -158.67 172.65 17.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.114 1.365 . . . . 0.0 107.915 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 14.6 mtt-85 46.65 21.61 0.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -53.29 153.25 3.97 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.65 1.18 . . . . 0.0 112.069 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.0 t -135.86 -110.49 0.2 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.866 0.466 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -148.61 -26.12 0.32 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.419 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -122.24 -32.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -166.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 40.75 151.38 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.778 2.831 . . . . 0.0 118.162 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.497 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.1 OUTLIER -149.69 148.33 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.256 1.822 . . . . 0.0 108.828 174.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -90.92 171.95 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.37 142.96 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -143.82 150.92 39.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.299 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 103.24 -2.75 47.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -49.25 126.6 15.71 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 127.728 2.411 . . . . 0.0 109.742 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.84 155.13 53.76 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.883 2.389 . . . . 0.0 110.269 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.79 -22.12 28.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.483 2.789 . . . . 0.0 112.561 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m -73.34 -9.22 58.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.391 1.076 . . . . 0.0 112.462 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.44 165.81 39.36 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 121.545 0.525 . . . . 0.0 112.598 -174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' SER . . . . . 0.423 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 30.1 t -161.72 167.79 24.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.184 1.394 . . . . 0.0 107.445 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -64.42 -26.93 68.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.857 0.753 . . . . 0.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -70.05 -28.95 65.87 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.004 -0.435 . . . . 0.0 111.706 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.606 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 75.1 m-20 -89.92 -13.65 35.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.766 0.257 . . . . 0.0 110.925 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.25 3.48 54.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.697 0.399 . . . . 0.0 111.024 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -110.26 -35.33 6.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.11 -3.88 11.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.32 1.048 . . . . 0.0 112.771 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' HIS . . . . . 0.44 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 6.4 t-80 -127.51 -36.44 2.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.286 0.494 . . . . 0.0 110.734 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 76.5 mmm -69.1 -19.07 64.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.577 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -48.57 -20.05 0.4 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.23 1.012 . . . . 0.0 112.811 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -41.76 97.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.002 0.521 . . . . 0.0 111.252 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.484 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.69 -29.76 69.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.563 . . . . 0.0 111.204 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.72 -177.49 35.31 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.14 118.0 14.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.998 0.399 . . . . 0.0 110.161 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -114.33 151.67 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 148' ' ' CYS . . . . . 0.417 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 7.4 p -130.7 -21.71 2.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.295 -0.859 . . . . 0.0 111.729 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -126.02 149.51 48.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 119.122 0.874 . . . . 0.0 111.805 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.43 19.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.436 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 19.5 t0 -141.93 154.61 45.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.528 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.9 p -132.19 145.61 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.185 0.517 . . . . 0.0 110.214 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.16 7.16 27.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.779 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.528 ' H ' HG22 ' B' ' 152' ' ' VAL . 24.6 mtp85 61.34 16.98 7.87 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.496 0.718 . . . . 0.0 112.77 170.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -137.95 -12.0 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.23 -2.99 2.13 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.799 0.727 . . . . 0.0 112.922 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.81 167.68 21.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.127 0.571 . . . . 0.0 109.799 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.74 -167.4 35.25 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 6.7 p -141.09 161.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.369 0.604 . . . . 0.0 110.613 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.7 159.93 2.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -157.75 154.12 27.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.01 -0.431 . . . . 0.0 111.527 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 22.7 m-85 -122.87 163.55 20.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.893 0.854 . . . . 0.0 112.248 -170.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.36 -8.82 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.43 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -152.9 154.72 35.63 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.071 0.549 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -69.15 -25.58 64.44 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -82.83 -31.77 27.91 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.197 0.453 . . . . 0.0 111.313 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -70.57 -2.28 13.71 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.699 0.4 . . . . 0.0 110.332 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.497 ' SD ' HG13 ' B' ' 123' ' ' VAL . 40.6 ttp -111.94 -46.85 3.18 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.864 1.265 . . . . 0.0 110.897 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 58.4 m -63.23 -20.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 6.3 t80 -70.57 -31.51 68.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.72 69.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.093 -0.38 . . . . 0.0 110.367 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.21 5.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -134.4 -19.02 1.93 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -19.5 5.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.81 2.73 13.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.136 0.574 . . . . 0.0 109.48 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.36 136.75 41.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.4 27.94 13.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.178 0.991 . . . . 0.0 111.255 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.3 p -138.09 179.46 6.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.438 0.695 . . . . 0.0 110.806 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -56.01 148.56 17.25 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' PHE . . . . . 0.44 ' HA ' ' NE2' ' B' ' 140' ' ' HIS . 24.8 t80 -146.57 159.16 43.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.344 1.857 . . . . 0.0 108.179 168.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -148.01 153.07 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 16.6 m -135.65 170.37 16.08 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.467 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 14.3 p-80 -57.37 -19.56 23.79 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.987 1.315 . . . . 0.0 113.468 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.417 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 32.8 mm-40 -77.55 -11.02 59.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 117.957 0.344 . . . . 0.0 111.07 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.57 40.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.722 0.677 . . . . 0.0 111.908 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -75.04 170.86 15.17 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.338 0.59 . . . . 0.0 111.134 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 2.9 p -135.79 169.04 18.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.168 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.92 -167.52 1.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.969 0.908 . . . . 0.0 108.784 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -115.02 155.06 27.69 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 30.8 pt -134.9 148.86 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.396 0.617 . . . . 0.0 110.778 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -113.33 84.63 2.04 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 107.997 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 t -67.81 87.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.959 0.904 . . . . 0.0 111.255 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' B' ' 194' ' ' VAL . 50.5 tptt -76.68 160.24 29.53 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 110.748 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.572 ' H ' ' HD2' ' B' ' 193' ' ' LYS . 8.1 p -57.97 -27.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.302 2.641 . . . . 0.0 117.774 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.557 ' HA ' HG23 ' B' ' 124' ' ' VAL . 38.1 t70 98.48 125.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.183 2.193 . . . . 0.0 110.141 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 CA-C-O 117.513 -1.715 . . . . 0.0 111.332 172.657 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 110.312 -3.459 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.247 2 C1'-O4'-C4' 105.156 -4.938 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . 0.446 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 O4'-C1'-N19 112.125 3.925 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.278 0 O4'-C1'-N19 112.145 3.945 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.237 3 C4'-C3'-C2' 98.275 -4.425 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . 0.453 ' H22' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.417 -2.963 2 O4'-C1'-N19 113.717 5.517 . 0.01 5q . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.613 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 O4'-C1'-N19 111.258 3.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . 0.434 " H5'" ' C6 ' ' A' ' 8' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C5'-C4'-C3' 111.108 -2.928 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.526 0.203 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.25 154.08 31.77 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.975 0.51 . . . . 0.0 109.645 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.21 9.06 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.069 3.179 . . . . 0.0 112.816 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -62.58 -11.17 15.03 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.43 -161.11 35.29 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 118.495 0.589 . . . . 0.0 112.219 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -134.37 -10.43 2.51 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.107 0.563 . . . . 0.0 111.025 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 35.2 t80 49.38 14.35 0.1 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.375 1.47 . . . . 0.0 113.8 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.13 66.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.318 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.06 -40.64 33.83 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.626 2.884 . . . . 0.0 115.18 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.33 147.1 37.89 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.034 2.49 . . . . 0.0 112.572 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 20.4 m -157.44 168.32 27.67 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.582 0.753 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 20.8 mtt-85 49.53 26.53 1.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ARG . . . . . 0.544 ' CZ ' ' HA ' ' B' ' 118' ' ' ARG . 4.1 mmp_? -52.23 155.35 2.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.29 1.036 . . . . 0.0 113.697 -174.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.7 t -155.97 -137.04 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.447 0.699 . . . . 0.0 111.724 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -138.04 -26.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -167.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.404 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.1 p30 -131.1 80.54 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.081 0.953 . . . . 0.0 111.644 -170.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -78.66 148.83 33.01 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.577 . . . . 0.0 113.81 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.479 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -141.57 136.42 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.687 1.595 . . . . 0.0 110.017 171.421 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' B' ' 193' ' ' LYS . 2.3 t -76.39 162.34 4.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.06 105.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -111.38 151.42 28.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.01 8.4 44.96 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 128' ' ' LEU . 5.6 tp -60.51 146.99 84.03 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 126.69 1.996 . . . . 0.0 111.503 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.9 164.87 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.952 3.101 . . . . 0.0 109.689 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.9 -21.52 43.8 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.262 2.641 . . . . 0.0 111.631 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -73.46 -15.76 61.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.383 0.673 . . . . 0.0 112.09 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.12 148.27 24.88 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.5 t -155.76 165.65 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.585 0.754 . . . . 0.0 109.447 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -72.19 -27.04 62.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.931 -0.48 . . . . 0.0 111.702 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -65.16 -31.35 72.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.804 0.729 . . . . 0.0 111.151 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 55.2 m-20 -83.14 -21.12 33.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.499 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 137' ' ' LEU . 1.0 OUTLIER -75.28 -17.03 60.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.29 0.496 . . . . 0.0 111.109 -176.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -89.15 -44.29 10.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.453 ' CG ' ' H22' ' A' ' 6' ' ' ' G' . 4.2 m-20 -68.95 -11.64 60.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -120.45 -30.9 4.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.398 0.999 . . . . 0.0 111.221 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.5 mmm -76.81 -14.8 59.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.94 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -43.77 -21.02 0.03 OUTLIER 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.47 -42.23 87.84 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 123.589 0.755 . . . . 0.0 111.245 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.495 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.79 -28.87 69.33 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.01 0.524 . . . . 0.0 110.499 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.41 32.94 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.39 123.83 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.35 -0.5 . . . . 0.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -120.8 154.25 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 148' ' ' CYS . . . . . 0.408 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 53.4 t -134.64 -24.86 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.526 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 71.3 t80 -127.15 153.68 45.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 118.992 0.814 . . . . 0.0 111.947 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.74 166.85 32.26 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.023 171.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.408 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 26.5 t0 -152.07 160.26 43.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.559 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -135.84 145.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.051 0.453 . . . . 0.0 110.03 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -109.42 6.55 24.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.257 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.559 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.6 mtt180 61.83 17.72 9.1 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.651 0.781 . . . . 0.0 112.611 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.39 10.19 2.5 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.6 6.01 27.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.572 0.624 . . . . 0.0 111.978 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.28 156.81 45.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.123 0.569 . . . . 0.0 109.586 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.51 -166.0 30.42 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 7.6 p -145.55 162.38 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.016 0.436 . . . . 0.0 111.539 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.6 p -151.17 157.62 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.354 1.062 . . . . 0.0 108.547 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -155.13 140.96 18.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.931 -0.481 . . . . 0.0 111.154 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 41.9 m-85 -110.25 167.61 10.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.809 0.814 . . . . 0.0 113.053 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.75 -11.08 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.306 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -150.5 141.97 23.43 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -65.18 -26.05 67.99 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.1 -31.15 64.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.035 0.38 . . . . 0.0 110.661 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.02 -20.35 60.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.815 0.341 . . . . 0.0 110.202 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.479 ' CG ' HG13 ' B' ' 123' ' ' VAL . 33.9 ttp -80.51 -55.37 4.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.371 0.669 . . . . 0.0 110.515 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 70.3 m -64.33 -18.26 64.46 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 5.4 t80 -73.48 -32.09 64.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.55 68.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.866 -0.521 . . . . 0.0 110.575 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.92 3.13 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -132.3 -17.26 2.67 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.04 0.836 . . . . 0.0 112.761 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -21.2 4.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.44 0.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.76 147.21 33.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.71 37.39 23.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.513 0.725 . . . . 0.0 112.913 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 66.9 p -133.26 167.59 20.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.128 0.49 . . . . 0.0 110.372 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -61.76 140.84 58.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.954 0.902 . . . . 0.0 113.175 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' B' ' 180' ' ' PHE . 0.1 OUTLIER -157.78 146.82 19.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.846 1.258 . . . . 0.0 110.284 169.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 181' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' B' ' 187' ' ' THR . 46.8 ttt180 167.07 -62.29 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.123 2.569 . . . . 0.0 108.954 165.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.5 m 46.06 24.82 0.28 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 167.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 2.6 p-80 -143.37 2.91 1.3 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.88 1.673 . . . . 0.0 114.594 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -128.2 -15.33 4.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.203 0.91 . . . . 0.0 112.778 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.32 -12.88 1.06 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.591 0.596 . . . . 0.0 114.591 171.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' B' ' 181' ' ' ARG . 12.3 pt-20 -155.98 -157.45 0.72 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.923 0.862 . . . . 0.0 109.639 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' THR . . . . . 0.568 ' HA ' ' HB3' ' B' ' 181' ' ' ARG . 40.5 p -151.18 168.1 25.74 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.158 1.383 . . . . 0.0 110.604 174.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.23 39.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.636 1.575 . . . . 0.0 107.477 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -67.61 145.46 54.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 110.676 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 38.1 pt -123.22 136.28 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.945 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -104.32 79.6 1.61 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.824 0.85 . . . . 0.0 108.733 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.88 131.1 26.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.454 ' HE2' HG11 ' B' ' 124' ' ' VAL . 55.2 pttt -133.67 165.36 25.11 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.428 HG22 ' H ' ' B' ' 194' ' ' VAL . 17.8 m -74.74 47.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 114.385 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 54.45 23.8 4.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.915 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 117.729 -1.595 . . . . 0.0 111.585 -172.269 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 110.865 -3.09 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.248 1 O4'-C1'-N19 113.044 4.844 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 O4'-C1'-N19 111.733 3.533 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 O4'-C1'-N19 110.659 2.459 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.298 0 C4'-C3'-C2' 98.972 -3.728 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.324 2 O4'-C1'-N19 114.172 5.972 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.601 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 P--O5' 1.617 2.421 0 N19-C1'-C2' 107.43 -3.731 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.156 0 C4'-C3'-C2' 100.241 -2.459 . 0.01 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.79 162.05 27.79 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.83 157.87 5.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.993 3.128 . . . . 0.0 113.376 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -145.92 178.95 7.8 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.855 1.262 . . . . 0.0 109.124 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.46 176.7 40.99 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 102.41 -5.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 127.871 2.468 . . . . 0.0 109.976 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -156.23 175.09 14.45 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.634 0.773 . . . . 0.0 110.026 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -175.83 -171.69 39.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.84 153.29 6.14 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.45 3.434 . . . . 0.0 112.768 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.8 166.07 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.852 3.035 . . . . 0.0 111.564 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 57.4 m -149.29 -42.93 0.14 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.442 0.697 . . . . 0.0 110.273 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -149.77 0.36 0.48 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.938 0.895 . . . . 0.0 112.336 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.69 171.96 0.79 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -134.42 -104.81 0.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -169.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -149.78 -25.18 0.27 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -166.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.15 -33.35 5.71 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -166.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 40.1 157.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.01 146.94 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.493 2.317 . . . . 0.0 107.849 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.72 168.63 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.0 p -137.45 130.47 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 58.3 p -138.42 153.53 48.88 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.36 6.01 53.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.27 139.16 97.52 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 127.811 2.444 . . . . 0.0 111.537 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.33 156.09 22.26 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.151 2.567 . . . . 0.0 110.145 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.69 -22.35 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.323 2.682 . . . . 0.0 112.07 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.9 m -73.08 7.5 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.319 1.448 . . . . 0.0 113.078 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 162.33 13.25 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.556 0.617 . . . . 0.0 111.585 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' SER . . . . . 0.401 ' CB ' ' N1 ' ' A' ' 7' ' ' ' A' . 45.1 t -156.67 173.11 17.44 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.12 0.968 . . . . 0.0 108.799 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -64.58 -30.59 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.657 -0.652 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -66.51 -23.72 66.29 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.912 0.324 . . . . 0.0 111.46 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.601 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 48.1 m-20 -94.66 -24.1 17.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -174.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -23.27 61.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.227 -0.295 . . . . 0.0 110.584 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -80.82 -39.43 26.66 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.82 -0.15 5.09 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.812 1.245 . . . . 0.0 114.194 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -135.0 -38.51 0.78 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.461 0.573 . . . . 0.0 111.262 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 84.4 mmm -68.39 -11.78 60.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.564 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -45.02 -24.6 0.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.296 1.038 . . . . 0.0 112.536 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.49 -41.0 93.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.972 -0.455 . . . . 0.0 111.205 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -68.74 -31.09 69.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.674 0.789 . . . . 0.0 111.475 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.54 -171.71 40.1 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -80.87 77.03 7.78 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.816 0.817 . . . . 0.0 110.593 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.43 143.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -126.57 -28.9 2.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.818 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -136.44 157.77 46.01 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 118.79 0.723 . . . . 0.0 111.018 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.88 166.93 31.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 49.3 t0 -147.51 147.48 30.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.62 HG22 ' H ' ' B' ' 154' ' ' ARG . 6.0 p -127.58 142.01 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 121.54 0.685 . . . . 0.0 111.195 -171.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -105.95 10.57 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.62 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.62 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.31 24.23 0.03 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 127.177 2.191 . . . . 0.0 114.994 178.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.46 5.31 1.42 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.31 -9.62 4.1 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 118.167 0.439 . . . . 0.0 113.373 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.07 167.83 21.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.331 0.566 . . . . 0.0 110.665 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.93 40.07 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 2.6 p -134.77 159.38 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.8 p -148.64 157.32 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.96 157.14 34.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.756 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.7 m-85 -130.9 169.2 16.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.852 0.861 . . . . 0.0 110.641 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.2 -13.75 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.759 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.95 156.36 46.08 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.625 0.77 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.85 -28.5 40.05 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.625 0.77 . . . . 0.0 112.007 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.05 -31.07 25.58 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -77.62 7.24 5.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.737 0.415 . . . . 0.0 110.353 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.85 -44.55 3.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.355 1.462 . . . . 0.0 110.028 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -62.41 -23.62 66.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.85 -29.8 70.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.35 -37.45 68.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.152 -0.343 . . . . 0.0 110.578 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.506 HG22 ' O ' ' B' ' 172' ' ' VAL 0.282 0.6 OUTLIER -82.91 28.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.447 0.641 . . . . 0.0 111.694 177.049 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.585 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.6 ptm180 -148.0 -25.2 0.35 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.243 -0.911 . . . . 0.0 112.789 171.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.585 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.2 OUTLIER -108.89 -26.77 10.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.446 0.566 . . . . 0.0 111.99 176.06 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.8 mm? -115.28 0.53 13.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.22 0.608 . . . . 0.0 110.186 -172.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -82.43 144.63 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.163 0.985 . . . . 0.0 109.708 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 26.2 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.792 0.837 . . . . 0.0 111.97 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -135.31 162.83 31.48 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.715 1.206 . . . . 0.0 108.6 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 18.2 ptmt -67.99 158.27 33.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.866 -1.515 . . . . 0.0 114.293 -168.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 148.04 34.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.235 167.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 181' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' B' ' 182' ' ' SER . 3.4 tmm_? -130.84 137.31 49.33 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -172.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.415 ' N ' ' HD2' ' B' ' 181' ' ' ARG . 47.6 p -145.08 -170.23 3.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.759 -172.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.463 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.7 p-80 -59.67 -176.19 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.447 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 4.6 mm-40 65.6 -23.34 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.432 1.893 . . . . 0.0 112.726 -173.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.11 26.66 4.55 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.983 170.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.76 178.21 7.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.437 1.119 . . . . 0.0 113.488 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.81 156.13 22.3 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.519 -177.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.51 160.51 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.79 1.236 . . . . 0.0 109.161 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 189' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 5.2 m-30 -65.91 151.16 47.35 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 39.8 pt -131.2 133.64 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.13 95.83 7.37 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.276 0.56 . . . . 0.0 109.823 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.95 116.08 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.9 tttt -90.57 171.88 9.08 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 173.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.417 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.4 p -66.98 -28.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 0.0 114.108 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 24.0 t70 141.87 163.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.653 2.381 . . . . 0.0 109.391 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.27 0 CA-C-O 117.413 -1.77 . . . . 0.0 111.351 176.103 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 1 O4'-C1'-N19 114.088 5.888 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 1 O4'-C1'-N19 113.913 5.713 . 0.237 5z . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 O4'-C1'-N19 111.898 3.698 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.785 0 C5'-C4'-C3' 109.59 -3.94 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 C4'-C3'-C2' 97.873 -4.827 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.766 0 O4'-C1'-N19 112.153 3.953 . 0.24 7r . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.607 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 N19-C1'-C2' 107.931 -3.418 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 111.918 -2.388 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -151.9 45.67 0.33 Allowed Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.051 0.541 . . . . 0.0 111.829 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 92.6 Cg_endo -71.82 -6.92 20.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.078 2.519 . . . . 0.0 112.318 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -145.17 168.21 20.93 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.508 0.723 . . . . 0.0 110.165 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.58 39.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -136.02 16.27 3.27 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.048 0.539 . . . . 0.0 111.816 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -139.68 160.32 40.15 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.932 -0.48 . . . . 0.0 110.584 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.91 -171.25 39.47 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.35 160.36 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.183 3.255 . . . . 0.0 112.322 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.3 164.92 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.248 3.299 . . . . 0.0 113.551 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 59.2 m -75.99 -32.35 59.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.02 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -170.14 -30.18 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.199 1.4 . . . . 0.0 110.108 -168.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' B' ' 119' ' ' SER . 0.2 OUTLIER 52.07 -173.48 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 126.379 1.872 . . . . 0.0 113.518 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.595 ' H ' ' HG3' ' B' ' 118' ' ' ARG . 0.8 OUTLIER -150.04 -178.39 6.46 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -176.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 120' ' ' GLU . . . . . 0.563 ' HB2' HD22 ' B' ' 121' ' ' ASN . 33.6 mt-10 -148.53 -29.3 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.39 1.876 . . . . 0.0 113.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.3 p30 -140.98 78.53 1.65 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.663 2.385 . . . . 0.0 107.535 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -89.58 150.61 22.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.653 0.739 . . . . 0.0 112.757 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -138.36 127.57 32.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 126.445 1.898 . . . . 0.0 107.866 174.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' B' ' 195' ' ' ASP . 74.1 t -68.13 157.23 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.05 114.54 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.9 p -129.06 146.29 51.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.74 -0.94 39.11 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.08 144.69 48.16 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 128.054 2.542 . . . . 0.0 110.535 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.98 161.1 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.802 2.335 . . . . 0.0 109.478 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.05 -11.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.833 2.355 . . . . 0.0 110.687 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m -79.13 -8.15 58.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.575 1.15 . . . . 0.0 112.225 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.04 164.66 40.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.264 0.484 . . . . 0.0 111.987 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' SER . . . . . 0.423 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 41.1 t -157.68 168.85 26.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.117 0.967 . . . . 0.0 108.4 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -63.36 -27.24 69.18 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.545 0.611 . . . . 0.0 111.773 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -68.33 -46.77 69.28 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.186 0.448 . . . . 0.0 110.705 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.607 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 81.9 m-20 -70.08 -24.39 63.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -20.76 60.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' B' ' 138' ' ' LYS . 50.1 mtpt -85.55 -34.89 21.38 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.566 0.621 . . . . 0.0 109.359 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.62 -40.43 66.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -81.03 -36.53 30.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.738 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.7 mmm -73.1 -20.65 60.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.398 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -51.27 -18.84 1.04 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.585 0.63 . . . . 0.0 112.403 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.81 -39.62 85.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.385 0.674 . . . . 0.0 111.39 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.52 -18.63 65.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.588 0.755 . . . . 0.0 111.775 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 168.39 -95.67 0.11 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.37 133.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -119.8 153.08 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.137 0.494 . . . . 0.0 110.44 -175.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.8 -21.08 3.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.311 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 51.8 t80 -144.31 157.38 44.3 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 120.22 1.373 . . . . 0.0 112.19 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.61 169.65 22.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.628 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -148.76 152.94 37.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.506 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -131.31 140.68 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.415 0.626 . . . . 0.0 109.853 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.14 5.07 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.126 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.506 ' H ' HG22 ' B' ' 152' ' ' VAL . 7.4 mtt180 61.47 16.28 7.41 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.548 0.739 . . . . 0.0 112.709 170.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -135.44 5.83 3.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.97 3.9 15.12 Favored Glycine 0 C--N 1.337 0.597 0 O-C-N 121.881 -0.512 . . . . 0.0 112.197 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.5 p -142.31 161.78 37.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 110.573 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.58 -168.61 37.51 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.3 p -141.45 165.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 117.393 0.596 . . . . 0.0 110.734 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.9 p -153.7 156.67 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.108 0.963 . . . . 0.0 109.246 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -151.09 156.25 40.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.663 0.268 . . . . 0.0 111.612 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 39.8 m-85 -120.43 163.58 17.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.697 1.237 . . . . 0.0 114.171 -169.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.96 -12.74 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.502 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -152.68 142.28 21.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -63.8 -21.01 66.22 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.91 -29.79 58.53 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.876 -0.515 . . . . 0.0 110.952 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -74.15 -18.71 60.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.433 ' CG ' HG13 ' B' ' 123' ' ' VAL . 32.9 ttp -77.17 -53.13 8.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -61.03 -20.6 62.72 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 7.4 t80 -74.13 -30.83 62.48 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.893 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.15 -33.08 67.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.073 -0.392 . . . . 0.0 110.561 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.0 4.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -133.72 -18.91 2.11 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 121.319 -0.863 . . . . 0.0 112.552 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 -19.96 5.41 Favored 'General case' 0 N--CA 1.46 0.047 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.29 2.71 14.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.71 140.52 34.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.365 1.066 . . . . 0.0 108.428 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 65.42 25.06 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.555 0.693 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 53.8 p -135.27 169.58 17.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.9 1.28 . . . . 0.0 108.507 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 9.9 pttt -75.23 155.87 36.33 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.248 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.44 166.23 24.79 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.483 170.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' ARG . . . . . 0.407 ' HD2' ' H ' ' B' ' 182' ' ' SER . 14.9 tpt180 -133.85 151.63 51.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.161 0.984 . . . . 0.0 110.157 -169.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' SER . . . . . 0.407 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 42.4 m -133.62 164.42 27.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.21 0.529 . . . . 0.0 111.42 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.448 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 15.4 p-80 -62.78 -13.1 29.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.027 1.331 . . . . 0.0 113.75 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.414 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 37.7 mm-40 -84.15 -16.67 42.7 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.54 0.609 . . . . 0.0 112.416 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.39 19.27 8.49 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.471 -0.627 . . . . 0.0 113.951 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.04 171.23 14.49 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.53 1.165 . . . . 0.0 111.406 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 69.1 p -138.57 161.23 37.61 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.816 0.446 . . . . 0.0 111.481 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.68 156.2 15.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.015 . . . . 0.0 108.9 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 189' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 2.6 m-30 -72.03 158.57 35.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.061 0.458 . . . . 0.0 111.118 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.03 145.08 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.113 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -102.73 102.39 12.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.976 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.9 79.72 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.047 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.22 158.29 23.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.153 0.501 . . . . 0.0 111.374 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.524 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.6 m -72.64 6.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 126.203 1.801 . . . . 0.0 113.705 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 3.8 t0 91.05 157.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.995 1.435 . . . . 0.0 110.277 170.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.561 -1.688 . . . . 0.0 111.33 174.262 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 C5'-C4'-C3' 111.823 -2.451 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.473 1 O4'-C1'-N19 112.247 4.047 . 0.36 5p . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 C5'-C4'-C3' 110.372 -3.419 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.336 0 O4'-C1'-N19 111.371 3.171 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.442 1 C4'-C3'-C2' 98.476 -4.224 . 0.247 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 1 O4'-C1'-N19 113.134 4.934 . 0.351 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.604 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.422 -2.584 0 C5'-C4'-C3' 110.221 -3.519 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . 0.49 " H5'" ' C6 ' ' A' ' 8' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.06 0 O4'-C1'-N19 110.85 2.65 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.44 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -60.01 -36.51 39.09 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.454 -0.784 . . . . 0.0 113.014 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 34.4 Cg_exo -60.11 3.77 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.707 2.938 . . . . 0.0 114.286 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 55.87 20.07 3.92 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.278 1.031 . . . . 0.0 112.277 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.06 177.38 47.7 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -152.16 12.25 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.602 0.361 . . . . 0.0 111.822 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -140.75 171.15 14.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.478 0.711 . . . . 0.0 110.338 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.88 -180.0 48.8 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' B' ' 115' ' ' PRO . 71.2 Cg_exo -50.74 156.44 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.969 3.78 . . . . 0.0 112.92 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 114' ' ' PRO . 78.0 Cg_exo -52.02 -35.01 59.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 113.602 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' B' ' 117' ' ' ARG . 15.0 m -165.3 -38.49 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' B' ' 116' ' ' SER 0.31 0.0 OUTLIER 161.83 27.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.736 3.214 . . . . 0.0 113.161 166.295 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.1 169.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.849 1.259 . . . . 0.0 113.476 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -140.46 -133.3 0.11 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.775 0.83 . . . . 0.0 112.151 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.64 -19.55 1.84 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -165.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.01 75.43 1.55 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.814 1.245 . . . . 0.0 109.788 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 66.5 mtm-85 -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.436 1.494 . . . . 0.0 113.398 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.4 OUTLIER -139.21 132.86 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 126.604 1.962 . . . . 0.0 108.111 174.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.2 t -66.52 156.59 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 109.774 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.18 100.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 77.3 p -111.3 146.94 36.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.407 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.47 -0.46 32.69 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.17 149.82 44.56 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 128.12 2.568 . . . . 0.0 111.29 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.31 165.16 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.5 2.8 . . . . 0.0 109.668 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.95 -15.69 36.46 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.786 2.324 . . . . 0.0 110.25 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 73.2 m -79.66 -2.57 43.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.875 1.27 . . . . 0.0 112.024 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.75 168.64 54.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' SER . . . . . 0.448 ' HB3' ' CE1' ' B' ' 183' ' ' HIS . 3.9 p -159.75 166.36 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -73.21 -28.67 62.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.334 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -68.34 -40.47 81.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 117.964 0.347 . . . . 0.0 110.246 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.604 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 72.7 m-20 -80.61 -19.73 44.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -34.05 70.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -74.65 -37.95 62.6 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.37 1.47 1.62 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.727 1.211 . . . . 0.0 113.5 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -132.96 -37.74 0.99 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.513 0.597 . . . . 0.0 111.403 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.5 mmm -71.63 -11.35 60.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.421 0.555 . . . . 0.0 110.189 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -47.59 -21.41 0.35 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 123.914 0.886 . . . . 0.0 113.114 171.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.4 -41.88 88.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -67.2 -27.81 67.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.15 -170.26 36.91 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -83.07 74.26 9.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.839 0.828 . . . . 0.0 110.565 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.4 OUTLIER -61.11 149.56 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 34.4 t -131.74 -33.37 1.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -136.37 158.89 43.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 110.609 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.45 166.28 33.19 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -145.19 150.52 36.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.576 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.8 p -129.49 141.38 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.599 0.714 . . . . 0.0 110.362 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.79 11.61 29.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.279 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.576 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.9 23.3 0.03 OUTLIER 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.954 2.101 . . . . 0.0 114.895 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.07 6.75 1.78 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.14 6.38 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 118.557 0.617 . . . . 0.0 113.202 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 2.9 p -142.73 163.46 32.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.271 0.536 . . . . 0.0 110.322 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.04 -168.29 35.43 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 160' ' ' VAL . 6.6 p -140.91 162.29 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 122.94 0.496 . . . . 0.0 111.105 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -154.59 153.95 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 124.327 1.051 . . . . 0.0 109.472 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 17.1 pt-20 -154.47 160.15 41.42 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -122.73 171.72 8.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 122.061 0.934 . . . . 0.0 111.984 -171.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.05 -20.11 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.22 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -145.11 143.89 30.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.135 0.574 . . . . 0.0 110.371 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.02 -24.32 63.26 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.29 -29.53 62.78 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.546 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.83 -19.33 60.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.478 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.2 ttp -78.17 -52.79 8.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.181 0.592 . . . . 0.0 110.481 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.3 m -64.8 -19.27 65.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -73.91 -27.63 61.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.03 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.46 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.03 -0.419 . . . . 0.0 110.891 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.38 3.25 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' ARG . . . . . 0.609 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 5.1 ptm180 -134.44 -21.45 1.78 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.833 0.742 . . . . 0.0 112.491 -173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.609 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.1 OUTLIER -113.06 -26.3 8.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.945 0.339 . . . . 0.0 111.116 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' B' ' 174' ' ' LYS . 1.8 mm? -118.23 2.22 11.95 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.763 0.825 . . . . 0.0 109.955 -172.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.0 152.39 29.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.107 0.563 . . . . 0.0 109.544 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.4 32.95 12.04 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 32.9 p -133.01 175.15 9.63 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.974 0.509 . . . . 0.0 110.632 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.75 147.19 28.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.899 0.88 . . . . 0.0 112.1 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -139.7 158.78 43.54 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.9 1.28 . . . . 0.0 109.639 170.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -141.68 144.46 34.12 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.766 1.226 . . . . 0.0 108.715 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 77.3 p -148.64 -178.05 6.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.8 0.44 . . . . 0.0 110.075 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.47 ' CD2' ' HG2' ' B' ' 184' ' ' GLU . 24.1 p-80 -62.07 -174.99 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.974 0.51 . . . . 0.0 110.954 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' GLU . . . . . 0.47 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 20.3 mm-40 69.55 -27.29 0.16 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.7 1.6 . . . . 0.0 111.623 -172.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 185' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 183' ' ' HIS . . . 108.02 29.76 4.2 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.617 171.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -129.13 178.75 6.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.892 0.846 . . . . 0.0 112.361 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 51.0 p -145.93 166.78 25.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.42 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.33 -159.43 0.58 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.404 0.681 . . . . 0.0 109.732 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.89 145.64 48.28 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.62 92.13 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.063 0 CA-C-O 121.535 0.683 . . . . 0.0 112.608 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.8 84.8 1.67 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.83 0.824 . . . . 0.0 109.489 170.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.55 133.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.134 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' B' ' 195' ' ' ASP . 54.6 mtmt -125.83 165.62 18.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.271 0.558 . . . . 0.0 112.114 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.421 HG22 ' H ' ' B' ' 194' ' ' VAL . 18.0 m -76.77 32.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 126.7 2.0 . . . . 0.0 112.679 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.501 ' HA ' HG23 ' B' ' 124' ' ' VAL . 1.0 OUTLIER 72.83 18.01 4.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.759 173.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.366 -1.797 . . . . 0.0 111.414 -173.308 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 111.802 3.602 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.769 0 O4'-C1'-N19 110.879 2.679 . 0.471 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 111.831 3.631 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.966 0 C5'-C4'-C3' 111.478 -2.681 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.953 0 C4'-C3'-C2' 100.098 -2.602 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ' G' . . . . . 0.5 ' H22' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.352 2 O4'-C1'-N19 113.888 5.688 . 0.148 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ' A' . . . . . 0.614 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 P--O5' 1.617 2.363 1 O4'-C1'-N19 112.372 4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 P-O3'-C3' 121.807 1.756 . 0.0 OUTLIER '7D dist 1L' 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.38 26.69 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.094 0.557 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.52 -13.97 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 124.573 3.516 . . . . 0.0 113.958 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 50.94 23.1 1.34 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 112.565 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.42 -178.01 47.82 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 43.28 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.115 1.766 . . . . 0.0 113.696 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -149.82 -0.61 0.45 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.752 0.421 . . . . 0.0 111.95 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.9 -171.3 44.32 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.4 161.44 43.23 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.715 2.943 . . . . 0.0 110.488 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.61 12.64 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.438 3.426 . . . . 0.0 113.153 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 3.5 p -175.35 141.01 0.51 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' B' ' 117' ' ' ARG . 0.0 OUTLIER -164.01 37.03 0.08 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 117.697 -1.601 . . . . 0.0 112.49 -159.043 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.7 -175.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -138.67 -135.35 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.289 37.7 mt-10 -136.65 -17.58 1.47 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.659 1.983 . . . . 0.0 115.214 -165.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.43 80.85 1.95 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.559 1.544 . . . . 0.0 108.558 -169.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -80.64 159.02 25.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.41 2.284 . . . . 0.0 113.429 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.437 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -147.7 138.87 17.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 128.722 2.809 . . . . 0.0 107.721 176.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' CA ' ' B' ' 195' ' ' ASP . 2.4 t -72.63 164.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.32 131.52 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.41 ' HB3' HG22 ' B' ' 157' ' ' THR . 93.3 p -137.19 140.14 41.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.869 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 132.35 -1.02 4.83 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.491 HD12 ' CE2' ' B' ' 180' ' ' PHE . 1.6 mm? -53.54 149.21 15.81 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 123.352 0.661 . . . . 0.0 110.981 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.26 166.43 29.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.309 3.339 . . . . 0.0 110.669 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.79 -3.59 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 1 C-N-CA 125.443 4.095 . . . . 0.0 116.308 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.11 10.47 1.52 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.644 1.111 . . . . 0.0 113.261 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.36 158.79 7.01 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' SER . . . . . 0.419 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 26.0 t -148.43 170.3 18.31 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.37 -0.488 . . . . 0.0 110.594 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -66.69 -27.07 67.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.555 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -68.38 -35.22 77.37 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.348 0.522 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.614 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 92.7 m-20 -84.03 -22.69 31.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.388 -0.195 . . . . 0.0 111.325 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -35.9 75.19 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -77.02 -36.62 56.12 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.5 ' CG ' ' H22' ' A' ' 6' ' ' ' G' . 4.1 m-20 -69.44 -2.05 10.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.234 1.014 . . . . 0.0 112.962 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 140' ' ' HIS . . . . . 0.455 ' NE2' ' HA ' ' B' ' 180' ' ' PHE . 7.6 t-80 -126.99 -37.6 2.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 110.882 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mmm -70.89 -11.31 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.885 -0.509 . . . . 0.0 110.205 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -49.53 -21.34 0.94 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.228 0.611 . . . . 0.0 112.439 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.26 -43.62 81.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.148 0.579 . . . . 0.0 111.073 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.13 68.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.055 0.542 . . . . 0.0 110.929 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.47 -167.67 37.1 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.05 74.3 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.669 0.747 . . . . 0.0 110.402 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 1.2 p -60.33 149.03 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 29.1 p -138.29 -13.64 1.35 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.984 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.54 155.76 32.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.332 -0.855 . . . . 0.0 110.638 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.9 130.24 8.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.678 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.97 120.96 43.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.534 HG22 ' H ' ' B' ' 154' ' ' ARG . 11.3 p -109.39 140.6 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.565 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.15 6.18 49.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.353 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.534 ' H ' HG22 ' B' ' 152' ' ' VAL . 13.8 mtt180 62.57 14.91 7.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.928 0.891 . . . . 0.0 112.669 172.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.59 -4.44 2.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 130.56 7.19 3.53 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 118.528 0.604 . . . . 0.0 113.118 177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' THR . . . . . 0.41 HG22 ' HB3' ' B' ' 126' ' ' SER . 0.1 OUTLIER -143.26 164.81 29.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.62 0.71 . . . . 0.0 110.614 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.85 -164.18 31.87 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.27 161.02 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 124.088 0.955 . . . . 0.0 108.423 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 p -152.03 156.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -156.18 159.6 39.12 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 162' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.2 m-85 -127.97 170.42 12.88 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.596 0.713 . . . . 0.0 111.314 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.58 -7.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -149.46 135.83 19.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.161 0.437 . . . . 0.0 110.119 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -66.81 -20.86 66.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.37 -31.96 54.65 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.507 -0.746 . . . . 0.0 110.56 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.61 -19.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 109.607 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' MET . . . . . 0.437 ' CG ' HG13 ' B' ' 123' ' ' VAL . 34.8 ttp -76.54 -52.45 9.73 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.017 0.927 . . . . 0.0 110.611 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -65.19 -19.38 65.94 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' TYR . . . . . 0.624 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 37.9 t80 -73.55 -27.66 61.46 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.452 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.13 66.61 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.385 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.3 4.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.4 -17.18 2.05 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.393 -0.817 . . . . 0.0 112.872 -172.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.624 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.3 mppt? -124.94 -21.59 4.67 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 173.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.21 1.62 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.912 0.485 . . . . 0.0 109.945 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 140.59 29.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 62.06 34.49 16.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.807 0.843 . . . . 0.0 111.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.7 p -138.04 177.77 7.63 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.469 0.708 . . . . 0.0 110.543 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -57.01 155.52 8.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.701 1.201 . . . . 0.0 113.704 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' PHE . . . . . 0.491 ' CE2' HD12 ' B' ' 128' ' ' LEU . 23.7 t80 -143.25 161.87 37.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.472 1.909 . . . . 0.0 108.873 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -146.56 146.22 30.4 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.19 0.996 . . . . 0.0 108.738 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 85.0 p -141.99 170.91 14.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.013 0.435 . . . . 0.0 111.872 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 183' ' ' HIS . . . . . 0.475 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.6 p-80 -59.41 -11.87 5.08 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.81 1.244 . . . . 0.0 113.135 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.27 -18.79 65.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.266 0.484 . . . . 0.0 111.148 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.74 14.44 34.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.61 178.68 7.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.788 0.794 . . . . 0.0 111.106 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 56.1 p -121.66 167.97 12.32 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.39 0.614 . . . . 0.0 111.329 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.84 -163.24 1.45 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.991 1.316 . . . . 0.0 107.755 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.03 156.34 38.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.07 146.53 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.577 0.703 . . . . 0.0 111.234 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -116.61 82.3 1.77 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 t -69.52 86.33 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.901 0.88 . . . . 0.0 111.219 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 193' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 12.7 tttt -71.08 169.32 15.24 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.02 -0.425 . . . . 0.0 110.869 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 194' ' ' VAL . . . . . 0.447 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 5.5 p -62.01 -28.67 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.062 1.745 . . . . 0.0 115.246 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.439 ' CA ' HG23 ' B' ' 124' ' ' VAL . 26.6 t70 134.6 167.36 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.068 2.547 . . . . 0.0 109.067 -173.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.258 0 CA-C-O 117.224 -1.875 . . . . 0.0 111.521 175.362 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -175.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.64 1.176 . . . . 0.0 112.586 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' B' ' 161' ' ' GLU . 0.0 OUTLIER -162.44 179.6 7.68 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . 0.575 ' HB2' HD22 ' B' ' 121' ' ' ASN . 26.5 mt-10 -149.35 -31.21 0.23 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.45 -1.704 . . . . 0.0 113.406 -172.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.6 p30 -140.49 78.74 1.67 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.325 1.85 . . . . 0.0 107.42 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -87.29 158.0 19.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.44 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.489 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -146.65 142.17 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 127.987 2.515 . . . . 0.0 107.279 176.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.91 159.48 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.07 102.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -117.79 150.65 38.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.193 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.95 -2.71 55.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 14.4 tp -53.42 145.18 28.57 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 128.14 2.576 . . . . 0.0 110.151 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.36 162.45 38.34 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.053 2.502 . . . . 0.0 109.448 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.33 -12.64 35.53 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.881 2.387 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -72.75 -23.0 60.77 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.091 0.957 . . . . 0.0 111.779 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.59 46.25 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.4 0.444 . . . . 0.0 112.645 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 43.8 t -158.12 168.66 26.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -64.49 -30.13 71.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.446 0.566 . . . . 0.0 110.727 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -66.61 -37.07 84.1 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.938 0.335 . . . . 0.0 111.568 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -84.67 -17.88 37.13 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.856 0.298 . . . . 0.0 111.441 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -32.17 66.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -77.73 -38.57 46.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.97 1.57 0.9 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.531 1.132 . . . . 0.0 113.658 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.626 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.6 t60 -136.68 -40.37 0.62 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.413 0.551 . . . . 0.0 111.568 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 86.4 mmm -68.55 -11.6 60.16 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.413 0.551 . . . . 0.0 110.051 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -47.39 -21.38 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.885 0.874 . . . . 0.0 112.504 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.23 -42.74 88.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.824 -0.548 . . . . 0.0 111.164 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.45 -27.72 66.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.65 0.78 . . . . 0.0 111.666 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.5 -167.54 37.06 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -87.22 77.9 8.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.915 0.864 . . . . 0.0 110.157 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -62.96 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 43.5 t -128.06 -23.77 3.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.743 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -139.59 155.79 47.26 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 119.162 0.892 . . . . 0.0 110.331 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.86 165.12 35.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -147.62 153.61 39.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.499 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -132.35 147.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.113 0.482 . . . . 0.0 110.305 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.78 10.98 17.93 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.999 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.499 ' H ' HG22 ' B' ' 152' ' ' VAL . 28.0 mtt180 59.24 17.39 5.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.681 0.792 . . . . 0.0 113.053 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.11 15.16 3.28 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.0 52.35 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 11.8 p -140.69 159.19 42.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.352 0.661 . . . . 0.0 110.395 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.78 -170.27 38.39 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.5 161.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.804 0.442 . . . . 0.0 111.131 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -153.49 156.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 123.459 0.704 . . . . 0.0 109.885 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.484 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 1.2 tm-20 -152.39 155.39 37.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.944 0.498 . . . . 0.0 111.728 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -124.17 163.62 21.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.883 1.273 . . . . 0.0 111.73 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.7 -8.37 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.507 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -147.8 133.8 19.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -63.57 -20.66 65.82 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -76.02 -29.37 58.1 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.649 -0.657 . . . . 0.0 110.744 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.8 -19.01 60.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.489 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.7 ttp -77.97 -52.97 7.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.345 1.058 . . . . 0.0 110.674 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -63.46 -21.45 66.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.279 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.592 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 46.0 t80 -74.53 -31.72 62.23 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.73 -17.56 60.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.288 0.635 . . . . 0.0 111.628 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.431 ' O ' HG22 ' B' ' 172' ' ' VAL . 14.5 p -113.21 34.23 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.714 0.769 . . . . 0.0 111.702 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.28 -17.5 0.64 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -123.54 -25.82 4.3 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.39 0.676 . . . . 0.0 112.611 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.38 -2.64 21.96 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.357 0.263 . . . . 0.0 110.533 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.22 145.9 32.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.008 0.923 . . . . 0.0 109.013 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 29.67 17.85 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.435 0.694 . . . . 0.0 112.532 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 47.4 p -133.44 169.49 16.88 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.965 0.506 . . . . 0.0 110.701 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -57.85 149.47 22.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.626 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.0 t80 -141.71 161.1 38.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.982 1.713 . . . . 0.0 108.937 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 . . . . . 0 C--N 1.338 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 110.178 -170.05 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.78 0.324 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.69 160.48 19.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.326 1.051 . . . . 0.0 108.849 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.98 157.23 38.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 110.346 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 26.9 pt -123.59 151.7 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.746 0.784 . . . . 0.0 109.64 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -118.41 78.76 1.29 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.78 144.54 10.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 5.3 tttp -126.68 168.78 13.89 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.437 ' H ' HG12 ' B' ' 194' ' ' VAL . 3.0 p -60.22 -29.55 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.526 1.531 . . . . 0.0 114.603 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 127.71 2.404 . . . . 0.0 109.058 -173.316 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -53.9 159.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.167 0.894 . . . . 0.0 112.192 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -140.1 -94.37 0.16 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -153.89 -30.51 0.12 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -165.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.94 -37.24 2.12 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -165.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . 0.52 ' H ' ' HG3' ' B' ' 161' ' ' GLU . 86.8 mtt180 46.3 165.33 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.619 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.0 OUTLIER -159.17 134.65 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 129.59 3.156 . . . . 0.0 107.717 170.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.16 165.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.2 136.41 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 54.6 p -135.32 147.45 49.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.907 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.07 -2.34 31.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.72 140.44 38.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 127.133 2.173 . . . . 0.0 110.076 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.3 162.35 19.92 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.638 2.892 . . . . 0.0 110.11 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -14.77 32.71 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.865 2.377 . . . . 0.0 109.761 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -83.1 6.24 19.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.689 1.196 . . . . 0.0 111.738 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.45 165.09 12.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -159.49 170.67 21.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -61.68 -28.45 69.41 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -69.31 -35.05 75.57 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.45 -19.59 22.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.25 0.477 . . . . 0.0 111.416 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.19 -26.48 59.04 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -75.22 -39.86 59.67 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.98 1.66 1.36 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.163 1.385 . . . . 0.0 113.179 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 8.4 t60 -135.38 -38.92 0.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.125 0.42 . . . . 0.0 111.37 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.0 mmm -68.14 -18.27 64.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.873 -0.517 . . . . 0.0 110.26 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -51.15 -19.88 1.32 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -56.57 -36.93 69.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.946 0.499 . . . . 0.0 111.169 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.2 -21.9 65.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.966 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.27 -93.82 0.11 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.902 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.8 121.1 6.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -121.84 150.54 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.02 -21.54 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.97 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -131.34 154.17 48.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.356 0.98 . . . . 0.0 111.801 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -158.28 161.48 37.71 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 18.0 t0 -145.56 148.46 33.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.632 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -128.45 141.97 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.208 0.528 . . . . 0.0 110.48 -172.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -103.3 5.82 37.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.497 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.632 ' H ' HG22 ' B' ' 152' ' ' VAL . 23.5 mtp85 62.55 17.21 9.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.461 0.705 . . . . 0.0 112.388 170.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -137.38 -11.96 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.06 -2.84 2.15 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 118.872 0.76 . . . . 0.0 113.181 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.2 165.85 26.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.51 -165.72 34.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 4.2 p -142.0 161.25 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 122.971 0.509 . . . . 0.0 110.02 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.5 p -147.62 159.63 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' B' ' 122' ' ' ARG . 42.9 tt0 -154.83 146.96 23.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.912 -0.492 . . . . 0.0 111.968 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 60.6 m-85 -117.94 156.93 27.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.595 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.1 m -61.71 -12.55 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.399 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -152.5 151.16 30.39 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.748 0.819 . . . . 0.0 109.07 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.67 -22.97 65.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.4 -32.83 48.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.597 0.635 . . . . 0.0 111.387 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.11 -17.66 61.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.123 0.487 . . . . 0.0 110.089 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.619 ' SD ' HG13 ' B' ' 123' ' ' VAL . 15.2 tmm? -82.95 -51.25 7.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.149 0.98 . . . . 0.0 111.202 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -61.75 -21.81 64.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.56 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 28.5 t80 -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.13 -12.47 60.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.204 0.602 . . . . 0.0 111.459 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.418 HG22 ' O ' ' B' ' 172' ' ' VAL 0.258 13.3 p -118.57 33.22 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 111.514 174.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.11 -16.5 0.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.506 169.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.9 mppt? -123.58 -25.85 4.29 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.571 0.748 . . . . 0.0 112.428 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.24 -3.36 19.85 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.808 0.276 . . . . 0.0 110.461 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.95 143.64 43.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.716 0.806 . . . . 0.0 110.174 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.16 36.59 27.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 43.0 p -135.55 172.84 12.43 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.278 0.631 . . . . 0.0 110.301 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -58.75 146.31 37.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.937 0.895 . . . . 0.0 112.274 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.582 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 19.0 t80 -136.73 156.5 48.43 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.905 1.282 . . . . 0.0 109.36 169.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 . . . . . 0 N--CA 1.457 -0.082 0 C-N-CA 124.788 1.235 . . . . 0.0 108.173 -173.519 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.086 0.469 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.8 -162.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.435 0.694 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.93 147.53 49.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 102.65 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.595 0.712 . . . . 0.0 112.449 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -80.16 89.11 5.42 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . 0.414 ' HB ' HG23 ' B' ' 172' ' ' VAL . 6.6 t -67.88 138.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.86 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -117.47 162.43 17.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.74 -29.96 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.333 1.853 . . . . 0.0 114.913 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 127.087 2.155 . . . . 0.0 108.826 -173.062 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 51.0 mtt180 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -61.64 166.32 4.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.375 1.443 . . . . 0.0 112.417 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t -146.29 -126.2 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.434 0.694 . . . . 0.0 112.513 -172.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -133.97 -25.79 1.58 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 114.397 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.443 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.9 p30 -130.31 79.97 1.93 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 110.052 -171.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -78.67 158.57 28.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.008 1.723 . . . . 0.0 112.895 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -149.92 142.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 127.733 2.413 . . . . 0.0 108.657 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.5 t -80.89 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.55 136.41 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.8 p -141.37 157.39 45.24 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.364 -0.21 . . . . 0.0 111.102 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 4.41 56.17 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.94 146.68 36.87 Favored Pre-proline 0 N--CA 1.452 -0.356 0 C-N-CA 125.287 1.435 . . . . 0.0 110.844 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.1 164.91 33.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.246 3.297 . . . . 0.0 110.948 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -54.17 -6.52 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 125.165 3.91 . . . . 0.0 116.257 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 13.03 1.16 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.604 1.093 . . . . 0.0 113.423 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -53.2 158.28 4.28 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -146.28 168.24 21.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.425 0.613 . . . . 0.0 110.44 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -65.54 -27.46 68.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.604 -0.236 . . . . 0.0 111.364 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -68.68 -40.11 80.27 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 117.928 0.331 . . . . 0.0 111.322 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -80.07 -21.22 43.62 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.132 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -32.51 70.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -79.86 -37.26 35.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.78 3.04 2.12 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.363 1.065 . . . . 0.0 112.916 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.7 t60 -132.51 -41.17 0.97 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.386 0.539 . . . . 0.0 111.159 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.3 mmm -69.66 -12.48 61.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.196 0.453 . . . . 0.0 110.315 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -45.2 -24.96 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 112.196 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.91 -42.2 94.93 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -69.96 -29.97 67.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.679 0.791 . . . . 0.0 111.505 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.9 -171.04 40.92 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -82.31 64.58 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.445 0.64 . . . . 0.0 111.254 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.3 OUTLIER -55.72 141.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 37.5 t -123.52 -30.55 3.62 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -133.1 158.77 41.94 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.658 0.742 . . . . 0.0 111.59 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -154.11 168.95 24.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.493 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 41.3 t0 -150.04 154.51 38.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.4 p -131.83 142.29 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.555 0.693 . . . . 0.0 110.473 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -105.07 5.69 32.67 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.11 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 14.3 mtt-85 61.56 17.66 8.76 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.867 0.867 . . . . 0.0 112.421 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -137.06 0.67 2.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.01 2.89 7.7 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 118.504 0.593 . . . . 0.0 112.401 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.64 165.9 26.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.458 0.647 . . . . 0.0 110.316 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.89 -166.79 36.01 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 3.6 p -138.86 162.02 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.867 0.467 . . . . 0.0 110.781 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.9 p -149.24 159.5 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 123.717 0.807 . . . . 0.0 108.872 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.42 147.12 20.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.156 -0.34 . . . . 0.0 111.661 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 4.8 m-85 -121.13 171.79 8.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.394 1.092 . . . . 0.0 111.771 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.38 -20.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.252 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -143.94 141.98 30.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.228 0.611 . . . . 0.0 110.561 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.17 -25.02 63.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.9 -31.43 59.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.762 0.71 . . . . 0.0 111.009 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.71 -16.4 60.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.782 0.325 . . . . 0.0 110.183 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 26.6 ttp -79.83 -50.84 9.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.91 0.884 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 43.9 m -65.37 -19.76 66.09 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -72.57 -27.23 62.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.467 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.03 -36.72 61.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 122.201 -0.312 . . . . 0.0 110.942 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.83 7.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.584 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.5 ptm180 -138.39 -25.04 0.94 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.866 0.757 . . . . 0.0 112.224 -174.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.584 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.69 -27.42 10.32 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.367 0.531 . . . . 0.0 110.934 175.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.9 mm? -115.98 -1.12 12.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.897 0.879 . . . . 0.0 109.892 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.35 141.08 28.94 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.623 0.769 . . . . 0.0 109.056 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.35 26.91 12.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 111.802 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 52.0 p -137.25 172.56 12.81 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.126 0.57 . . . . 0.0 110.169 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -54.38 150.58 8.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.453 1.101 . . . . 0.0 113.965 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.593 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.4 t80 -141.68 162.06 36.4 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.873 2.069 . . . . 0.0 108.038 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 CA--C 1.521 -0.152 0 C-N-CA 123.897 0.879 . . . . 0.0 109.031 -171.112 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.65 158.35 17.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.506 1.123 . . . . 0.0 108.132 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.53 154.3 41.56 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.245 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.81 152.16 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.972 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.96 87.09 2.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.38 89.33 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 110.751 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.5 tttt -71.13 171.47 10.92 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 120.713 0.292 . . . . 0.0 111.037 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.456 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.8 p -65.28 -27.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.779 1.632 . . . . 0.0 114.67 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' B' ' 124' ' ' VAL . 23.5 t0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 128.199 2.599 . . . . 0.0 108.977 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -54.05 167.47 0.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.844 1.258 . . . . 0.0 111.602 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -130.75 -97.33 0.34 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -153.53 -29.56 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -165.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.27 -35.81 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -165.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 39.73 158.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -153.55 142.54 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 127.428 2.291 . . . . 0.0 107.417 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -78.14 165.23 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.54 129.72 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 98.1 p -138.92 138.54 37.47 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.254 0.549 . . . . 0.0 111.504 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.92 0.28 7.69 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.51 145.08 21.6 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.588 1.155 . . . . 0.0 110.622 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.0 169.99 21.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.01 3.14 . . . . 0.0 109.621 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.92 -6.87 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.571 3.514 . . . . 0.0 115.793 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 30.1 m -138.16 5.46 2.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -54.97 153.66 10.83 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -147.32 168.9 20.6 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.302 -0.528 . . . . 0.0 110.978 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -65.35 -28.53 69.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.18 -46.27 74.46 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.364 0.529 . . . . 0.0 110.724 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -76.37 -16.26 59.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.381 -0.199 . . . . 0.0 111.165 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -34.57 71.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -76.55 -37.63 56.31 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.59 -1.71 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.205 1.002 . . . . 0.0 113.652 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.591 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.0 t60 -128.0 -36.25 1.99 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.767 0.712 . . . . 0.0 111.23 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.5 mmm -73.73 -12.17 60.63 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.889 -0.507 . . . . 0.0 110.434 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttm105 -44.87 -25.16 0.27 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.913 0.885 . . . . 0.0 112.489 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.3 -42.14 93.36 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.916 -0.49 . . . . 0.0 111.328 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.26 -31.23 69.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.092 0.557 . . . . 0.0 111.386 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.13 -171.35 41.17 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -80.45 72.94 7.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.903 0.859 . . . . 0.0 110.939 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.8 OUTLIER -63.14 146.53 12.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 36.8 t -130.75 -31.63 1.74 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.691 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . 0.435 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 6.2 t80 -137.15 161.53 35.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 110.458 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.86 169.87 23.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -148.14 155.34 41.31 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.498 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.5 p -132.63 143.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.465 0.65 . . . . 0.0 109.944 -175.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -105.3 10.58 33.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.1 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.498 ' H ' HG22 ' B' ' 152' ' ' VAL . 35.4 mtp180 61.73 15.39 6.93 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.34 3.14 3.07 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.46 5.03 13.06 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -140.61 166.5 24.57 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.426 0.69 . . . . 0.0 110.511 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.88 -164.83 32.82 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.43 162.31 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.576 0.75 . . . . 0.0 110.45 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 12.6 p -144.27 160.08 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.1 141.62 24.33 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.453 0.701 . . . . 0.0 110.756 -168.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.5 m-85 -128.42 165.19 21.11 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.932 0.872 . . . . 0.0 110.59 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.6 -5.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.37 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -150.34 144.69 25.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.195 0.452 . . . . 0.0 110.125 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -70.82 -23.09 62.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.412 0.285 . . . . 0.0 111.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -88.7 -32.98 17.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.883 0.31 . . . . 0.0 111.726 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -74.37 -8.88 57.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.253 0.549 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.429 ' SD ' HG13 ' B' ' 123' ' ' VAL . 37.6 ttp -94.76 -42.3 8.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.11 1.364 . . . . 0.0 110.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 92.7 m -66.26 -17.42 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 42.8 t80 -72.4 -27.5 62.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -38.09 64.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.378 -0.201 . . . . 0.0 110.567 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 m -73.16 5.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -134.23 -16.18 2.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.898 0.772 . . . . 0.0 112.857 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.634 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.2 mppt? -125.64 -21.09 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.31 1.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.85 144.31 31.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.777 0.831 . . . . 0.0 109.426 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.6 36.45 23.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.019 0.928 . . . . 0.0 112.709 174.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 33.5 p -133.69 178.96 6.53 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.361 0.664 . . . . 0.0 110.335 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -53.41 149.38 7.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.591 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 17.6 t80 -147.73 168.72 21.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.738 2.015 . . . . 0.0 107.749 168.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.423 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.199 0.523 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.78 -168.99 2.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.592 1.157 . . . . 0.0 108.319 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.63 142.47 51.49 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -129.55 133.02 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.499 0.666 . . . . 0.0 112.665 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -94.94 89.76 5.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.52 92.74 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.173 0.589 . . . . 0.0 110.13 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 6.5 tttp -75.36 173.02 11.47 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 111.224 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.457 ' H ' HG12 ' B' ' 194' ' ' VAL . 2.8 p -65.85 -28.82 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.247 1.819 . . . . 0.0 114.436 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 20.9 t70 . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 127.38 2.272 . . . . 0.0 108.949 -173.668 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.355 0.122 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.68 167.6 0.72 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.715 1.206 . . . . 0.0 112.759 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.9 t -150.85 -124.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.266 0.627 . . . . 0.0 111.793 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.25 35.5 mt-10 -138.5 -15.23 1.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.513 1.525 . . . . 0.0 114.796 -167.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.0 p30 -138.42 77.18 1.61 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.407 1.483 . . . . 0.0 110.995 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -79.44 154.0 29.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.58 1.952 . . . . 0.0 112.499 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.6 OUTLIER -145.07 133.66 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.811 2.045 . . . . 0.0 108.407 173.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' B' ' 195' ' ' ASP . 37.8 t -70.52 160.37 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-O 121.101 0.477 . . . . 0.0 109.774 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.51 107.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.1 p -118.23 147.94 42.9 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.04 -1.92 35.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.42 153.69 13.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 111.411 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.85 158.15 38.95 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.69 2.26 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.83 -17.71 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.039 2.493 . . . . 0.0 111.482 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 56.5 m -79.01 -10.94 59.98 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.788 0.835 . . . . 0.0 112.412 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.73 161.99 50.99 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 23.5 t -152.06 170.23 20.44 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.302 0.641 . . . . 0.0 109.817 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 41.5 p-90 -64.85 -28.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.96 -0.463 . . . . 0.0 111.525 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.75 -37.34 82.0 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.025 0.375 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.55 -29.52 27.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 111.299 0.111 . . . . 0.0 111.299 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -35.31 77.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.015 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -72.02 -41.95 66.95 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.61 2.79 1.64 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.347 1.459 . . . . 0.0 113.959 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -131.42 -38.24 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.773 0.715 . . . . 0.0 111.243 -175.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.9 mmm -69.84 -17.31 63.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.02 -0.425 . . . . 0.0 110.244 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -46.96 -19.29 0.1 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.959 0.903 . . . . 0.0 113.382 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.98 -41.43 95.44 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.148 0.579 . . . . 0.0 111.322 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.76 -26.18 67.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.366 0.666 . . . . 0.0 111.412 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.17 -171.73 33.99 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -74.08 114.77 12.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.282 0.541 . . . . 0.0 109.911 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -120.26 147.46 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.49 -17.05 2.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -135.49 153.85 51.6 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.764 1.165 . . . . 0.0 111.819 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -156.92 147.14 21.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.476 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -129.43 119.38 23.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.9 p -106.66 148.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.487 -169.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -111.24 9.12 21.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.724 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.37 25.88 0.05 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 126.789 2.036 . . . . 0.0 114.787 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -142.78 5.98 1.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.31 -4.85 6.76 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 121.813 -0.554 . . . . 0.0 113.006 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -143.43 162.91 34.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 109.725 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.69 -169.21 39.07 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.9 160.68 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 117.285 0.542 . . . . 0.0 109.623 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -146.24 156.2 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -150.52 145.82 26.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 111.91 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 44.6 m-85 -112.94 160.91 17.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.256 1.027 . . . . 0.0 112.799 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.42 -20.42 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.362 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -150.35 145.88 26.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 110.117 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.25 -24.81 65.84 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.88 -31.01 62.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.913 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.05 -17.06 61.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.669 0.271 . . . . 0.0 110.569 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.462 ' SD ' HG13 ' B' ' 123' ' ' VAL . 29.5 ttp -81.46 -52.79 6.88 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.761 0.824 . . . . 0.0 110.685 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.5 m -65.59 -17.19 64.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.553 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 22.1 t80 -73.3 -29.59 62.82 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.765 -0.585 . . . . 0.0 109.53 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.8 64.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.063 -0.398 . . . . 0.0 110.663 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.96 6.09 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -133.94 -15.56 2.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.623 0.647 . . . . 0.0 112.569 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.4 mppt? -125.4 -21.43 4.55 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.76 2.82 14.52 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.62 142.78 31.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.22 38.86 31.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.092 0.473 . . . . 0.0 111.752 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.3 p -137.6 169.36 17.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.247 1.419 . . . . 0.0 108.515 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -66.8 165.07 15.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.866 -170.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.498 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.9 t80 -150.72 172.78 15.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.173 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' B' ' 180' ' ' PHE . 15.2 tpt180 . . . . . 0 N--CA 1.457 -0.114 0 C-N-CA 123.573 0.749 . . . . 0.0 109.167 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.777 0.798 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.15 -163.97 1.21 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.999 1.72 . . . . 0.0 107.192 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.31 156.38 44.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 22.6 pt -131.78 146.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.76 0.79 . . . . 0.0 111.129 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -114.71 79.91 1.33 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 34.7 t -60.76 133.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.49 160.54 31.99 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.135 0.574 . . . . 0.0 110.178 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' B' ' 123' ' ' VAL . 0.1 OUTLIER -60.42 -37.38 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' B' ' 124' ' ' VAL . 24.4 t70 . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 109.712 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -55.71 167.04 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.54 0.736 . . . . 0.0 112.735 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 14.6 t -146.53 -122.56 0.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.337 0.655 . . . . 0.0 112.085 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -134.9 -22.86 1.59 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.599 1.56 . . . . 0.0 114.442 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.79 77.28 1.73 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.695 1.198 . . . . 0.0 110.668 -169.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -78.92 150.17 32.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.852 1.661 . . . . 0.0 113.013 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.494 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -139.61 129.26 29.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.877 1.671 . . . . 0.0 108.532 171.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.86 158.69 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.08 109.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 81.0 p -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.665 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.14 53.49 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.3 147.0 77.2 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 127.871 2.468 . . . . 0.0 111.034 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.14 160.49 33.07 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.903 2.402 . . . . 0.0 109.273 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 -9.99 25.88 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.83 2.353 . . . . 0.0 111.09 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -75.01 -11.81 60.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.261 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.71 164.9 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 121.732 0.629 . . . . 0.0 112.842 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.7 t -158.99 166.63 31.34 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.903 1.281 . . . . 0.0 108.004 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 40.5 p-90 -66.64 -30.2 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.523 0.601 . . . . 0.0 111.753 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -65.98 -32.08 73.35 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.414 0.552 . . . . 0.0 110.635 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -87.64 -20.62 26.08 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 117.738 0.245 . . . . 0.0 111.512 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -29.97 64.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -79.65 -39.79 30.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.77 -1.75 7.81 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.496 1.118 . . . . 0.0 113.429 -176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.651 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 14.0 t60 -129.52 -41.74 1.35 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.132 0.424 . . . . 0.0 111.12 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 85.1 mmm -65.48 -16.93 64.15 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -42.24 -27.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.683 1.593 . . . . 0.0 113.13 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.03 -41.49 96.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 111.573 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.407 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.93 -29.26 69.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.333 0.653 . . . . 0.0 111.751 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.88 -175.8 34.32 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -73.02 115.79 12.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 122.369 -0.489 . . . . 0.0 110.333 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -113.63 151.18 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.4 p -132.99 -26.04 1.76 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.915 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -134.33 152.94 52.1 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.81 1.186 . . . . 0.0 112.125 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -149.81 169.18 21.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.655 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -149.67 141.41 23.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 168.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.577 HG22 ' H ' ' B' ' 154' ' ' ARG . 4.8 p -122.41 142.54 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.629 0.728 . . . . 0.0 111.02 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -108.79 9.96 26.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.682 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.577 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.0 24.57 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.215 2.206 . . . . 0.0 114.991 178.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.49 10.45 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.94 -4.21 7.93 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.106 0.412 . . . . 0.0 113.0 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.2 162.28 36.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.893 0.477 . . . . 0.0 110.415 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.28 -169.26 37.53 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.43 162.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.26 0.53 . . . . 0.0 110.755 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.2 p -149.75 158.53 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.898 0.879 . . . . 0.0 108.934 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.62 147.27 24.23 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.901 -0.499 . . . . 0.0 111.535 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 30.4 m-85 -116.49 168.5 10.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 122.281 1.038 . . . . 0.0 113.322 -172.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.3 m -75.67 -10.52 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.658 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -151.46 142.85 23.44 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.88 -23.53 66.67 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.31 -30.97 62.3 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.252 0.478 . . . . 0.0 110.86 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.06 -19.36 60.64 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 110.323 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.494 ' CG ' HG13 ' B' ' 123' ' ' VAL . 30.8 ttp -82.33 -53.44 6.02 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.764 0.826 . . . . 0.0 111.048 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -63.23 -21.79 66.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.539 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 29.2 t80 -73.53 -33.73 64.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.41 60.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.066 0.546 . . . . 0.0 111.362 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.438 ' O ' HG22 ' B' ' 172' ' ' VAL 0.261 8.2 p -116.07 33.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 111.198 174.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.3 ptm180 -143.64 -17.32 0.62 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -122.82 -27.36 4.3 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.326 0.65 . . . . 0.0 112.531 173.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' B' ' 175' ' ' LEU . 2.6 mm? -104.61 -7.52 19.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' B' ' 172' ' ' VAL . 15.2 t70 -75.35 147.16 40.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.8 0.84 . . . . 0.0 110.278 168.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 57.85 28.93 16.74 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.128 0.971 . . . . 0.0 112.367 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 63.6 p -136.95 174.55 10.5 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.88 0.472 . . . . 0.0 110.811 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -54.36 145.35 18.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 113.063 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 5.2 t80 -138.56 160.04 40.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.771 1.629 . . . . 0.0 108.144 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 CA--C 1.523 -0.074 0 C-N-CA 123.709 0.804 . . . . 0.0 109.795 -169.245 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.71 158.75 20.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.555 1.142 . . . . 0.0 108.143 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -71.17 161.28 31.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.424 0.631 . . . . 0.0 110.425 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 28.9 pt -130.18 156.0 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.429 169.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -122.02 87.06 2.68 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.429 1.092 . . . . 0.0 108.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.22 142.19 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.261 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -134.09 158.48 43.5 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.282 0.563 . . . . 0.0 110.725 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.5 m -74.9 3.81 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 126.286 1.835 . . . . 0.0 113.76 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 7.3 t0 . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 125.314 1.446 . . . . 0.0 110.377 171.424 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -53.91 168.69 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.704 1.202 . . . . 0.0 112.26 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.6 t -138.61 -93.84 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.292 15.1 mt-10 -159.01 -27.56 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -164.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -25.73 4.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -161.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 35.07 155.93 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.401 3.081 . . . . 0.0 119.278 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -147.78 122.66 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.634 174.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' B' ' 195' ' ' ASP . 24.2 t -67.46 158.96 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.97 112.96 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 83.2 p -122.18 152.64 39.74 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.7 35.8 3.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.503 ' N ' ' HD3' ' B' ' 129' ' ' PRO . 13.0 tp -111.45 31.29 0.1 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' B' ' 128' ' ' LEU . 80.7 Cg_exo -46.93 -33.51 14.59 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.572 2.181 . . . . 0.0 116.307 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.438 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 89.5 Cg_exo -47.88 167.04 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.298 2.666 . . . . 0.0 114.094 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 7.0 t -71.27 19.68 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.77 0.828 . . . . 0.0 112.076 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' B' ' 130' ' ' PRO . . . -46.95 154.71 0.89 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.403 1.001 . . . . 0.0 113.206 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -146.69 166.13 27.52 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.131 0.972 . . . . 0.0 108.652 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -63.32 -28.64 70.15 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.849 -0.532 . . . . 0.0 111.289 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -67.59 -24.79 65.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.05 0.386 . . . . 0.0 111.528 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.14 -18.74 17.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.095 0.407 . . . . 0.0 111.612 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -29.18 64.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -77.63 -39.8 44.05 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.02 -0.69 9.98 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.259 1.024 . . . . 0.0 113.462 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -128.86 -35.11 1.9 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.341 0.519 . . . . 0.0 111.036 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 78.7 mmm -73.27 -14.64 61.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -47.14 -21.37 0.24 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 112.797 172.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.57 -41.23 96.41 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.274 0.63 . . . . 0.0 110.992 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.61 68.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.942 0.497 . . . . 0.0 111.567 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.43 -169.59 37.77 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.83 81.71 2.76 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.801 0.81 . . . . 0.0 110.759 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -76.78 146.37 8.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.3 p -131.34 -25.02 2.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.797 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -139.31 157.1 46.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.436 1.016 . . . . 0.0 111.594 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.26 167.75 26.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.905 174.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -148.32 137.15 21.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.0 p -118.84 142.34 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.845 0.831 . . . . 0.0 110.373 -171.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . 0.405 ' C ' ' HD3' ' B' ' 154' ' ' ARG . 3.2 m-30 -107.37 9.22 29.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.0 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.42 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.606 1.962 . . . . 0.0 114.446 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.05 8.16 1.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.35 -5.98 6.72 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.24 0.473 . . . . 0.0 112.973 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.4 p -144.12 165.61 27.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.173 0.487 . . . . 0.0 110.459 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.33 -166.27 33.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.51 162.74 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 CA-C-N 117.228 0.514 . . . . 0.0 110.251 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.464 HG13 HG23 ' B' ' 123' ' ' VAL . 8.8 p -147.74 161.12 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.008 0.923 . . . . 0.0 108.806 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -153.4 151.96 30.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 110.64 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 3.7 m-85 -129.53 164.58 23.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.926 0.869 . . . . 0.0 110.138 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 25.5 m -66.19 -5.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.53 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -152.6 155.9 38.25 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.554 0.615 . . . . 0.0 110.24 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.18 -28.04 65.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.757 0.423 . . . . 0.0 112.039 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.76 -30.9 18.69 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.064 -0.397 . . . . 0.0 112.022 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -72.62 -9.75 58.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.407 ' SD ' HG13 ' B' ' 123' ' ' VAL . 41.4 ttp -98.27 -42.95 7.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.464 1.506 . . . . 0.0 110.958 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.0 m -63.12 -19.25 64.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 24.9 t80 -71.31 -28.56 64.19 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.931 -0.48 . . . . 0.0 109.993 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.53 -36.71 65.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.21 4.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -133.95 -16.48 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.5 mppt? -124.91 -21.57 4.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.14 0.94 13.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.011 0.524 . . . . 0.0 109.886 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.53 143.03 27.18 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.929 0.891 . . . . 0.0 109.099 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.65 24.99 14.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.279 1.032 . . . . 0.0 111.669 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 81.6 p -137.62 179.29 6.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.341 0.591 . . . . 0.0 111.707 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.36 144.88 34.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.901 1.681 . . . . 0.0 114.708 -170.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.519 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 3.7 t80 -143.43 161.45 38.36 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.104 1.762 . . . . 0.0 108.54 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 N--CA 1.457 -0.119 0 C-N-CA 124.282 1.033 . . . . 0.0 109.224 -171.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.29 160.87 16.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -72.07 148.25 45.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.0 139.33 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -100.59 86.07 3.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.33 1.052 . . . . 0.0 108.724 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 10.6 t -71.18 81.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.577 0.751 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.98 159.82 32.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.872 0.869 . . . . 0.0 110.721 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' B' ' 123' ' ' VAL . 19.1 m -75.18 3.46 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 126.03 1.732 . . . . 0.0 114.69 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.489 ' HA ' HG23 ' B' ' 124' ' ' VAL . 19.7 t70 . . . . . 0 C--N 1.326 -0.432 0 C-N-CA 126.402 1.881 . . . . 0.0 110.408 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -53.14 173.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 9.0 t -140.81 -127.67 0.1 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.368 1.067 . . . . 0.0 111.919 -175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -133.91 -28.36 1.39 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.336 1.455 . . . . 0.0 114.18 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.8 p30 -127.3 82.78 2.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.744 1.218 . . . . 0.0 110.396 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -78.36 158.53 28.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.711 2.004 . . . . 0.0 112.87 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.443 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -150.08 142.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.792 2.437 . . . . 0.0 109.06 173.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -79.5 170.65 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.51 136.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.4 p -143.75 157.7 44.2 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 121.057 0.456 . . . . 0.0 112.078 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.96 53.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.53 123.23 88.95 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 127.5 2.32 . . . . 0.0 112.949 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.29 156.83 12.66 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.984 2.456 . . . . 0.0 111.422 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.34 -10.9 29.1 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.101 2.534 . . . . 0.0 110.705 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 68.1 m -75.19 -9.02 58.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.095 0.958 . . . . 0.0 112.616 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.34 165.44 41.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 44.5 t -157.39 167.98 28.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.241 1.016 . . . . 0.0 109.155 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -64.65 -29.93 70.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.738 -0.601 . . . . 0.0 110.057 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -68.4 -16.16 63.81 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.428 0.291 . . . . 0.0 111.49 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -104.03 -22.73 13.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 112.054 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.54 -30.7 66.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.942 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -73.94 -40.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.6 -1.92 7.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.464 1.106 . . . . 0.0 113.304 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 30.4 t60 -131.92 -33.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.641 0.655 . . . . 0.0 111.552 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' B' ' 141' ' ' MET . 0.0 OUTLIER -74.86 -19.97 59.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -51.64 -18.88 1.31 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -59.0 -37.59 77.21 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.031 0.532 . . . . 0.0 110.852 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -65.82 -22.38 66.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.71 0.804 . . . . 0.0 111.307 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.98 -90.49 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -157.07 134.1 10.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -130.56 157.6 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 14.7 p -129.15 -35.63 1.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.014 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 7.9 t80 -132.69 159.02 40.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.61 1.096 . . . . 0.0 111.723 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.17 170.95 20.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.301 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -149.11 155.75 41.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.553 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -133.31 145.01 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.34 0.59 . . . . 0.0 110.483 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.55 22.11 16.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.208 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.553 ' H ' HG22 ' B' ' 152' ' ' VAL . 59.6 mtp180 74.83 -15.85 0.61 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 126.062 1.745 . . . . 0.0 113.123 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.04 138.63 2.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.667 0.667 . . . . 0.0 111.679 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 -31.26 0.69 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 166.39 28.4 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.91 1.355 . . . . 0.0 111.982 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.43 -171.29 41.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 163.19 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.485 0.642 . . . . 0.0 110.763 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 9.1 p -150.72 160.03 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.817 0.847 . . . . 0.0 109.365 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 32.4 tt0 -152.08 136.39 16.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.088 -0.382 . . . . 0.0 111.618 -172.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 80.4 m-85 -104.31 168.08 9.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.15 -11.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.621 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -151.73 137.21 17.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.73 -23.41 66.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.3 -32.92 55.7 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.226 0.466 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -75.21 -20.12 59.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.022 0.439 . . . . 0.0 109.841 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.445 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 36.5 ttp -76.17 -52.84 9.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 111.469 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 49.0 m -65.65 -20.69 66.4 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -71.92 -27.19 62.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.264 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' B' ' 175' ' ' LEU . . . -74.07 -37.12 64.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.207 -0.308 . . . . 0.0 111.069 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.71 8.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.566 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 15.1 ptm180 -137.74 -23.92 1.05 Allowed 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 121.704 -0.622 . . . . 0.0 112.191 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.566 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.97 -28.25 9.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.375 0.534 . . . . 0.0 111.191 175.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' B' ' 171' ' ' ALA . 1.7 mm? -116.01 -6.88 11.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.47 0.708 . . . . 0.0 109.729 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -85.12 144.09 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 64.53 23.88 12.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.91 0.884 . . . . 0.0 111.627 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 72.0 p -138.91 178.03 7.46 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.627 0.727 . . . . 0.0 111.247 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -61.54 148.59 41.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.017 1.327 . . . . 0.0 114.176 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.519 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.3 OUTLIER -143.74 145.28 32.29 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.115 1.766 . . . . 0.0 108.028 169.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 . . . . . 0 C--N 1.337 0.049 0 C-N-CA 124.006 0.923 . . . . 0.0 109.36 -170.442 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.897 0.38 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.58 165.98 29.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.572 1.149 . . . . 0.0 108.955 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -68.58 155.75 39.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.25 0.547 . . . . 0.0 110.998 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.91 152.4 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.774 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.361 1.064 . . . . 0.0 108.788 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.36 94.28 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.651 0.78 . . . . 0.0 110.761 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.4 tttt -74.37 171.14 14.24 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 122.552 0.341 . . . . 0.0 110.742 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.446 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.4 p -66.05 -27.12 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 126.298 1.839 . . . . 0.0 114.732 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.491 ' HA ' HG23 ' B' ' 124' ' ' VAL . 25.2 t70 . . . . . 0 N--CA 1.468 0.469 0 C-N-CA 128.463 2.705 . . . . 0.0 109.237 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.44 ' HD3' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt180 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -54.13 160.23 1.62 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.476 1.034 . . . . 0.0 112.607 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 -139.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 112.228 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.254 40.2 mt-10 -132.21 -18.99 2.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -165.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.37 77.25 1.64 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.976 1.31 . . . . 0.0 109.941 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtm-85 -83.37 148.27 27.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.452 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.488 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -136.79 129.55 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 126.508 1.923 . . . . 0.0 107.402 173.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.81 153.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.7 106.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 53.7 p -105.13 152.55 22.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.976 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.82 18.11 5.29 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 4.7 mp -95.79 13.72 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 90.5 Cg_exo -42.67 -38.33 6.34 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.586 2.191 . . . . 0.0 116.63 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 82.4 Cg_exo -44.59 -61.72 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 6.0 t 179.41 -42.96 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.674 1.19 . . . . 0.0 107.822 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.24 -172.58 0.04 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.877 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -168.59 165.84 12.14 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.863 -0.786 . . . . 0.0 109.152 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -76.5 -30.28 57.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -68.51 -39.94 81.04 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.89 -26.97 54.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.484 -0.135 . . . . 0.0 110.847 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -34.93 78.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HD3' ' B' ' 117' ' ' ARG . 9.6 mtpm? -74.38 -39.28 62.81 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -1.48 3.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.441 1.097 . . . . 0.0 113.713 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 38.5 t60 -129.89 -39.19 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.551 0.614 . . . . 0.0 111.523 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . 0.422 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 84.0 mmm -70.39 -14.22 62.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.37 0.532 . . . . 0.0 109.987 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -47.72 -20.93 0.32 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.698 0.799 . . . . 0.0 112.599 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.97 -42.92 84.33 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.226 0.611 . . . . 0.0 111.132 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -27.74 65.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.639 0.776 . . . . 0.0 111.569 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.37 -166.46 36.53 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.28 79.3 9.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.462 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.2 OUTLIER -65.86 148.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 52.0 t -128.08 -33.28 2.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.861 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -134.58 157.72 45.86 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.048 0.84 . . . . 0.0 110.787 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -152.74 164.27 38.1 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -145.4 151.32 38.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.604 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -130.54 140.02 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 121.743 0.782 . . . . 0.0 110.504 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -104.06 10.66 35.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.845 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.604 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 41.73 26.25 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.51 2.324 . . . . 0.0 114.26 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -143.33 3.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.72 -10.32 3.98 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.154 0.434 . . . . 0.0 113.677 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -142.84 166.73 23.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.122 0.461 . . . . 0.0 110.639 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.86 -164.6 29.89 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.412 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.0 p -142.74 163.06 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 122.773 0.429 . . . . 0.0 111.344 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -156.04 154.91 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.374 1.069 . . . . 0.0 109.705 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.28 159.54 40.09 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -125.88 171.07 11.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 122.01 0.909 . . . . 0.0 112.202 -171.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.22 -9.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.443 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -149.7 139.3 21.64 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.028 0.531 . . . . 0.0 109.585 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.13 -22.67 66.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.77 -29.43 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.047 -0.408 . . . . 0.0 110.802 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.45 -20.4 60.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.14 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.488 ' CG ' HG13 ' B' ' 123' ' ' VAL . 29.8 ttp -79.48 -52.24 8.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -63.13 -21.84 66.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 43.5 t80 -74.77 -33.04 62.22 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.422 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -73.56 -15.83 61.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.331 0.652 . . . . 0.0 111.701 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.422 ' O ' HG22 ' B' ' 172' ' ' VAL 0.251 8.8 p -115.47 32.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.859 0.838 . . . . 0.0 111.643 175.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -142.63 -16.7 0.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.137 169.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -124.19 -25.37 4.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 112.534 173.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.49 -2.82 20.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.415 0.286 . . . . 0.0 110.248 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.6 143.41 42.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.118 0.967 . . . . 0.0 110.269 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.41 27.8 10.62 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.8 p -127.91 166.69 17.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.03 144.31 29.3 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.567 0.747 . . . . 0.0 111.952 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.594 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 2.5 t80 -137.48 161.23 36.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.275 1.83 . . . . 0.0 109.074 171.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 . . . . . 0 C--O 1.228 -0.043 0 C-N-CA 123.941 0.897 . . . . 0.0 109.537 -170.218 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.883 0.373 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.99 162.56 18.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.156 0.982 . . . . 0.0 108.669 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -69.46 152.02 45.37 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.106 -0.371 . . . . 0.0 110.555 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -127.48 114.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.446 0.641 . . . . 0.0 109.996 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -85.77 95.32 9.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.23 0.538 . . . . 0.0 109.91 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 8.0 t -67.29 146.56 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.188 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -135.04 158.08 45.28 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 121.015 0.436 . . . . 0.0 110.514 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.3 m -73.65 4.57 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.26 1.824 . . . . 0.0 113.628 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 C--N 1.328 -0.338 0 C-N-CA 125.367 1.467 . . . . 0.0 110.703 171.165 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -56.92 171.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.669 1.188 . . . . 0.0 112.796 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 7.5 t -144.29 -129.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.0 -19.77 1.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.6 77.55 1.67 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.956 1.302 . . . . 0.0 110.953 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -77.75 148.48 34.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.229 1.812 . . . . 0.0 113.407 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -139.27 127.04 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.982 2.113 . . . . 0.0 108.37 172.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.461 HG23 ' HA ' ' B' ' 195' ' ' ASP . 54.0 t -63.51 159.03 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 O-C-N 121.787 -0.571 . . . . 0.0 109.614 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.01 116.17 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 85.4 p -125.67 143.69 50.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.094 0.473 . . . . 0.0 111.798 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.74 -1.7 26.02 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.34 147.88 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 127.522 2.329 . . . . 0.0 110.244 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.07 162.8 38.17 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.487 2.791 . . . . 0.0 111.421 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 -10.74 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 1 C-N-CA 125.379 4.053 . . . . 0.0 115.838 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -133.81 12.2 4.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.051 0.842 . . . . 0.0 112.91 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.57 167.28 4.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -148.68 166.94 26.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.243 -0.563 . . . . 0.0 110.489 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -75.32 -28.16 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.348 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -67.85 -38.06 82.67 Favored 'General case' 0 C--O 1.231 0.089 0 O-C-N 122.339 -0.226 . . . . 0.0 110.824 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -79.81 -19.65 47.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -29.8 66.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -78.75 -38.78 37.91 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.42 -1.78 5.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.4 1.08 . . . . 0.0 113.342 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.5 t60 -130.32 -36.53 1.48 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.702 0.683 . . . . 0.0 111.356 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.3 mmm -72.73 -10.93 60.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.122 0.419 . . . . 0.0 111.069 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -48.96 -16.59 0.14 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -71.75 -42.26 67.43 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.98 0.512 . . . . 0.0 111.02 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.74 -29.14 68.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.476 0.71 . . . . 0.0 111.168 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.93 -168.36 36.25 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -80.57 79.4 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 0.0 110.412 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.469 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.6 OUTLIER -64.1 149.68 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.8 t -134.36 -35.98 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.214 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 8.8 t80 -134.61 160.56 37.71 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.79 0.805 . . . . 0.0 110.17 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.09 168.67 26.55 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -148.1 158.43 44.06 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 168.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.7 p -135.57 143.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 121.176 0.512 . . . . 0.0 110.12 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -108.36 6.97 26.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.26 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.0 mtt-85 61.4 18.63 9.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.491 0.717 . . . . 0.0 112.209 170.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -137.64 6.26 2.71 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.32 22.13 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 121.555 -0.716 . . . . 0.0 112.194 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -141.16 160.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.241 0.616 . . . . 0.0 110.083 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.28 -164.42 30.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.99 162.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.257 0.528 . . . . 0.0 110.876 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.8 p -148.0 160.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.129 0.971 . . . . 0.0 108.65 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 37.7 tt0 -157.53 152.84 26.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.056 -0.403 . . . . 0.0 110.819 -170.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -126.43 170.56 11.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.689 0.757 . . . . 0.0 112.181 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.22 -9.63 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.369 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -149.99 139.76 21.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -64.65 -21.36 66.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.32 -31.51 58.2 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.311 0.505 . . . . 0.0 111.004 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -72.89 -21.49 60.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.107 0.479 . . . . 0.0 109.825 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.495 ' SD ' HG13 ' B' ' 123' ' ' VAL . 38.2 ttp -77.63 -52.58 8.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.356 0.663 . . . . 0.0 110.754 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 75.4 m -63.38 -18.71 63.97 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.564 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 30.6 t80 -75.37 -28.75 59.66 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.91 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.19 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 122.086 -0.384 . . . . 0.0 110.388 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.69 2.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.0 -16.26 2.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.564 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.7 mppt? -126.21 -21.63 4.22 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.84 3.54 12.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.867 0.467 . . . . 0.0 109.862 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.826 0.85 . . . . 0.0 108.819 172.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 58.44 35.93 25.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.005 0.522 . . . . 0.0 111.346 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 51.8 p -136.43 175.07 9.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 110.64 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -62.33 148.65 44.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.505 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 9.9 t80 -146.35 165.6 28.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.045 2.138 . . . . 0.0 107.439 167.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--N 1.334 -0.066 0 O-C-N 121.907 -0.495 . . . . 0.0 109.681 -174.099 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.993 0.425 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 -168.91 2.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.862 0.865 . . . . 0.0 108.896 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.21 149.93 47.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.59 108.51 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.213 0.53 . . . . 0.0 112.206 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -83.27 88.34 6.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 7.9 t -76.14 81.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.765 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.79 159.44 22.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.24 0.616 . . . . 0.0 111.534 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.1 m -73.0 5.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 126.514 1.926 . . . . 0.0 114.292 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.461 ' HA ' HG23 ' B' ' 124' ' ' VAL . 4.4 t0 . . . . . 0 C--N 1.328 -0.335 0 O-C-N 124.833 1.333 . . . . 0.0 110.624 171.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 14.6 mtt-85 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -53.29 153.25 3.97 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.65 1.18 . . . . 0.0 112.069 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.0 t -135.86 -110.49 0.2 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.866 0.466 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -148.61 -26.12 0.32 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.419 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 0.8 OUTLIER -122.24 -32.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -166.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 40.75 151.38 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.778 2.831 . . . . 0.0 118.162 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.497 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.1 OUTLIER -149.69 148.33 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.256 1.822 . . . . 0.0 108.828 174.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -90.92 171.95 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.37 142.96 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -143.82 150.92 39.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.299 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 103.24 -2.75 47.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -49.25 126.6 15.71 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 127.728 2.411 . . . . 0.0 109.742 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.84 155.13 53.76 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.883 2.389 . . . . 0.0 110.269 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.79 -22.12 28.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.483 2.789 . . . . 0.0 112.561 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m -73.34 -9.22 58.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.391 1.076 . . . . 0.0 112.462 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.44 165.81 39.36 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 121.545 0.525 . . . . 0.0 112.598 -174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 30.1 t -161.72 167.79 24.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.184 1.394 . . . . 0.0 107.445 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -64.42 -26.93 68.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.857 0.753 . . . . 0.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -70.05 -28.95 65.87 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.004 -0.435 . . . . 0.0 111.706 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -89.92 -13.65 35.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.766 0.257 . . . . 0.0 110.925 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.25 3.48 54.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.697 0.399 . . . . 0.0 111.024 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -110.26 -35.33 6.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.11 -3.88 11.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.32 1.048 . . . . 0.0 112.771 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.64 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 10.0 t60 -127.51 -36.44 2.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.286 0.494 . . . . 0.0 110.734 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 76.5 mmm -69.1 -19.07 64.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.577 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -48.57 -20.05 0.4 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.23 1.012 . . . . 0.0 112.811 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -41.76 97.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.002 0.521 . . . . 0.0 111.252 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.484 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.69 -29.76 69.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.563 . . . . 0.0 111.204 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.72 -177.49 35.31 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.14 118.0 14.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.998 0.399 . . . . 0.0 110.161 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -114.33 151.67 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . 0.417 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 7.4 p -130.7 -21.71 2.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.295 -0.859 . . . . 0.0 111.729 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -126.02 149.51 48.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 119.122 0.874 . . . . 0.0 111.805 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.43 19.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.436 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 19.5 t0 -141.93 154.61 45.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.528 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.9 p -132.19 145.61 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.185 0.517 . . . . 0.0 110.214 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.16 7.16 27.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.779 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.528 ' H ' HG22 ' B' ' 152' ' ' VAL . 24.6 mtp85 61.34 16.98 7.87 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.496 0.718 . . . . 0.0 112.77 170.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -137.95 -12.0 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.23 -2.99 2.13 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.799 0.727 . . . . 0.0 112.922 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.81 167.68 21.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.127 0.571 . . . . 0.0 109.799 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.74 -167.4 35.25 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 6.7 p -141.09 161.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.369 0.604 . . . . 0.0 110.613 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.7 159.93 2.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -157.75 154.12 27.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.01 -0.431 . . . . 0.0 111.527 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 22.7 m-85 -122.87 163.55 20.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.893 0.854 . . . . 0.0 112.248 -170.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.36 -8.82 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.43 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -152.9 154.72 35.63 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.071 0.549 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -69.15 -25.58 64.44 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -82.83 -31.77 27.91 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.197 0.453 . . . . 0.0 111.313 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -70.57 -2.28 13.71 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.699 0.4 . . . . 0.0 110.332 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.497 ' SD ' HG13 ' B' ' 123' ' ' VAL . 40.6 ttp -111.94 -46.85 3.18 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.864 1.265 . . . . 0.0 110.897 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 58.4 m -63.23 -20.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 6.3 t80 -70.57 -31.51 68.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.72 69.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.093 -0.38 . . . . 0.0 110.367 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.21 5.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -134.4 -19.02 1.93 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -19.5 5.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.81 2.73 13.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.136 0.574 . . . . 0.0 109.48 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.36 136.75 41.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.4 27.94 13.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.178 0.991 . . . . 0.0 111.255 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.3 p -138.09 179.46 6.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.438 0.695 . . . . 0.0 110.806 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -56.01 148.56 17.25 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.64 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 24.8 t80 -146.57 159.16 43.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.344 1.857 . . . . 0.0 108.179 168.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -170.332 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.15 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.92 -167.52 1.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.969 0.908 . . . . 0.0 108.784 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -115.02 155.06 27.69 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 30.8 pt -134.9 148.86 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.396 0.617 . . . . 0.0 110.778 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -113.33 84.63 2.04 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 107.997 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 t -67.81 87.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.959 0.904 . . . . 0.0 111.255 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' B' ' 194' ' ' VAL . 50.5 tptt -76.68 160.24 29.53 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 110.748 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.572 ' H ' ' HD2' ' B' ' 193' ' ' LYS . 8.1 p -57.97 -27.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.302 2.641 . . . . 0.0 117.774 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.557 ' HA ' HG23 ' B' ' 124' ' ' VAL . 38.1 t70 . . . . . 0 N--CA 1.469 0.491 0 C-N-CA 127.183 2.193 . . . . 0.0 110.141 -170.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 20.8 mtt-85 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . 0.544 ' CZ ' ' HA ' ' B' ' 118' ' ' ARG . 4.1 mmp_? -52.23 155.35 2.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.29 1.036 . . . . 0.0 113.697 -174.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.7 t -155.97 -137.04 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.447 0.699 . . . . 0.0 111.724 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -138.04 -26.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -167.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.404 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.1 p30 -131.1 80.54 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.081 0.953 . . . . 0.0 111.644 -170.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -78.66 148.83 33.01 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.577 . . . . 0.0 113.81 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.479 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -141.57 136.42 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.687 1.595 . . . . 0.0 110.017 171.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' B' ' 193' ' ' LYS . 2.3 t -76.39 162.34 4.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.06 105.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -111.38 151.42 28.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.01 8.4 44.96 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 128' ' ' LEU . 5.6 tp -60.51 146.99 84.03 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 126.69 1.996 . . . . 0.0 111.503 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.9 164.87 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.952 3.101 . . . . 0.0 109.689 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.9 -21.52 43.8 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.262 2.641 . . . . 0.0 111.631 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -73.46 -15.76 61.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.383 0.673 . . . . 0.0 112.09 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.12 148.27 24.88 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.5 t -155.76 165.65 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.585 0.754 . . . . 0.0 109.447 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -72.19 -27.04 62.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.931 -0.48 . . . . 0.0 111.702 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -65.16 -31.35 72.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.804 0.729 . . . . 0.0 111.151 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -83.14 -21.12 33.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.499 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 137' ' ' LEU . 1.0 OUTLIER -75.28 -17.03 60.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.29 0.496 . . . . 0.0 111.109 -176.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -89.15 -44.29 10.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.95 -11.64 60.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -120.45 -30.9 4.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.398 0.999 . . . . 0.0 111.221 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.5 mmm -76.81 -14.8 59.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.94 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -43.77 -21.02 0.03 OUTLIER 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.47 -42.23 87.84 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 123.589 0.755 . . . . 0.0 111.245 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.495 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.79 -28.87 69.33 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.01 0.524 . . . . 0.0 110.499 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.41 32.94 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.39 123.83 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.35 -0.5 . . . . 0.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -120.8 154.25 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . 0.408 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 53.4 t -134.64 -24.86 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.526 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 71.3 t80 -127.15 153.68 45.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 118.992 0.814 . . . . 0.0 111.947 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.74 166.85 32.26 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.023 171.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.408 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 26.5 t0 -152.07 160.26 43.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.559 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -135.84 145.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.051 0.453 . . . . 0.0 110.03 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -109.42 6.55 24.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.257 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.559 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.6 mtt180 61.83 17.72 9.1 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.651 0.781 . . . . 0.0 112.611 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.39 10.19 2.5 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.6 6.01 27.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.572 0.624 . . . . 0.0 111.978 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.28 156.81 45.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.123 0.569 . . . . 0.0 109.586 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.51 -166.0 30.42 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 7.6 p -145.55 162.38 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.016 0.436 . . . . 0.0 111.539 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.6 p -151.17 157.62 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.354 1.062 . . . . 0.0 108.547 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -155.13 140.96 18.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.931 -0.481 . . . . 0.0 111.154 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 41.9 m-85 -110.25 167.61 10.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.809 0.814 . . . . 0.0 113.053 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.75 -11.08 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.306 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -150.5 141.97 23.43 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -65.18 -26.05 67.99 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.1 -31.15 64.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.035 0.38 . . . . 0.0 110.661 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.02 -20.35 60.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.815 0.341 . . . . 0.0 110.202 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.479 ' CG ' HG13 ' B' ' 123' ' ' VAL . 33.9 ttp -80.51 -55.37 4.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.371 0.669 . . . . 0.0 110.515 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 70.3 m -64.33 -18.26 64.46 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 5.4 t80 -73.48 -32.09 64.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.55 68.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.866 -0.521 . . . . 0.0 110.575 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.92 3.13 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -132.3 -17.26 2.67 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.04 0.836 . . . . 0.0 112.761 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -21.2 4.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.44 0.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.76 147.21 33.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.71 37.39 23.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.513 0.725 . . . . 0.0 112.913 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 66.9 p -133.26 167.59 20.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.128 0.49 . . . . 0.0 110.372 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -61.76 140.84 58.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.954 0.902 . . . . 0.0 113.175 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' B' ' 180' ' ' PHE . 0.1 OUTLIER -157.78 146.82 19.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.846 1.258 . . . . 0.0 110.284 169.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' B' ' 187' ' ' THR . 46.8 ttt180 . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 128.123 2.569 . . . . 0.0 108.954 165.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . 0.568 ' HA ' ' HB3' ' B' ' 181' ' ' ARG . 40.5 p . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.349 0.595 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.23 39.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.636 1.575 . . . . 0.0 107.477 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -67.61 145.46 54.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 110.676 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 38.1 pt -123.22 136.28 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.945 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -104.32 79.6 1.61 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.824 0.85 . . . . 0.0 108.733 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.88 131.1 26.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.454 ' HE2' HG11 ' B' ' 124' ' ' VAL . 55.2 pttt -133.67 165.36 25.11 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.428 HG22 ' H ' ' B' ' 194' ' ' VAL . 17.8 m -74.74 47.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 114.385 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.915 174.165 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.69 171.96 0.79 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -134.42 -104.81 0.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -169.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -149.78 -25.18 0.27 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -166.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.15 -33.35 5.71 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -166.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 40.1 157.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.01 146.94 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.493 2.317 . . . . 0.0 107.849 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.72 168.63 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.0 p -137.45 130.47 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 58.3 p -138.42 153.53 48.88 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.36 6.01 53.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.27 139.16 97.52 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 127.811 2.444 . . . . 0.0 111.537 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.33 156.09 22.26 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.151 2.567 . . . . 0.0 110.145 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.69 -22.35 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.323 2.682 . . . . 0.0 112.07 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.9 m -73.08 7.5 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.319 1.448 . . . . 0.0 113.078 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 162.33 13.25 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.556 0.617 . . . . 0.0 111.585 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 45.1 t -156.67 173.11 17.44 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.12 0.968 . . . . 0.0 108.799 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -64.58 -30.59 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.657 -0.652 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -66.51 -23.72 66.29 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.912 0.324 . . . . 0.0 111.46 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -94.66 -24.1 17.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -23.27 61.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.227 -0.295 . . . . 0.0 110.584 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -80.82 -39.43 26.66 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.82 -0.15 5.09 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.812 1.245 . . . . 0.0 114.194 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 24.8 t60 -135.0 -38.51 0.78 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.461 0.573 . . . . 0.0 111.262 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 84.4 mmm -68.39 -11.78 60.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.564 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -45.02 -24.6 0.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.296 1.038 . . . . 0.0 112.536 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.49 -41.0 93.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.972 -0.455 . . . . 0.0 111.205 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -68.74 -31.09 69.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.674 0.789 . . . . 0.0 111.475 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.54 -171.71 40.1 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -80.87 77.03 7.78 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.816 0.817 . . . . 0.0 110.593 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.43 143.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -126.57 -28.9 2.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.818 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -136.44 157.77 46.01 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 118.79 0.723 . . . . 0.0 111.018 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.88 166.93 31.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 49.3 t0 -147.51 147.48 30.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.62 HG22 ' H ' ' B' ' 154' ' ' ARG . 6.0 p -127.58 142.01 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 121.54 0.685 . . . . 0.0 111.195 -171.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -105.95 10.57 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.62 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.62 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.31 24.23 0.03 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 127.177 2.191 . . . . 0.0 114.994 178.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.46 5.31 1.42 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.31 -9.62 4.1 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 118.167 0.439 . . . . 0.0 113.373 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.07 167.83 21.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.331 0.566 . . . . 0.0 110.665 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.93 40.07 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 2.6 p -134.77 159.38 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.8 p -148.64 157.32 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.96 157.14 34.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.756 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.7 m-85 -130.9 169.2 16.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.852 0.861 . . . . 0.0 110.641 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.2 -13.75 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.759 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.95 156.36 46.08 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.625 0.77 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.85 -28.5 40.05 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.625 0.77 . . . . 0.0 112.007 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.05 -31.07 25.58 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -77.62 7.24 5.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.737 0.415 . . . . 0.0 110.353 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.85 -44.55 3.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.355 1.462 . . . . 0.0 110.028 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -62.41 -23.62 66.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.85 -29.8 70.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.35 -37.45 68.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.152 -0.343 . . . . 0.0 110.578 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.506 ' O ' HG22 ' B' ' 172' ' ' VAL 0.282 0.6 OUTLIER -82.91 28.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.447 0.641 . . . . 0.0 111.694 177.049 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.585 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.6 ptm180 -148.0 -25.2 0.35 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.243 -0.911 . . . . 0.0 112.789 171.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.585 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.2 OUTLIER -108.89 -26.77 10.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.446 0.566 . . . . 0.0 111.99 176.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.8 mm? -115.28 0.53 13.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.22 0.608 . . . . 0.0 110.186 -172.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -82.43 144.63 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.163 0.985 . . . . 0.0 109.708 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 26.2 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.792 0.837 . . . . 0.0 111.97 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -135.31 162.83 31.48 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.715 1.206 . . . . 0.0 108.6 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 18.2 ptmt -67.99 158.27 33.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.866 -1.515 . . . . 0.0 114.293 -168.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.473 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -143.98 148.04 34.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.235 167.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 C--O 1.23 0.073 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -172.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 121.301 0.572 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.51 160.51 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.79 1.236 . . . . 0.0 109.161 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 5.2 m-30 -65.91 151.16 47.35 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 39.8 pt -131.2 133.64 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.13 95.83 7.37 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.276 0.56 . . . . 0.0 109.823 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.95 116.08 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.9 tttt -90.57 171.88 9.08 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 173.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.417 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.4 p -66.98 -28.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 0.0 114.108 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 N--CA 1.466 0.325 0 C-N-CA 127.653 2.381 . . . . 0.0 109.391 -173.217 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' B' ' 119' ' ' SER . 0.2 OUTLIER 52.07 -173.48 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 126.379 1.872 . . . . 0.0 113.518 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.595 ' H ' ' HG3' ' B' ' 118' ' ' ARG . 0.8 OUTLIER -150.04 -178.39 6.46 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -176.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . 0.563 ' HB2' HD22 ' B' ' 121' ' ' ASN . 33.6 mt-10 -148.53 -29.3 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.39 1.876 . . . . 0.0 113.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.3 p30 -140.98 78.53 1.65 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.663 2.385 . . . . 0.0 107.535 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -89.58 150.61 22.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.653 0.739 . . . . 0.0 112.757 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -138.36 127.57 32.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 126.445 1.898 . . . . 0.0 107.866 174.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' B' ' 195' ' ' ASP . 74.1 t -68.13 157.23 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.05 114.54 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.9 p -129.06 146.29 51.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.74 -0.94 39.11 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.08 144.69 48.16 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 128.054 2.542 . . . . 0.0 110.535 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.98 161.1 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.802 2.335 . . . . 0.0 109.478 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.05 -11.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.833 2.355 . . . . 0.0 110.687 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m -79.13 -8.15 58.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.575 1.15 . . . . 0.0 112.225 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.04 164.66 40.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.264 0.484 . . . . 0.0 111.987 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.1 t -157.68 168.85 26.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.117 0.967 . . . . 0.0 108.4 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -63.36 -27.24 69.18 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.545 0.611 . . . . 0.0 111.773 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -68.33 -46.77 69.28 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.186 0.448 . . . . 0.0 110.705 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.08 -24.39 63.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -20.76 60.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' B' ' 138' ' ' LYS . 50.1 mtpt -85.55 -34.89 21.38 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.566 0.621 . . . . 0.0 109.359 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.62 -40.43 66.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.2 t60 -81.03 -36.53 30.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.738 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.7 mmm -73.1 -20.65 60.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.398 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -51.27 -18.84 1.04 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.585 0.63 . . . . 0.0 112.403 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.81 -39.62 85.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.385 0.674 . . . . 0.0 111.39 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.52 -18.63 65.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.588 0.755 . . . . 0.0 111.775 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 168.39 -95.67 0.11 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.37 133.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -119.8 153.08 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.137 0.494 . . . . 0.0 110.44 -175.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.8 -21.08 3.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.311 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 51.8 t80 -144.31 157.38 44.3 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 120.22 1.373 . . . . 0.0 112.19 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.61 169.65 22.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.628 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -148.76 152.94 37.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.506 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -131.31 140.68 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.415 0.626 . . . . 0.0 109.853 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.14 5.07 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.126 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.506 ' H ' HG22 ' B' ' 152' ' ' VAL . 7.4 mtt180 61.47 16.28 7.41 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.548 0.739 . . . . 0.0 112.709 170.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -135.44 5.83 3.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.97 3.9 15.12 Favored Glycine 0 C--N 1.337 0.597 0 O-C-N 121.881 -0.512 . . . . 0.0 112.197 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.5 p -142.31 161.78 37.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 110.573 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.58 -168.61 37.51 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.3 p -141.45 165.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 117.393 0.596 . . . . 0.0 110.734 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.9 p -153.7 156.67 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.108 0.963 . . . . 0.0 109.246 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -151.09 156.25 40.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.663 0.268 . . . . 0.0 111.612 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 39.8 m-85 -120.43 163.58 17.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.697 1.237 . . . . 0.0 114.171 -169.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.96 -12.74 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.502 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -152.68 142.28 21.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -63.8 -21.01 66.22 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.91 -29.79 58.53 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.876 -0.515 . . . . 0.0 110.952 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -74.15 -18.71 60.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.433 ' CG ' HG13 ' B' ' 123' ' ' VAL . 32.9 ttp -77.17 -53.13 8.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -61.03 -20.6 62.72 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 7.4 t80 -74.13 -30.83 62.48 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.893 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.15 -33.08 67.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.073 -0.392 . . . . 0.0 110.561 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.0 4.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -133.72 -18.91 2.11 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 121.319 -0.863 . . . . 0.0 112.552 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 -19.96 5.41 Favored 'General case' 0 N--CA 1.46 0.047 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.29 2.71 14.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.71 140.52 34.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.365 1.066 . . . . 0.0 108.428 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 65.42 25.06 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.555 0.693 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 53.8 p -135.27 169.58 17.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.9 1.28 . . . . 0.0 108.507 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 9.9 pttt -75.23 155.87 36.33 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.248 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.513 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -138.44 166.23 24.79 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.483 170.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 124.161 0.984 . . . . 0.0 110.157 -169.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.918 0.39 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.68 156.2 15.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.015 . . . . 0.0 108.9 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 2.6 m-30 -72.03 158.57 35.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.061 0.458 . . . . 0.0 111.118 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.03 145.08 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.113 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -102.73 102.39 12.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.976 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.9 79.72 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.047 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.22 158.29 23.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.153 0.501 . . . . 0.0 111.374 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.524 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.6 m -72.64 6.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 126.203 1.801 . . . . 0.0 113.705 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 3.8 t0 . . . . . 0 C--N 1.327 -0.397 0 O-C-N 124.995 1.435 . . . . 0.0 110.277 170.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . 0.31 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.1 169.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.849 1.259 . . . . 0.0 113.476 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -140.46 -133.3 0.11 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.775 0.83 . . . . 0.0 112.151 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.64 -19.55 1.84 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -165.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.01 75.43 1.55 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.814 1.245 . . . . 0.0 109.788 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 66.5 mtm-85 -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.436 1.494 . . . . 0.0 113.398 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.4 OUTLIER -139.21 132.86 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 126.604 1.962 . . . . 0.0 108.111 174.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.2 t -66.52 156.59 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 109.774 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.18 100.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 77.3 p -111.3 146.94 36.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.407 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.47 -0.46 32.69 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.17 149.82 44.56 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 128.12 2.568 . . . . 0.0 111.29 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.31 165.16 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.5 2.8 . . . . 0.0 109.668 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.95 -15.69 36.46 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.786 2.324 . . . . 0.0 110.25 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 73.2 m -79.66 -2.57 43.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.875 1.27 . . . . 0.0 112.024 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.75 168.64 54.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 3.9 p -159.75 166.36 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -73.21 -28.67 62.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.334 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -68.34 -40.47 81.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 117.964 0.347 . . . . 0.0 110.246 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -80.61 -19.73 44.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -34.05 70.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -74.65 -37.95 62.6 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.37 1.47 1.62 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.727 1.211 . . . . 0.0 113.5 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 12.0 t60 -132.96 -37.74 0.99 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.513 0.597 . . . . 0.0 111.403 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.5 mmm -71.63 -11.35 60.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.421 0.555 . . . . 0.0 110.189 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -47.59 -21.41 0.35 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 123.914 0.886 . . . . 0.0 113.114 171.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.4 -41.88 88.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -67.2 -27.81 67.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.15 -170.26 36.91 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -83.07 74.26 9.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.839 0.828 . . . . 0.0 110.565 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.4 OUTLIER -61.11 149.56 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 34.4 t -131.74 -33.37 1.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -136.37 158.89 43.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 110.609 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.45 166.28 33.19 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -145.19 150.52 36.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.576 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.8 p -129.49 141.38 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.599 0.714 . . . . 0.0 110.362 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.79 11.61 29.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.279 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.576 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.9 23.3 0.03 OUTLIER 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.954 2.101 . . . . 0.0 114.895 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.07 6.75 1.78 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.14 6.38 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 118.557 0.617 . . . . 0.0 113.202 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 2.9 p -142.73 163.46 32.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.271 0.536 . . . . 0.0 110.322 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.04 -168.29 35.43 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 160' ' ' VAL . 6.6 p -140.91 162.29 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 122.94 0.496 . . . . 0.0 111.105 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -154.59 153.95 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 124.327 1.051 . . . . 0.0 109.472 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 17.1 pt-20 -154.47 160.15 41.42 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -122.73 171.72 8.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 122.061 0.934 . . . . 0.0 111.984 -171.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.05 -20.11 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.22 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -145.11 143.89 30.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.135 0.574 . . . . 0.0 110.371 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.02 -24.32 63.26 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.29 -29.53 62.78 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.546 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.83 -19.33 60.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.478 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.2 ttp -78.17 -52.79 8.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.181 0.592 . . . . 0.0 110.481 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.3 m -64.8 -19.27 65.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -73.91 -27.63 61.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.03 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.46 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.03 -0.419 . . . . 0.0 110.891 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.38 3.25 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . 0.609 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 5.1 ptm180 -134.44 -21.45 1.78 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.833 0.742 . . . . 0.0 112.491 -173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.609 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.1 OUTLIER -113.06 -26.3 8.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.945 0.339 . . . . 0.0 111.116 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' B' ' 174' ' ' LYS . 1.8 mm? -118.23 2.22 11.95 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.763 0.825 . . . . 0.0 109.955 -172.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.0 152.39 29.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.107 0.563 . . . . 0.0 109.544 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.4 32.95 12.04 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 32.9 p -133.01 175.15 9.63 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.974 0.509 . . . . 0.0 110.632 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.75 147.19 28.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.899 0.88 . . . . 0.0 112.1 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.552 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.4 t80 -139.7 158.78 43.54 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.9 1.28 . . . . 0.0 109.639 170.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 . . . . . 0 CA--C 1.52 -0.209 0 C-N-CA 124.766 1.226 . . . . 0.0 108.715 -174.186 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.608 0.242 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.33 -159.43 0.58 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.404 0.681 . . . . 0.0 109.732 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.89 145.64 48.28 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.62 92.13 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.063 0 CA-C-O 121.535 0.683 . . . . 0.0 112.608 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.8 84.8 1.67 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.83 0.824 . . . . 0.0 109.489 170.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.55 133.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.134 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' B' ' 195' ' ' ASP . 54.6 mtmt -125.83 165.62 18.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.271 0.558 . . . . 0.0 112.114 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.421 HG22 ' H ' ' B' ' 194' ' ' VAL . 18.0 m -76.77 32.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 126.7 2.0 . . . . 0.0 112.679 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.501 ' HA ' HG23 ' B' ' 124' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.759 173.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' B' ' 117' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.7 -175.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -138.67 -135.35 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.289 37.7 mt-10 -136.65 -17.58 1.47 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.659 1.983 . . . . 0.0 115.214 -165.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -131.43 80.85 1.95 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.559 1.544 . . . . 0.0 108.558 -169.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -80.64 159.02 25.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.41 2.284 . . . . 0.0 113.429 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.437 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -147.7 138.87 17.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 128.722 2.809 . . . . 0.0 107.721 176.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' CA ' ' B' ' 195' ' ' ASP . 2.4 t -72.63 164.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.32 131.52 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.41 ' HB3' HG22 ' B' ' 157' ' ' THR . 93.3 p -137.19 140.14 41.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.869 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 132.35 -1.02 4.83 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.491 HD12 ' CE2' ' B' ' 180' ' ' PHE . 1.6 mm? -53.54 149.21 15.81 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 123.352 0.661 . . . . 0.0 110.981 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.26 166.43 29.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.309 3.339 . . . . 0.0 110.669 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.79 -3.59 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 1 C-N-CA 125.443 4.095 . . . . 0.0 116.308 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.11 10.47 1.52 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.644 1.111 . . . . 0.0 113.261 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.36 158.79 7.01 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 26.0 t -148.43 170.3 18.31 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.37 -0.488 . . . . 0.0 110.594 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -66.69 -27.07 67.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.555 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -68.38 -35.22 77.37 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.348 0.522 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -84.03 -22.69 31.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.388 -0.195 . . . . 0.0 111.325 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -35.9 75.19 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -77.02 -36.62 56.12 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.44 -2.05 10.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.234 1.014 . . . . 0.0 112.962 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' HIS . . . . . 0.655 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 17.9 t60 -126.99 -37.6 2.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 110.882 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mmm -70.89 -11.31 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.885 -0.509 . . . . 0.0 110.205 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -49.53 -21.34 0.94 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.228 0.611 . . . . 0.0 112.439 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.26 -43.62 81.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.148 0.579 . . . . 0.0 111.073 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.13 68.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.055 0.542 . . . . 0.0 110.929 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.47 -167.67 37.1 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.05 74.3 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.669 0.747 . . . . 0.0 110.402 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 1.2 p -60.33 149.03 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 29.1 p -138.29 -13.64 1.35 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.984 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.54 155.76 32.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.332 -0.855 . . . . 0.0 110.638 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.9 130.24 8.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.678 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.97 120.96 43.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.534 HG22 ' H ' ' B' ' 154' ' ' ARG . 11.3 p -109.39 140.6 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.565 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.15 6.18 49.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.353 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.534 ' H ' HG22 ' B' ' 152' ' ' VAL . 13.8 mtt180 62.57 14.91 7.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.928 0.891 . . . . 0.0 112.669 172.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.59 -4.44 2.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 130.56 7.19 3.53 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 118.528 0.604 . . . . 0.0 113.118 177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' THR . . . . . 0.41 HG22 ' HB3' ' B' ' 126' ' ' SER . 0.1 OUTLIER -143.26 164.81 29.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.62 0.71 . . . . 0.0 110.614 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.85 -164.18 31.87 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.27 161.02 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 124.088 0.955 . . . . 0.0 108.423 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 p -152.03 156.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -156.18 159.6 39.12 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.2 m-85 -127.97 170.42 12.88 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.596 0.713 . . . . 0.0 111.314 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.58 -7.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -149.46 135.83 19.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.161 0.437 . . . . 0.0 110.119 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -66.81 -20.86 66.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.37 -31.96 54.65 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.507 -0.746 . . . . 0.0 110.56 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.61 -19.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 109.607 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' MET . . . . . 0.437 ' CG ' HG13 ' B' ' 123' ' ' VAL . 34.8 ttp -76.54 -52.45 9.73 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.017 0.927 . . . . 0.0 110.611 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -65.19 -19.38 65.94 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' TYR . . . . . 0.624 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 37.9 t80 -73.55 -27.66 61.46 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.452 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.13 66.61 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.385 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.3 4.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.4 -17.18 2.05 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.393 -0.817 . . . . 0.0 112.872 -172.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.624 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.3 mppt? -124.94 -21.59 4.67 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 173.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.21 1.62 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.912 0.485 . . . . 0.0 109.945 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 140.59 29.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 62.06 34.49 16.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.807 0.843 . . . . 0.0 111.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.7 p -138.04 177.77 7.63 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.469 0.708 . . . . 0.0 110.543 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -57.01 155.52 8.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.701 1.201 . . . . 0.0 113.704 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' PHE . . . . . 0.655 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 23.7 t80 -143.25 161.87 37.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.472 1.909 . . . . 0.0 108.873 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 . . . . . 0 C--N 1.339 0.125 0 C-N-CA 124.19 0.996 . . . . 0.0 108.738 -173.235 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 56.1 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.39 0.614 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.84 -163.24 1.45 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.991 1.316 . . . . 0.0 107.755 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.03 156.34 38.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.07 146.53 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.577 0.703 . . . . 0.0 111.234 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -116.61 82.3 1.77 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 t -69.52 86.33 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.901 0.88 . . . . 0.0 111.219 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 193' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 12.7 tttt -71.08 169.32 15.24 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.02 -0.425 . . . . 0.0 110.869 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 194' ' ' VAL . . . . . 0.447 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 5.5 p -62.01 -28.67 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.062 1.745 . . . . 0.0 115.246 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.439 ' CA ' HG23 ' B' ' 124' ' ' VAL . 26.6 t70 . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 128.068 2.547 . . . . 0.0 109.067 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 111.84 3.64 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.716 0 C5'-C4'-C3' 110.272 -3.485 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 O4'-C1'-N19 111.431 3.231 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.625 0 O4'-C1'-N19 112.054 3.854 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . 0.433 ' C8 ' ' CZ2' ' B' ' 134' ' ' TRP . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C4'-C3'-C2' 98.124 -4.576 . 0.183 0i . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 3 O4'-C1'-N19 116.001 7.801 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.619 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.667 1 O4'-C1'-N19 112.74 4.54 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 C5'-C4'-C3' 111.863 -2.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 119.773 -0.156 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . 34.52 56.09 1.94 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.959 1.304 . . . . 0.0 113.186 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.46 167.28 25.8 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.286 2.657 . . . . 0.0 111.923 -174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' B' ' 111' ' ' ARG . 12.1 ptp85 -142.33 -8.26 0.88 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.56 177.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.31 19.34 59.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.52 0.581 . . . . 0.0 113.251 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' B' ' 109' ' ' ARG . 82.9 mtt85 -146.69 169.29 19.33 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.252 1.021 . . . . 0.0 110.341 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -62.83 150.61 41.24 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.821 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.46 174.51 22.34 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.97 111.13 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.171 3.247 . . . . 0.0 110.225 175.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.75 -58.06 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.541 2.828 . . . . 0.0 116.432 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.18 -30.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -8.66 3.46 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -175.64 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.64 1.176 . . . . 0.0 112.586 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.484 ' HB3' ' CG ' ' B' ' 161' ' ' GLU . 0.0 OUTLIER -162.44 179.6 7.68 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . 0.575 ' HB2' HD22 ' B' ' 121' ' ' ASN . 26.5 mt-10 -149.35 -31.21 0.23 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.45 -1.704 . . . . 0.0 113.406 -172.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.6 p30 -140.49 78.74 1.67 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.325 1.85 . . . . 0.0 107.42 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -87.29 158.0 19.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.44 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.489 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -146.65 142.17 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 127.987 2.515 . . . . 0.0 107.279 176.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.91 159.48 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.07 102.9 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -117.79 150.65 38.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.193 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.95 -2.71 55.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 14.4 tp -53.42 145.18 28.57 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 128.14 2.576 . . . . 0.0 110.151 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.36 162.45 38.34 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.053 2.502 . . . . 0.0 109.448 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.33 -12.64 35.53 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.881 2.387 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -72.75 -23.0 60.77 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.091 0.957 . . . . 0.0 111.779 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.59 46.25 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.4 0.444 . . . . 0.0 112.645 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 43.8 t -158.12 168.66 26.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . 0.433 ' CZ2' ' C8 ' ' A' ' 5' ' ' ' G' . 34.6 p-90 -64.49 -30.13 71.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.446 0.566 . . . . 0.0 110.727 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -66.61 -37.07 84.1 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.938 0.335 . . . . 0.0 111.568 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.619 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 86.6 m-20 -84.67 -17.88 37.13 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.856 0.298 . . . . 0.0 111.441 -176.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -32.17 66.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -77.73 -38.57 46.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.97 1.57 0.9 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.531 1.132 . . . . 0.0 113.658 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.626 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.6 t60 -136.68 -40.37 0.62 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.413 0.551 . . . . 0.0 111.568 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 86.4 mmm -68.55 -11.6 60.16 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 118.413 0.551 . . . . 0.0 110.051 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -47.39 -21.38 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.885 0.874 . . . . 0.0 112.504 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.23 -42.74 88.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.824 -0.548 . . . . 0.0 111.164 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.45 -27.72 66.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.65 0.78 . . . . 0.0 111.666 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.5 -167.54 37.06 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -87.22 77.9 8.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.915 0.864 . . . . 0.0 110.157 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -62.96 141.71 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 43.5 t -128.06 -23.77 3.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.743 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -139.59 155.79 47.26 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 119.162 0.892 . . . . 0.0 110.331 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.86 165.12 35.51 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -147.62 153.61 39.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.499 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -132.35 147.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.113 0.482 . . . . 0.0 110.305 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.78 10.98 17.93 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.999 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.499 ' H ' HG22 ' B' ' 152' ' ' VAL . 28.0 mtt180 59.24 17.39 5.68 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.681 0.792 . . . . 0.0 113.053 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.11 15.16 3.28 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.0 52.35 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 11.8 p -140.69 159.19 42.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.352 0.661 . . . . 0.0 110.395 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.78 -170.27 38.39 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.5 161.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.804 0.442 . . . . 0.0 111.131 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -153.49 156.54 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 123.459 0.704 . . . . 0.0 109.885 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.484 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 1.2 tm-20 -152.39 155.39 37.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.944 0.498 . . . . 0.0 111.728 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -124.17 163.62 21.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.883 1.273 . . . . 0.0 111.73 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -62.7 -8.37 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.507 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -147.8 133.8 19.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -63.57 -20.66 65.82 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -76.02 -29.37 58.1 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.649 -0.657 . . . . 0.0 110.744 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.8 -19.01 60.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.489 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.7 ttp -77.97 -52.97 7.98 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.345 1.058 . . . . 0.0 110.674 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.6 m -63.46 -21.45 66.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.279 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.592 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 46.0 t80 -74.53 -31.72 62.23 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.73 -17.56 60.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.288 0.635 . . . . 0.0 111.628 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 172' ' ' VAL . 14.5 p -113.21 34.23 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.714 0.769 . . . . 0.0 111.702 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.28 -17.5 0.64 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -123.54 -25.82 4.3 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.39 0.676 . . . . 0.0 112.611 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.38 -2.64 21.96 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.357 0.263 . . . . 0.0 110.533 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.22 145.9 32.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.008 0.923 . . . . 0.0 109.013 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 29.67 17.85 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.435 0.694 . . . . 0.0 112.532 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 47.4 p -133.44 169.49 16.88 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.965 0.506 . . . . 0.0 110.701 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -57.85 149.47 22.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.626 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.0 t80 -141.71 161.1 38.77 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.982 1.713 . . . . 0.0 108.937 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . 0.404 ' HD2' ' H ' ' B' ' 182' ' ' SER . 15.0 tpt180 -139.33 155.76 47.48 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.047 0.939 . . . . 0.0 110.178 -170.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.404 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 41.8 t -141.77 162.56 35.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.303 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.466 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 18.2 p-80 -59.75 -20.57 57.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.208 1.403 . . . . 0.0 113.319 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.42 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 46.8 mm-40 -72.0 -13.15 61.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.986 0.357 . . . . 0.0 111.573 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.35 20.51 13.38 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 119.615 -0.547 . . . . 0.0 113.017 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.18 171.48 14.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.103 0.951 . . . . 0.0 110.99 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -139.01 161.56 37.07 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 -173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.69 160.48 19.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.326 1.051 . . . . 0.0 108.849 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.98 157.23 38.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.965 0.412 . . . . 0.0 110.346 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 26.9 pt -123.59 151.7 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.746 0.784 . . . . 0.0 109.64 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -118.41 78.76 1.29 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.78 144.54 10.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 5.3 tttp -126.68 168.78 13.89 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.437 ' H ' HG12 ' B' ' 194' ' ' VAL . 3.0 p -60.22 -29.55 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.526 1.531 . . . . 0.0 114.603 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 22.6 t70 143.59 163.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.71 2.404 . . . . 0.0 109.058 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.436 -1.758 . . . . 0.0 110.988 175.817 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 0 O4'-C1'-N19 109.948 1.748 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 O4'-C1'-N19 110.722 2.522 OUTLIER-DELTA 0.0 OUTLIER '7D dist 5d' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.405 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.809 0 O4'-C1'-N19 111.985 3.785 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 O4'-C1'-N19 111.242 3.042 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.301 1 C4'-C3'-C2' 98.04 -4.66 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 2 O4'-C1'-N19 115.337 7.137 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.608 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.75 1 O4'-C1'-N19 113.416 5.216 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 C5'-C4'-C3' 112.983 -1.678 . 0.013 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.627 0.251 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.93 157.78 35.32 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.591 0.756 . . . . 0.0 109.13 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 10.8 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.929 3.086 . . . . 0.0 112.661 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -143.64 18.24 1.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.07 0.948 . . . . 0.0 110.731 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.19 34.41 0.35 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 mtm-85 -59.97 -18.1 43.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.65 7.42 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.404 0.547 . . . . 0.0 112.357 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.83 -173.31 45.5 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.28 160.78 47.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.908 2.405 . . . . 0.0 109.528 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.17 151.64 66.8 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.906 2.404 . . . . 0.0 109.703 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 3.0 m -160.57 159.29 30.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 53.52 4.59 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 169.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -53.9 159.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.167 0.894 . . . . 0.0 112.192 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -140.1 -94.37 0.16 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -153.89 -30.51 0.12 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -165.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.94 -37.24 2.12 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -165.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . 0.52 ' H ' ' HG3' ' B' ' 161' ' ' GLU . 86.8 mtt180 46.3 165.33 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.619 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.0 OUTLIER -159.17 134.65 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 129.59 3.156 . . . . 0.0 107.717 170.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.16 165.75 3.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -137.2 136.41 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 54.6 p -135.32 147.45 49.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.907 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.07 -2.34 31.48 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 tp -52.72 140.44 38.59 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 127.133 2.173 . . . . 0.0 110.076 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.3 162.35 19.92 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.638 2.892 . . . . 0.0 110.11 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.9 -14.77 32.71 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.865 2.377 . . . . 0.0 109.761 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -83.1 6.24 19.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.689 1.196 . . . . 0.0 111.738 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.45 165.09 12.66 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -159.49 170.67 21.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -61.68 -28.45 69.41 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.788 -0.57 . . . . 0.0 110.905 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -69.31 -35.05 75.57 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.608 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 70.7 m-20 -91.45 -19.59 22.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.25 0.477 . . . . 0.0 111.416 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.19 -26.48 59.04 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -75.22 -39.86 59.67 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -65.98 1.66 1.36 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.163 1.385 . . . . 0.0 113.179 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 8.4 t60 -135.38 -38.92 0.75 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.125 0.42 . . . . 0.0 111.37 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.0 mmm -68.14 -18.27 64.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.873 -0.517 . . . . 0.0 110.26 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -51.15 -19.88 1.32 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -56.57 -36.93 69.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.946 0.499 . . . . 0.0 111.169 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.2 -21.9 65.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.966 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.27 -93.82 0.11 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.902 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.8 121.1 6.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -121.84 150.54 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 6.1 p -131.02 -21.54 2.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.97 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -131.34 154.17 48.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.356 0.98 . . . . 0.0 111.801 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -158.28 161.48 37.71 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 18.0 t0 -145.56 148.46 33.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.632 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -128.45 141.97 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.208 0.528 . . . . 0.0 110.48 -172.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -103.3 5.82 37.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.497 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.632 ' H ' HG22 ' B' ' 152' ' ' VAL . 23.5 mtp85 62.55 17.21 9.43 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.461 0.705 . . . . 0.0 112.388 170.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -137.38 -11.96 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.06 -2.84 2.15 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 118.872 0.76 . . . . 0.0 113.181 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.2 165.85 26.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.51 -165.72 34.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 4.2 p -142.0 161.25 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 122.971 0.509 . . . . 0.0 110.02 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.5 p -147.62 159.63 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' B' ' 122' ' ' ARG . 42.9 tt0 -154.83 146.96 23.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.912 -0.492 . . . . 0.0 111.968 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 60.6 m-85 -117.94 156.93 27.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.595 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.1 m -61.71 -12.55 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.399 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -152.5 151.16 30.39 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.748 0.819 . . . . 0.0 109.07 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.67 -22.97 65.27 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.4 -32.83 48.98 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.597 0.635 . . . . 0.0 111.387 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.11 -17.66 61.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.123 0.487 . . . . 0.0 110.089 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.619 ' SD ' HG13 ' B' ' 123' ' ' VAL . 15.2 tmm? -82.95 -51.25 7.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.149 0.98 . . . . 0.0 111.202 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.5 m -61.75 -21.81 64.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.56 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 28.5 t80 -75.29 -33.57 61.23 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.13 -12.47 60.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.204 0.602 . . . . 0.0 111.459 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.418 HG22 ' O ' ' B' ' 172' ' ' VAL 0.258 13.3 p -118.57 33.22 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.813 0.816 . . . . 0.0 111.514 174.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.4 ptm180 -143.11 -16.5 0.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.506 169.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.9 mppt? -123.58 -25.85 4.29 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.571 0.748 . . . . 0.0 112.428 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.24 -3.36 19.85 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.808 0.276 . . . . 0.0 110.461 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.95 143.64 43.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.716 0.806 . . . . 0.0 110.174 169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.16 36.59 27.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 43.0 p -135.55 172.84 12.43 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.278 0.631 . . . . 0.0 110.301 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -58.75 146.31 37.3 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.937 0.895 . . . . 0.0 112.274 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.582 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 19.0 t80 -136.73 156.5 48.43 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.905 1.282 . . . . 0.0 109.36 169.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -145.44 142.15 29.03 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.788 1.235 . . . . 0.0 108.173 -173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 47.3 p -152.43 -176.11 5.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.958 0.503 . . . . 0.0 109.733 -175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.468 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 17.7 p-80 -58.3 -177.4 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.455 0.702 . . . . 0.0 112.031 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 3.5 mm-40 67.98 -13.38 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.783 1.633 . . . . 0.0 112.46 -173.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 94.23 27.37 12.17 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.459 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -128.85 176.07 8.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 72.1 p -137.71 166.61 23.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.332 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.8 -162.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.435 0.694 . . . . 0.0 109.447 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.93 147.53 49.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 102.65 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.595 0.712 . . . . 0.0 112.449 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -80.16 89.11 5.42 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . 0.414 ' HB ' HG23 ' B' ' 172' ' ' VAL . 6.6 t -67.88 138.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.86 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -117.47 162.43 17.98 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.74 -29.96 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.333 1.853 . . . . 0.0 114.913 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.8 t70 143.17 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.087 2.155 . . . . 0.0 108.826 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.216 -1.88 . . . . 0.0 111.064 175.348 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.949 1 O4'-C1'-N19 112.565 4.365 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.036 1 C3'-C2'-C1' 105.164 4.071 OUTLIER-EPSILON 0.074 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.571 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.835 1 C5'-C4'-C3' 108.243 -4.838 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.848 0 C3'-C2'-C1' 105.076 3.973 . 0.056 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.471 1 C4'-C3'-C2' 98.509 -4.191 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.237 2 O4'-C1'-N19 113.309 5.109 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.788 2 C4'-C3'-C2' 98.317 -4.383 . 0.176 '#a' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.348 0 C5'-C4'-C3' 111.253 -2.831 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.2 155.42 33.24 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.83 0.452 . . . . 0.0 109.936 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.62 171.45 17.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.615 2.877 . . . . 0.0 110.822 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -144.35 170.35 16.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.894 0.878 . . . . 0.0 109.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 174.13 178.97 44.44 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -153.72 169.0 24.4 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.243 0.617 . . . . 0.0 110.462 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -147.91 14.21 1.04 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.081 0.552 . . . . 0.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.1 -169.25 24.08 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -44.35 136.93 8.22 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.727 3.618 . . . . 0.0 112.369 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.2 -43.36 0.73 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.83 2.353 . . . . 0.0 110.818 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 1.6 m -176.91 163.39 2.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.328 1.051 . . . . 0.0 109.503 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 51.0 mtt180 54.91 -5.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 118.304 2.705 . . . . 0.0 118.304 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -61.64 166.32 4.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.375 1.443 . . . . 0.0 112.417 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t -146.29 -126.2 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.434 0.694 . . . . 0.0 112.513 -172.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -133.97 -25.79 1.58 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 114.397 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.443 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.9 p30 -130.31 79.97 1.93 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 110.052 -171.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -78.67 158.57 28.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.008 1.723 . . . . 0.0 112.895 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -149.92 142.86 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 127.733 2.413 . . . . 0.0 108.657 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.5 t -80.89 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.55 136.41 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.8 p -141.37 157.39 45.24 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.364 -0.21 . . . . 0.0 111.102 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.43 4.41 56.17 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.94 146.68 36.87 Favored Pre-proline 0 N--CA 1.452 -0.356 0 C-N-CA 125.287 1.435 . . . . 0.0 110.844 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.1 164.91 33.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.246 3.297 . . . . 0.0 110.948 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -54.17 -6.52 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 125.165 3.91 . . . . 0.0 116.257 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 13.03 1.16 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.604 1.093 . . . . 0.0 113.423 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -53.2 158.28 4.28 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -146.28 168.24 21.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.425 0.613 . . . . 0.0 110.44 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -65.54 -27.46 68.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.604 -0.236 . . . . 0.0 111.364 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -68.68 -40.11 80.27 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-N 117.928 0.331 . . . . 0.0 111.322 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 90.7 m-20 -80.07 -21.22 43.62 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.132 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -32.51 70.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -79.86 -37.26 35.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.78 3.04 2.12 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.363 1.065 . . . . 0.0 112.916 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 23.7 t60 -132.51 -41.17 0.97 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.386 0.539 . . . . 0.0 111.159 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.3 mmm -69.66 -12.48 61.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.196 0.453 . . . . 0.0 110.315 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -45.2 -24.96 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 112.196 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.91 -42.2 94.93 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.076 0.465 . . . . 0.0 110.936 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -69.96 -29.97 67.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.679 0.791 . . . . 0.0 111.505 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.9 -171.04 40.92 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -82.31 64.58 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.445 0.64 . . . . 0.0 111.254 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.3 OUTLIER -55.72 141.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 37.5 t -123.52 -30.55 3.62 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -133.1 158.77 41.94 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.658 0.742 . . . . 0.0 111.59 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -154.11 168.95 24.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.493 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 41.3 t0 -150.04 154.51 38.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 167.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.4 p -131.83 142.29 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.555 0.693 . . . . 0.0 110.473 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -105.07 5.69 32.67 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.11 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 14.3 mtt-85 61.56 17.66 8.76 Favored 'General case' 0 C--O 1.23 0.071 0 C-N-CA 123.867 0.867 . . . . 0.0 112.421 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -137.06 0.67 2.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.01 2.89 7.7 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 118.504 0.593 . . . . 0.0 112.401 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.64 165.9 26.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.458 0.647 . . . . 0.0 110.316 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.89 -166.79 36.01 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 3.6 p -138.86 162.02 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.867 0.467 . . . . 0.0 110.781 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 8.9 p -149.24 159.5 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 123.717 0.807 . . . . 0.0 108.872 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.42 147.12 20.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.156 -0.34 . . . . 0.0 111.661 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 4.8 m-85 -121.13 171.79 8.43 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 122.394 1.092 . . . . 0.0 111.771 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.38 -20.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.252 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -143.94 141.98 30.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.228 0.611 . . . . 0.0 110.561 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.17 -25.02 63.25 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.9 -31.43 59.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.762 0.71 . . . . 0.0 111.009 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -75.71 -16.4 60.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.782 0.325 . . . . 0.0 110.183 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 26.6 ttp -79.83 -50.84 9.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.91 0.884 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 43.9 m -65.37 -19.76 66.09 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -72.57 -27.23 62.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.467 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.03 -36.72 61.89 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 122.201 -0.312 . . . . 0.0 110.942 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.83 7.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.584 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.5 ptm180 -138.39 -25.04 0.94 Allowed 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.866 0.757 . . . . 0.0 112.224 -174.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.584 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.69 -27.42 10.32 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.367 0.531 . . . . 0.0 110.934 175.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.9 mm? -115.98 -1.12 12.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.897 0.879 . . . . 0.0 109.892 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.35 141.08 28.94 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.623 0.769 . . . . 0.0 109.056 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.35 26.91 12.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 111.802 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 52.0 p -137.25 172.56 12.81 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.126 0.57 . . . . 0.0 110.169 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -54.38 150.58 8.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.453 1.101 . . . . 0.0 113.965 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.593 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.4 t80 -141.68 162.06 36.4 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.873 2.069 . . . . 0.0 108.038 169.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 -142.89 145.73 33.38 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.897 0.879 . . . . 0.0 109.031 -171.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 78.3 p -142.33 171.65 13.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.311 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.467 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.1 p-80 -58.69 -11.62 3.32 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.563 1.145 . . . . 0.0 113.015 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.18 -18.46 65.27 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.751 0.421 . . . . 0.0 110.989 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.02 9.5 55.96 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -136.61 -178.49 5.2 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.003 0.906 . . . . 0.0 112.018 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 57.3 p -134.43 161.94 33.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.212 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.65 158.35 17.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.506 1.123 . . . . 0.0 108.132 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -71.53 154.3 41.56 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.245 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.81 152.16 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.972 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.96 87.09 2.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.38 89.33 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 110.751 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.5 tttt -71.13 171.47 10.92 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 120.713 0.292 . . . . 0.0 111.037 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.456 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.8 p -65.28 -27.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 125.779 1.632 . . . . 0.0 114.67 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' B' ' 124' ' ' VAL . 23.5 t0 130.68 166.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.199 2.599 . . . . 0.0 108.977 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 117.463 -1.743 . . . . 0.0 110.818 175.21 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.458 " H3'" H5'' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.859 0 C5'-C4'-C3' 110.835 -3.11 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . 0.458 H5'' " H3'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.98 0 C5'-C4'-C3' 110.133 -3.578 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.407 ' C8 ' H5'' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 111.692 3.492 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 C5'-C4'-C3' 111.391 -2.739 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.467 1 C4'-C3'-C2' 98.688 -4.012 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 1 O4'-C1'-N19 112.686 4.486 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.782 1 O4'-C1'-N19 112.528 4.328 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 C5'-C4'-C3' 111.702 -2.532 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.15 155.6 33.4 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 122.885 0.474 . . . . 0.0 109.857 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.76 170.94 18.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.749 2.966 . . . . 0.0 111.053 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -145.27 9.47 1.24 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.739 0.416 . . . . 0.0 112.07 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.27 178.88 48.66 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -82.52 -6.16 59.16 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 122.761 0.424 . . . . 0.0 111.251 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 49.43 22.19 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.389 1.076 . . . . 0.0 112.652 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.34 -173.72 46.1 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.18 164.34 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.828 3.685 . . . . 0.0 112.961 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.96 -28.16 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.858 3.706 . . . . 0.0 114.558 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' B' ' 117' ' ' ARG . 17.8 m -167.23 -48.22 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' B' ' 116' ' ' SER . 0.0 OUTLIER -173.01 24.87 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.128 1.517 . . . . 0.0 112.89 166.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -54.05 167.47 0.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.844 1.258 . . . . 0.0 111.602 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -130.75 -97.33 0.34 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -153.53 -29.56 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -165.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.27 -35.81 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -165.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 39.73 158.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 118.265 2.691 . . . . 0.0 118.265 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.429 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -153.55 142.54 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 127.428 2.291 . . . . 0.0 107.417 177.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -78.14 165.23 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.54 129.72 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 98.1 p -138.92 138.54 37.47 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.254 0.549 . . . . 0.0 111.504 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.92 0.28 7.69 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.51 145.08 21.6 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.588 1.155 . . . . 0.0 110.622 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.0 169.99 21.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.01 3.14 . . . . 0.0 109.621 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.92 -6.87 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.571 3.514 . . . . 0.0 115.793 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 30.1 m -138.16 5.46 2.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -54.97 153.66 10.83 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -147.32 168.9 20.6 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.302 -0.528 . . . . 0.0 110.978 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -65.35 -28.53 69.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.18 -46.27 74.46 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.364 0.529 . . . . 0.0 110.724 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 81.3 m-20 -76.37 -16.26 59.77 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 122.381 -0.199 . . . . 0.0 111.165 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -34.57 71.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -76.55 -37.63 56.31 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.59 -1.71 3.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.205 1.002 . . . . 0.0 113.652 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.591 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.0 t60 -128.0 -36.25 1.99 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.767 0.712 . . . . 0.0 111.23 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 82.5 mmm -73.73 -12.17 60.63 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.889 -0.507 . . . . 0.0 110.434 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttm105 -44.87 -25.16 0.27 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.913 0.885 . . . . 0.0 112.489 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.3 -42.14 93.36 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.916 -0.49 . . . . 0.0 111.328 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.26 -31.23 69.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.092 0.557 . . . . 0.0 111.386 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.13 -171.35 41.17 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -80.45 72.94 7.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.903 0.859 . . . . 0.0 110.939 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.8 OUTLIER -63.14 146.53 12.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 171.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 36.8 t -130.75 -31.63 1.74 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.691 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.435 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 6.2 t80 -137.15 161.53 35.9 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 110.458 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.86 169.87 23.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -148.14 155.34 41.31 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.498 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.5 p -132.63 143.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.465 0.65 . . . . 0.0 109.944 -175.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -105.3 10.58 33.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.155 -0.93 . . . . 0.0 113.1 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.498 ' H ' HG22 ' B' ' 152' ' ' VAL . 35.4 mtp180 61.73 15.39 6.93 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.34 3.14 3.07 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.46 5.03 13.06 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -140.61 166.5 24.57 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.426 0.69 . . . . 0.0 110.511 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.88 -164.83 32.82 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.43 162.31 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.576 0.75 . . . . 0.0 110.45 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 12.6 p -144.27 160.08 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.1 141.62 24.33 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.453 0.701 . . . . 0.0 110.756 -168.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.5 m-85 -128.42 165.19 21.11 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.932 0.872 . . . . 0.0 110.59 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.6 -5.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.37 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -150.34 144.69 25.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.195 0.452 . . . . 0.0 110.125 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -70.82 -23.09 62.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.412 0.285 . . . . 0.0 111.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -88.7 -32.98 17.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.883 0.31 . . . . 0.0 111.726 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -74.37 -8.88 57.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.253 0.549 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.429 ' SD ' HG13 ' B' ' 123' ' ' VAL . 37.6 ttp -94.76 -42.3 8.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.11 1.364 . . . . 0.0 110.534 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 92.7 m -66.26 -17.42 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 42.8 t80 -72.4 -27.5 62.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -38.09 64.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.378 -0.201 . . . . 0.0 110.567 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 m -73.16 5.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -134.23 -16.18 2.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.898 0.772 . . . . 0.0 112.857 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.634 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.2 mppt? -125.64 -21.09 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.31 1.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.85 144.31 31.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.777 0.831 . . . . 0.0 109.426 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.6 36.45 23.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.019 0.928 . . . . 0.0 112.709 174.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 33.5 p -133.69 178.96 6.53 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.361 0.664 . . . . 0.0 110.335 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -53.41 149.38 7.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.591 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 17.6 t80 -147.73 168.72 21.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.738 2.015 . . . . 0.0 107.749 168.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -148.22 149.75 32.48 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.8 t -128.21 153.62 46.72 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.249 0.547 . . . . 0.0 110.394 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.47 ' CD2' ' HG2' ' B' ' 184' ' ' GLU . 54.7 p-80 -58.72 -19.69 42.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.08 1.352 . . . . 0.0 113.524 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.47 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 22.7 pt-20 -156.04 26.23 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.19 0.45 . . . . 0.0 111.558 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.26 13.94 4.59 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.175 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 51.72 -170.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.32 1.048 . . . . 0.0 111.963 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 29.9 p -76.71 160.76 29.07 Favored 'General case' 0 C--O 1.231 0.105 0 O-C-N 121.775 -0.578 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.78 -168.99 2.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.592 1.157 . . . . 0.0 108.319 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.63 142.47 51.49 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 37.0 pt -129.55 133.02 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.499 0.666 . . . . 0.0 112.665 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -94.94 89.76 5.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.52 92.74 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.173 0.589 . . . . 0.0 110.13 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 6.5 tttp -75.36 173.02 11.47 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 111.224 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.457 ' H ' HG12 ' B' ' 194' ' ' VAL . 2.8 p -65.85 -28.82 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.247 1.819 . . . . 0.0 114.436 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 20.9 t70 141.56 163.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.38 2.272 . . . . 0.0 108.949 -173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.231 -1.872 . . . . 0.0 111.072 175.391 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.672 0 C5'-C4'-C3' 110.536 -3.309 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.093 0 C3'-C2'-C1' 104.329 3.144 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 O4'-C1'-N19 111.928 3.728 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C5'-C4'-C3' 111.776 -2.482 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.264 0 C4'-C3'-C2' 99.04 -3.66 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.209 2 O4'-C1'-N19 113.348 5.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.606 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.417 -3.038 0 O4'-C1'-N19 110.828 2.628 . 0.0 OUTLIER '7D dist #a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.166 0 C5'-C4'-C3' 110.514 -3.324 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.515 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -147.92 25.26 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 92.2 Cg_endo -73.0 157.99 50.34 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.65 1.567 . . . . 0.0 110.47 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 44.13 30.43 0.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.708 1.203 . . . . 0.0 113.121 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.62 -173.66 33.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -151.33 173.04 14.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.113 0.565 . . . . 0.0 110.612 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -148.66 177.97 9.04 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.013 0.925 . . . . 0.0 109.121 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -160.78 158.98 30.56 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.59 156.05 18.63 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.702 2.935 . . . . 0.0 111.466 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.19 155.73 33.24 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.535 2.823 . . . . 0.0 109.043 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -162.67 -41.19 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 O-C-N 122.179 -0.326 . . . . 0.0 111.75 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -147.27 12.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.237 1.015 . . . . 0.0 110.884 -169.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.68 167.6 0.72 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.715 1.206 . . . . 0.0 112.759 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.9 t -150.85 -124.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.266 0.627 . . . . 0.0 111.793 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.25 35.5 mt-10 -138.5 -15.23 1.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.513 1.525 . . . . 0.0 114.796 -167.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.44 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.0 p30 -138.42 77.18 1.61 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.407 1.483 . . . . 0.0 110.995 -168.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -79.44 154.0 29.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.58 1.952 . . . . 0.0 112.499 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.6 OUTLIER -145.07 133.66 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.811 2.045 . . . . 0.0 108.407 173.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' B' ' 195' ' ' ASP . 37.8 t -70.52 160.37 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-O 121.101 0.477 . . . . 0.0 109.774 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.51 107.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 80.1 p -118.23 147.94 42.9 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.04 -1.92 35.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.42 153.69 13.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 111.411 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.85 158.15 38.95 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.69 2.26 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.83 -17.71 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.039 2.493 . . . . 0.0 111.482 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 56.5 m -79.01 -10.94 59.98 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.788 0.835 . . . . 0.0 112.412 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.73 161.99 50.99 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 23.5 t -152.06 170.23 20.44 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.302 0.641 . . . . 0.0 109.817 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 41.5 p-90 -64.85 -28.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.96 -0.463 . . . . 0.0 111.525 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.75 -37.34 82.0 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.025 0.375 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.606 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 83.3 m-20 -83.55 -29.52 27.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 111.299 0.111 . . . . 0.0 111.299 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -35.31 77.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.015 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -72.02 -41.95 66.95 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.61 2.79 1.64 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.347 1.459 . . . . 0.0 113.959 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -131.42 -38.24 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.773 0.715 . . . . 0.0 111.243 -175.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.9 mmm -69.84 -17.31 63.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.02 -0.425 . . . . 0.0 110.244 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -46.96 -19.29 0.1 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.959 0.903 . . . . 0.0 113.382 170.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.98 -41.43 95.44 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.148 0.579 . . . . 0.0 111.322 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.76 -26.18 67.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.366 0.666 . . . . 0.0 111.412 -178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.17 -171.73 33.99 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -74.08 114.77 12.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.282 0.541 . . . . 0.0 109.911 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -120.26 147.46 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.49 -17.05 2.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -135.49 153.85 51.6 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.764 1.165 . . . . 0.0 111.819 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -156.92 147.14 21.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.476 176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -129.43 119.38 23.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.9 p -106.66 148.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.487 -169.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -111.24 9.12 21.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.724 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.37 25.88 0.05 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 126.789 2.036 . . . . 0.0 114.787 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -142.78 5.98 1.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.31 -4.85 6.76 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 121.813 -0.554 . . . . 0.0 113.006 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.3 p -143.43 162.91 34.54 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.237 0.541 . . . . 0.0 109.725 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.69 -169.21 39.07 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.9 160.68 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 117.285 0.542 . . . . 0.0 109.623 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -146.24 156.2 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -150.52 145.82 26.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 111.91 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 44.6 m-85 -112.94 160.91 17.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 122.256 1.027 . . . . 0.0 112.799 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.42 -20.42 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.362 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -150.35 145.88 26.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 110.117 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.25 -24.81 65.84 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.88 -31.01 62.93 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.913 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.05 -17.06 61.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.669 0.271 . . . . 0.0 110.569 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.462 ' SD ' HG13 ' B' ' 123' ' ' VAL . 29.5 ttp -81.46 -52.79 6.88 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.761 0.824 . . . . 0.0 110.685 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.5 m -65.59 -17.19 64.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.553 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 22.1 t80 -73.3 -29.59 62.82 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.765 -0.585 . . . . 0.0 109.53 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.8 64.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.063 -0.398 . . . . 0.0 110.663 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.96 6.09 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -133.94 -15.56 2.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.623 0.647 . . . . 0.0 112.569 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.4 mppt? -125.4 -21.43 4.55 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.76 2.82 14.52 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.62 142.78 31.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.2 m120 55.22 38.86 31.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.092 0.473 . . . . 0.0 111.752 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.3 p -137.6 169.36 17.91 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.247 1.419 . . . . 0.0 108.515 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -66.8 165.07 15.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.866 -170.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.498 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 7.9 t80 -150.72 172.78 15.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.173 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . 0.4 ' N ' ' CG ' ' B' ' 180' ' ' PHE . 15.2 tpt180 -148.53 143.55 26.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.573 0.749 . . . . 0.0 109.167 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 83.7 p -144.54 167.83 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.059 0.457 . . . . 0.0 110.905 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.474 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 11.1 p-80 -64.77 -179.67 0.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.01 -11.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.304 1.841 . . . . 0.0 113.648 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . -162.98 -132.12 1.3 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -134.24 -145.43 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 111.325 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 49.8 p -80.69 168.02 19.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.979 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.15 -163.97 1.21 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.999 1.72 . . . . 0.0 107.192 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.31 156.38 44.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 22.6 pt -131.78 146.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.76 0.79 . . . . 0.0 111.129 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -114.71 79.91 1.33 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 34.7 t -60.76 133.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.49 160.54 31.99 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.135 0.574 . . . . 0.0 110.178 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' B' ' 123' ' ' VAL . 0.1 OUTLIER -60.42 -37.38 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' B' ' 124' ' ' VAL . 24.4 t70 131.38 155.97 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 109.712 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 117.522 -1.71 . . . . 0.0 111.335 174.041 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 0 C5'-C4'-C3' 109.694 -3.871 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.887 0 C5'-C4'-C3' 111.417 -2.722 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.543 0 O4'-C1'-N19 111.447 3.247 OUTLIER-DELTA 0.01 6g . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.477 " H1'" " H1'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C1'-N19 111.354 3.154 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . 0.545 ' H22' ' HA ' ' B' ' 151' ' ' ASP . . . . . . . . 0 O4'--C4' 1.415 -3.135 3 O4'-C1'-N19 113.557 5.357 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . 0.401 ' H22' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.302 2 O4'-C1'-N19 113.739 5.539 . 0.01 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.612 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.419 -2.801 1 O4'-C1'-N19 112.517 4.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 C5'-C4'-C3' 111.78 -2.48 . 0.0 OUTLIER '7D dist 1[' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . 39.95 54.11 5.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.395 1.078 . . . . 0.0 113.38 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.09 -3.18 13.19 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.187 2.592 . . . . 0.0 112.143 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -152.23 162.27 41.39 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.336 0.655 . . . . 0.0 109.255 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.22 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.536 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -154.38 178.75 9.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.575 0.75 . . . . 0.0 109.761 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -143.61 11.36 1.66 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.498 0.319 . . . . 0.0 111.293 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.4 176.05 43.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 169.05 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.696 3.598 . . . . 0.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.89 -177.23 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.719 2.946 . . . . 0.0 110.177 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m -131.73 -42.39 1.03 Allowed 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -149.18 5.27 0.64 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.036 0.534 . . . . 0.0 112.106 -173.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -55.71 167.04 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.54 0.736 . . . . 0.0 112.735 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 14.6 t -146.53 -122.56 0.07 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.337 0.655 . . . . 0.0 112.085 -171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -134.9 -22.86 1.59 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.599 1.56 . . . . 0.0 114.442 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.79 77.28 1.73 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.695 1.198 . . . . 0.0 110.668 -169.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -78.92 150.17 32.18 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.852 1.661 . . . . 0.0 113.013 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.494 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -139.61 129.26 29.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 125.877 1.671 . . . . 0.0 108.532 171.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.86 158.69 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.08 109.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 81.0 p -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.665 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.47 3.14 53.49 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -59.3 147.0 77.2 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 127.871 2.468 . . . . 0.0 111.034 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.14 160.49 33.07 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.903 2.402 . . . . 0.0 109.273 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 -9.99 25.88 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.83 2.353 . . . . 0.0 111.09 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -75.01 -11.81 60.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.261 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -77.71 164.9 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 121.732 0.629 . . . . 0.0 112.842 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 41.7 t -158.99 166.63 31.34 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.903 1.281 . . . . 0.0 108.004 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . 0.452 ' CZ2' " H2'" ' A' ' 5' ' ' ' G' . 40.5 p-90 -66.64 -30.2 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.523 0.601 . . . . 0.0 111.753 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -65.98 -32.08 73.35 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.414 0.552 . . . . 0.0 110.635 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.612 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 73.7 m-20 -87.64 -20.62 26.08 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 117.738 0.245 . . . . 0.0 111.512 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -29.97 64.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -79.65 -39.79 30.64 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.401 ' CG ' ' H22' ' A' ' 6' ' ' ' G' . 6.6 m-20 -68.77 -1.75 7.81 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.496 1.118 . . . . 0.0 113.429 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.651 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 14.0 t60 -129.52 -41.74 1.35 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.132 0.424 . . . . 0.0 111.12 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 85.1 mmm -65.48 -16.93 64.15 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -42.24 -27.0 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.683 1.593 . . . . 0.0 113.13 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.03 -41.49 96.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 111.573 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.407 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.93 -29.26 69.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.333 0.653 . . . . 0.0 111.751 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.88 -175.8 34.32 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -73.02 115.79 12.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 122.369 -0.489 . . . . 0.0 110.333 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -113.63 151.18 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.4 p -132.99 -26.04 1.76 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.915 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -134.33 152.94 52.1 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.81 1.186 . . . . 0.0 112.125 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -149.81 169.18 21.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.655 174.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.545 ' HA ' ' H22' ' A' ' 5' ' ' ' G' . 35.5 t0 -149.67 141.41 23.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 168.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.577 HG22 ' H ' ' B' ' 154' ' ' ARG . 4.8 p -122.41 142.54 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.629 0.728 . . . . 0.0 111.02 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -108.79 9.96 26.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.682 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.577 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.0 24.57 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.215 2.206 . . . . 0.0 114.991 178.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.49 10.45 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -170.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.94 -4.21 7.93 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.106 0.412 . . . . 0.0 113.0 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.2 162.28 36.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.893 0.477 . . . . 0.0 110.415 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.28 -169.26 37.53 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.43 162.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.26 0.53 . . . . 0.0 110.755 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.2 p -149.75 158.53 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.898 0.879 . . . . 0.0 108.934 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.62 147.27 24.23 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.901 -0.499 . . . . 0.0 111.535 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 30.4 m-85 -116.49 168.5 10.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 122.281 1.038 . . . . 0.0 113.322 -172.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.3 m -75.67 -10.52 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.658 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -151.46 142.85 23.44 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.88 -23.53 66.67 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.31 -30.97 62.3 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.252 0.478 . . . . 0.0 110.86 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.06 -19.36 60.64 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 110.323 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.494 ' CG ' HG13 ' B' ' 123' ' ' VAL . 30.8 ttp -82.33 -53.44 6.02 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.764 0.826 . . . . 0.0 111.048 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 85.0 m -63.23 -21.79 66.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.539 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 29.2 t80 -73.53 -33.73 64.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.41 60.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.066 0.546 . . . . 0.0 111.362 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 172' ' ' VAL 0.261 8.2 p -116.07 33.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 111.198 174.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' B' ' 170' ' ' TYR . 15.3 ptm180 -143.64 -17.32 0.62 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -122.82 -27.36 4.3 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.326 0.65 . . . . 0.0 112.531 173.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' B' ' 175' ' ' LEU . 2.6 mm? -104.61 -7.52 19.6 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' B' ' 172' ' ' VAL . 15.2 t70 -75.35 147.16 40.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.8 0.84 . . . . 0.0 110.278 168.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 57.85 28.93 16.74 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.128 0.971 . . . . 0.0 112.367 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 63.6 p -136.95 174.55 10.5 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.88 0.472 . . . . 0.0 110.811 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -54.36 145.35 18.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 113.063 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.651 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 5.2 t80 -138.56 160.04 40.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.771 1.629 . . . . 0.0 108.144 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -137.59 151.32 48.22 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.709 0.804 . . . . 0.0 109.795 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -135.89 165.03 26.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.241 0.543 . . . . 0.0 111.174 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.461 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 12.7 p-80 -60.86 -16.35 40.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.061 1.344 . . . . 0.0 113.471 -177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.43 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 41.1 mm-40 -77.36 -13.09 60.0 Favored 'General case' 0 CA--C 1.526 0.037 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -175.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.44 20.15 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.115 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.39 172.26 12.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.982 0.891 . . . . 0.0 110.928 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -136.17 163.25 30.8 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.066 0.46 . . . . 0.0 111.442 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.71 158.75 20.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.555 1.142 . . . . 0.0 108.143 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -71.17 161.28 31.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.424 0.631 . . . . 0.0 110.425 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 28.9 pt -130.18 156.0 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.429 169.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -122.02 87.06 2.68 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.429 1.092 . . . . 0.0 108.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.22 142.19 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.261 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -134.09 158.48 43.5 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.282 0.563 . . . . 0.0 110.725 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.5 m -74.9 3.81 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 126.286 1.835 . . . . 0.0 113.76 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 7.3 t0 90.32 158.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.314 1.446 . . . . 0.0 110.377 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 117.265 -1.853 . . . . 0.0 111.324 174.606 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.128 2 O4'-C1'-N19 113.642 5.442 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 O4'-C1'-N19 111.066 2.866 . 0.074 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 1 C5'-C4'-C3' 109.127 -4.249 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 P-O3'-C3' 123.682 3.318 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . 0.527 ' H22' ' HA ' ' B' ' 151' ' ' ASP . . . . . . . . 0 O4'--C4' 1.412 -3.38 1 C4'-C3'-C2' 98.071 -4.629 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.252 2 O4'-C1'-N19 113.059 4.859 . 0.01 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.617 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.418 -2.881 0 O4'-C1'-N19 112.046 3.846 . 0.05 '#a' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 N19-C1'-C2' 109.28 -2.575 . 0.188 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 111.071 0.026 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.8 156.36 35.9 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 123.125 0.57 . . . . 0.0 109.829 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.23 7.43 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.202 3.268 . . . . 0.0 112.202 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 48.2 36.16 6.36 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.719 0.808 . . . . 0.0 112.468 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.33 -174.56 13.53 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -64.95 -8.61 16.43 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -64.13 160.65 17.82 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.045 0.384 . . . . 0.0 110.901 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.18 174.46 49.59 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.11 119.38 6.13 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.574 2.85 . . . . 0.0 111.187 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.6 174.61 10.28 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.73 2.953 . . . . 0.0 110.229 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -154.86 -43.89 0.09 Allowed 'General case' 0 C--N 1.338 0.094 0 CA-C-O 120.857 0.36 . . . . 0.0 110.66 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -148.58 8.74 0.79 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.188 0.995 . . . . 0.0 111.003 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -53.91 168.69 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.704 1.202 . . . . 0.0 112.26 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.6 t -138.61 -93.84 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.292 15.1 mt-10 -159.01 -27.56 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 -164.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.26 -25.73 4.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -161.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 35.07 155.93 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.401 3.081 . . . . 0.0 119.278 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -147.78 122.66 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.634 174.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' B' ' 195' ' ' ASP . 24.2 t -67.46 158.96 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 6.5 p -131.97 112.96 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 83.2 p -122.18 152.64 39.74 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.7 35.8 3.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.503 ' N ' ' HD3' ' B' ' 129' ' ' PRO . 13.0 tp -111.45 31.29 0.1 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -168.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' B' ' 128' ' ' LEU . 80.7 Cg_exo -46.93 -33.51 14.59 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.572 2.181 . . . . 0.0 116.307 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.438 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 89.5 Cg_exo -47.88 167.04 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.298 2.666 . . . . 0.0 114.094 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 7.0 t -71.27 19.68 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.77 0.828 . . . . 0.0 112.076 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' B' ' 130' ' ' PRO . . . -46.95 154.71 0.89 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.403 1.001 . . . . 0.0 113.206 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -146.69 166.13 27.52 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.131 0.972 . . . . 0.0 108.652 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . 0.427 ' CE3' ' C6 ' ' A' ' 5' ' ' ' G' . 39.4 p-90 -63.32 -28.64 70.15 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.849 -0.532 . . . . 0.0 111.289 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -67.59 -24.79 65.54 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.05 0.386 . . . . 0.0 111.528 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.617 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 68.5 m-20 -99.14 -18.74 17.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.095 0.407 . . . . 0.0 111.612 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -29.18 64.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -77.63 -39.8 44.05 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.02 -0.69 9.98 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.259 1.024 . . . . 0.0 113.462 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.7 t60 -128.86 -35.11 1.9 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.341 0.519 . . . . 0.0 111.036 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 78.7 mmm -73.27 -14.64 61.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -47.14 -21.37 0.24 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 112.797 172.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.57 -41.23 96.41 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.274 0.63 . . . . 0.0 110.992 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.61 68.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.942 0.497 . . . . 0.0 111.567 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.43 -169.59 37.77 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.83 81.71 2.76 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.801 0.81 . . . . 0.0 110.759 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -76.78 146.37 8.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.3 p -131.34 -25.02 2.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.797 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -139.31 157.1 46.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.436 1.016 . . . . 0.0 111.594 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -151.26 167.75 26.87 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.905 174.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.527 ' HA ' ' H22' ' A' ' 5' ' ' ' G' . 38.6 t0 -148.32 137.15 21.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 168.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.536 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.0 p -118.84 142.34 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.845 0.831 . . . . 0.0 110.373 -171.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . 0.405 ' C ' ' HD3' ' B' ' 154' ' ' ARG . 3.2 m-30 -107.37 9.22 29.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.0 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.536 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.42 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.606 1.962 . . . . 0.0 114.446 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.05 8.16 1.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 128.35 -5.98 6.72 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 118.24 0.473 . . . . 0.0 112.973 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.4 p -144.12 165.61 27.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.173 0.487 . . . . 0.0 110.459 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.33 -166.27 33.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.51 162.74 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 CA-C-N 117.228 0.514 . . . . 0.0 110.251 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.464 HG13 HG23 ' B' ' 123' ' ' VAL . 8.8 p -147.74 161.12 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.008 0.923 . . . . 0.0 108.806 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -153.4 151.96 30.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 110.64 -172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 3.7 m-85 -129.53 164.58 23.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.926 0.869 . . . . 0.0 110.138 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 25.5 m -66.19 -5.24 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.53 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -152.6 155.9 38.25 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.554 0.615 . . . . 0.0 110.24 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.18 -28.04 65.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.757 0.423 . . . . 0.0 112.039 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.76 -30.9 18.69 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 122.064 -0.397 . . . . 0.0 112.022 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -72.62 -9.75 58.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.407 ' SD ' HG13 ' B' ' 123' ' ' VAL . 41.4 ttp -98.27 -42.95 7.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.464 1.506 . . . . 0.0 110.958 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 88.0 m -63.12 -19.25 64.27 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 24.9 t80 -71.31 -28.56 64.19 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.931 -0.48 . . . . 0.0 109.993 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.53 -36.71 65.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.21 4.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -133.95 -16.48 2.23 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.5 mppt? -124.91 -21.57 4.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.14 0.94 13.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.011 0.524 . . . . 0.0 109.886 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.53 143.03 27.18 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.929 0.891 . . . . 0.0 109.099 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.65 24.99 14.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.279 1.032 . . . . 0.0 111.669 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 81.6 p -137.62 179.29 6.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.341 0.591 . . . . 0.0 111.707 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.36 144.88 34.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.901 1.681 . . . . 0.0 114.708 -170.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.519 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 3.7 t80 -143.43 161.45 38.36 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.104 1.762 . . . . 0.0 108.54 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . 0.413 ' HD2' ' H ' ' B' ' 182' ' ' SER . 12.5 tpt180 -142.54 156.63 45.14 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.282 1.033 . . . . 0.0 109.224 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.413 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 38.7 t -131.98 162.93 29.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 111.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.461 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 56.5 p-80 -66.92 14.58 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.608 1.963 . . . . 0.0 114.673 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -129.97 -20.96 3.06 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.05 0.841 . . . . 0.0 111.9 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 132.87 -19.18 4.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.704 171.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -76.1 156.47 33.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.673 0.736 . . . . 0.0 111.154 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 81.1 p -145.54 154.23 41.96 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.577 0.751 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -166.29 160.87 16.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -72.07 148.25 45.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.0 139.33 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -100.59 86.07 3.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.33 1.052 . . . . 0.0 108.724 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 10.6 t -71.18 81.7 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.577 0.751 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.98 159.82 32.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.872 0.869 . . . . 0.0 110.721 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' B' ' 123' ' ' VAL . 19.1 m -75.18 3.46 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 C-N-CA 126.03 1.732 . . . . 0.0 114.69 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.489 ' HA ' HG23 ' B' ' 124' ' ' VAL . 19.7 t70 107.97 159.03 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.402 1.881 . . . . 0.0 110.408 170.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 117.129 -1.928 . . . . 0.0 110.964 173.847 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.115 2 O4'-C1'-N19 113.279 5.079 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 C4'-C3'-O3' 117.535 2.667 OUTLIER-EPSILON 0.344 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.464 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 P-O3'-C3' 125.372 4.726 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.13 0 C3'-C2'-C1' 104.492 3.325 . 0.104 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.248 2 O4'-C1'-N19 113.018 4.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 3 O4'-C1'-N19 115.866 7.666 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.62 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.42 -2.738 1 O4'-C1'-N19 112.649 4.449 . 0.0 OUTLIER '7D dist 6n' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.094 0 O4'-C1'-N19 110.325 2.125 . 0.01 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.72 155.99 32.81 Favored Pre-proline 0 C--O 1.233 0.199 0 C-N-CA 123.097 0.559 . . . . 0.0 109.953 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.24 166.15 30.18 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.277 2.651 . . . . 0.0 110.737 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 45.39 32.56 1.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.422 1.089 . . . . 0.0 112.619 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.43 7.51 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.746 -0.475 . . . . 0.0 112.481 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -138.48 1.73 2.18 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.815 0.807 . . . . 0.0 111.09 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -155.34 6.88 0.24 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.114 0.566 . . . . 0.0 111.603 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -173.4 176.84 46.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.85 161.64 43.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.237 3.291 . . . . 0.0 111.585 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.36 160.36 48.95 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.85 3.033 . . . . 0.0 111.696 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 9.3 p 150.42 145.41 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 128.711 2.804 . . . . 0.0 103.854 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.85 47.59 0.15 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 116.899 -1.92 . . . . 0.0 113.494 -160.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -53.14 173.13 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 9.0 t -140.81 -127.67 0.1 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.368 1.067 . . . . 0.0 111.919 -175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -133.91 -28.36 1.39 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.336 1.455 . . . . 0.0 114.18 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 1.8 p30 -127.3 82.78 2.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.744 1.218 . . . . 0.0 110.396 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -78.36 158.53 28.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.711 2.004 . . . . 0.0 112.87 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.443 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -150.08 142.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.792 2.437 . . . . 0.0 109.06 173.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -79.5 170.65 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.51 136.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 68.4 p -143.75 157.7 44.2 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 121.057 0.456 . . . . 0.0 112.078 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.96 53.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.53 123.23 88.95 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 127.5 2.32 . . . . 0.0 112.949 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.29 156.83 12.66 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.984 2.456 . . . . 0.0 111.422 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.34 -10.9 29.1 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.101 2.534 . . . . 0.0 110.705 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 68.1 m -75.19 -9.02 58.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.095 0.958 . . . . 0.0 112.616 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.34 165.44 41.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 44.5 t -157.39 167.98 28.67 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.241 1.016 . . . . 0.0 109.155 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 27.5 p-90 -64.65 -29.93 70.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.738 -0.601 . . . . 0.0 110.057 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -68.4 -16.16 63.81 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.428 0.291 . . . . 0.0 111.49 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.62 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 80.5 m-20 -104.03 -22.73 13.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 112.054 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.54 -30.7 66.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.942 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -73.94 -40.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.6 -1.92 7.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.464 1.106 . . . . 0.0 113.304 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 30.4 t60 -131.92 -33.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.641 0.655 . . . . 0.0 111.552 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' B' ' 141' ' ' MET . 0.0 OUTLIER -74.86 -19.97 59.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -51.64 -18.88 1.31 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -59.0 -37.59 77.21 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.031 0.532 . . . . 0.0 110.852 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -65.82 -22.38 66.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.71 0.804 . . . . 0.0 111.307 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.98 -90.49 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -157.07 134.1 10.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -130.56 157.6 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 14.7 p -129.15 -35.63 1.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.014 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 7.9 t80 -132.69 159.02 40.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.61 1.096 . . . . 0.0 111.723 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.17 170.95 20.65 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.301 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -149.11 155.75 41.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.553 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.4 p -133.31 145.01 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.34 0.59 . . . . 0.0 110.483 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.55 22.11 16.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.208 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.553 ' H ' HG22 ' B' ' 152' ' ' VAL . 59.6 mtp180 74.83 -15.85 0.61 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 126.062 1.745 . . . . 0.0 113.123 172.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.04 138.63 2.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.667 0.667 . . . . 0.0 111.679 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 -31.26 0.69 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 166.39 28.4 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.91 1.355 . . . . 0.0 111.982 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.43 -171.29 41.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 163.19 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 117.485 0.642 . . . . 0.0 110.763 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 9.1 p -150.72 160.03 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.817 0.847 . . . . 0.0 109.365 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 32.4 tt0 -152.08 136.39 16.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.088 -0.382 . . . . 0.0 111.618 -172.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 80.4 m-85 -104.31 168.08 9.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.15 -11.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.621 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -151.73 137.21 17.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.73 -23.41 66.74 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.3 -32.92 55.7 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.226 0.466 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -75.21 -20.12 59.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.022 0.439 . . . . 0.0 109.841 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.445 ' SD ' ' HB2' ' B' ' 121' ' ' ASN . 36.5 ttp -76.17 -52.84 9.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.038 0.935 . . . . 0.0 111.469 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 49.0 m -65.65 -20.69 66.4 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -71.92 -27.19 62.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.264 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' B' ' 175' ' ' LEU . . . -74.07 -37.12 64.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.207 -0.308 . . . . 0.0 111.069 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.71 8.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.566 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 15.1 ptm180 -137.74 -23.92 1.05 Allowed 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 121.704 -0.622 . . . . 0.0 112.191 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.566 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.3 OUTLIER -107.97 -28.25 9.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.375 0.534 . . . . 0.0 111.191 175.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' B' ' 171' ' ' ALA . 1.7 mm? -116.01 -6.88 11.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.47 0.708 . . . . 0.0 109.729 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -85.12 144.09 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 64.53 23.88 12.97 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.91 0.884 . . . . 0.0 111.627 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 72.0 p -138.91 178.03 7.46 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.627 0.727 . . . . 0.0 111.247 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -61.54 148.59 41.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.017 1.327 . . . . 0.0 114.176 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.519 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.3 OUTLIER -143.74 145.28 32.29 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.115 1.766 . . . . 0.0 108.028 169.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -123.96 157.15 35.03 Favored 'General case' 0 C--N 1.337 0.049 0 C-N-CA 124.006 0.923 . . . . 0.0 109.36 -170.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 88.4 p -138.79 165.79 26.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.542 0.687 . . . . 0.0 112.015 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.473 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 23.1 p-80 -68.35 -14.4 62.97 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.182 1.393 . . . . 0.0 113.162 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.91 -15.27 56.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.94 12.28 9.41 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.654 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.05 168.88 18.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.693 1.247 . . . . 0.0 111.918 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.01 157.3 43.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.948 0.899 . . . . 0.0 110.356 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -160.58 165.98 29.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.572 1.149 . . . . 0.0 108.955 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -68.58 155.75 39.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.25 0.547 . . . . 0.0 110.998 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.91 152.4 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.774 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.361 1.064 . . . . 0.0 108.788 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.36 94.28 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.651 0.78 . . . . 0.0 110.761 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.4 tttt -74.37 171.14 14.24 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 122.552 0.341 . . . . 0.0 110.742 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.446 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 4.4 p -66.05 -27.12 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 126.298 1.839 . . . . 0.0 114.732 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.491 ' HA ' HG23 ' B' ' 124' ' ' VAL . 25.2 t70 125.35 165.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.463 2.705 . . . . 0.0 109.237 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.895 175.272 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 C5'-C4'-C3' 112.753 -1.831 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 1 O4'-C1'-N19 113.736 5.536 . 0.109 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.416 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 C4'-C3'-C2' 99.377 -3.323 . 0.536 6n . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.416 ' C8 ' " H2'" ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 111.242 3.042 . 0.197 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.253 1 C4'-C3'-C2' 98.158 -4.542 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . 0.479 ' H1 ' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.297 3 O4'-C1'-N19 116.513 8.313 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.607 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.675 1 O4'-C1'-N19 112.513 4.313 . 0.01 6n . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.189 -2.874 . 0.1 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.73 31.53 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.998 0.519 . . . . 0.0 109.956 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.39 170.36 20.09 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.466 2.778 . . . . 0.0 111.061 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -69.98 -11.92 61.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.964 0.506 . . . . 0.0 112.094 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.96 -17.35 0.26 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.714 -0.492 . . . . 0.0 112.505 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -153.18 155.18 36.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 117.86 0.83 . . . . 0.0 109.985 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -152.29 167.49 28.48 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.465 0.706 . . . . 0.0 109.595 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.99 -58.02 0.17 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.505 -0.609 . . . . 0.0 111.88 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.06 153.81 46.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.794 2.329 . . . . 0.0 110.288 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.28 -49.23 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.612 2.208 . . . . 0.0 111.045 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.4 m -174.26 155.95 2.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.34 1.056 . . . . 0.0 109.343 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.44 ' HD3' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt180 55.96 -1.37 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 167.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -54.13 160.23 1.62 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.476 1.034 . . . . 0.0 112.607 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 -139.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 112.228 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.254 40.2 mt-10 -132.21 -18.99 2.54 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -165.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.37 77.25 1.64 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.976 1.31 . . . . 0.0 109.941 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 mtm-85 -83.37 148.27 27.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.452 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.488 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -136.79 129.55 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 126.508 1.923 . . . . 0.0 107.402 173.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.81 153.06 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.7 106.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 53.7 p -105.13 152.55 22.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.976 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.82 18.11 5.29 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' B' ' 129' ' ' PRO . 4.7 mp -95.79 13.72 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' B' ' 128' ' ' LEU . 90.5 Cg_exo -42.67 -38.33 6.34 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.586 2.191 . . . . 0.0 116.63 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' B' ' 128' ' ' LEU . 82.4 Cg_exo -44.59 -61.72 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 6.0 t 179.41 -42.96 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.674 1.19 . . . . 0.0 107.822 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.24 -172.58 0.04 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.877 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -168.59 165.84 12.14 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.863 -0.786 . . . . 0.0 109.152 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -76.5 -30.28 57.16 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -68.51 -39.94 81.04 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.607 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 81.2 m-20 -76.89 -26.97 54.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.484 -0.135 . . . . 0.0 110.847 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -34.93 78.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HD3' ' B' ' 117' ' ' ARG . 9.6 mtpm? -74.38 -39.28 62.81 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.479 ' CG ' ' H1 ' ' A' ' 6' ' ' ' G' . 2.9 m-20 -66.68 -1.48 3.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.441 1.097 . . . . 0.0 113.713 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 38.5 t60 -129.89 -39.19 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.551 0.614 . . . . 0.0 111.523 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . 0.422 ' CE ' ' HB1' ' B' ' 171' ' ' ALA . 84.0 mmm -70.39 -14.22 62.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.37 0.532 . . . . 0.0 109.987 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -47.72 -20.93 0.32 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.698 0.799 . . . . 0.0 112.599 170.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.97 -42.92 84.33 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.226 0.611 . . . . 0.0 111.132 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.37 -27.74 65.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.639 0.776 . . . . 0.0 111.569 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.37 -166.46 36.53 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.28 79.3 9.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.462 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.2 OUTLIER -65.86 148.02 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 172.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 52.0 t -128.08 -33.28 2.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.861 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -134.58 157.72 45.86 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.048 0.84 . . . . 0.0 110.787 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -152.74 164.27 38.1 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -145.4 151.32 38.07 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.604 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -130.54 140.02 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 121.743 0.782 . . . . 0.0 110.504 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -104.06 10.66 35.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.845 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.604 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 41.73 26.25 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.51 2.324 . . . . 0.0 114.26 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -143.33 3.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.72 -10.32 3.98 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 118.154 0.434 . . . . 0.0 113.677 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.2 p -142.84 166.73 23.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 117.122 0.461 . . . . 0.0 110.639 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.86 -164.6 29.89 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.412 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.0 p -142.74 163.06 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 122.773 0.429 . . . . 0.0 111.344 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.0 p -156.04 154.91 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.374 1.069 . . . . 0.0 109.705 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.28 159.54 40.09 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.3 m-85 -125.88 171.07 11.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 122.01 0.909 . . . . 0.0 112.202 -171.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.22 -9.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.443 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -149.7 139.3 21.64 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.028 0.531 . . . . 0.0 109.585 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -65.13 -22.67 66.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.77 -29.43 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.047 -0.408 . . . . 0.0 110.802 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.45 -20.4 60.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.14 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.488 ' CG ' HG13 ' B' ' 123' ' ' VAL . 29.8 ttp -79.48 -52.24 8.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -63.13 -21.84 66.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 43.5 t80 -74.77 -33.04 62.22 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.422 ' HB1' ' CE ' ' B' ' 141' ' ' MET . . . -73.56 -15.83 61.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.331 0.652 . . . . 0.0 111.701 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 172' ' ' VAL 0.251 8.8 p -115.47 32.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.859 0.838 . . . . 0.0 111.643 175.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -142.63 -16.7 0.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.137 169.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 1.8 mppt? -124.19 -25.37 4.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 112.534 173.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.49 -2.82 20.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.415 0.286 . . . . 0.0 110.248 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -75.6 143.41 42.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.118 0.967 . . . . 0.0 110.269 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.41 27.8 10.62 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 36.8 p -127.91 166.69 17.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.03 144.31 29.3 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.567 0.747 . . . . 0.0 111.952 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.594 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 2.5 t80 -137.48 161.23 36.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.275 1.83 . . . . 0.0 109.074 171.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -138.99 149.45 44.71 Favored 'General case' 0 C--O 1.228 -0.043 0 C-N-CA 123.941 0.897 . . . . 0.0 109.537 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 93.2 p -138.57 170.11 16.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 111.733 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.449 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 14.7 p-80 -62.65 -15.33 51.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.765 1.226 . . . . 0.0 112.489 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.59 -43.36 99.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.049 0.452 . . . . 0.0 110.753 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.9 13.92 3.21 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -138.16 178.88 6.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.238 0.615 . . . . 0.0 111.641 -173.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 68.1 p -144.41 158.88 43.53 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.541 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -165.99 162.56 18.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.156 0.982 . . . . 0.0 108.669 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -69.46 152.02 45.37 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.106 -0.371 . . . . 0.0 110.555 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -127.48 114.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.446 0.641 . . . . 0.0 109.996 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -85.77 95.32 9.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.23 0.538 . . . . 0.0 109.91 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 8.0 t -67.29 146.56 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.188 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -135.04 158.08 45.28 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 121.015 0.436 . . . . 0.0 110.514 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.3 m -73.65 4.57 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.26 1.824 . . . . 0.0 113.628 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.3 t70 90.97 157.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.367 1.467 . . . . 0.0 110.703 171.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.203 0 CA-C-O 117.274 -1.848 . . . . 0.0 111.19 174.51 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 C5'-C4'-C3' 112.032 -2.312 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 1 O4'-C1'-N19 112.242 4.042 . 0.372 5p . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O4'-C1'-N19 111.837 3.637 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 C5'-C4'-C3' 111.344 -2.77 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 1 C4'-C3'-C2' 98.112 -4.588 . 0.199 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 O4'-C1'-N19 112.813 4.613 . 0.404 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.604 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.416 -3.087 1 O4'-C1'-N19 112.648 4.448 . 0.03 '#a' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.778 0 C5'-C4'-C3' 110.804 -3.131 . 0.599 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.44 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -150.46 40.48 0.2 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.201 0.601 . . . . 0.0 112.118 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 76.7 Cg_endo -68.85 8.71 0.54 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.691 2.928 . . . . 0.0 112.603 -175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -141.59 9.63 2.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.469 0.708 . . . . 0.0 110.94 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.64 26.59 0.23 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -60.61 -15.56 29.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.769 0.827 . . . . 0.0 112.899 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -140.74 9.71 2.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.178 0.444 . . . . 0.0 112.167 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 175.86 -176.23 47.5 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.32 170.43 12.11 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.774 2.983 . . . . 0.0 110.686 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.01 11.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 1 C-N-CA 126.023 4.482 . . . . 0.0 116.721 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.483 ' C ' ' HD2' ' B' ' 117' ' ' ARG . 42.4 m -155.39 -2.17 0.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.894 0.878 . . . . 0.0 109.054 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' B' ' 116' ' ' SER . 0.2 OUTLIER 34.2 46.7 0.17 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.113 2.165 . . . . 0.0 116.484 167.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -56.92 171.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.669 1.188 . . . . 0.0 112.796 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' B' ' 161' ' ' GLU . 7.5 t -144.29 -129.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.0 -19.77 1.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -135.6 77.55 1.67 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.956 1.302 . . . . 0.0 110.953 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -77.75 148.48 34.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.229 1.812 . . . . 0.0 113.407 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -139.27 127.04 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.982 2.113 . . . . 0.0 108.37 172.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.461 HG23 ' HA ' ' B' ' 195' ' ' ASP . 54.0 t -63.51 159.03 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 O-C-N 121.787 -0.571 . . . . 0.0 109.614 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.01 116.17 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 85.4 p -125.67 143.69 50.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.094 0.473 . . . . 0.0 111.798 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.74 -1.7 26.02 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.34 147.88 26.06 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 127.522 2.329 . . . . 0.0 110.244 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.07 162.8 38.17 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.487 2.791 . . . . 0.0 111.421 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.16 -10.74 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 1 C-N-CA 125.379 4.053 . . . . 0.0 115.838 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' B' ' 184' ' ' GLU . 14.9 m -133.81 12.2 4.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.051 0.842 . . . . 0.0 112.91 -176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.57 167.28 4.08 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -148.68 166.94 26.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.243 -0.563 . . . . 0.0 110.489 -172.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -75.32 -28.16 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.348 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -67.85 -38.06 82.67 Favored 'General case' 0 C--O 1.231 0.089 0 O-C-N 122.339 -0.226 . . . . 0.0 110.824 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.604 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 57.0 m-20 -79.81 -19.65 47.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -29.8 66.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -78.75 -38.78 37.91 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.42 -1.78 5.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.4 1.08 . . . . 0.0 113.342 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 15.5 t60 -130.32 -36.53 1.48 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.702 0.683 . . . . 0.0 111.356 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.3 mmm -72.73 -10.93 60.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.122 0.419 . . . . 0.0 111.069 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -48.96 -16.59 0.14 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -71.75 -42.26 67.43 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.98 0.512 . . . . 0.0 111.02 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.74 -29.14 68.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.476 0.71 . . . . 0.0 111.168 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 160.93 -168.36 36.25 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -80.57 79.4 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.649 0.737 . . . . 0.0 110.412 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.469 ' H ' HG12 ' B' ' 147' ' ' VAL . 0.6 OUTLIER -64.1 149.68 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 5.8 t -134.36 -35.98 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.214 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 8.8 t80 -134.61 160.56 37.71 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.79 0.805 . . . . 0.0 110.17 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' B' ' 149' ' ' TYR . . . -156.09 168.67 26.55 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -148.1 158.43 44.06 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 168.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.606 HG22 ' H ' ' B' ' 154' ' ' ARG . 7.7 p -135.57 143.48 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-O 121.176 0.512 . . . . 0.0 110.12 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -108.36 6.97 26.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.26 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.606 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.0 mtt-85 61.4 18.63 9.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.491 0.717 . . . . 0.0 112.209 170.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -137.64 6.26 2.71 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.32 22.13 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 121.555 -0.716 . . . . 0.0 112.194 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.6 p -141.16 160.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.241 0.616 . . . . 0.0 110.083 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.28 -164.42 30.89 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.99 162.54 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.257 0.528 . . . . 0.0 110.876 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.8 p -148.0 160.14 7.46 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.129 0.971 . . . . 0.0 108.65 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' B' ' 119' ' ' SER . 37.7 tt0 -157.53 152.84 26.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.056 -0.403 . . . . 0.0 110.819 -170.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -126.43 170.56 11.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.689 0.757 . . . . 0.0 112.181 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.22 -9.63 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.369 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -149.99 139.76 21.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -64.65 -21.36 66.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.32 -31.51 58.2 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.311 0.505 . . . . 0.0 111.004 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -72.89 -21.49 60.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.107 0.479 . . . . 0.0 109.825 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.495 ' SD ' HG13 ' B' ' 123' ' ' VAL . 38.2 ttp -77.63 -52.58 8.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.356 0.663 . . . . 0.0 110.754 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 75.4 m -63.38 -18.71 63.97 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.564 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 30.6 t80 -75.37 -28.75 59.66 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.91 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.19 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 122.086 -0.384 . . . . 0.0 110.388 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.69 2.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.0 -16.26 2.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.564 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.7 mppt? -126.21 -21.63 4.22 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.84 3.54 12.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.867 0.467 . . . . 0.0 109.862 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.826 0.85 . . . . 0.0 108.819 172.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 58.44 35.93 25.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.005 0.522 . . . . 0.0 111.346 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 51.8 p -136.43 175.07 9.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 110.64 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -62.33 148.65 44.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.505 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 9.9 t80 -146.35 165.6 28.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.045 2.138 . . . . 0.0 107.439 167.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -141.25 135.34 30.57 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.907 -0.495 . . . . 0.0 109.681 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.5 t -70.4 -174.83 0.9 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.06 0.944 . . . . 0.0 111.512 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.472 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 27.2 p-80 -117.39 11.64 14.0 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.134 0.573 . . . . 0.0 109.821 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' B' ' 131' ' ' SER . 33.1 mm-40 -127.22 -13.74 5.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.036 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.36 155.78 7.01 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 56.86 -175.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.218 1.807 . . . . 0.0 114.724 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 23.3 p -122.88 171.05 9.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.548 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 -168.91 2.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.862 0.865 . . . . 0.0 108.896 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.21 149.93 47.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.59 108.51 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.213 0.53 . . . . 0.0 112.206 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -83.27 88.34 6.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 7.9 t -76.14 81.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.765 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.79 159.44 22.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.24 0.616 . . . . 0.0 111.534 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.1 m -73.0 5.37 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 126.514 1.926 . . . . 0.0 114.292 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.461 ' HA ' HG23 ' B' ' 124' ' ' VAL . 4.4 t0 88.2 155.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 124.833 1.333 . . . . 0.0 110.624 171.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.277 0 CA-C-O 117.108 -1.94 . . . . 0.0 111.013 174.641 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 110.343 -3.438 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . 0.56 HO2' ' N ' ' B' ' 106' ' ' MET . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C5'-C4'-C3' 110.676 -3.216 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.501 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.835 0 C3'-C2'-C1' 104.485 3.316 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 O4'-C1'-N19 112.023 3.823 . 0.103 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.567 1 C1'-O4'-C4' 105.502 -4.554 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 O4'-C1'-N19 112.878 4.678 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.606 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 N19-C1'-C2' 107.787 -3.508 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 C5'-C4'-C3' 110.535 -3.31 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.56 ' N ' HO2' ' A' ' 2' ' ' ' G' . 1.7 mpt? . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.44 167.11 15.17 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.162 0.985 . . . . 0.0 108.389 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -50.38 -18.97 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.845 3.03 . . . . 0.0 114.414 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 23.8 mmm-85 -142.14 30.56 1.59 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.839 1.256 . . . . 0.0 109.736 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.02 30.62 1.9 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -69.07 -17.51 63.89 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.496 1.119 . . . . 0.0 111.648 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -146.98 -167.45 2.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.379 0.671 . . . . 0.0 110.097 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.84 -169.84 14.78 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.414 ' N ' ' HD2' ' B' ' 115' ' ' PRO . 87.7 Cg_exo -45.02 -42.21 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.188 3.258 . . . . 0.0 114.904 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' B' ' 114' ' ' PRO . 96.6 Cg_endo -75.97 126.64 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.536 1.491 . . . . 0.0 110.786 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.8 m -158.67 172.65 17.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.114 1.365 . . . . 0.0 107.915 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 14.6 mtt-85 46.65 21.61 0.14 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 22.7 tpp85 -53.29 153.25 3.97 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.65 1.18 . . . . 0.0 112.069 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.0 t -135.86 -110.49 0.2 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.866 0.466 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -148.61 -26.12 0.32 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.419 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 0.8 OUTLIER -122.24 -32.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -166.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 40.75 151.38 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.778 2.831 . . . . 0.0 118.162 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.497 HG13 ' SD ' ' B' ' 168' ' ' MET . 0.1 OUTLIER -149.69 148.33 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.256 1.822 . . . . 0.0 108.828 174.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.1 t -90.92 171.95 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 p -140.37 142.96 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 59.5 p -143.82 150.92 39.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.299 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 103.24 -2.75 47.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -49.25 126.6 15.71 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 127.728 2.411 . . . . 0.0 109.742 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.84 155.13 53.76 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.883 2.389 . . . . 0.0 110.269 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.79 -22.12 28.29 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.483 2.789 . . . . 0.0 112.561 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 66.4 m -73.34 -9.22 58.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.391 1.076 . . . . 0.0 112.462 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.44 165.81 39.36 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 121.545 0.525 . . . . 0.0 112.598 -174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . 0.423 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 30.1 t -161.72 167.79 24.4 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.184 1.394 . . . . 0.0 107.445 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -64.42 -26.93 68.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.857 0.753 . . . . 0.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -70.05 -28.95 65.87 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.004 -0.435 . . . . 0.0 111.706 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.606 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 75.1 m-20 -89.92 -13.65 35.85 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.766 0.257 . . . . 0.0 110.925 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.25 3.48 54.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.697 0.399 . . . . 0.0 111.024 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -110.26 -35.33 6.11 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.11 -3.88 11.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.32 1.048 . . . . 0.0 112.771 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.64 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 10.0 t60 -127.51 -36.44 2.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 118.286 0.494 . . . . 0.0 110.734 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 76.5 mmm -69.1 -19.07 64.05 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.577 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -48.57 -20.05 0.4 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.23 1.012 . . . . 0.0 112.811 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -41.76 97.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.002 0.521 . . . . 0.0 111.252 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.484 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -67.69 -29.76 69.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.563 . . . . 0.0 111.204 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 158.72 -177.49 35.31 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.14 118.0 14.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.998 0.399 . . . . 0.0 110.161 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -114.33 151.67 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . 0.417 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 7.4 p -130.7 -21.71 2.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.295 -0.859 . . . . 0.0 111.729 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -126.02 149.51 48.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 119.122 0.874 . . . . 0.0 111.805 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.43 19.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.436 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 19.5 t0 -141.93 154.61 45.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.528 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.9 p -132.19 145.61 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.185 0.517 . . . . 0.0 110.214 -170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.16 7.16 27.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.779 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.528 ' H ' HG22 ' B' ' 152' ' ' VAL . 24.6 mtp85 61.34 16.98 7.87 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.496 0.718 . . . . 0.0 112.77 170.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -137.95 -12.0 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 141.23 -2.99 2.13 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.799 0.727 . . . . 0.0 112.922 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.81 167.68 21.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.127 0.571 . . . . 0.0 109.799 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.74 -167.4 35.25 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 6.7 p -141.09 161.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.369 0.604 . . . . 0.0 110.613 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.7 159.93 2.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -157.75 154.12 27.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.01 -0.431 . . . . 0.0 111.527 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 22.7 m-85 -122.87 163.55 20.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.893 0.854 . . . . 0.0 112.248 -170.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.36 -8.82 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.43 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -152.9 154.72 35.63 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.071 0.549 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -69.15 -25.58 64.44 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -82.83 -31.77 27.91 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.197 0.453 . . . . 0.0 111.313 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -70.57 -2.28 13.71 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.699 0.4 . . . . 0.0 110.332 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.497 ' SD ' HG13 ' B' ' 123' ' ' VAL . 40.6 ttp -111.94 -46.85 3.18 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.864 1.265 . . . . 0.0 110.897 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 58.4 m -63.23 -20.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 6.3 t80 -70.57 -31.51 68.57 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.72 69.38 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.093 -0.38 . . . . 0.0 110.367 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.21 5.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -134.4 -19.02 1.93 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -19.5 5.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.81 2.73 13.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.136 0.574 . . . . 0.0 109.48 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.36 136.75 41.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.686 1.194 . . . . 0.0 108.487 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.4 27.94 13.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.178 0.991 . . . . 0.0 111.255 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.3 p -138.09 179.46 6.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.438 0.695 . . . . 0.0 110.806 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -56.01 148.56 17.25 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.64 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 24.8 t80 -146.57 159.16 43.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.344 1.857 . . . . 0.0 108.179 168.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -148.01 153.07 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 16.6 m -135.65 170.37 16.08 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.467 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 14.3 p-80 -57.37 -19.56 23.79 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.987 1.315 . . . . 0.0 113.468 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.417 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 32.8 mm-40 -77.55 -11.02 59.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 117.957 0.344 . . . . 0.0 111.07 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.57 40.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 123.722 0.677 . . . . 0.0 111.908 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -75.04 170.86 15.17 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.338 0.59 . . . . 0.0 111.134 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 2.9 p -135.79 169.04 18.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.168 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -163.92 -167.52 1.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.969 0.908 . . . . 0.0 108.784 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -115.02 155.06 27.69 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 30.8 pt -134.9 148.86 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.396 0.617 . . . . 0.0 110.778 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -113.33 84.63 2.04 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 107.997 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 9.7 t -67.81 87.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.959 0.904 . . . . 0.0 111.255 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' B' ' 194' ' ' VAL . 50.5 tptt -76.68 160.24 29.53 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 110.748 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.572 ' H ' ' HD2' ' B' ' 193' ' ' LYS . 8.1 p -57.97 -27.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.302 2.641 . . . . 0.0 117.774 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.557 ' HA ' HG23 ' B' ' 124' ' ' VAL . 38.1 t70 98.48 125.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.183 2.193 . . . . 0.0 110.141 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 CA-C-O 117.513 -1.715 . . . . 0.0 111.332 172.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 110.312 -3.459 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.247 2 C1'-O4'-C4' 105.156 -4.938 OUTLIER-EPSILON 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . 0.446 H5'' ' C8 ' ' A' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 O4'-C1'-N19 112.125 3.925 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.278 0 O4'-C1'-N19 112.145 3.945 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.237 3 C4'-C3'-C2' 98.275 -4.425 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . 0.453 ' H22' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.417 -2.963 2 O4'-C1'-N19 113.717 5.517 . 0.01 5q . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.613 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 O4'-C1'-N19 111.258 3.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . 0.434 ' C6 ' " H5'" ' A' ' 8' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C5'-C4'-C3' 111.108 -2.928 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.526 0.203 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.25 154.08 31.77 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.975 0.51 . . . . 0.0 109.645 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.21 9.06 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.069 3.179 . . . . 0.0 112.816 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -62.58 -11.17 15.03 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 63.43 -161.11 35.29 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 118.495 0.589 . . . . 0.0 112.219 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -134.37 -10.43 2.51 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.107 0.563 . . . . 0.0 111.025 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 35.2 t80 49.38 14.35 0.1 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.375 1.47 . . . . 0.0 113.8 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.13 66.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.318 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.06 -40.64 33.83 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.626 2.884 . . . . 0.0 115.18 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.33 147.1 37.89 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.034 2.49 . . . . 0.0 112.572 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 20.4 m -157.44 168.32 27.67 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.582 0.753 . . . . 0.0 109.281 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' B' ' 148' ' ' CYS . 20.8 mtt-85 49.53 26.53 1.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . 0.544 ' CZ ' ' HA ' ' B' ' 118' ' ' ARG . 4.1 mmp_? -52.23 155.35 2.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.29 1.036 . . . . 0.0 113.697 -174.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.7 t -155.97 -137.04 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.447 0.699 . . . . 0.0 111.724 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -138.04 -26.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -167.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.404 ' HB2' ' SD ' ' B' ' 168' ' ' MET . 2.1 p30 -131.1 80.54 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.081 0.953 . . . . 0.0 111.644 -170.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -78.66 148.83 33.01 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.577 . . . . 0.0 113.81 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.479 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.5 OUTLIER -141.57 136.42 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.687 1.595 . . . . 0.0 110.017 171.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' B' ' 193' ' ' LYS . 2.3 t -76.39 162.34 4.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.06 105.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 95.8 p -111.38 151.42 28.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 102.01 8.4 44.96 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 128' ' ' LEU . 5.6 tp -60.51 146.99 84.03 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 126.69 1.996 . . . . 0.0 111.503 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.9 164.87 32.59 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.952 3.101 . . . . 0.0 109.689 175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.9 -21.52 43.8 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.262 2.641 . . . . 0.0 111.631 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -73.46 -15.76 61.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.383 0.673 . . . . 0.0 112.09 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.12 148.27 24.88 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 25.5 t -155.76 165.65 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.585 0.754 . . . . 0.0 109.447 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -72.19 -27.04 62.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.931 -0.48 . . . . 0.0 111.702 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -65.16 -31.35 72.49 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.804 0.729 . . . . 0.0 111.151 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.613 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 55.2 m-20 -83.14 -21.12 33.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.499 -176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 137' ' ' LEU . 1.0 OUTLIER -75.28 -17.03 60.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.29 0.496 . . . . 0.0 111.109 -176.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -89.15 -44.29 10.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.453 ' CG ' ' H22' ' A' ' 6' ' ' ' G' . 4.2 m-20 -68.95 -11.64 60.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -120.45 -30.9 4.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.398 0.999 . . . . 0.0 111.221 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.5 mmm -76.81 -14.8 59.88 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.94 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -43.77 -21.02 0.03 OUTLIER 'General case' 0 C--N 1.345 0.412 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.47 -42.23 87.84 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 123.589 0.755 . . . . 0.0 111.245 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.495 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -65.79 -28.87 69.33 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.01 0.524 . . . . 0.0 110.499 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.41 32.94 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -71.39 123.83 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.35 -0.5 . . . . 0.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.1 OUTLIER -120.8 154.25 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . 0.408 ' O ' ' HD3' ' B' ' 117' ' ' ARG . 53.4 t -134.64 -24.86 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.526 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 71.3 t80 -127.15 153.68 45.72 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 118.992 0.814 . . . . 0.0 111.947 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -155.74 166.85 32.26 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.023 171.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.408 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 26.5 t0 -152.07 160.26 43.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.559 HG22 ' H ' ' B' ' 154' ' ' ARG . 8.0 p -135.84 145.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.051 0.453 . . . . 0.0 110.03 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -109.42 6.55 24.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.257 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.559 ' H ' HG22 ' B' ' 152' ' ' VAL . 16.6 mtt180 61.83 17.72 9.1 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.651 0.781 . . . . 0.0 112.611 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.39 10.19 2.5 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.6 6.01 27.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.572 0.624 . . . . 0.0 111.978 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.28 156.81 45.3 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.123 0.569 . . . . 0.0 109.586 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.51 -166.0 30.42 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 7.6 p -145.55 162.38 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.016 0.436 . . . . 0.0 111.539 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 10.6 p -151.17 157.62 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.354 1.062 . . . . 0.0 108.547 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -155.13 140.96 18.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.931 -0.481 . . . . 0.0 111.154 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 41.9 m-85 -110.25 167.61 10.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.809 0.814 . . . . 0.0 113.053 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 m -75.75 -11.08 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.306 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -150.5 141.97 23.43 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -65.18 -26.05 67.99 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -73.1 -31.15 64.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.035 0.38 . . . . 0.0 110.661 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.02 -20.35 60.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.815 0.341 . . . . 0.0 110.202 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.479 ' CG ' HG13 ' B' ' 123' ' ' VAL . 33.9 ttp -80.51 -55.37 4.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.371 0.669 . . . . 0.0 110.515 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 70.3 m -64.33 -18.26 64.46 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 5.4 t80 -73.48 -32.09 64.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.55 68.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 121.866 -0.521 . . . . 0.0 110.575 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.92 3.13 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -132.3 -17.26 2.67 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.04 0.836 . . . . 0.0 112.761 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -21.2 4.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.44 0.48 14.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.76 147.21 33.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.71 37.39 23.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.513 0.725 . . . . 0.0 112.913 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 66.9 p -133.26 167.59 20.1 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.128 0.49 . . . . 0.0 110.372 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -61.76 140.84 58.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.954 0.902 . . . . 0.0 113.175 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' B' ' 180' ' ' PHE . 0.1 OUTLIER -157.78 146.82 19.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.846 1.258 . . . . 0.0 110.284 169.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' B' ' 187' ' ' THR . 46.8 ttt180 167.07 -62.29 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.123 2.569 . . . . 0.0 108.954 165.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.5 m 46.06 24.82 0.28 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 167.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 2.6 p-80 -143.37 2.91 1.3 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.88 1.673 . . . . 0.0 114.594 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -128.2 -15.33 4.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.203 0.91 . . . . 0.0 112.778 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.32 -12.88 1.06 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.591 0.596 . . . . 0.0 114.591 171.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' B' ' 181' ' ' ARG . 12.3 pt-20 -155.98 -157.45 0.72 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.923 0.862 . . . . 0.0 109.639 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . 0.568 ' HA ' ' HB3' ' B' ' 181' ' ' ARG . 40.5 p -151.18 168.1 25.74 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.158 1.383 . . . . 0.0 110.604 174.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.23 39.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.636 1.575 . . . . 0.0 107.477 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -67.61 145.46 54.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 110.676 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 38.1 pt -123.22 136.28 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.945 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -104.32 79.6 1.61 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.824 0.85 . . . . 0.0 108.733 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.88 131.1 26.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.454 ' HE2' HG11 ' B' ' 124' ' ' VAL . 55.2 pttt -133.67 165.36 25.11 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.428 HG22 ' H ' ' B' ' 194' ' ' VAL . 17.8 m -74.74 47.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 114.385 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 54.45 23.8 4.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.168 -1.833 . . . . 0.0 112.915 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 117.729 -1.595 . . . . 0.0 111.585 -172.269 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 110.865 -3.09 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.248 1 O4'-C1'-N19 113.044 4.844 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 O4'-C1'-N19 111.733 3.533 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 O4'-C1'-N19 110.659 2.459 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.298 0 C4'-C3'-C2' 98.972 -3.728 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.324 2 O4'-C1'-N19 114.172 5.972 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.601 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 P--O5' 1.617 2.421 0 N19-C1'-C2' 107.43 -3.731 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.156 0 C4'-C3'-C2' 100.241 -2.459 . 0.01 1L . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.79 162.05 27.79 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 110.028 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -51.83 157.87 5.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.993 3.128 . . . . 0.0 113.376 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -145.92 178.95 7.8 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.855 1.262 . . . . 0.0 109.124 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.46 176.7 40.99 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 102.41 -5.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 127.871 2.468 . . . . 0.0 109.976 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -156.23 175.09 14.45 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.634 0.773 . . . . 0.0 110.026 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -175.83 -171.69 39.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.84 153.29 6.14 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.45 3.434 . . . . 0.0 112.768 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.8 166.07 27.59 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.852 3.035 . . . . 0.0 111.564 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 57.4 m -149.29 -42.93 0.14 Allowed 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.442 0.697 . . . . 0.0 110.273 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -149.77 0.36 0.48 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.938 0.895 . . . . 0.0 112.336 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.69 171.96 0.79 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -134.42 -104.81 0.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -169.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -149.78 -25.18 0.27 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -166.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.15 -33.35 5.71 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -166.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 40.1 157.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.01 146.94 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.493 2.317 . . . . 0.0 107.849 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.72 168.63 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 10.0 p -137.45 130.47 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 58.3 p -138.42 153.53 48.88 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.36 6.01 53.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.27 139.16 97.52 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 127.811 2.444 . . . . 0.0 111.537 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.33 156.09 22.26 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.151 2.567 . . . . 0.0 110.145 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.69 -22.35 35.95 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.323 2.682 . . . . 0.0 112.07 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 48.9 m -73.08 7.5 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.319 1.448 . . . . 0.0 113.078 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 162.33 13.25 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.556 0.617 . . . . 0.0 111.585 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . 0.401 ' CB ' ' N1 ' ' A' ' 7' ' ' ' A' . 45.1 t -156.67 173.11 17.44 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.12 0.968 . . . . 0.0 108.799 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -64.58 -30.59 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.657 -0.652 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -66.51 -23.72 66.29 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.912 0.324 . . . . 0.0 111.46 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.601 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 48.1 m-20 -94.66 -24.1 17.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -174.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -23.27 61.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.227 -0.295 . . . . 0.0 110.584 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -80.82 -39.43 26.66 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.82 -0.15 5.09 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.812 1.245 . . . . 0.0 114.194 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 24.8 t60 -135.0 -38.51 0.78 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.461 0.573 . . . . 0.0 111.262 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 84.4 mmm -68.39 -11.78 60.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.564 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -45.02 -24.6 0.24 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.296 1.038 . . . . 0.0 112.536 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.49 -41.0 93.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.972 -0.455 . . . . 0.0 111.205 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -68.74 -31.09 69.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.674 0.789 . . . . 0.0 111.475 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.54 -171.71 40.1 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -80.87 77.03 7.78 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.816 0.817 . . . . 0.0 110.593 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -65.43 143.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -126.57 -28.9 2.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.818 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -136.44 157.77 46.01 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 118.79 0.723 . . . . 0.0 111.018 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.88 166.93 31.38 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 175.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' CG1' ' B' ' 159' ' ' VAL . 49.3 t0 -147.51 147.48 30.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 167.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.62 HG22 ' H ' ' B' ' 154' ' ' ARG . 6.0 p -127.58 142.01 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 121.54 0.685 . . . . 0.0 111.195 -171.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -105.95 10.57 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.62 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.62 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.31 24.23 0.03 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 127.177 2.191 . . . . 0.0 114.994 178.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.46 5.31 1.42 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 136.31 -9.62 4.1 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 118.167 0.439 . . . . 0.0 113.373 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 1.1 p -143.07 167.83 21.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.331 0.566 . . . . 0.0 110.665 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.74 -169.93 40.07 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' B' ' 151' ' ' ASP . 2.6 p -134.77 159.38 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 11.8 p -148.64 157.32 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.96 157.14 34.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.756 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.7 m-85 -130.9 169.2 16.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.852 0.861 . . . . 0.0 110.641 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.2 -13.75 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.759 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -140.95 156.36 46.08 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.625 0.77 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -79.85 -28.5 40.05 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.625 0.77 . . . . 0.0 112.007 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.05 -31.07 25.58 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -77.62 7.24 5.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.737 0.415 . . . . 0.0 110.353 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . . . . . . . . . 34.7 ttp -114.85 -44.55 3.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.355 1.462 . . . . 0.0 110.028 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -62.41 -23.62 66.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -65.85 -29.8 70.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.35 -37.45 68.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.152 -0.343 . . . . 0.0 110.578 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.506 ' O ' HG22 ' B' ' 172' ' ' VAL 0.282 0.6 OUTLIER -82.91 28.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.447 0.641 . . . . 0.0 111.694 177.049 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.585 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 13.6 ptm180 -148.0 -25.2 0.35 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.243 -0.911 . . . . 0.0 112.789 171.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.585 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.2 OUTLIER -108.89 -26.77 10.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.446 0.566 . . . . 0.0 111.99 176.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' B' ' 144' ' ' ALA . 1.8 mm? -115.28 0.53 13.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.22 0.608 . . . . 0.0 110.186 -172.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -82.43 144.63 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.163 0.985 . . . . 0.0 109.708 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 26.2 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.792 0.837 . . . . 0.0 111.97 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -135.31 162.83 31.48 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 124.715 1.206 . . . . 0.0 108.6 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 18.2 ptmt -67.99 158.27 33.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.866 -1.515 . . . . 0.0 114.293 -168.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.473 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -143.98 148.04 34.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.44 -1.709 . . . . 0.0 109.235 167.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' B' ' 182' ' ' SER . 3.4 tmm_? -130.84 137.31 49.33 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -172.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.415 ' N ' ' HD2' ' B' ' 181' ' ' ARG . 47.6 p -145.08 -170.23 3.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.759 -172.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.463 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.7 p-80 -59.67 -176.19 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 112.071 177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.447 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 4.6 mm-40 65.6 -23.34 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.432 1.893 . . . . 0.0 112.726 -173.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 111.11 26.66 4.55 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.983 170.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.76 178.21 7.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.437 1.119 . . . . 0.0 113.488 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.81 156.13 22.3 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.519 -177.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.51 160.51 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.79 1.236 . . . . 0.0 109.161 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 5.2 m-30 -65.91 151.16 47.35 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 39.8 pt -131.2 133.64 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.13 95.83 7.37 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.276 0.56 . . . . 0.0 109.823 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.95 116.08 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 13.9 tttt -90.57 171.88 9.08 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 173.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.417 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 3.4 p -66.98 -28.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 0.0 114.108 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 24.0 t70 141.87 163.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.653 2.381 . . . . 0.0 109.391 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.27 0 CA-C-O 117.413 -1.77 . . . . 0.0 111.351 176.103 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 1 O4'-C1'-N19 114.088 5.888 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 1 O4'-C1'-N19 113.913 5.713 . 0.237 5z . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 O4'-C1'-N19 111.898 3.698 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.785 0 C5'-C4'-C3' 109.59 -3.94 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 C4'-C3'-C2' 97.873 -4.827 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.766 0 O4'-C1'-N19 112.153 3.953 . 0.24 7r . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.607 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 N19-C1'-C2' 107.931 -3.418 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 111.918 -2.388 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -151.9 45.67 0.33 Allowed Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.051 0.541 . . . . 0.0 111.829 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 92.6 Cg_endo -71.82 -6.92 20.12 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.078 2.519 . . . . 0.0 112.318 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -145.17 168.21 20.93 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.508 0.723 . . . . 0.0 110.165 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.58 39.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -136.02 16.27 3.27 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.048 0.539 . . . . 0.0 111.816 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -139.68 160.32 40.15 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.932 -0.48 . . . . 0.0 110.584 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.91 -171.25 39.47 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.35 160.36 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.183 3.255 . . . . 0.0 112.322 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.3 164.92 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.248 3.299 . . . . 0.0 113.551 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 59.2 m -75.99 -32.35 59.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.02 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -170.14 -30.18 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.199 1.4 . . . . 0.0 110.108 -168.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' B' ' 119' ' ' SER . 0.2 OUTLIER 52.07 -173.48 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 126.379 1.872 . . . . 0.0 113.518 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.595 ' H ' ' HG3' ' B' ' 118' ' ' ARG . 0.8 OUTLIER -150.04 -178.39 6.46 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -176.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . 0.563 ' HB2' HD22 ' B' ' 121' ' ' ASN . 33.6 mt-10 -148.53 -29.3 0.29 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.39 1.876 . . . . 0.0 113.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' B' ' 120' ' ' GLU . 1.3 p30 -140.98 78.53 1.65 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.663 2.385 . . . . 0.0 107.535 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -89.58 150.61 22.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.653 0.739 . . . . 0.0 112.757 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' B' ' 194' ' ' VAL . 0.2 OUTLIER -138.36 127.57 32.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 126.445 1.898 . . . . 0.0 107.866 174.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' B' ' 195' ' ' ASP . 74.1 t -68.13 157.23 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.05 114.54 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 87.9 p -129.06 146.29 51.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.74 -0.94 39.11 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.08 144.69 48.16 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 128.054 2.542 . . . . 0.0 110.535 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.98 161.1 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.802 2.335 . . . . 0.0 109.478 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.05 -11.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.833 2.355 . . . . 0.0 110.687 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 72.9 m -79.13 -8.15 58.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.575 1.15 . . . . 0.0 112.225 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.04 164.66 40.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 118.264 0.484 . . . . 0.0 111.987 -175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . 0.423 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 41.1 t -157.68 168.85 26.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.117 0.967 . . . . 0.0 108.4 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -63.36 -27.24 69.18 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.545 0.611 . . . . 0.0 111.773 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -68.33 -46.77 69.28 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.186 0.448 . . . . 0.0 110.705 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.607 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 81.9 m-20 -70.08 -24.39 63.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -20.76 60.08 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' B' ' 138' ' ' LYS . 50.1 mtpt -85.55 -34.89 21.38 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.566 0.621 . . . . 0.0 109.359 175.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.62 -40.43 66.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 22.2 t60 -81.03 -36.53 30.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.738 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.7 mmm -73.1 -20.65 60.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.398 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -51.27 -18.84 1.04 Allowed 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.585 0.63 . . . . 0.0 112.403 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.81 -39.62 85.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.385 0.674 . . . . 0.0 111.39 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' B' ' 170' ' ' TYR . . . -66.52 -18.63 65.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.588 0.755 . . . . 0.0 111.775 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 168.39 -95.67 0.11 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -157.37 133.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.2 OUTLIER -119.8 153.08 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.137 0.494 . . . . 0.0 110.44 -175.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.8 -21.08 3.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.311 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' B' ' 150' ' ' ALA . 51.8 t80 -144.31 157.38 44.3 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 120.22 1.373 . . . . 0.0 112.19 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.61 169.65 22.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.628 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -148.76 152.94 37.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.506 HG22 ' H ' ' B' ' 154' ' ' ARG . 9.8 p -131.31 140.68 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.415 0.626 . . . . 0.0 109.853 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.14 5.07 34.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.126 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.506 ' H ' HG22 ' B' ' 152' ' ' VAL . 7.4 mtt180 61.47 16.28 7.41 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.548 0.739 . . . . 0.0 112.709 170.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -135.44 5.83 3.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.97 3.9 15.12 Favored Glycine 0 C--N 1.337 0.597 0 O-C-N 121.881 -0.512 . . . . 0.0 112.197 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 3.5 p -142.31 161.78 37.14 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 110.573 -176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.58 -168.61 37.51 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 160' ' ' VAL . 7.3 p -141.45 165.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 117.393 0.596 . . . . 0.0 110.734 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.9 p -153.7 156.67 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.108 0.963 . . . . 0.0 109.246 177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -151.09 156.25 40.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.663 0.268 . . . . 0.0 111.612 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 39.8 m-85 -120.43 163.58 17.68 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.697 1.237 . . . . 0.0 114.171 -169.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.96 -12.74 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.502 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -152.68 142.28 21.83 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -63.8 -21.01 66.22 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.91 -29.79 58.53 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.876 -0.515 . . . . 0.0 110.952 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -74.15 -18.71 60.75 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.433 ' CG ' HG13 ' B' ' 123' ' ' VAL . 32.9 ttp -77.17 -53.13 8.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -61.03 -20.6 62.72 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' B' ' 144' ' ' ALA . 7.4 t80 -74.13 -30.83 62.48 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.893 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.15 -33.08 67.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.073 -0.392 . . . . 0.0 110.561 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.0 4.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -133.72 -18.91 2.11 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 121.319 -0.863 . . . . 0.0 112.552 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 -19.96 5.41 Favored 'General case' 0 N--CA 1.46 0.047 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.29 2.71 14.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.71 140.52 34.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.365 1.066 . . . . 0.0 108.428 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 65.42 25.06 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.555 0.693 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 53.8 p -135.27 169.58 17.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.9 1.28 . . . . 0.0 108.507 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 189' ' ' TYR . 9.9 pttt -75.23 155.87 36.33 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.248 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.513 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 0.0 OUTLIER -138.44 166.23 24.79 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.483 170.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . 0.407 ' HD2' ' H ' ' B' ' 182' ' ' SER . 14.9 tpt180 -133.85 151.63 51.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.161 0.984 . . . . 0.0 110.157 -169.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . 0.407 ' H ' ' HD2' ' B' ' 181' ' ' ARG . 42.4 m -133.62 164.42 27.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.21 0.529 . . . . 0.0 111.42 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.448 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 15.4 p-80 -62.78 -13.1 29.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.027 1.331 . . . . 0.0 113.75 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.414 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 37.7 mm-40 -84.15 -16.67 42.7 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.54 0.609 . . . . 0.0 112.416 -175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 109.39 19.27 8.49 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.471 -0.627 . . . . 0.0 113.951 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.04 171.23 14.49 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.53 1.165 . . . . 0.0 111.406 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 69.1 p -138.57 161.23 37.61 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.816 0.446 . . . . 0.0 111.481 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.68 156.2 15.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.015 . . . . 0.0 108.9 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' B' ' 179' ' ' LYS . 2.6 m-30 -72.03 158.57 35.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.061 0.458 . . . . 0.0 111.118 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.03 145.08 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.113 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -102.73 102.39 12.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.976 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.9 79.72 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.047 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.22 158.29 23.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.153 0.501 . . . . 0.0 111.374 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.524 ' HA ' HG12 ' B' ' 123' ' ' VAL . 27.6 m -72.64 6.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 126.203 1.801 . . . . 0.0 113.705 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 194' ' ' VAL . 3.8 t0 91.05 157.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.995 1.435 . . . . 0.0 110.277 170.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.561 -1.688 . . . . 0.0 111.33 174.262 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 C5'-C4'-C3' 111.823 -2.451 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.473 1 O4'-C1'-N19 112.247 4.047 . 0.36 5p . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 C5'-C4'-C3' 110.372 -3.419 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.336 0 O4'-C1'-N19 111.371 3.171 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.442 1 C4'-C3'-C2' 98.476 -4.224 . 0.247 0i . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 1 O4'-C1'-N19 113.134 4.934 . 0.351 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.604 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 O4'--C4' 1.422 -2.584 0 C5'-C4'-C3' 110.221 -3.519 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . 0.49 ' C6 ' " H5'" ' A' ' 8' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.06 0 O4'-C1'-N19 110.85 2.65 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.44 ' N ' ' CD ' ' B' ' 108' ' ' PRO . . . -60.01 -36.51 39.09 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.454 -0.784 . . . . 0.0 113.014 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 107' ' ' ALA . 34.4 Cg_exo -60.11 3.77 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.707 2.938 . . . . 0.0 114.286 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 55.87 20.07 3.92 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.278 1.031 . . . . 0.0 112.277 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.06 177.38 47.7 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -152.16 12.25 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.602 0.361 . . . . 0.0 111.822 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -140.75 171.15 14.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.478 0.711 . . . . 0.0 110.338 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.88 -180.0 48.8 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' B' ' 115' ' ' PRO . 71.2 Cg_exo -50.74 156.44 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.969 3.78 . . . . 0.0 112.92 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 114' ' ' PRO . 78.0 Cg_exo -52.02 -35.01 59.57 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.826 3.017 . . . . 0.0 113.602 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' B' ' 117' ' ' ARG . 15.0 m -165.3 -38.49 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' B' ' 116' ' ' SER 0.31 0.0 OUTLIER 161.83 27.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.736 3.214 . . . . 0.0 113.161 166.295 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.1 169.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.849 1.259 . . . . 0.0 113.476 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -140.46 -133.3 0.11 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.775 0.83 . . . . 0.0 112.151 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.64 -19.55 1.84 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -165.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -136.01 75.43 1.55 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.814 1.245 . . . . 0.0 109.788 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' B' ' 161' ' ' GLU . 66.5 mtm-85 -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.436 1.494 . . . . 0.0 113.398 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.4 OUTLIER -139.21 132.86 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 126.604 1.962 . . . . 0.0 108.111 174.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' B' ' 195' ' ' ASP . 2.2 t -66.52 156.59 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 109.774 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.18 100.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 77.3 p -111.3 146.94 36.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.407 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.47 -0.46 32.69 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.17 149.82 44.56 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 128.12 2.568 . . . . 0.0 111.29 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.31 165.16 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.5 2.8 . . . . 0.0 109.668 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.95 -15.69 36.46 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.786 2.324 . . . . 0.0 110.25 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 73.2 m -79.66 -2.57 43.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.875 1.27 . . . . 0.0 112.024 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.75 168.64 54.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . 0.448 ' HB3' ' CE1' ' B' ' 183' ' ' HIS . 3.9 p -159.75 166.36 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -73.21 -28.67 62.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.334 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -68.34 -40.47 81.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 117.964 0.347 . . . . 0.0 110.246 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.604 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 72.7 m-20 -80.61 -19.73 44.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -34.05 70.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -74.65 -37.95 62.6 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.37 1.47 1.62 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.727 1.211 . . . . 0.0 113.5 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 12.0 t60 -132.96 -37.74 0.99 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.513 0.597 . . . . 0.0 111.403 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 83.5 mmm -71.63 -11.35 60.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.421 0.555 . . . . 0.0 110.189 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -47.59 -21.41 0.35 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 123.914 0.886 . . . . 0.0 113.114 171.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.4 -41.88 88.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' B' ' 175' ' ' LEU . . . -67.2 -27.81 67.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.15 -170.26 36.91 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -83.07 74.26 9.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.839 0.828 . . . . 0.0 110.565 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 0.4 OUTLIER -61.11 149.56 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 34.4 t -131.74 -33.37 1.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -136.37 158.89 43.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 110.609 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 160' ' ' VAL . . . -153.45 166.28 33.19 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -145.19 150.52 36.88 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.576 HG22 ' H ' ' B' ' 154' ' ' ARG . 5.8 p -129.49 141.38 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.599 0.714 . . . . 0.0 110.362 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.79 11.61 29.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.279 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.576 ' H ' HG22 ' B' ' 152' ' ' VAL . 0.0 OUTLIER 42.9 23.3 0.03 OUTLIER 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.954 2.101 . . . . 0.0 114.895 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.07 6.75 1.78 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.14 6.38 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 118.557 0.617 . . . . 0.0 113.202 174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . . . . . . . . . 2.9 p -142.73 163.46 32.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.271 0.536 . . . . 0.0 110.322 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.04 -168.29 35.43 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 160' ' ' VAL . 6.6 p -140.91 162.29 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 122.94 0.496 . . . . 0.0 111.105 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' B' ' 150' ' ' ALA . 14.7 p -154.59 153.95 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 124.327 1.051 . . . . 0.0 109.472 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' B' ' 122' ' ' ARG . 17.1 pt-20 -154.47 160.15 41.42 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 2.1 m-85 -122.73 171.72 8.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 122.061 0.934 . . . . 0.0 111.984 -171.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.05 -20.11 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.22 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -145.11 143.89 30.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.135 0.574 . . . . 0.0 110.371 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.02 -24.32 63.26 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.29 -29.53 62.78 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.546 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.83 -19.33 60.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.478 ' CG ' HG13 ' B' ' 123' ' ' VAL . 31.2 ttp -78.17 -52.79 8.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.181 0.592 . . . . 0.0 110.481 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.3 m -64.8 -19.27 65.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -73.91 -27.63 61.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.03 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.46 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.03 -0.419 . . . . 0.0 110.891 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.38 3.25 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . 0.609 ' C ' ' HE2' ' B' ' 174' ' ' LYS . 5.1 ptm180 -134.44 -21.45 1.78 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.833 0.742 . . . . 0.0 112.491 -173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.609 ' HE2' ' C ' ' B' ' 173' ' ' ARG . 0.1 OUTLIER -113.06 -26.3 8.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 117.945 0.339 . . . . 0.0 111.116 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' B' ' 174' ' ' LYS . 1.8 mm? -118.23 2.22 11.95 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.763 0.825 . . . . 0.0 109.955 -172.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.0 152.39 29.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.107 0.563 . . . . 0.0 109.544 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.4 32.95 12.04 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 32.9 p -133.01 175.15 9.63 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.974 0.509 . . . . 0.0 110.632 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -57.75 147.19 28.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.899 0.88 . . . . 0.0 112.1 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.552 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 6.4 t80 -139.7 158.78 43.54 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.9 1.28 . . . . 0.0 109.639 170.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -141.68 144.46 34.12 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.766 1.226 . . . . 0.0 108.715 -174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 77.3 p -148.64 -178.05 6.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.8 0.44 . . . . 0.0 110.075 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.47 ' CD2' ' HG2' ' B' ' 184' ' ' GLU . 24.1 p-80 -62.07 -174.99 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.974 0.51 . . . . 0.0 110.954 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . 0.47 ' HG2' ' CD2' ' B' ' 183' ' ' HIS . 20.3 mm-40 69.55 -27.29 0.16 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.7 1.6 . . . . 0.0 111.623 -172.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 183' ' ' HIS . . . 108.02 29.76 4.2 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.617 171.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -129.13 178.75 6.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.892 0.846 . . . . 0.0 112.361 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 51.0 p -145.93 166.78 25.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.42 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -162.33 -159.43 0.58 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.404 0.681 . . . . 0.0 109.732 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.89 145.64 48.28 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.62 92.13 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.063 0 CA-C-O 121.535 0.683 . . . . 0.0 112.608 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.8 84.8 1.67 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.83 0.824 . . . . 0.0 109.489 170.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.55 133.66 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.134 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' B' ' 195' ' ' ASP . 54.6 mtmt -125.83 165.62 18.35 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.271 0.558 . . . . 0.0 112.114 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.421 HG22 ' H ' ' B' ' 194' ' ' VAL . 18.0 m -76.77 32.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 C-N-CA 126.7 2.0 . . . . 0.0 112.679 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.501 ' HA ' HG23 ' B' ' 124' ' ' VAL . 1.0 OUTLIER 72.83 18.01 4.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.759 173.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.366 -1.797 . . . . 0.0 111.414 -173.308 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 111.802 3.602 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.769 0 O4'-C1'-N19 110.879 2.679 . 0.471 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 111.831 3.631 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.966 0 C5'-C4'-C3' 111.478 -2.681 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.953 0 C4'-C3'-C2' 100.098 -2.602 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ' G' . . . . . 0.5 ' H22' ' CG ' ' B' ' 139' ' ' ASP . . . . . . . . 0 O4'--C4' 1.425 -2.352 2 O4'-C1'-N19 113.888 5.688 . 0.148 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ' A' . . . . . 0.614 ' N6 ' ' OD1' ' B' ' 136' ' ' ASP . . . . . . . . 0 P--O5' 1.617 2.363 1 O4'-C1'-N19 112.372 4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 P-O3'-C3' 121.807 1.756 . 0.0 OUTLIER '7D dist 1L' 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.38 26.69 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.094 0.557 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.52 -13.97 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 124.573 3.516 . . . . 0.0 113.958 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 50.94 23.1 1.34 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 112.565 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.42 -178.01 47.82 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 43.28 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.115 1.766 . . . . 0.0 113.696 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -149.82 -0.61 0.45 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.752 0.421 . . . . 0.0 111.95 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.9 -171.3 44.32 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.4 161.44 43.23 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.715 2.943 . . . . 0.0 110.488 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.61 12.64 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.438 3.426 . . . . 0.0 113.153 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 3.5 p -175.35 141.01 0.51 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' B' ' 117' ' ' ARG . 0.0 OUTLIER -164.01 37.03 0.08 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 117.697 -1.601 . . . . 0.0 112.49 -159.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.7 -175.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -172.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 8.3 t -138.67 -135.35 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . 0.289 37.7 mt-10 -136.65 -17.58 1.47 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.659 1.983 . . . . 0.0 115.214 -165.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -131.43 80.85 1.95 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.559 1.544 . . . . 0.0 108.558 -169.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -80.64 159.02 25.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.41 2.284 . . . . 0.0 113.429 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.437 HG13 ' CG ' ' B' ' 168' ' ' MET . 0.2 OUTLIER -147.7 138.87 17.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 128.722 2.809 . . . . 0.0 107.721 176.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' CA ' ' B' ' 195' ' ' ASP . 2.4 t -72.63 164.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.32 131.52 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.41 ' HB3' HG22 ' B' ' 157' ' ' THR . 93.3 p -137.19 140.14 41.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.869 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 132.35 -1.02 4.83 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.491 HD12 ' CE2' ' B' ' 180' ' ' PHE . 1.6 mm? -53.54 149.21 15.81 Favored Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 123.352 0.661 . . . . 0.0 110.981 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.26 166.43 29.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 124.309 3.339 . . . . 0.0 110.669 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.79 -3.59 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 1 C-N-CA 125.443 4.095 . . . . 0.0 116.308 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.11 10.47 1.52 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.644 1.111 . . . . 0.0 113.261 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.36 158.79 7.01 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . 0.419 ' HB3' ' N1 ' ' A' ' 7' ' ' ' A' . 26.0 t -148.43 170.3 18.31 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.37 -0.488 . . . . 0.0 110.594 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -66.69 -27.07 67.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.555 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -68.38 -35.22 77.37 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.348 0.522 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.614 ' OD1' ' N6 ' ' A' ' 7' ' ' ' A' . 92.7 m-20 -84.03 -22.69 31.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 122.388 -0.195 . . . . 0.0 111.325 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -35.9 75.19 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -77.02 -36.62 56.12 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.5 ' CG ' ' H22' ' A' ' 6' ' ' ' G' . 4.1 m-20 -69.44 -2.05 10.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.234 1.014 . . . . 0.0 112.962 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' HIS . . . . . 0.655 ' CE1' ' HA ' ' B' ' 180' ' ' PHE . 17.9 t60 -126.99 -37.6 2.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 110.882 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' MET . . . . . . . . . . . . . 81.1 mmm -70.89 -11.31 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.885 -0.509 . . . . 0.0 110.205 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -49.53 -21.34 0.94 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.228 0.611 . . . . 0.0 112.439 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -67.26 -43.62 81.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.148 0.579 . . . . 0.0 111.073 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.13 68.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.055 0.542 . . . . 0.0 110.929 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.47 -167.67 37.1 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.05 74.3 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.669 0.747 . . . . 0.0 110.402 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' B' ' 162' ' ' PHE . 1.2 p -60.33 149.03 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' CYS . . . . . . . . . . . . . 29.1 p -138.29 -13.64 1.35 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.984 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.54 155.76 32.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.332 -0.855 . . . . 0.0 110.638 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.9 130.24 8.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.678 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.97 120.96 43.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.534 HG22 ' H ' ' B' ' 154' ' ' ARG . 11.3 p -109.39 140.6 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.565 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.15 6.18 49.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.353 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.534 ' H ' HG22 ' B' ' 152' ' ' VAL . 13.8 mtt180 62.57 14.91 7.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.928 0.891 . . . . 0.0 112.669 172.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.59 -4.44 2.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 130.56 7.19 3.53 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 118.528 0.604 . . . . 0.0 113.118 177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' THR . . . . . 0.41 HG22 ' HB3' ' B' ' 126' ' ' SER . 0.1 OUTLIER -143.26 164.81 29.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.62 0.71 . . . . 0.0 110.614 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.85 -164.18 31.87 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.27 161.02 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 124.088 0.955 . . . . 0.0 108.423 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 p -152.03 156.86 5.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -156.18 159.6 39.12 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' B' ' 147' ' ' VAL . 1.2 m-85 -127.97 170.42 12.88 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.596 0.713 . . . . 0.0 111.314 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.58 -7.13 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -149.46 135.83 19.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.161 0.437 . . . . 0.0 110.119 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -66.81 -20.86 66.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -77.37 -31.96 54.65 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.507 -0.746 . . . . 0.0 110.56 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.61 -19.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 109.607 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' MET . . . . . 0.437 ' CG ' HG13 ' B' ' 123' ' ' VAL . 34.8 ttp -76.54 -52.45 9.73 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.017 0.927 . . . . 0.0 110.611 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 87.4 m -65.19 -19.38 65.94 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' TYR . . . . . 0.624 ' CE2' ' HE3' ' B' ' 174' ' ' LYS . 37.9 t80 -73.55 -27.66 61.46 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.452 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.13 66.61 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 119.599 -0.238 . . . . 0.0 110.385 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.3 4.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -134.4 -17.18 2.05 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.393 -0.817 . . . . 0.0 112.872 -172.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.624 ' HE3' ' CE2' ' B' ' 170' ' ' TYR . 2.3 mppt? -124.94 -21.59 4.67 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 173.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.21 1.62 13.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.912 0.485 . . . . 0.0 109.945 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.97 140.59 29.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 62.06 34.49 16.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.807 0.843 . . . . 0.0 111.791 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' THR . . . . . . . . . . . . . 60.7 p -138.04 177.77 7.63 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.469 0.708 . . . . 0.0 110.543 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -57.01 155.52 8.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.701 1.201 . . . . 0.0 113.704 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' PHE . . . . . 0.655 ' HA ' ' CE1' ' B' ' 140' ' ' HIS . 23.7 t80 -143.25 161.87 37.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.472 1.909 . . . . 0.0 108.873 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -146.56 146.22 30.4 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.19 0.996 . . . . 0.0 108.738 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 85.0 p -141.99 170.91 14.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.013 0.435 . . . . 0.0 111.872 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . 0.475 ' ND1' ' OD2' ' B' ' 136' ' ' ASP . 13.6 p-80 -59.41 -11.87 5.08 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.81 1.244 . . . . 0.0 113.135 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.27 -18.79 65.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.266 0.484 . . . . 0.0 111.148 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' GLY . . . . . . . . . . . . . . . 99.74 14.44 34.54 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.61 178.68 7.8 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.788 0.794 . . . . 0.0 111.106 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' THR . . . . . . . . . . . . . 56.1 p -121.66 167.97 12.32 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.39 0.614 . . . . 0.0 111.329 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.84 -163.24 1.45 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.991 1.316 . . . . 0.0 107.755 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.03 156.34 38.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.07 146.53 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.577 0.703 . . . . 0.0 111.234 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -116.61 82.3 1.77 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 t -69.52 86.33 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.901 0.88 . . . . 0.0 111.219 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' B' ' 194' ' ' VAL . 12.7 tttt -71.08 169.32 15.24 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.02 -0.425 . . . . 0.0 110.869 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' VAL . . . . . 0.447 ' H ' ' HG2' ' B' ' 193' ' ' LYS . 5.5 p -62.01 -28.67 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.062 1.745 . . . . 0.0 115.246 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.439 ' CA ' HG23 ' B' ' 124' ' ' VAL . 26.6 t70 134.6 167.36 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.068 2.547 . . . . 0.0 109.067 -173.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.258 0 CA-C-O 117.224 -1.875 . . . . 0.0 111.521 175.362 . . . . . . . . 0 0 . 1 stop_ save_